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ABSTRACT 
 
The Mediterranean diet is a popular construct and already promoted by dietary guidelines 
as a healthy way to eat. It is also the most widely studied dietary pattern within nutrition 
science, having been associated with multiple health benefits for chronic disease. One of 
the least well researched areas, however, relates to brain health. Finding ways to prevent, 
slow or reverse cognitive decline has been identified as a priority for society and 
governments due to increasing rates of dementia within an ageing global population. 
Therefore, determining the effect of the Mediterranean diet on cognition and brain 
morphology and function, particularly for at-risk groups, is considered of paramount 
importance. However, there are inconsistencies in the definition of the Mediterranean 
diet, and these have impeded comparisons across trials.  
 
The terminology for the Mediterranean diet came into existence after the Seven Countries 
Study conducted in the late 1950s and early 1960s. It therefore referred to the ‘traditional’ 
Mediterranean cuisine during that time period. Yet over the last 50 years the term 
‘Mediterranean diet’ has been loosely used, often without specificity to the archetypal 
diet. Hence, Mediterranean diet interventions and adherence tools have variably 
represented the ‘traditional’ dietary pattern. In addition, no adherence tool exists that has 
been specifically developed and validated for online and in-person use to assess 
adherence to the ‘traditional’ Mediterranean dietary pattern and aspects of cuisine within 
at-risk Western cohorts, including individuals diagnosed with mild cognitive impairment 
(MCI). 
 
To address these gaps, this thesis had four specific aims. First, to empirically describe the 
‘traditional’ Mediterranean cuisine, improving its understanding within the literature. 
Second, to systematically investigate and synthesise findings from existing clinical trials 
using a Mediterranean diet intervention for cognition and brain morphology or function 
outcomes, and inform future research requirements. A particular focus of this review was 
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on the quality of interventions used and how they related to the ‘traditional’ dietary 
pattern, in terms of types and quantities of prescribed foods. Third, to develop a new diet 
index tool to assess, more broadly, adherence to the ‘traditional’ Mediterranean dietary 
pattern and aspects of cuisine for use within Western cohorts. Fourth, to test the reliability 
and validity of this tool for online administration to healthy Australians [based on n=84 
from the Maintain Your Brain (MYB) validity study cohort] and in-person use among 
individuals from the same country diagnosed with MCI [based on n=68 from the Study 
of Mental and Resistance Training (SMART) cohort]. The goal of the discussion chapter 
was to sum up the thesis findings and discuss their implications, and delineate remaining 
research gaps to progress the field. 
 
For the first aim, a narrative review was conducted investigating the evolution of the 
Mediterranean diet and cuisine from ancient to modern time periods (see Chapter Two). 
This review identified some additional concepts from the ‘traditional’ cuisine, which have 
previously been poorly captured, overlooked or not fully examined, but which may be 
potentially important and influence health outcomes. It also found that popular 
Mediterranean diet index tools rarely assess such elements. To address the second aim, a 
pre-defined protocol was developed and the first systematic review exclusively of 
randomised controlled trials was conducted on the effect of a Mediterranean diet on 
cognition and brain morphology and function (see Chapter Three). This review 
established that previous interventions varied considerably and did not necessarily 
represent the ‘traditional’ diet and cuisine. Overall, the results showed no benefit for a 
Mediterranean diet intervention, with mostly non-significant and small effect sizes for 
cognition, and no evidence for brain morphology or connectivity outcomes across the 
limited experimental evidence. However, in the most robustly-designed trial, which also 
included a more ‘traditional’ intervention, there was evidence for attenuation of cognitive 
decline over four years of ageing compared to a lower fat diet, with significant effect sizes 
for three domain composite scores representing Memory, Frontal and Global function. 
This finding persisted with the recent corrections within the original paper for a sub-
cohort of this study. Hence, promising clinical evidence exists to support that a more 
‘traditional’ Mediterranean diet may slow progression of cognitive decline in older adults 
with cardiovascular risk factors. To achieve the third aim, a new Mediterranean diet index 
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tool was developed (see Chapter Four). This was informed by earlier findings described 
in Chapter Two and the reported limitations of existing tools, which may be reducing 
their ability to consistently predict health outcomes. The tool, named Mediterranean Diet 
and Culinary Index (MediCul), is in the form of a survey. Scoring is from 0 to 100, with 
higher scores indicating greater adherence to the ‘traditional’ Mediterranean dietary 
pattern. MediCul includes both elements and cut-off points based on the ‘traditional’ 
Mediterranean diet and cuisine. It takes approximately 20 minutes to complete, and is 
therefore less onerous than a typical food frequency questionnaire, but more 
comprehensive than a short screener. Importantly, MediCul assesses exposure to 
discretionary foods that contribute significantly to energy intakes within Western 
countries. It also enables indirect derivation of a score for the popular Spanish 
Mediterranean Diet Adherence Screener (MEDAS), increasing its potential future utility. 
The fourth aim was met in Chapters Five and Six, which have reported on the reliability 
and validity testing of MediCul for use online and in-person with middle-aged and older 
Australians, including individuals diagnosed with MCI. Taken together, these Chapters 
are in agreement that MediCul is a highly reliable tool, based on intra-class correlation 
coefficients (ICC) (ICC=0.86, 95% CI: 0.789, 0.910 and ICC=0.93, 95% CI: 0.884, 
0.954, respectively, p<0.0001). MediCul also has moderate validity according to Bland-
Altman plots with the tool overestimating the MediCul score by 6% in both studies 
compared to a food record reference method. MediCul can therefore be used in future 
research to assess adherence to the ‘traditional’ Mediterranean dietary pattern and aspects 
of cuisine in middle-aged and older Australians who are at risk of cognitive decline.  
 
While various nutrients, foods and plant-based dietary patterns may benefit health and 
slow cognitive decline, most evidence exists to support the Mediterranean diet. This diet 
has been identified as being of particular significance for older people and an ageing 
population, such as in Australia, since the confirmed benefits for the Mediterranean diet 
are relevant to key areas of morbidity and survival. Unfortunately, most Australians 
consume a poor quality Western diet according to the Australian Institute of Health and 
Welfare, and Western diets are associated with increased risk of cognitive decline and 
dementia. The Westernised nature of Australian diets was supported by the cohorts 
studied within this thesis. These cohorts had moderately low MediCul scores [MYB 
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cohort: 55.2/100.0 (11.6); SMART cohort: 54.6/100.0 (13.0)] and derived MEDAS scores 
[MYB cohort: 6.5/14.0 (1.7); SMART cohort: 6.1/14.0 (2.2)], indicating poor adherence 
with a Mediterranean dietary pattern. Yet such individuals may benefit most by adopting 
more of a Mediterranean diet, due to their existing risk factors and/or age.  
 
As there is no pharmacologic prevention or cure for dementia, robust trials are urgently 
required to test whether a healthy diet and lifestyle can slow the rate and severity of 
cognitive decline, both within normal ageing and for neurodegenerative disease. Trials 
are warranted specifically on the ‘traditional’ Mediterranean diet as an intervention, 
which may be combined with other lifestyle modalities. Future trials should fully describe 
their interventions so they can be replicated. They should also use a validated diet index 
tool to assess adherence to the ‘traditional’ Mediterranean dietary pattern.  
 
In conclusion, promotion of lifestyle interventions to slow progression of cognitive 
decline in at-risk groups is critical. Additional well-designed trials on the relationship of 
the ‘traditional’ Mediterranean diet with cognitive health and other outcomes are 
warranted. This thesis has improved understanding of the ‘traditional’ Mediterranean 
cuisine, underpinning the development of a new diet index tool called MediCul to assess 
adherence to this pattern and provide greater discernment with other plant-based dietary 
patterns. MediCul has been tested in two Western cohorts at increased dementia risk, for 
online and in-person administration, and shown to be suitable for use. This new tool is 
now available for download from the Supplementary Materials in the British Journal of 
Nutrition where it was published, for researchers and educators globally. Availability of 
validated tools such as MediCul may advance understanding of the role of diet in healthy 
brain ageing. 
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OUTLINE OF THESIS 
This thesis is organised into seven chapters, with material submitted and published in 
peer-reviewed journals during the time of candidature. 
Chapter One is an introduction to the thesis. It provides on overview of the significant 
issues identified within the thesis, the research gaps and specific aims to be addressed 
within the remaining chapters. 
Chapter Two presents a literature review describing the evolution of Mediterranean diets 
and cuisine. It defines the ‘traditional’ diet using empirical data and identifies key 
concepts from this time period, frequently lacking in existing Mediterranean diet 
adherence tools. This work has been published in the Asia Pacific Journal of Clinical 
Nutrition. 
Chapter Three presents a systematic review of randomised controlled trials on the effect 
of the Mediterranean diet on cognition and brain morphology. It includes a focus on how 
previous interventions have reflected the ‘traditional’ dietary pattern and makes detailed 
recommendations to assist future research. This work has been published in the American 
Journal of Clinical Nutrition.  
Chapter Four details the development of a new diet index tool to assess adherence to the 
‘traditional’ Mediterranean dietary pattern and aspects of cuisine within Western 
populations. This tool has overcome common limitations of existing tools and 
incorporates additional features to increase its potential future utility.  
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Chapter Five presents the findings for the reliability and validity testing of the new index 
tool when administered online to healthy middle aged and older Australians. This work 
has been published in the journal Nutrients. 
 
Chapter Six presents the findings for the reliability and validity testing of the new index 
tool when administered in-person to older Australians diagnosed with mild cognitive 
impairment, who are known to be at increased dementia risk. This work has been 
published in the British Journal of Nutrition.  
 
Chapter Seven discusses the key findings from Chapters Two to Six and strengths and 
limitations of the thesis. It delineates remaining gaps in the evidence base and highlights 
implications of the contributed knowledge from this thesis for future research, public 
health and clinical practice. 
 
Each chapter includes its own reference list and any Supplementary Materials published 
for that chapter.  
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CHAPTER ONE 
Introduction
1
1.1 Popularity and promotion of the Mediterranean diet 
The Mediterranean diet has become increasingly popular in both the scientific and lay 
literature. It was ranked the ‘best diet’ for 2019 by a panel of experts (US News and World 
Report, 2019) and is already being promoted by health authorities around the world. For 
example, the Australian and US dietary guidelines recommend the Mediterranean diet as 
a healthy eating pattern (National Health and Medical Research Council, 2013; US 
Department of Health and Human Services and US Department of Agriculture, 2015) as 
does the UK National Health Service (NHS, 2017). Various Mediterranean diet 
guidelines and pyramids exist for use in nutrition education (Bach-Faig et al., 2011; 
Fidanza & Alberti, 2005; Ministry of Health and Welfare: Supreme Scientific Health 
Council, 1999; Oldways, 2008; Willett et al., 1995). In Australia, the Royal Australian 
College of General Practitioners recommends a Mediterranean diet for primary and 
secondary prevention of cardiovascular events (National Health and Medical Research 
Council level 1 evidence) as part of their online Handbook of Non-Drug Interventions 
(HANDI) (The Royal Australian College of General Practitioners, 2014). Most recently, 
a Mediterranean-like diet is being promoted by the World Health Organization (WHO) 
for risk reduction of cognitive decline and dementia (World Health Organization, 2019). 
 
1.1.1 Protection by UNESCO 
This gastronomic eating pattern with intense colours and flavours is also the only diet in 
the world protected by UNESCO (United Nations Educational Scientific and Cultural 
Organization, 2010) to safeguard its ‘traditional’ aspects, which are increasingly being 
abandoned in Mediterranean countries (De Lorenzo et al., 2001; Hatzis et al., 2013). In 
2010, UNESCO first recognised the Mediterranean diet as an ‘Intangible Cultural 
Heritage’ for safeguarding within Spain, Greece, Italy and Morocco. In 2013, this was 
extended to also include the countries of Croatia, Cyprus and Portugal (United Nations 
Educational Scientific and Cultural Organization, 2013). Further, this diet is the most 
extensively researched diet worldwide (Scarmeas, Anastasiou, & Yannakoulia, 2018). 
Interestingly, a large number of studies on the Mediterranean diet, investigating various 
outcomes, have been conducted outside the Mediterranean region (Bonaccio et al., 2018), 
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and span countries ranging from Sweden (Sjögren et al., 2010) and China (Woo et al., 
2001) to the US (Fung et al., 2009) and Australia (Itsiopoulos et al., 2011). 
 
1.1.2 Opportunity for healthier ageing 
Adopting the Mediterranean diet could benefit wellbeing and promote healthier ageing 
by reducing the risk of, and better managing, chronic disease especially among middle-
aged and older adults where health problems become evident and progressively increase. 
Improved metabolic health with ageing may also be effective for brain health (Wahl et 
al., 2019). Healthy ageing is a priority area for governments as there is rapid global 
population growth (Roser & Ortiz-Ospina, 2018) with shifts towards larger proportions 
of older adults, particularly in Western countries (Bongaarts, 2009). The United Nations 
recently projected that people aged 60 and older will outnumber children in 2047 (United 
Nations Department of Economic and Social Affairs Population Division, 2013). Hence, 
ageing is not just a biological process but a public policy issue with economic and societal 
impacts (Kennedy et al., 2014). To help promote healthy ageing, including for the brain, 
the UK National Institute for Health and Care Excellence guidelines on mid-life 
approaches to prevent or delay onset of dementia, disability and frailty (National Institute 
for Health and Care Excellence, 2015) recommend a diet mainly based on vegetables, 
fruits, beans and pulses, wholegrains and fish. These food groups represent key elements 
of healthy plant-based diets, including those rooted in ‘traditional’ culture, such as the 
Mediterranean diet. 
 
1.2 Health benefits for chronic disease 
Although the Mediterranean diet was not widely recognised until the 1990s (de Lorgeril, 
2013) mounting evidence now exists that eating the Mediterranean way may provide a 
range of benefits to target risk factors, as well as existing chronic disease, thereby 
promoting healthier ageing. However, this evidence is primarily, but not exclusively, 
from observational studies with the highest level of evidence i.e., clinical, available for 
cardiovascular disease (Martínez-González, Gea, & Ruiz-Canela, 2019). The areas of 
research relevant to chronic disease prevention and management include the following:  
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• body weight/obesity (Buckland, Bach, & Serra‐Majem, 2008; Estruch et al., 2016; 
Martínez-González et al., 2012; Panagiotakos, Chrysohoou, Pitsavos, & 
Stefanadis, 2006);  
• cancer (Li et al., 2018; Sofi, Cesari, Abbate, Gensini, & Casini, 2008; Sofi, 
Macchi, Abbate, Gensini, & Casini, 2014; Toledo et al., 2015);  
• cardiovascular disease (CVD) (Davis et al., 2017; de Lorgeril et al., 1994; Estruch 
et al., 2018; Grosso et al., 2017);  
• dementia and mild cognitive impairment (Alonso et al., 2009; Psaltopoulou et al., 
2013; Singh et al., 2014; Sofi et al., 2008);  
• gallstones (Barré, Gusto, Cadeau, Carbonnel, & Boutron-Ruault, 2017);  
• hip fracture (Benetou et al., 2013; Benetou et al., 2018);  
• kidney disease (Huang et al., 2013; Khatri et al., 2014);  
• macular degeneration (Hogg et al., 2016; Merle, Silver, Rosner, & Seddon, 2015);  
• mental health, including quality of life (Bonaccio et al., 2013; Govindaraju, Sahle, 
McCaffrey, McNeil, & Owen, 2018; Henríquez Sánchez et al., 2012) and 
depression (Jacka et al., 2017; Lassale et al., 2018; Parletta et al., 2017);  
• metabolic syndrome (Kastorini et al., 2011);  
• mortality risk (Sofi et al., 2014; Trichopoulou, Costacou, Bamia, & Trichopoulos, 
2003), including in the elderly (Bonaccio et al., 2018; Kouris-Blazos & 
Itsiopoulos, 2014); 
• non-alcoholic fatty liver disease (Cueto-Galán et al., 2017; Kontogianni et al., 
2014; Papamiltiadous et al., 2016; Ryan et al., 2013);  
• osteoarthritis (Veronese et al., 2017; Veronese et al., 2018);  
• Parkinson’s disease (PD) (Psaltopoulou et al., 2013; Sofi et al., 2008) and 
prodromal PD (Maraki et al., 2019);   
• physical function (Struijk, Guallar-Castillón, Rodríguez-Artalejo, & López-
García, 2018) and frailty (Kojima, Avgerinou, Iliffe, & Walters, 2018);  
• telomere length (Boccardi et al., 2013; Crous-Bou et al., 2014);  
• the microbiome (De Filippis et al., 2016; Shively et al., 2018);  
• type 2 diabetes (Davies et al., 2018; Esposito et al., 2015; Itsiopoulos et al., 2011; 
Salas-Salvadó et al., 2014). 
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Various metabolic and molecular mechanisms have been proposed whereby particular 
nutrients, foods, the dietary pattern and cuisine aspects (e.g., food combinations, fasting, 
infrequent snacking) of the Mediterranean diet, as well as the synergies afforded (Jacobs 
& Tapsell, 2013), may influence multiple chronic diseases. These include lipid lowering 
effects; reduced oxidative stress, chronic systemic inflammation and platelet aggregation; 
as well as modification of hormones,  growth factors, and nutrient sensing pathways via 
the microbiome (Tosti, Bertozzi, & Fontana, 2017), which are discussed more fully in 
Chapter Three. 
 
1.2.1 Cognition, brain morphology and function 
Most recently, interest has increased in healthy brain ageing and research is focussing on 
how the Mediterranean diet may influence cognition (Valls-Pedret et al., 2015), as well 
as brain morphology and function (Luciano et al., 2017; Pelletier et al., 2015) (see Chapter 
Three). This is imperative since pathological changes in the brain such as amyloid plaques 
and neurofibrillary tangles start appearing several decades before the onset of any clinical 
symptoms (Sperling et al., 2011). Interestingly, the ageing process and dementia share 
common characteristics at the cellular, molecular and system levels (Xia, Jiang, 
McDermott, & Han, 2018). A spectrum has therefore been proposed that links normal 
brain ageing and dementia, as the hallmarks of ageing are also present in dementia e.g., 
reduced DNA repair, abnormal neuronal activity and neuroinflammation (Wahl et al., 
2019). However, while minor cognitive changes are common during normal brain ageing 
(Fletcher et al., 2018), dementia is progressive and influences function across various 
domains e.g., multiple domains of cognition, neuropsychiatric symptoms, activities of 
daily living (Livingston et al., 2017) and the degree of neuropathology, rather than 
specific pathological features, often differentiates normal brain ageing from dementia 
(Anderton, 1997). Successful interventions for cognitive decline may therefore be 
beneficial to both ends of this spectrum – normal brain ageing and dementia. In one 
longitudinal brain imaging study of cognitively normal people aged 30 to 60 years, higher 
adherence to a Mediterranean diet was associated with less beta-amyloid and a slower 
decline in brain metabolism over a three-year period. The authors of this study estimated 
5
that high Mediterranean diet adherence may provide 1.5 to 3.5 years of protection against 
Alzheimer’s Disease (AD), the most common type of dementia (Berti et al., 2018).  
According to the Academy of Nutrition and Dietetics, “the total diet or overall pattern of 
food eaten is the most important focus of healthy eating” (Freeland-Graves & Nitzke, 
2013). Although the study of individual nutrients remains relevant (Wahl et al., 2018), 
nutrition science is moving away from a reductionist model (Fardet & Rock, 2014; Rutjes 
et al., 2018). The greatest evidence for cognitive benefits exists for dietary patterns that 
represent a ‘whole of diet approach’, which can also capture synergies between dietary 
elements. There is currently more evidence to support a Mediterranean dietary pattern 
than any other, such as patterns based on the Dietary Approaches to Stop Hypertension 
(DASH), Mediterranean-Dietary Approaches to Stop Hypertension (MIND) or the Nordic 
diet (Scarmeas et al., 2018). Hence, the Mediterranean diet is being increasingly studied, 
including within Australia (Hardman, Kennedy, Macpherson, Scholey, & Pipingas, 2015; 
McMaster et al., 2018; Wade et al., 2017) in an attempt to find ways to prevent or slow 
cognitive decline due to the significant burden of dementia (Livingston et al., 2017). 
1.2.1.1 Burden of dementia 
Dementia has been identified as the greatest challenge globally for health and social care 
in the 21st century (Livingston et al., 2017), with one new case being diagnosed every 3
seconds and a projected prevalence of 75 million by 2030 (Prince et al., 2015). In 
Australia, dementia is the second cause of death overall (Australian Institute of Health 
and Welfare, 2012) but the leading cause in women (Australian Institute of Health and 
Welfare, 2018). It is also the second most feared disease after cancer, among the general 
public (Pfizer, 2011). In terms of disability burden, which affects quality of life, dementia 
is the foremost contributor among Australians aged 65 years and older (Australian 
Institute of Health and Welfare, 2012). Hence, effective preventive measures and 
interventions are urgently required.
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1.2.1.2 Limits of existing medical treatment 
Despite the alarming trends and likely future healthcare costs, there is currently no 
medication that can successfully modify the course of cognitive decline towards dementia 
(Cooper, Li, Lyketsos, & Livingston, 2013). Development of dementia drugs has proven 
to be very difficult, with few candidates and frequent failures (Cummings, Morstorf, & 
Zhong, 2014). For example, during the 2002 to 2012 period, there was a very high attrition 
rate for compounds tested in drug trials, with only 0.4% success rate (99.6% failure rate) 
for progression to regulatory review (Cummings et al., 2014). This rate of success is 
among the lowest found in any therapeutic area. The success rate for development of 
cancer drugs, for example, is 19% (Tufts Center for the Study of Drug Development, 
2013). Due to disappointing pharmaceutical research results in the dementia field, one 
major company recently announced they are pulling out of neuroscience research 
(Hawkes, 2018).  
 
At best, existing medications may temporarily improve memory or behaviour by 
stabilising cognition and neuropsychiatric symptoms such as agitation, sleep and apathy, 
in a minority of individuals. However, their use is also associated with undesirable side 
effects (Buckley & Salpeter, 2015) and these medications do not improve long-term 
prognosis or survival (Casey, Antimisiaris, & O’Brien, 2010). 
  
Therefore, finding new ways to prevent, slow and potentially reverse cognitive decline 
towards dementia is a high priority for society and governments (Australian Institute of 
Health and Welfare, 2012). For AD alone, if interventions could delay or slow its 
progression by just one year there would be 9 million fewer cases in 2050, according to 
estimates (Brookmeyer, Johnson, Ziegler-Graham, & Arrighi, 2007). Yet current 
approximations suggest there are nearly eight times as many people who have pre-clinical 
AD (amyloidosis, neurodegeneration or both without overt symptoms) as those with 
clinical AD and mild cognitive impairment (MCI) (Brookmeyer, Abdalla, Kawas, & 
Corrada, 2018). Thus, dementia statistics under-represent the extent of the problem and 
are akin to the ‘tip of an iceberg’, due to the known trajectory of the underlying disease 
pathology. 
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1.2.1.3 Dementia risk factors 
Lifestyle has been identified as a modifiable risk factor for cognitive decline and 
dementia. Healthy lifestyle indicators, such as good quality sleep (Sexton, Storsve, 
Walhovd, Johansen-Berg, & Fjell, 2014) and a clear purpose in life (Ryff, Heller, 
Schaefer, van Reekum, & Davidson, 2016), have positive effects on brain health and 
ageing. Sedentary behaviour on the otherhand, which includes both screen time and total 
sitting time, is associated with increased mortality risk (Stamatakis et al., 2015) and lower 
cognitive performance over the lifespan (Falck, Davis, & Liu-Ambrose, 2017). A healthy 
diet contributes significantly to a healthy lifestyle and is already known to reduce the risk 
of stroke (Rutten-Jacobs et al., 2018), a condition associated with doubling the risk of 
dementia (Kuźma et al., 2018). Lifestyle interventions are appealing as potential 
prevention modalities for dementia as they can influence risk factors (Peters et al., 2019) 
and medical conditions through multiple pathways. Genes are thought to play a much 
smaller role (Livingston et al., 2017).  
Presently, nine specific risk factors amenable to lifestyle change are estimated to 
collectively contribute to 35% of dementia cases (Livingston et al., 2017) (see Table 1.1). 
It is known that diet can significantly modulate at least four of these risk factors, namely 
hypertension, obesity, depression and diabetes. Urgent, well-designed, clinical trials are 
therefore required to test the effect of healthy diets on cognition, brain morphology and 
function, including the ‘traditional’ Mediterranean diet.  
However, there is inconsistency in the definition of the Mediterranean diet (see Chapter 
Two) influencing the quality of the interventions used in clinical trials (Villani, Sultana, 
Doecke, & Mantzioris, 2018). Consequently, experts in the field have recognised that “the 
very definition of a Mediterranean dietary pattern is not a minor issue” (Martínez-
González & Sánchez-Villegas, 2004). Further, there is substantial heterogeneity in the 
tools and scoring cut-off points used to measure adherence to a Mediterranean dietary 
pattern, and these tools do not necessarily reflect the ‘traditional’ cuisine (see Chapter 
Four). This is impeding comparison of data across studies (Galbete, Schwingshackl, 
Schwedhelm, Boeing, & Schulze, 2018).   
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Table 1.1.  Modifiable risk factors for dementia, which in combination contribute to 
approximately 35% of dementia cases (Livingston et al., 2017) 
 Risk factor 
1 No education beyond age 11-12 years or primary school only 
2 mid-life hypertension 
3 mid-life obesity 
4 hearing loss 
5 late-life depression 
6 diabetes 
7 physical inactivity 
8 smoking 
9 social isolation 
 
1.3 Measurement of Mediterranean diet adherence  
The ‘traditional’ Mediterranean diet within the literature represents the diets consumed in 
Southern Italy and Crete, Greece, in the late 1950s and early 1960s at the time of the 
Seven Countries Study (SCS) (see Chapter Two). Indeed, the ‘Mediterranean diet’ 
terminology in common use today was introduced as a result of the SCS (Hatzis, Sifaki-
Pistolla, & Kafatos, 2015). Yet no previous studies have fully examined the effects of this 
‘traditional’ Mediterranean diet (Trichopoulou et al., 2014), except for an Australian trial 
of people with type 2 diabetes, which utilised a fully reconstructed ‘traditional’ Cretan 
Mediterranean diet (Itsiopoulos et al., 2011). This archetypal ‘traditional’ diet may share 
similarities and also vary somewhat with diets from other Mediterranean countries during 
traditional and other times. Accurate measurement of adherence to the ‘traditional’ 
Mediterranean dietary pattern, including aspects of cuisine, would help progress the field. 
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1.3.1 Options for dietary assessment methods 
Various options exist to assess adherence to a given diet or dietary pattern. The best 
method will depend on the purpose of study and degree of accuracy and precision required 
(Tapsell, Flood, Probst, Charlton, & Williams, 2013) and international guides are 
available to facilitate appropriate choice (NHS National Institute for Health Research and 
Medical Research Council, n.d.; NIH National Cancer Institute, n.d.). While food 
frequency questionnaires (FFQs) retrospectively assess usual diet (Thompson & Subar, 
2017), they can be burdensome for participants since they typically include between 100 
and 350 elements (Cade, Thompson, Burley, & Warm, 2002; Calfas, Zabinski, & Rupp, 
2000). They also usually lack cuisine details, such as cooking methods and snacking 
habits. Food records (FR) prospectively assess actual intake (estimated or weighed) and 
can be used to determine dietary patterns but their data relates to a limited number of 
days, which may not represent usual diet depending on the days selected, chosen meals 
while recording and recording skills of participants (Thompson & Subar, 2017). Food 
records are also known to increase both participant and researcher burden and they may 
introduce optimistic biases (Miles & Scaife, 2003) and social desirability bias (Hebert, 
Clemow, Pbert, Ockene, & Ockene, 1995). Hence, FRs are utilised more in clinical trials 
rather than observational studies, and within cohorts that are motivated and literate. The 
24-hour dietary recall method may be less burdensome for participants but it also only 
provides a snapshot of food intake from the previous day. Therefore, multiple recalls are 
usually undertaken and this method is mostly used within research to assess the diet of a 
population (Thompson & Subar, 2017).  
 
In recent times, Short Question Surveys have become a popular way to derive an index 
or score for a Mediterranean dietary pattern (see Chapter Four). These tools are relatively 
simple to use and also have reduced burden for the researcher in terms of cost and 
analysis. They are developed using an a priori approach, with the included dietary 
elements usually informed by historical food intake data using a theoretical framework 
(Burggraf, Teuber, Brosig, & Meier, 2018). However, there are limitations of dietary 
patterns determined a priori, due to the subjectivity in selecting the elements for the index 
tool and defining their cut-off points. In contrast, dietary patterns can also be derived a 
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posteriori, using data from existing FFQs, FRs or 24-hour dietary recalls. In this instance, 
they are elicited through statistical methods that aggregate dietary elements into factors 
or clusters to reveal common underlying patterns e.g., Principal Component Analysis 
(PCA), K-Means (Newby & Tucker, 2004). However, these type of dietary patterns are 
often not reproducible since they are derived for a specific population (Burggraf et al., 
2018). They are also not immune from inherent subjectivity as the methods used and the 
treatment of variables can vary across studies affecting the number and types of patterns 
derived (Newby & Tucker, 2004). Therefore, for future studies of the ‘traditional’ 
Mediterranean dietary pattern and aspects of cuisine, the use of a priori scores derived 
directly from diet index tools may offer various advantages and better reflect the 
‘traditional’ Mediterranean diet (D'Alessandro & De Pergola, 2015). For example, when 
dietary indexes first started to gain momentum in research, an analysis of the famous 
Nurses’ Health Study found that the composite diet index score more strongly predicted 
risk of coronary heart disease in women than the major dietary patterns derived from 
factor analysis (Stampfer, Hu, Manson, Rimm, & Willett, 2000). 
 
1.3.2 Statistical analysis for reliability and validity 
Mediterranean diet index tools should be tested for reliability and validity. Reliability 
refers to the extent a tool provides the same/similar score when administered under similar 
circumstances whereas validity refers to whether the tool accurately measures what it is 
supposed to measure (Gleason, Harris, Sheean, Boushey, & Bruemmer, 2010). While 
different measures of reliability exist, test-retest reliability (within the same participant 
on two occasions) appears particularly important, and such analyses are currently lacking 
for most existing Mediterranean diet index tools (Zaragoza-Martí, Cabañero-Martínez, 
Hurtado-Sánchez, Laguna-Pérez, & Ferrer-Cascales, 2018). In the past, correlation 
coefficients, such as Pearson’s correlation coefficient used for continuous variables, were 
most frequently employed to describe the strength of the relationship between repeated 
measures from the same tool. However, since a high correlation does not necessarily mean 
good agreement, the Bland-Altman method was proposed more than 30 years ago as a 
more appropriate measure (Bland & Altman, 1986; Peat, 2001). Paired t-tests can be 
utilised to describe agreement between mean scores of two measures derived from the 
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same tool (Atkinson & Nevill, 1998; Margetts & Nelson, 1997). The intraclass correlation 
coefficient (ICC) is another useful test for reliability of a continuous score because it 
reflects both the degree of correlation and agreement between two measures (Koo & Li, 
2016). Cohen’s kappa coefficient can be a reliability indicator for comparing percent 
agreement between categorical variables, such as food groups, derived from a diet index 
score, as it summarises cross classification with repeated measures (Peat, 2001). 
 
With respect to the validity of a tool, different constructs have been tested in research, 
such as absolute validity (also known as criterion validity), content validity, convergent 
validity, discriminant validity, external validity, face validity, internal validity, predictive 
validity and relative validity (also known as concurrent validity) (Gleason et al., 2010). 
While the highest form is absolute validity, absolute or objective measures are lacking 
for many research areas, especially nutrition and total diets or dietary patterns (Margetts 
& Nelson, 1997; Streiner, Norman, & Cairney, 2015). Therefore, it is important that 
concurrent validity is established for a Mediterranean diet index tool, especially against 
a dietary reference method that is generally accepted as less biased and more accurate 
e.g., food record (Thompson & Subar, 2017). Convergent validity and discriminant 
validity are subtypes of concurrent validity that measure expected agreement or 
discrimination between a tool and other methods of assessment (Gleason et al., 2010). 
Face validity and content validity measure whether the tool captures the concept it is 
intending to measure and if it captures all the dimensions present in the concept, 
respectively. However, these are both subjective methods. The internal validity of a tool 
refers to how well the tool captures the intended concept among the population within 
which it was tested. External validity relates to whether the tool is valid for use across 
broader populations (Gleason et al., 2010) and this is simply described in text rather than 
measured using different statistical methods (Peat, 2001). Predictive validity refers to 
whether the tool can be associated with health and other outcomes in a predictive capacity 
(Panagiotakos, Pitsavos, Arvaniti, & Stefanadis, 2007).
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For validity testing of diet index tools, which are used in medical and health sciences 
research, the Bland-Altman method mentioned above is generally preferred as it enables 
a graphical presentation of how well two quantitative methods agree with each other 
(Bland & Altman, 1999; Margetts & Nelson, 1997). The difference in the scores derived 
from the two methods is plotted against the means of the scores, with limits of agreement 
(LOA) shown as two standard deviations above, and below, the mean difference. The 
mean difference tells the researcher if the new tool is tending to under or over-report the 
score compared to the reference method and is referred to as the bias. The LOA show 
where 95% of the values for the mean difference in scores would be expected to fall. 
Linear regression is also used to indicate the direction of the bias and whether this is 
constant across the mean scores of the two measures. However, while the Bland-Altman 
plot quantifies the difference between two methods it does not provide a single statistic 
to confirm or deny a tool is valid, requiring interpretation by the researcher as to whether 
acceptable agreement exists. Importantly, it can identify whether any disagreement 
appears to be systematic (e.g., all values of one tool higher or lower than another), or non-
systematic (e.g., degree of disagreement increases or decreases according to the absolute 
value of the construct in question). Indirect validity of a diet index tool can also be 
supported by analysis of expected Mediterranean nutrient trends (from the reference 
method) across quantiles of the tool score, using parametric or non-parametric tests, as 
required e.g., one-way ANOVA and Kruskal-Wallis, respectively. 
 
Finally, it is important to stress that all dietary assessment methods are subject to 
measurement error (Kant, 2004) and the use of various statistical tests can strengthen the 
reliability and validity findings for a given tool. To date, few Mediterranean diet index 
tools have fulfilled quality criteria for both test-retest reliability and concurrent validity 
(Zaragoza-Martí et al., 2018), especially against a dietary reference method (see Chapter 
Four and Appendix Five). The available tools also have additional limitations with respect 
to the measurement of adherence to the actual ‘traditional’ Mediterranean dietary pattern. 
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1.3.3 Limitations of existing Mediterranean diet index tools 
Heterogeneity exists among the currently available Mediterranean diet index tools with 
respect to the elements assessed, cut-off points used and the points awarded for scoring 
(see Chapter Four), limiting data synthesis and meta-analyses (Li et al., 2018). Most 
studies reporting health outcomes have used the Mediterranean Diet Score (MDS), which 
was originally developed and revised for a Greek population (Trichopoulou et al., 1995; 
Trichopoulou et al., 2003). While the elements in this tool were based on the ‘traditional’ 
diet, the cut-off points for scoring related to medians of this Mediterranean population. 
Medians in other populations, especially from Western countries, may not reflect 
‘traditional’ Mediterranean intakes. 
 
Furthermore, most available tools do not attempt to measure various aspects of cuisine, 
some of which are uniquely Mediterranean and may also contribute to health outcomes. 
These aspects include characterising foods (e.g., extra virgin olive oil (EVOO)), food 
combinations (e.g., sofrito, a tomato, onion/garlic and EVOO based sauce used as a base 
for many savoury dishes) and drinks (i.e., pure water); the lower temperature, moist, 
cooking methods traditionally used; and various habits related to eating (e.g., infrequent 
snacking occasions).  
 
It is also of considerable concern that relatively few Mediterranean diet index tools 
(Hebestreit et al., 2017; Schroder et al., 2011; Sotos-Prieto et al., 2015) have been 
validated against a reference dietary method, particularly one that is not limited by the 
same recall bias as the tool being tested, such as a food record mentioned above. In 
addition, most Mediterranean diet scores reported have been indirectly derived from a 
food frequency questionnaire (FFQ) containing the required information for scoring, 
which also may or may not have been validated (see Chapter Four). However, 
repeatability coefficients are higher for a Mediterranean diet score calculated directly by 
administering the index tool itself (Bountziouka et al., 2012). Hence, existing tools have 
various limitations and do not necessarily measure adherence to the ‘traditional’ 
Mediterranean dietary pattern and aspects of cuisine.
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1.3.4 Discernment for the ‘traditional’ diet 
The ‘traditional’ Mediterranean dietary pattern should be discernible from other dietary 
patterns. However, most reported Mediterranean diet scores may simply be reflecting 
adherence to a more prudent, plant-based dietary pattern or measuring adherence to 
different types of Mediterranean diets, including modernised ones. For example, in an 
analysis of data from the Nurses’ Health Study II, increased adherence to three healthful 
dietary patterns, including the Mediterranean diet and the DASH diet, has been associated 
with a lower risk of hearing loss (Curhan, Wang, Eavey, Stampfer, & Curhan, 2018). 
Similarly, in another prospective study, high adherence to either the Mediterranean diet 
or MIND diet (a hybrid of the Mediterranean and DASH diets) was associated with 
reduced risk of incident AD (Morris et al., 2015). While overall diet quality may be most 
important, and explain the association of multiple healthy dietary patterns with improved 
health outcomes, greater discernment is required for the ‘traditional’ Mediterranean 
dietary pattern if studies are to claim this as their intervention or the dietary pattern 
followed. 
 
Therefore, future research studying the effects of the ‘traditional’ Mediterranean diet 
requires a robust tool that includes both elements and scoring cut-off points determined a 
priori, based on empirical data. Such a tool should also be validated for use in Western 
populations, including consideration of the method for tool administration. 
 
1.4 Gaps in research 
With respect to the intent of this thesis, there is limited clinical research considering the 
effect of a Mediterranean diet on cognition or brain morphology and function. While 
systematic reviews on observational studies are plentiful, prior to research conducted in 
this thesis there was no systematic review focussed exclusively on clinical trials, which 
also included a focus on the quality of interventions and how these relate to the 
‘traditional’ dietary pattern and aspects of cuisine (see Chapter Three). 
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Further, no publicly available tool has been specifically developed for, nor validated 
within, individuals at higher risk of cognitive decline, such as those diagnosed with MCI 
(see Chapter Six). Mild cognitive impairment may be a window of opportunity for 
interventions that might benefit the lives of carers, families and sufferers, since 
approximately 12% of people with MCI convert to AD per year, compared to an annual 
conversion rate of 1-2% in the general population (Petersen et al., 1999).  
 
Finally, no Mediterranean diet adherence tool has been validated for use in an Australian 
population (representing a Western cohort), for online (see Chapter Five) and in-person 
(see Chapter Six) administration, which could broaden its utility for observational and 
clinical trials with potential cost savings to research budgets, as well as allowing it to be 
used in national and international population-based studies and surveys.  
 
Addressing these gaps is a research priority as the ‘traditional’ Mediterranean diet holds 
promise to promote health (including brain health) and simultaneously reduce the risk of 
multiple chronic diseases, which increase with ageing. It is also a sustainable eating 
pattern, which is an important consideration for feeding the planet in the future (Dernini 
& Berry, 2015; Willett et al., 2019). 
 
1.5 Thesis aims 
The health benefits of the Mediterranean diet continue to be established, especially in the 
area of cognitive health. However, the existing definitions and measurement tools miss 
important ‘traditional’ cuisine elements, which could be incorporated into valid and 
reliable instruments for use in future clinical and observational studies. Therefore, it was 
hypothesised that a new measurement tool of Mediterranean diet and cuisine could be 
developed, drawing on the literature and dietary assessment methodology, and that the 
new tool would be able to be validated and tested for reliability among populations at risk 
of cognitive decline, suggesting a potential use for future clinical and observational 
studies.   
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Hence, the specific aims of this thesis were to: 
1. Define the ‘traditional’ Mediterranean diet and cuisine from empirical data (see 
Chapter Two);  
2. Investigate the relationship in clinical trials between a Mediterranean diet and 
cognition and brain morphology and function with a particular focus on the quality 
of interventions used and how they relate to the ‘traditional’ dietary pattern (see 
Chapter Three); 
3. Develop a new Mediterranean diet index tool to assess adherence to the 
‘traditional’ dietary pattern and aspects of cuisine, suitable for use within Western 
populations (see Chapter Four); 
4. Test the reliability and validity of the new Mediterranean diet index tool, a) 
administered online to middle aged and older people with risk factors for cognitive 
decline, but no current diagnosis of dementia or neurodegenerative disease (see 
Chapter Five), and b) administered in-person to older individuals diagnosed with 
MCI (see Chapter Six). 
 
The goal of the final chapter of this thesis (see Chapter Seven) was to sum up the thesis 
findings and discuss their implications, and to delineate remaining research gaps.
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CHAPTER TWO 
 
Evolution of Mediterranean diets and cuisine:  
Concepts and definitions 
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PREFACE 
 
The usefulness of studies on the Mediterranean diet is dependent on a clear understanding 
of its definition. However, there is confusion with various definitions used in 
interventions, pyramids and diet index tools, which do not all reflect the archetypal diet. 
This is impeding the quality, consistency and synthesis across trials. An improved 
understanding of the concepts and cuisine is important to assess how well previous 
interventions have reflected the ‘traditional’ dietary pattern, and to inform future research 
design and education initiatives. It is also required to adapt existing, or develop new, diet 
index tools to better capture this unique dietary pattern. 
 
The aim of this chapter was to improve understanding of the ‘traditional’ Mediterranean 
cuisine and related eating habits and to identify any additional elements previously 
omitted or poorly studied, which may impact on health outcomes. To this end, a narrative 
review was selected as the preferred methodology, since it provides a broad scope to 
capture historical data and consolidate previous work. 
 
This chapter was published in the Asia Pacific Journal of Clinical Nutrition. It includes 
the peer-reviewed version of the final form of the following article: 
• Radd-Vagenas, S., Kouris-Blazos, A., Fiatarone Singh, M., & Flood, V. M. 
(2017). Evolution of Mediterranean diets and cuisine: Concepts and definitions. 
Asia Pacific Journal of Clinical Nutrition, 26(5), 749-763. 
doi:10.6133/apjcn.082016.06 
 
The published article may be used for non-commercial purposes in accordance with 
Wiley Terms and Conditions for Use of Self-Archived Versions. 
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Background and Objectives: The Mediterranean diet has been demonstrated to provide a range of health bene-
fits in observational and clinical trials and adopted by various dietary guidelines. However, a broad range of defi-
nitions exist impeding synthesis across trials. This review aims to provide a historical description of Mediterrane-
an diets, from the ancient to the modern, to inform future educational and diet index tool development represent-
ing the ‘traditional’ Mediterranean diet. Methods and Study Design: Nine databases were searched from incep-
tion to July 2015 to identify papers defining the Mediterranean diet.  The definition accepted by the United Na-
tions Educational, Scientific and Cultural Organization (UNESCO) was also reviewed. Results: The ‘traditional’ 
Mediterranean diet is described as high in unprocessed plant foods (grains, vegetables, fruits, legumes, nuts/seeds 
and extra virgin olive oil), moderate in fish/shellfish and wine and low in meat, dairy, eggs, animal fats and dis-
cretionary foods. Additional elements relating to cuisine and eating habits identified in this review include fre-
quent intake of home cooked meals; use of moist, lower temperature, cooking methods; eating main meals in 
company; reduced snacking occasions; fasting practice; ownership of a vegetable garden; use of traditional foods 
and combinations; and napping after the midday meal. Conclusions: Scope exists for future tools to incorporate 
additional elements of the ‘traditional’ Mediterranean diet to improve the quality, consistency, and synthesis of 
ongoing research on the Mediterranean diet. 
 
Key Words: Mediterranean diet, plant based diet, traditional foods, diet pattern, diet index 
 
 
 
INTRODUCTION 
The Mediterranean diet has been associated with multiple 
health benefits and increased survival.1-7 However, this 
diet has proven difficult to define in the literature as it is 
surprisingly complex and varies between countries and 
time periods. Variations exist in definitions provided by 
educational materials such as Mediterranean diet pyra-
mids and dietary guidelines used by educators and health 
professionals when dealing with the general public.8-11 
Disparities also occur in the criteria, cut offs and scoring 
systems selected by common Mediterranean diet pattern 
index tools or scores, which researchers use to assess ad-
herence to this diet pattern in observational studies and 
clinical trials.5,12-16 
This review provides a brief description of the ancient 
Mediterranean diet, focusses mostly on what is common-
ly regarded in the scientific literature as the ‘traditional’ 
Mediterranean diet and, mentions some variations to this 
with modern Mediterranean diets. It summarises key ‘tra-
ditional’ Mediterranean diet foods and dishes. It also 
identifies additional elements relating to ‘traditional’ cui-
sine and eating habits that have not been consistently or 
collectively assessed in the majority of research studies to 
date, yet may have an influence on wellbeing and health  
 
 
outcomes, to inform development of future educational 
and diet index tools. 
 
METHODS 
We conducted a review of Mediterranean diet definitions 
as described by various literature and characterised by 
diet index tools.  Nine databases were searched from in-
ception to July 2015 to identify papers for a related sys-
tematic review on the Mediterranean diet and cognitive 
functioning and brain morphology or function.  These 
were MEDLINE, Premedline, AMED, All EBM review 
databases including Cochrane Database of Systematic 
Reviews (DSR), ACP Journal Club, Database of Ab-
stracts of Reviews of Effects (DARE), Cochrane Central 
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Register of Controlled Trials (CCTR), NHS Economic 
Evaluation Database (CLEED), Cochrane Methodology 
Register (CLMCR), Health Technology Assessment 
(CLHTA), CINAHL, EMBASE, PubMed, PsychINFO, 
Web of Science. Key search terms included Mediterrane-
an diet, Mediterranean dietary pattern, Mediterranean 
type diet, Cretan diet, MedDiet, MeDi and MeDiet. In 
addition grey literature was searched and additional use-
ful historical references were identified from reference 
lists.  Details of the search can be found in our PROS-
PERO protocol registered at http://www.crd.york.ac.uk/ 
PROSPERO/as CRD42015024088. 
In the search we identified more than 30 Mediterranean 
diet index tools. We chose to review seven of these to 
illustrate the diversity of tools in existence that measure 
adherence to a Mediterranean diet. The tools selected 
were either widely cited and/or included a greater number 
of elements to assess the intake of Mediterranean foods, 
aspects of cuisine and broader eating habits. 
 
RESULTS 
Our main findings are presented within the following 
framework: a) a historical time line of Mediterranean 
diets (ancient, ‘traditional’, modern), with details of char-
acterising foods and cooking methods used within the 
‘traditional’ Mediterranean diet b) additional culinary and 
psycho-social elements of the ‘traditional’ Mediterranean 
diet and c) relevance of existing diet index tools to the 
‘traditional’ Mediterranean diet. 
 
Ancient Mediterranean diet 
The Mediterranean diet has its origins in antiquity, from 
the foods and dietary patterns of countries surrounding 
the Mediterranean basin considered by historians as the 
“cradle of civilization”.17 This region was a melting pot of 
influences from ancient civilizations such as the Minoan 
(7000 BC-2000 BC) and Phoenician (1200 BC – 332 BC) 
to various Greek periods, e.g., Classical Greece (479 BC-
323 BC) and the Roman Empire (31 BC – 476 AD).18-20  It 
was also exposed to Arabic/Islamic culture and food dis-
coveries from the New World.  The diet in the Mediterra-
nean is therefore not a single construct but has progres-
sively evolved over time and lands. Specific food compo-
nents have been more or less emphasised according to the 
historical period, culture, religion, agricultural production 
and the economy of the time. In addition, climatic condi-
tions, poverty and hardship have contributed to shaping 
the Mediterranean diet rather than intellectual insight or 
wisdom, which tends to be the method used in modern 
times to construct popular diets.21 
A study of the writings of the Greek philosopher Plato 
(5th to 4th Century BC) provides valuable insight into 
some of the early dietary customs of the Mediterranean 
region. For example, Plato stated that a healthy diet con-
sists of cereals, legumes, fruit, milk, honey, fish and wa-
ter. He cautioned that meat, confectionary and wine 
should only be consumed in moderate quantities.22 
In the Roman tradition, which was based on the ancient 
Greek model, bread, wine and oil were the triad charac-
teristic of the Mediterranean diet. Additional foods in-
cluded some sheep’s cheese, vegetables (chicory, leeks, 
lettuce, mallow and mushrooms) and only a small 
amount of meat with a strong preference for fish and sea-
food.17 
One significant yet underappreciated influence on the 
historical path of the Mediterranean diet is the contribu-
tion made by Arabic/Islamic culture.  As an example, at 
the time when the Moors occupied much of Spain, the 
Christian (Catholic) diet was based on meat, wine and 
grains with poor dietary variety. However, in Islamic 
food culture meat comprised only a small part of the diet, 
whereas a variety of vegetables were plentiful.23 Islamic 
culture helped to transform the Mediterranean culinary 
model by introducing many new varieties of foods, such 
as eggplant, spinach, citrus, pomegranate, almonds and 
spices, as well as providing preparation methods for reci-
pes.17 Grains, such as wheat, barley and rice (and espe-
cially bread), were considered important by Muslims and 
many legumes were classified as having medicinal prop-
erties.23 
A further noteworthy influence on the Mediterranean 
diet was the discovery of the Americas. Christopher Co-
lumbus’s voyages (first journey was in 1492) resulted in 
novel foods from the New World, such as tomato, potato, 
capsicum, corn, various legumes and chilli, later becom-
ing commonplace within this diet.17,24 For example, while 
the tomato is now generally considered the food most 
synonymous with Mediterranean cuisine, the historical 
account testifies this was not the case in the ancient diet.17 
 
‘Traditional’ Mediterranean diet 
When speaking of the ‘traditional’ Mediterranean diet in 
the scientific literature, most researchers tend to refer to a 
plant based dietary pattern common to the olive growing 
areas of the Mediterranean region as described in the late 
1950s and early 1960s on the island of Crete, Greece and 
rural villages in Southern Italy such as Nicotera, which 
were part of the famous Seven Countries Study.25-27 
‘Traditional’ is defined by the European Union Eu-
roFIR project as referring to practices or specifications 
established prior to the Second World War, meaning be-
fore the modern era of factory farming and mass scale 
food production.28 As Trichopoulou et al point out, ‘tradi-
tional’ reflects a period “when most population groups 
still applied simple, time honoured approaches” to grow 
most of the food they personally consumed.29 It also re-
fers to a time before the globalisation of ultra-processed 
foods. Although sounding like the distant past, Keys30 
argued the ‘traditional’ Mediterranean diet definition was 
a relatively new invention rather than what was consumed 
by natives of the Mediterranean region in ancient times. 
The ‘traditional’ Mediterranean diet can be defined as 
being high in unprocessed plant foods (cereals (grains), 
vegetables, fruits, legumes, nuts/seeds and extra virgin 
olive oil); moderate in fish/shellfish (until recent times, 
fish consumption was a function of proximity to the sea) 
and wine (usually consumed only with meals and if ac-
ceptable by religious belief); and low in meat and dairy 
products, eggs, animal fats and discretionary foods.31 
When the ratio of plant versus animal foods is considered, 
the ‘traditional’ Mediterranean diet presents as a semi 
vegetarian diet, abundant in unrefined plant foods with a 
notable absence of ultra-processed foods, such as extrud-
ed snacks, sugary foods and drinks, fast foods and refined  
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fats and oils, now commonplace in modern day diets. 
 
A plant based diet 
In his personal reflections, the principal investigator of 
the Seven Countries Study, Ancel Keys,30 stated the 
“heart of this diet is mainly vegetarian and differs from 
American and Northern European diets in that it is much 
lower in meat and dairy products and uses fruit for des-
sert”. Keys described “pasta in many forms, leaves sprin-
kled with olive oil, all kinds of vegetables in season, and 
often cheese, all finished off with fruit, and frequently 
washed down with wine”. Further, when comparing mod-
ern interpretations of the Mediterranean diet he criticised 
Italian restaurants in the US and England as serving a 
travesty of the healthy ‘traditional’ Mediterranean diet as 
“everything has to be loaded with butter or margarine and 
ground meat”. Also, he rebuked them because “serving 
only fruit for dessert is not common” whereas “ice cream 
or pie is customary”.30 
Despite the fact that the dishes traditionally consumed 
by the Greeks were not the same as that consumed by the 
Spaniards, Lebanese or Moroccan, the Cretan diet circa 
1960’s remains the preferred prototype in the literature 
for the ‘traditional’ Mediterranean diet.21,32 See Table1 
for a descriptive list of foods consumed by Cretan men in 
the 1960’s.   
 
Bread as a staple food 
Local food choices available for the preparation of ‘tradi-
tional’ Mediterranean meals were influenced by the sea-
sons, which can help promote dietary diversity over the 
year or be a vulnerability in the case of bad weather. Sea-
sons determined the cuisine, helped to impart varied fla-
vours and increase phytonutrient intakes when abundant 
harvests were available.  Unlike recent times where low 
carbohydrate diets have been increasingly promoted in 
the popular and social media, it was common to eat large  
quantities of unrefined bread in many forms with each 
meal including soups, cooked dishes, salads and even 
fruit.5 These breads were based on stone ground whole-
meal flour and made with sourdough culture, and would 
therefore have been lower in Glycaemic Index (GI) than 
most modern breads consumed.31 Rusks (paximadia) 
made from barley were staple foods in Crete. These 
would presumably have elicited a particularly low gly-
caemic response since barley is rich in viscous dietary 
fibre and the GI of barley is low compared with other 
grains.33,34 In addition, rusks were always softened with 
olive oil prior to consumption further lowering their gly-
caemic response. Whole grains, including any foods made 
from unrefined or minimally processed grains such as 
whole wheat and barley (intact, cracked, rolled or flour 
products), also provided good amounts of dietary fibre 
and unique phytonutrients such as lignans, phytates and 
phenolic acids that complemented those found in fruit and 
vegetables.35 
 
Dishes based on vegetables, legumes and extra virgin 
olive oil 
Large amounts of salads, soups and cooked vegetable 
dishes were traditionally consumed.  These were based on 
seasonal vegetables and legumes from the region (e.g., 
lentils, chickpeas, broad beans, white beans, lupins), 
doused with copious amounts of extra virgin olive oil 
leading to composite dishes with mixtures of antioxi-
dants.33 Examples include stuffed vegetables (tomato, 
capsicum, eggplant and zucchini), white beans with fen-
nel, chickpeas with spinach and broad beans with wild 
artichokes. Lemon juice or vinegar, herbs and on-
ion/garlic were also frequently used to season salads or 
legume soups before consumption, as well as in food 
preparation, such as when baking ‘lemon potatoes’ or 
cooking goat or lamb.  Modern research suggests addition 
of condiments such as lemon juice/vinegar may help low-
er the GI of a meal and reduce the formation of advanced 
glycation end products (AGE’s), generally low in raw or 
 
Table 1. Description of the food intake of Cretan men in the 1960’s† 
 
Food  Description Quantity/frequency 
Bread Made with stoneground wholemeal flour, sourdough At least 6 slices per day 
Fruit Seasonal e.g. grapes, figs, apples, melons At least 2 pieces per day 
Vegetables Seasonal; regular inclusion of wild greens and dishes cooked in a 
rich tomato sauce with onions/garlic, herbs and olive oil 
 
Meat Mainly sheep or goat; usually boiled or casseroled Once per week or less 
Fish/seafood Any type available, depending on proximity to the sea e.g. sardines, 
cod, herring, octopus 
Once per week or less 
Legumes Lentils, chickpeas, broad beans etc. in place of meat 2-3 times per week 
Nuts All types available e.g. walnuts, almonds, chestnuts At least 3 times per week 
Olives All types available Daily 
Eggs Free range Average of 3 per week 
Cheese/yoghurt Made from sheep/goats milk 2-3 times per week or more  
Milk From sheep/goats milk; full cream Reserved for children  
Olive oil Extra virgin More than 4 tablespoons daily 
Wine Red wine or retsina 100-200 mL per day 
Tea Sage, mountain tea (sideritis or ironwort), lemon verbena, dittany, 
chamomile, mint 
Daily 
Coffee Made from grounds and boiled Daily, if available 
Herbs Oregano, parsley, celery leaf, dill etc. Daily 
Spices Cinnamon, cumin, cloves, saffron etc. Several times per week 
 
†Adapted from Kouris-Blazos et al and used with permission.32 
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boiled vegetables but formed in significant amounts 
when frying potatoes with added fat at high temperature 
e.g. French fries.36,37 
While Greece still claims the highest per capita con-
sumption of olive oil as a country, Cretans still consume 
the largest amounts in the world.38,39 A survey carried out 
by the American Rockefeller Foundation in 1948 in Crete 
indicated that olive oil contributed heavily to the daily 
caloric intake and “food seemed literally to be ‘swim-
ming’ in oil”.40 Recently, Ramirez-Anaya Jdel et al 
showed that frying vegetables in extra virgin olive oil can 
increase their overall polyphenol content by virtue of ab-
sorption of the polyphenols from the oil.41 In Greece and 
Southern Italy, cooking vegetables in olive oil was com-
monplace. Fresh dark green leaves and/or boiled wild 
(often bitter) varieties such as endive, chicory, sow thistle, 
amaranth and purslane drizzled with olive oil and lemon 
juice were an important part of daily cuisine when in sea-
son. Vine leaves stuffed with rice and spices were also 
consumed. The bitter cooking water that remained after 
boiling greens was usually drunk by the cook as it was 
believed to be highly nutritious. More than 80 different 
edible varieties of wild greens (weeds) have been identi-
fied on Crete.33 Wild greens and green pies prepared with 
a combination of leaves and herbs were found to contain 
exceptionally high levels of antioxidants, including a 
wide range of flavonoids.27 Dark leafy greens are also 
particularly rich in the carotenoid lutein, which can be 
preferentially taken up by the brain and macula and pro-
vides antioxidant and anti-inflammatory effects.42 Further, 
in addition to beetroot, which was cooked (both bulb and 
leaves) and eaten cold as a salad dressed with olive oil 
and lemon or vinegar, dark green leafy vegetables were a 
major contributor to the high nitrate content of the ‘tradi-
tional’ Mediterranean diet, which promotes vasodilation 
of blood vessels and lowers blood pressure.43-45 Emerging 
research has also shown that leafy greens contain a sugar 
called sulfoquinovose that can beneficially improve the 
gut microbiota.46 
The type of olive oil used traditionally for all cooking 
and eating purposes was extra virgin.  There are two ma-
jor reasons why extra virgin olive oil might be preferen-
tial for health compared with refined olive or vegetable 
oil extracted with solvents. First, it contains a high pro-
portion of monounsaturated to polyunsaturated fatty acids, 
which makes it more resistant to lipid peroxidation.47 Se-
cond, ‘extra virgin’ means that the olives were mechani-
cally pressed to squeeze out their juice, preserving their 
polyphenol and tocopherol content. Such phytonutrients 
further contribute to oxidative stability and may provide 
anti-inflammatory benefits.48 It was not customary to 
spread any butter or margarine on bread in the Mediterra-
nean. Twice baked Cretan rusks, which could survive 
long journeys by shepherds were softened before eating 
by drizzling with extra virgin olive oil and fresh tomato 
juices.33 Olives themselves, a fermented food with live 
cultures, were also regularly consumed as a condiment to 
meals.  
 
Traditional seasonings 
Onion and garlic were generously used, both raw as part 
of daily salads and as the basis of most cooked dishes,  
including the preparation of rich tomato pasta sauces 
where, together with the extra virgin olive oil, they in-
creased the content of flavonoids.49,50 The regular use of 
herbs/spices in cooking, even in small quantities, further 
contributed to a higher dietary intake of polyphenols.21,51 
For example, dried oregano, which is one of the richest 
sources of polyphenols among herbs, was regularly added 
to almost all dishes, along with some salt, pepper, lemon 
and extra virgin olive oil.52 Cultivated for centuries in the 
Mediterranean, and used also as medicine, oregano has 
more recently been shown to contain several antioxidants 
with anti-inflammatory, blood glucose and lipid lowering 
potential although clinical trials are lacking.53 Other 
popular herbs used traditionally include dill, mint, rose-
mary and wild fennel, although their usage depended on 
the region. Recent analyses of traditional Greek foods and 
dishes determined that the addition of capers in a sauce to 
the humble Santorini dish called fava (made from split 
peas cooked with onion) further enriched it with flavonol, 
flavone and flavan-3-ol.29 A simple green bean dish 
(known as fasolakia) was found to contain the highest 
content of flavonoids in an analysis of a weekly Mediter-
ranean menu due to the addition of onion and parsley in 
cooking.21 Indeed, the Greek version of the Mediterrane-
an diet used for this analysis was found to be high in fla-
vonoids compared with diets in Northern European coun-
tries.21 Interestingly, Cretan cuisine incorporated a wider 
range of herbs and spices due to its extensive history of 
invasions from the Byzantines and Arabs to the Venetians 
and Ottoman Turks prior to Crete becoming unified with 
and influenced by mainland Greece.  For example, herbs 
and spices often associated with Asian cuisine, such as 
cumin, coriander and saffron, were used.  This may help 
explain why Cretan cuisine was even more beneficial 
than the cuisine of mainland Greece at that time period.33 
Trichopoulou29 pointed out that the nutritional secrets of 
‘traditional’ Mediterranean foods and dishes were not 
immediately obvious as they appeared to relate to their 
phytonutrients. This is not surprising since dietary analy-
sis using standard food composition tables found in most 
apps and software programs omits the diverse range of 
phytonutrients existing in plant foods (as there is incom-
plete compositional data), so that the analytical focus re-
mains on macro and micronutrients. 
 
Nuts and honey to make nutritive sweets 
Nuts and seeds were eaten by the handful and used to  
make nutritive sweets together with honey e.g. pastelli 
(made from sesame seeds and honey) or grape juice syr-
up/must (petimezi) and occasionally dried fruit, since the 
use of table sugar was very low in the ‘traditional’ diet.  
Spoon sweets were made by cooking fruit, vegetables or 
green walnuts in their shell with sugar to create a syrupy 
sweet. However, these sweets were considered only an 
occasional treat, provided as one spoonful followed by 
water, and mostly served to guests as a gesture of hospi-
tality. Key Mediterranean nuts include almonds, hazel-
nuts, pine nuts, pistachios, and walnuts.54 Walnuts pro-
vide a particularly rich source of alpha linolenic acid and 
the highest level of phenolic compounds compared to 
other nuts.55 Honey has been used traditionally as medi-
cine and recent research suggests it can provide antioxi-
44
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dant, anti-inflammatory and anti-microbial effects benefi-
cial for treating certain conditions.56,57 
 
Beverages: water as the main drink 
In addition to water being consumed as the daily drink, 
moderate amounts of herbal tea, such as from sage and 
various mountain herbs, and/or boiled Greek coffee were 
consumed as part of the ‘traditional’ Mediterranean diet, 
although there is a paucity of data on actual quantities.58 
It was the job of children to pick herbs for making tea, 
while the coffee beans were purchased according to 
household budgets which, for most, were limited.  More 
recent research has confirmed these beverages supply 
various antioxidants, which may provide health bene-
fits.59,60 While coffee consumption may potentially pro-
vide both positive and negative health effects, Siasos et al 
reported boiled Greek coffee contained only a moderate 
amount of caffeine while it is rich in antioxidants, such as 
polyphenols, and magnesium.61,62 In the ‘traditional’ diet, 
herbal teas and coffee were also consumed with lower 
quantities of honey or sugar compared with amounts of 
added sugars contained per serve in modern sugar sweet-
ened beverages.   
 
Some dairy from sheep and goats 
Dairy was traditionally sourced from sheep and goats 
(occasionally buffalo), which provide A2 beta-casein, as 
found in breast milk.63 In Western society however, most 
milk is sourced from cows that exist in mixed herds sup-
plying a combination of A1 and A2 beta-casein.  While 
further research is required, some studies suggest A2 be-
ta-casein may be better tolerated by certain individuals 
and may be associated with a reduced risk of some chron-
ic diseases compared with A1 beta-casein.63,64 In the Med-
iterranean, full cream sheep or goats milk was reserved 
for drinking by children, whereas yoghurt (usually 
strained, which decreases lactose and increases the pro-
tein content) and soft white fermented cheese was pre-
ferred by adults. In Greece, for example, fetta cheese 
(with live cultures) was regularly added to salads and to 
finish the preparation of vegetable stews.5 On Crete, myz-
ithra (a mild whey cheese that hardens with age and can 
be grated) was most commonly produced, used and 
shipped around the Mediterranean as the cheeses of Crete 
have been famous since antiquity.33 It has been suggested 
that fermented foods in the ‘traditional’ Mediterranean 
diet, including yoghurt, cheese, trahana (fermented wheat 
and milk), olives and sourdough bread, may contribute to 
a healthy microbiome and that, at least, some of the bene-
fits obtained from Mediterranean diets might be operating 
through the microbiome.32 
 
Meat in very small amounts 
The small amount of meat consumed in the prototype 
Cretan diet usually came from small animals that grazed 
on pasture, (e.g., goats and sheep), rather than cows lot 
fed or lot finished with grains, as is the case with most 
beef produced today in Western countries.65 These ani-
mals provided an additional source of omega-3 fatty acids 
to the diet, as did snails which were popular during reli-
gious fasting and throughout the year.66 As compared to 
modern diets where meat takes centre stage on the plate 
and dishes are named accordingly further elevating the 
status of meat, legumes were the pillars of the ‘tradition-
al’ Mediterranean diet. The Southern Greeks had quite a 
puritanical attitude towards meat, viewing regular meat 
intake as being greedy.33 
Further, the cooking methods used to prepare meats 
were usually lower temperature and higher moisture e.g. 
boiling, stewing with the frequent addition of herbs and 
lemon retarding the formation of AGE’s, polyaromatic 
hydrocarbons (PAH’s) and/or heterocyclic amines 
(HCA’s), which have all been associated with chronic 
disease.37,67 
While traditional dishes varied in Mediterranean coun-
tries, modulated by ethnic background, agricultural pro-
duction, economy and religious beliefs, what all Mediter-
ranean countries shared in common was the unrefined 
plant based dietary pattern typical of this time period.68 
See Table 2 for a sample one day ‘traditional’ Mediterra-
nean (Greek) summer menu. 
 
Whole diet pattern more important than individual 
foods 
With regards to the question of which food/s in a Medi-
terranean diet are most important, current data suggest 
there is no specific food or component that is as benefi-
cial as the whole diet pattern and, possibly, the broader 
traditional cuisine and lifestyle habits which may be sig-
nificant elements. This is because simply changing one 
 
Table 2.  Sample one day ‘traditional’ Mediterranean (Greek) summer menu 
 
Eating occasion Foods 
Breakfast Sourdough bread topped with grated fresh tomato and raw onion, crumbled feta, dried oregano and  
drizzled with extra virgin olive oil 
Herbal tea or boiled Greek coffee  
 
Lunch (main meal) Oven baked giant Lima beans in tomato sauce + boiled potato and endive drizzled with olive oil and lemon 
+ sourdough bread 
Small glass red wine or retsina 
 
Dinner (lighter meal) Vegetable stew with eggplant, green beans, zucchini, potato, tomato, onion, garlic and parsley + sour-
dough bread OR village salad with barley rusks, tomato, cucumber, onion, olives and oregano drizzled 
with extra virgin olive oil OR Greek yoghurt topped with walnuts and drizzled with honey 
 
Snacks Water 
Fresh fruit in season 
Nuts 
Dried fruit e.g. figs, raisins 
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food or adding a few traditional dietary components may 
not completely override the detrimental effects of a West-
ern diet.69 
However, some studies have attempted to identify the 
relative importance of individual foods within predictive 
index tools.  When considering the Mediterranean Diet 
Pattern Score (MDPS) used for data from the Food Habits 
in Later Life (FHILL) study, which included five ethnic 
cohorts, Darmadi-Blackberry et al found that a higher 
legume intake was the most predictive dietary factor for 
longevity, with a 7-8% reduction in mortality risk for 
every 20 g increase in daily legume intake.70 In the Greek 
European Prospective Investigation into Cancer and Nu-
trition (EPIC) where a higher adherence to the Mediterra-
nean diet was associated with a significant reduction in 
total mortality, the dominant components of the Mediter-
ranean diet pattern index that predicted lower mortality 
were moderate alcohol intake, low intake of meat and 
meat products and high intake of vegetables, fruits and 
nuts, olive oil and legumes.71 A meta-analysis on the 
Mediterranean diet and cardiovascular disease (CVD) 
revealed that the protective effects of the diet pattern spe-
cifically related to CVD as an outcome, and assessed us-
ing various index tools, could mostly be attributed to ol-
ive oil, fruit, vegetables and legumes.72 
 
Modern Mediterranean diet 
While it is believed that Ancel Keys first coined the term 
‘Mediterranean diet’, the concept of the Mediterranean 
diet was not widely recognised in the scientific literature 
until the 1990s with the publication of the Lyon Diet 
Heart Study. This clinical trial showed a 50% reduction in 
risk of a second heart attack or cardiovascular complica-
tions, fewer cancers and a significant decrease in all-
cause mortality among those receiving the intervention 
diet.73-75 Yet despite being a type of Mediterranean diet, 
the intervention used in the Lyon Diet Heart Study was 
not ‘traditional’ and included some variations. For exam-
ple, the intervention was not high in total fat and the sub-
jects were provided with an additional margarine made 
from rapeseed oil to increase their alpha linolenic acid 
intake, since at the time of the study the exact dietary 
sources of alpha linolenic acid in the ‘traditional’ Medi-
terranean (Greek) diet were unknown.73 
More recently, the Mediterranean diet gained acclaim 
after the publication of the PREDIMED trial from Spain. 
This was a primary prevention trial of subjects at high 
risk of CVD placed on one of two versions of a Mediter-
ranean diet compared with a slightly lower fat control diet. 
The findings were a 30% reduction in CVD risk, primari-
ly due to decreased stroke risk, with either of the Mediter-
ranean diets.76 Also, a reduction in the risk of type 2 dia-
betes and peripheral artery disease was reported, as well 
as attenuation of decline or slight improvement in some 
aspects of cognitive function over time, compared with 
the control diet.7,77 PREDIMED is a further example of a 
modernised Mediterranean diet since the design of the 
study meant that one intervention group was supplement-
ed with polyphenol rich extra virgin olive oil while the 
other received supplements of mixed nuts to encourage a 
higher intake of these key foods in the respective groups, 
compared with controls. Also, a higher allowance for 
meat intake was provided in PREDIMED (less than one 
serve daily) compared with intakes in the ‘traditional’ 
Mediterranean diet (a few times per month). Unlike other 
studies, PREDIMED did include cuisine based advice 
with the recommendation to consume meals with sofrito 
(a rich sauce made with tomato and onion, often includ-
ing garlic and aromatic herbs, slowly simmered in olive 
oil) at least two times per week. 
Therefore, strictly speaking, neither the Lyon Diet 
Heart Study nor PREDIMED used a purely ‘traditional’ 
Mediterranean diet as their intervention, making interpre-
tation and comparison of the results more complex.73 It is 
interesting, however, that both trials were stopped early 
as interim analyses indicated the Mediterranean diet 
groups had a significantly reduced risk of disease com-
pared with controls.  
Unfortunately, the diets currently consumed in Mediter-
ranean countries (including the region where the proto-
type ‘traditional’ Mediterranean diet was described) are 
progressively being modernised and influenced by West-
ern dietary habits due to rapid economic development and 
high urbanisation rates and there is decreasing adherence 
to a ‘traditional’ Mediterranean diet pattern.78 While the 
influence of American fast food culture can easily be ob-
served, some of the move towards a greater use of animal 
products in modern Greek diets and a reduced use of 
herbs and spices has been more subtle and can be traced 
back to earlier culinary instruction by the famous Chef 
Tselementes (1878-1958). After spending considerable 
time abroad at prestigious eating establishments, Tsele-
mentes returned to Greece in the early 20th century to 
open a cooking school and publish his first cookbook. His 
cooking methods reduced the emphasis on herbs and 
spices and, instead, added butter and cream to foods so 
that recipes conformed more to classic French cuisine and 
appealed to the cosmopolitan upper class.79 While his 
influence was not apparent in Crete in the 1960s (the ma-
jor location and period that defined the “traditional” Med-
iterranean diet), it prevails today in most modern Greek 
kitchens in the form of more bland dishes with rich cream 
sauces i.e. bechamel, such as moussaka and pasticcio, 
which are mistakenly considered traditional.  Hence, 
modern Mediterranean diets have been shaped by external 
and internal forces.     
Ironically, Tourlouki et al have suggested the ‘tradi-
tional’ Mediterranean diet is being forsaken at the fastest 
pace possibly within the countries of its origin, based on 
data from the MEDIS (Mediterranean Islands Study) of 
people aged over 65 years from 12 islands in the Mediter-
ranean, and research conducted on primary school chil-
dren in Malta.80,81 In the MEDIS study of ‘elders’, Crete 
was recently found to have the highest frequency of fast 
food and sweets consumption.81 
 
Additional culinary and psycho-social elements of the 
‘traditional’ Mediterranean diet 
In 2010 the United Nations Educational, Scientific and 
Cultural Organization (UNESCO) recognised the Medi-
terranean diet as an Intangible Cultural Heritage.  Indeed, 
to date, it is the only diet in the world protected by 
UNESCO in an effort to safeguard the traditional aspects 
of the diet, which are at risk of being abolished. As the 
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word ‘diet’ comes from the Greek word ‘diaita’, meaning 
a way of life or lifestyle, the recognised Mediterranean 
diet is much more than just a diet pattern that can be de-
scribed by consideration of its foods and/or nutrients, 
although a quantitative definition may have particular 
uses in research.82 The Candidature Dossier submitted to 
UNESCO describes the Mediterranean diet as “a social 
practice based on the set of skills, knowledge, practices 
and traditions ranging from the landscape to the cuisine, 
which in the Mediterranean basin concern the crops, har-
vesting, fishing, conservation, processing, preparation and, 
particularly, consumption”.83 Hence, domestic cooking 
using distinct methods, as well as eating and other social 
habits that revolve around the foods consumed, also play 
an integral role in the ‘traditional’ Mediterranean diet.  
Yet these elements have generally escaped the attention 
of researchers, despite the likelihood that they may inter-
act with the type and quantity of foods consumed and 
possibly exert independent health effects. While evidence 
is currently lacking within the context of a Mediterranean 
diet to support the importance of such elements, emerging 
research within the wider scientific literature suggests 
these elements could be a significant contributing factor 
to the value of the ‘traditional’ Mediterranean diet.   
In the Mediterranean, food was traditionally cooked at 
home or prepared by family and friends rather than by 
commercial and industrial operators. This is important 
because recent data on Western populations has suggested 
more home cooking is associated with higher diet quality 
as indicated by increased consumption of fruit, vegetables 
and salads.84,85 Because of their dominant role within the 
home in the past, Mediterranean women were the custo-
dians of their culinary culture and self-production of 
food.86 Second, the traditional slow cooking methods 
used in the Mediterranean included high moisture and 
lower temperature, e.g., boiling or stewing. These condi-
tions are now known to reduce the formation of various 
noxious chemicals in foods such as AGE’s, mentioned 
above, and acrylamide produced by faster modern cook-
ing methods using intense and dry heat, associated with 
chronic disease.37,87-91 It is also now appreciated that 
preparation methods where vegetables are soft cooked so 
that cell walls are broken down increase bioavailability of 
phytonutrients, further aided by the presence of olive oil 
since many phytonutrients, e.g. carotenoids, are fat solu-
ble.  Third, main meals in the Mediterranean were usual-
ly consumed by sitting around the table (rather than in 
front of a screen or while driving), where food can be 
savoured and eaten more mindfully in a convivial envi-
ronment with the company of family and friends.92 The 
Greek historian Plutarch stated “we do not sit at table to 
eat, but to eat together”.83 This method of eating provides 
social connectedness and a sense of community, now rec-
ognised to be important for health.93 Indeed, frequent 
socialisation is a hallmark of Mediterranean traditions 
renowned for their longevity.94 Fourth, frequent snacking 
between meals was not common in the ‘traditional’ Medi-
terranean diet. In contrast, 96% of Australians say they 
regularly consume snack foods and Australians are now 
snacking four times as much as they did a decade ago 
according to market research.95,96 Recent data from four 
US surveys suggests excessive grazing between main 
meals may drive obesity as eating frequency has been 
shown to account for twice the variance in energy intake 
compared with portion size.97 Fifth, in the Orthodox, 
Catholic and Islamic religions some form of ‘fasting’ or 
food restriction was traditionally practised. For example, 
those compliant with the Orthodox Church recommenda-
tions abstain from eating most foods of animal origin eve-
ry Wednesday and Friday as well as for three other signif-
icant periods leading to religious holidays. This means 
they virtually follow a total plant based diet (vegan) for 
up to 200 days, or more than half of the year.98 Modern 
science has confirmed fasting or abstaining from meat, 
chicken, fish, dairy and eggs may have a favourable im-
pact on the microbiome and result in less production of 
potentially harmful bacterial metabolites and inflamma-
tion.32,99-102 Further, high fibre vegetable based diets 
whether they be vegan, vegetarian or Mediterranean are 
associated with increased levels of faecal short chain fatty 
acids, which confer a protective effect against various 
chronic diseases.103 Fasting practice may also contribute 
to moderation in overall food intake and a more frugal 
diet, which is less commonly observed in Western society.  
Sixth, Mediterranean people traditionally grew most of 
their own produce, a practice which has been suggested 
to impact consumption levels of vegetables. The Australi-
an arm of the MEDIS found having a home garden is pos-
itively correlated with a high Mediterranean diet pattern 
index score.104 Seventh, certain traditional foods and 
culinary combinations were consumed regularly in the 
‘traditional’ Mediterranean diet, such as Greek yoghurt 
and olives (both fermented foods), tomato salsa/sofrito, 
wild dark green leafy vegetables drizzled with lemon 
juice and olive oil and vegetables and/or legumes cooked 
with herbs and olive oil, discussed earlier. Such foods and 
combinations lend themselves to providing a greater di-
versity and/or higher concentration of phytonutrients 
compared with adding a slice of tasty cheese, squirt of 
ketchup, a side salad without dressing (or low fat dressing) 
or a portion of steamed vegetables to the dinner plate, 
which tends to be more common in Western society.  
Eighth, taking a short nap following the main midday 
meal is well known to be part of the ‘traditional’ Mediter-
ranean lifestyle,105 which also included a considerable 
amount of physical activity. A daily siesta has been asso-
ciated with reduced coronary mortality in a Greek popula-
tion,106 with a recent study on midday napping finding an 
association with reduced blood pressure.107 However, 
while the additional elements identified in this review, 
were an integral part of the ‘traditional’ Mediterranean 
lifestyle, further research is required to confirm their con-
tribution to reducing chronic disease risk within the con-
text of that lifestyle. Finally, despite the ‘traditional’ 
Mediterranean diet being used as a valuable reference 
point for health within the scientific literature, capturing 
such a diet and trying to preserve and use it in different 
contexts may be fraught with difficulties and may have 
some unintended consequences. For example, gender 
roles, time availability and daily routines are changing 
across the world, which may impact on the ability to 
regularly cook at home, tend a garden or take a short nap 
after the midday meal, even in Mediterranean countries. 
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Relevance of existing diet index tools to the ‘traditional’ 
Mediterranean diet 
Existing Mediterranean diet pattern index tools have been 
used in epidemiology and clinical trials to assess whole 
dietary patterns and measure the combined effects of food 
components on disease outcomes, overcoming limitations 
of studies on single nutrients or foods.108,109 However, 
there have been disparities in their ability to predict simi-
lar risk reductions for chronic disease.  These tools, de-
veloped a priori, have mostly focussed their attention on 
foods and, in some cases, nutrients and they generally do 
not attempt to measure the broader elements of the ‘tradi-
tional’ Mediterranean diet and cuisine discussed in this 
review.5,12-14,16 Most index tools, with the exception of 
MEDLIFE (see below), are also not based on the defini-
tion of the ‘traditional’ Mediterranean diet.110 
The first Mediterranean diet pattern index tool (MDPS) 
was developed in 1995 by Trichopoulou et al.5 It exam-
ined the association between defined Mediterranean food 
patterns and overall survival using data collected for the 
FHILL study. Scoring for the MDPS ranged from 0-8 and 
focussed on broad food groups derived from the tradi-
tional Cretan diet as described in the Seven Countries 
Study but it did not reflect cooking methods or other as-
pects of cuisine. Nevertheless this pioneering tool, and 
the study it was based on, facilitated the work of re-
searchers around the world to explore additional benefits 
of a Mediterranean diet, resulting in rapid growth of pub-
lications and development of multiple other index tools 
with variations.111 
The variations in index tools appear primarily due to 
differences in purpose and how these tools were con-
structed.  While the majority of Mediterranean diet pat-
tern tools seemingly aim to assess overall adherence to a 
Mediterranean diet pattern, specific elements included in 
some tools would suggest greater relevance to a particular 
health outcome or population being studied. For example, 
Ciccarone et al who studied peripheral artery disease in 
Italian patients with type 2 diabetes, included a frequency 
measure of raw vegetable, carrot, butter and cream intake, 
presumably to enable some proxy for carotenoid and satu-
rated fat intake, which are related to diabetes complica-
tions.112 The Mediterranean Diet Adherence Screener 
(MEDAS) used in PREDIMED on the other hand seems 
to have been largely designed to enable a rapid assess-
ment of compliance to a Mediterranean diet pattern so 
feedback can be provided to participants during dietary 
interventions as part of a clinical trial. Unfortunately, 
MEDAS also lacks a measure for frequency of intake of 
home cooked meals, the cooking methods used, socialisa-
tion at meals, snacking occasions throughout the day, 
fasting practice, availability of a home vegetable garden 
and napping after the main meal, which are characteristics 
of the ‘traditional’ Mediterranean diet.15,113 
Indices also vary according to the number and actual 
dietary elements assessed, whether quantity or frequency 
of the elements is being measured, cut-offs used for scor-
ing (absolute or a scale, and determined a priori or based 
on gender specific mean intakes of the population as-
sessed, which may not reflect true adherence to the ‘tradi-
tional’ Mediterranean diet) and the computation method.  
Some index tools include composite food groups such as 
fruit and nuts or legumes, nuts and seeds, whereas others 
incorporate measures for discretionary foods not part of 
the ‘traditional’ Mediterranean diet, such as sugary bev-
erages and sweets, in order to capture the potentially neg-
ative effects of such items now common in Westernised 
diets. The intake of discretionary foods may be of particu-
lar interest when assessing non-Mediterranean popula-
tions, and the degree of acculturation by Mediterranean 
populations. 
While an exhaustive comparison of Mediterranean diet 
index tools is beyond the scope of this review, the ele-
ments from seven commonly used tools out of more than 
30 existing in the literature are provided (see Table 3).  A 
comparison of these example indices reveals that all in-
clude some measure of vegetables, meat and meat prod-
ucts and fruit (even if as a composite group with nuts).  
Most include a measure of fish/seafood, dairy, legumes, 
alcohol and olive oil intake.  Few include a measure of 
wholegrain cereals, sofrito, poultry/white meat, eggs, 
vegetable oil, butter, margarine, cream, sugary beverages 
and sweets while none include a measure of vegetable 
variety, dark green leafy vegetables, onions/garlic/leeks/ 
shallots, olives, fermented dairy, ‘extra virgin’ olive oil, 
lemon/vinegar use in food preparation, herbs and spices, 
water, herbal tea and coffee, despite the latter being part 
of the ‘traditional’ Mediterranean diet and cuisine.   
Therefore, it has been suggested that while existing 
Mediterranean diet pattern index tools may be a helpful 
way of describing a Mediterranean diet, such indices may 
have led to an over simplification and confusion about the 
‘traditional’ Mediterranean diet.73 There are also currently 
no Mediterranean diet indices that capture the broader 
elements of ‘traditional’ cuisine and consumption habits 
discussed in this review.  The most holistic example iden-
tified is MEDLIFE, a 28 item index based on criteria 
from the new Spanish Mediterranean diet pyramid.  This 
includes measures for diet, physical activity patterns and 
social interaction but lacks the same elements as the edu-
cational pyramid, discussed above, upon which it is based. 
8,114 
 
DISCUSSION 
Emulating and assessing the ‘traditional’ Mediterranean 
diet can be a challenge. The Mediterranean Diet Founda-
tion from Spain in conjunction with experts in the field, 
recently updated the ‘traditional’ Mediterranean diet pyr-
amid in areas that have evolved with modernisation and 
to incorporate cultural and lifestyle elements.8 However, 
some of the updated dietary recommendations may be 
controversial, such as the higher allowance for red and 
processed meat, which exceeds amounts consumed tradi-
tionally in the prototype diet.26 Also, despite considering 
a wide range of Mediterranean lifestyle elements, this 
educational tool does not emphasise the potentially im-
portant role of traditional cooking methods such as stew-
ing rather than barbecuing meat, unique traditional foods 
such as fermented dairy products, fasting practice, and 
ownership of a home vegetable garden, which may con-
tribute to the health outcomes provided by the ‘tradition-
al’ Mediterranean diet. 
The literature supports that the ‘traditional’ Mediterra-
nean diet is much more comprehensive than just a collec- 
48
                                                                                                                      Historical review Med diets and cuisine                                                                                                              757                                                            
 
Table 3.  Elements measured in selected Mediterranean diet index tools† 
 
 Trichopoulou et al 
1995,5 
Trichopoulou et al 
2003,16 
Ciccarone et al 
2003,112 
Goulet et al  
2003,13 
Panagiotakos et al  
2007,109 
Schroder et al 
2011,15 
Sotos-Prieto et al 
2014,114 
 Greece (MDPS) Greece Italy Canada Greece (MedDietScore) Spain (MEDAS) Spain (MEDLIFE) 
Type of index Mediterranean diet 
pattern 
Mediterranean diet 
pattern 
Mediterranean diet 
pattern 
Mediterranean  diet 
pattern 
Mediterranean diet  
pattern 
Mediterranean diet 
pattern + cuisine 
Mediterranean diet 
pattern + lifestyle 
Number of elements assessed 8 9 15 11 11 14 28 
Vegetables X X X X X X X 
Vegetables raw - - X - - - - 
Vegetables variety - - - - - - - 
Dark green leafy vegetables - - - - - - - 
Sofrito  - - - - - X - 
Carrots - - X - - - - 
Potatoes - - - - X - X 
Onions/garlic/leeks/shallots - - - - - - - 
Fruit - - X X X X X 
Fruits & nuts composite X X - - - - - 
Nuts - - - - - X - 
Olives - - - - - - - 
Nuts & olives composite - - - - - - X 
Legumes X X - - X X X 
Legumes, nuts & seeds compo-
site 
- - - X - - - 
Cereals X X - - - - X 
Cereals wholegrain - - - X X - - 
Wholegrain preference - - - - - - X 
Dairy  X X - X X - - 
Dairy low fat - - - - - - X 
Dairy fermented e.g., yoghurt, 
fetta 
- - - - - - - 
Cheese (all types) - - X - - - - 
Meat & meat products X X X X X X X 
Processed meat - - X - - - X 
Poultry/white meat - - - X X - X 
White meat preference - - - - - X - 
Fish/seafood - X X X X X X 
Eggs - - X X - - X 
Olive oil extra virgin - - - - - - - 
Olive oil - - X X X X X 
Olive oil principal fat - - - - - X - 
Vegetable oil - - X - - - - 
 
†For the sake of brevity, the lifestyle and non-food elements of cooking or eating behaviour discussed in this review are not represented in this table as none of the existing tools assessed these except for a measure of 
snacking behaviour in MEDLIFE, which also includes additional lifestyle elements.  For Goulet et al a maximum of 1 point from refined grain products counted towards wholegrain products; a maximum of 1 point 
from vegetable juice counted towards vegetables; a maximum of 1 point from fruit juice counted towards fruit; a maximum of 1 point from canola oil or olive oil margarine counted towards olive oil.13 
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Table 3.  Elements measured in selected Mediterranean diet index tools† (cont.) 
 
 Trichopoulou et al 
1995,5 
Trichopoulou et al 
2003,16 
Ciccarone et al 
2003,112 
Goulet et al  
2003,13 
Panagiotakos et al  
2007,109 
Schroder et al 
2011,15 
Sotos-Prieto et al 
2014,114 
 Greece (MDPS) Greece Italy Canada Greece (MedDietScore) Spain (MEDAS) Spain (MEDLIFE) 
Type of index Mediterranean diet 
pattern 
Mediterranean diet 
pattern 
Mediterranean diet 
pattern 
Mediterranean diet 
pattern 
Mediterranean diet  
pattern 
Mediterranean diet 
pattern + cuisine 
Mediterranean diet 
pattern + lifestyle 
Butter - - X - - - - 
Margarine - - X - - - - 
Cream - - X - - - - 
Butter, margarine, cream compo-
site 
- - X - - X - 
MUFA: saturated fat ratio X X - - - - - 
Sugary beverages - - - - - X - 
Sugary beverages limited intake - - - - - - X 
Sweets - - - X - X X 
Processed snacks - - - - - - X 
Salt limit at meals - - - - - - X 
Lemon/vinegar in food prepara-
tion 
- - - - - - - 
Herbs & spices - - - - - - - 
Herbs, spices & onion/garlic 
garnish 
- - - - - - X 
Water - - - - - - - 
Herbal teas - - - - - - - 
Water or herbal teas - - - - - - X 
Coffee - - - - - - - 
Alcohol  X X X - X - - 
Wine - - - - - X X 
Snacking behaviour - - - - - - X 
 
†For the sake of brevity, the lifestyle and non-food elements of cooking or eating behaviour discussed in this review are not represented in this table as none of the existing tools assessed these except for a measure of 
snacking behaviour in MEDLIFE, which also includes additional lifestyle elements.  For Goulet et al a maximum of 1 point from refined grain products counted towards wholegrain products; a maximum of 1 point 
from vegetable juice counted towards vegetables; a maximum of 1 point from fruit juice counted towards fruit; a maximum of 1 point from canola oil or olive oil margarine counted towards olive oil.13 
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tion of foods.  It includes a cuisine with unique recipes 
and other psycho-social factors that may also impact on 
food and nutrient intake, although a broader discussion of 
social science parameters is outside the scope of this re-
view. Taking these factors into consideration, it has been 
proposed that integrating the concept of the Mediterrane-
an diet with the concept of the Mediterranean way of 
cooking should become a priority for the future.115 Can-
non116 suggests nutrition scientists should pay attention to 
the history, tradition and culture of foods as they do to 
biochemistry, food chemistry and other emerging and 
relevant scientific areas e.g., the microbiome and nutri-
genomics. 
When designing new tools or updating existing ones to 
assess or promote adherence to the ‘traditional’ Mediter-
ranean diet, researchers may wish to consider a more ho-
listic definition as endorsed by UNESCO and include 
additional measures (either directly or by proxy), while 
giving consideration to regional food cultures where the 
tool is intended for use.117 These measures include: 
1. Frequency of intake of home cooked meals 
2. Style of cooking methods used 
3. Frequency of eating main meals in company vs. alone 
4. Number of snacking occasions outside main meals 
5. Regular fasting of any type 
6. Availability of a home vegetable garden 
7. Use of traditional foods (or their nutritional counter-
parts) and combinations within dishes 
8. Napping after the main midday meal 
Tools that incorporate traditional culinary practices and 
eating habits from the ‘traditional’ Mediterranean diet 
may have increased usefulness for researchers, health 
professionals, school educators, chefs and the general 
public.113,118,119 
 
Conclusion 
Plant based diets appear best for the prevention of chronic 
disease,67,120 and a more sustainable way of eating for the 
future.121 The Mediterranean diet shares many food simi-
larities with modern vegetarian diets, but may find greater 
acceptance due to its high palatability and allowance for a 
low intake of animal foods.122,123 The Mediterranean diet 
is recommended for use by dietary guidelines in Australia 
and the US.124,125 Increased compliance with a Mediterra-
nean diet pattern, even in non-Mediterranean countries, 
has been associated with protection against chronic dis-
ease and a decreased risk of premature mortality.29,73,126 
As the ‘traditional’ Mediterranean diet includes additional 
culinary and consumption habits for a ‘way of life’ un-
common in modern society, future research should assess 
the relevant contribution of these elements to the effec-
tiveness of the Mediterranean diet and give consideration 
to their inclusion in educational and index tools for re-
search, clinical practice and public health promotion. 
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CHAPTER THREE
 
Effect of the Mediterranean diet on cognition and 
brain morphology and function: 
A systematic review of randomised controlled trials
56
PREFACE
Dementia is a major health problem worldwide that has no effective medical treatment to 
prevent, delay or modify its course. Observational studies show promising associations 
between increased adherence to the Mediterranean diet and a slower rate of cognitive 
decline and brain atrophy with ageing, as well as a reduced risk of mild cognitive 
impairment (MCI), dementia and conversion of MCI to dementia. However, data from 
randomised controlled trials are limited. As there is urgency to identify successful 
interventions that may promote healthy brain ageing, an understanding of the existing 
literature and the gaps in previous clinical trials is required to progress the field.
The aim of this chapter was to conduct the first systematic review exclusively focussed 
on randomised controlled trials (RCTs), on the effect of a Mediterranean diet intervention 
on cognition and brain morphology and function. An additional focus was to determine 
the quality of the interventions prescribed, including their relation to the ‘traditional’ 
Mediterranean dietary pattern. A systematic review was selected as the preferred 
methodology since it provides a rigorous approach for a specific and quantitative focus, 
which can be reproduced by others.
This is a pre-copyedited, author-produced version of an article accepted for publication 
in the American Journal of Clinical Nutrition following peer-review. English (Australia) 
spelling has been retained for the purposes of this thesis. The version of record [Radd-
Vagenas, S., Duffy, S. L., Naismith, S. L., Brew, B. J., Flood, V. M., & Fiatarone Singh, 
M. A. (2018). Effect of the Mediterranean diet on cognition and brain morphology and
function: A systematic review of randomized controlled trials. American Journal of
Clinical Nutrition, 107(3), 389-404.] is available online at: 
https://academic.oup.com/ajcn/article/107/3/389/4939347?searchresult=1 or 
https://doi.org/10.1093/ajcn/nqx070
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The chapter includes 13 published supplementary materials:
- Sample search strategy for PsychINFO
- Quality rating of Mediterranean diet interventions template
- Study design – randomised controlled trials (RCTs) with pre/post-test 
comparisons
- Study design – PREDIMED RCT with only post-test comparisons
- Participant characteristics
- Intervention characteristics – means of implementation of the experimental 
Mediterranean and control condition
- Dietary compliance outcomes
- Intervention characteristics – dietary elements/nutritional behaviours prescribed 
for experimental Mediterranean condition
- Intervention characteristics – dietary elements/nutritional behaviours prescribed 
for control/comparative condition
- Quality review of five included studies according to modified PEDro scale
- Quality review of five included studies for Mediterranean diet interventions
- Cognitive function outcomes
- Brain morphology or function outcomes
Shortly prior to finalising this thesis, and since publication of this chapter as a paper in
the American Journal of Clinical Nutrition, the authors of one of the included publications 
(Valls-Pedret et al., 2015) corrected some values within their original paper for a subset 
of the Prevencion con Dieta Mediterranea (PREDIMED) cohort. They did this as it was 
discovered that 5/344 of their participants were randomised incorrectly to the same 
intervention as previously randomised relatives residing in the same household. Their 
corrected values for individual cognitive test scores were minor (see Appendix Four).
However, the two neuropsychological tests (i.e., Rey Auditory Verbal Learning Test 
(RAVLT) total learning and the Color Trail Test part 2) that were significantly improved 
in the experimental Mediterranean diet plus extra virgin olive oil arm became non-
significant. Importantly, however, there were no appreciable differences in the three 
composite cognitive domain change scores, which remained significant. Hence, the 
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conclusion in this paper remained the same, i.e., that a Mediterranean diet supplemented 
with extra virgin olive oil or nuts was associated with improved composite measures of 
cognitive function over four years of ageing, as compared to a healthy lower fat diet.
Further information related to this chapter is presented in Appendices Three and Four and 
includes: the PROSPERO protocol and the corrections within PREDIMED for cognitive 
outcomes.
Part of the work produced in this chapter has been presented at the following conference:
x Radd, S., Duffy, S., Naismith, S., Brew, B., Flood, V., & Fiatarone Singh, M. 
Effect of the Mediterranean diet on cognition and brain morphology/function: A 
systematic review and meta-analysis of RCTs. 10th Asia Pacific Conference on 
Clinical Nutrition, Adelaide, Australia., 26-29th November 2017.
x Radd-Vagenas, S., Duffy, S. L., Naismith, S. L., Brew, B. J., Flood, V. M., & 
Fiatarone Singh, M. A. (2018). Could a plant-based diet affect cognition? 
Findings from a systematic review of randomized controlled trials on the 
Mediterranean diet. 7th International Congress on Vegetarian Nutrition, Loma 
Linda University, Loma Linda, USA, 26-28th February 2018.
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 3.1 Abstract
Background:
Observational studies of the Mediterranean diet suggest cognitive benefits, potentially 
reducing dementia risk.
Objectives:
To perform the first published review to our knowledge of randomised controlled trials 
(RCTs) investigating Mediterranean diet effects on cognition or brain 
morphology/function, with an additional focus on intervention diet quality and its relation 
to ‘traditional’ Mediterranean dietary patterns.
Design:
We searched nine databases from inception to July 2017 to identify RCTs which tested a 
Mediterranean diet compared to an alternate diet for cognitive or brain 
morphology/function outcomes.
Results:
Analyses were based on 66 cognitive tests and one brain function outcome from five 
included studies (n=1888 participants). The prescribed Mediterranean diets varied 
considerably between studies, particularly with regards to quantitative food advice. Only 
8/66 (12.1%) of individual cognitive outcomes at trial level significantly favoured a 
Mediterranean diet for cognitive performance, with effect sizes (ESs) ranging from small 
(0.32) to large (1.66); whereas two outcomes favoured control. Data limitations precluded 
a meta-analysis. In eight domain composite cognitive scores from two studies, the three 
(Memory, Frontal and Global function) from PREDIMED (Prevención con Dieta 
Mediterránea) were significant, with ESs ranging from 0.39 to 1.29. A post-test 
comparison at a second PREDIMED site found the Mediterranean diet modulates the 
effect of several genotypes associated with dementia risk for some cognitive outcomes, 
with mixed results. Finally, the risk of low plasma Brain-derived Neurotrophic Factor 
(BDNF) was reduced by 78% (OR=0.22; 95% CI: 0.05, 0.90) in those on a Mediterranean 
diet compared to control at 3 years in this trial. There was no benefit of the Mediterranean 
diet for incident cognitive impairment or dementia.
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 Conclusions: 
Five RCTs of the Mediterranean diet and cognition have been published to date. The data 
are mostly non-significant, with small ESs. However, the significant improvements in 
cognitive domain composites in the most robustly-designed study warrant additional 
research.
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 3.2 Introduction
Dementia is a major health problem worldwide, with one new case diagnosed every three 
seconds and a projected global prevalence of 75 million by 2030 (1). An estimated 5.4 
million Americans were affected by the most common type — Alzheimer’s Disease (AD)
— in 2016 with more than 96% aged 65 and over (2). Demographic shifts thus suggest 
that dementia incidence will double by 2050 (3), increasing the burden of disability, and 
reducing the quality of life for sufferers, carers and families (4, 5). Currently there is no 
medical treatment to prevent, delay, or modify the course of dementia (6). Therefore, 
attention has turned to the control of vascular and other risk factors, including 
hypertension and diabetes, as well as the promotion of lifestyle behaviours such as diet 
and exercise, which are associated with the rate of cognitive decline and dementia risk 
(7-11).
With respect to human nutrition, particular nutrients, foods and dietary patterns have been 
associated with cognitive function and brain morphology/function (12-21). Among these, 
the Mediterranean dietary pattern has generated recent interest based on observational 
data suggesting it promotes slower cognitive decline, lower risk of dementia (especially 
AD), reduced conversion of Mild Cognitive Impairment (MCI) to AD and better overall 
survival in those affected (22-25). A Mediterranean diet has been defined as a plant-based 
dietary pattern common to the olive growing areas of the Mediterranean region as 
described in the late 1950s and early 1960s in the Seven Countries Study (26, 27). The 
‘traditional’ pattern was high in unprocessed plant foods (grains, vegetables, fruits, 
legumes, nuts/seeds and extra virgin olive oil), moderate in fish/shellfish and red wine 
and low in meat, dairy, eggs, animal fats and discretionary foods. It also included 
additional cuisine elements, such as use of moist, lower temperature cooking methods, 
reduced snacking occasions and fasting practice (28).
There are now at least 13 systematic reviews of a Mediterranean diet or dietary pattern 
considering cognition (18, 19, 25, 29-38). However, these are primarily reviews of 
observational studies, with only three reviews including 1 to 3 randomised controlled 
trials (RCTs) (18, 31, 33), and none including a pre-defined protocol to identify RCTs 
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 with cognition and brain morphology/function outcomes. Notably, the experimental 
evidence linking a Mediterranean diet to cognition or brain morphology/function is 
limited and has not been comprehensively reviewed. Therefore, our aim was to perform 
the first systematic review and meta-analysis of all published RCTs investigating the 
effects of a Mediterranean diet compared to an alternate diet, on any aspect of cognition 
or brain morphology/function, with additional focus on the quality of the intervention and 
how it is related to the ‘traditional’ Mediterranean dietary pattern.
3.3 Methods
We used a protocol prospectively designed and registered with PROSPERO 
(registration number: CRD42011100485
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015024088) 
and followed the statement and general principles of Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) (39).
3.3.1 Criteria for study inclusion
Studies were included if they met all the following criteria: 
(1) RCT design or post-test comparison within an RCT;
(2) full length article published in peer-reviewed journal in any language;
(3) only human participants of any age;
(4) intervention included a Mediterranean diet (with/without supplied food); for the 
purpose of this review, all studies that described their intervention as a 
Mediterranean diet or Mediterranean-style dietary pattern were included;
(5) comparator included an alternate or usual diet;
(6) outcomes included at least one measure of cognition, or brain 
morphology/function;
(7) outcomes were measured at two time points or compared at one time point during 
follow-up between the intervention and comparator groups.
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 Studies were excluded if:
(1) acute/single exposures were tested and duration of study period was less than 10 
days, at which time point it could be expected that physiological and cognitive 
outcomes of repeated/chronic exposures might be observed;
(2) single foods/nutrients or a partial Mediterranean diet was tested (e.g. low fat, low 
carbohydrate, low calorie);
(3) additional non-dietary modalities (e.g., exercise) were not equally prescribed to 
intervention and comparator groups. 
3.3.2 Search strategy
The following nine electronic databases were searched from inception to July 2015 with 
a final update in December 2017: MEDLINE, PreMedline, AMED, all EBM review 
databases including Cochrane Database of Systematic Reviews (DSR), ACP Journal 
Club, Database of Abstracts of Reviews of Effects (DARE), Cochrane Central Register 
of Controlled Trials (CCTR), NHS Economic Evaluation Database (CLEED), Cochrane 
Methodology Register (CLMCR), Health Technology Assessment (CLHTA), CINAHL, 
EMBASE, PubMed, PsycINFO, Web of Science. Between the comprehensive searches, 
the lead author reviewed reference lists of eligible trials and review articles, hand 
searched relevant websites and journals and was in contact with known experts in the 
field to identify additional studies.
A search strategy was developed for each database. This included a combination of 
'Intervention' AND 'Outcome' terms (Figure 3.1) and did not include 'Population', 
'Comparator' or 'Study design' terms. We searched for ‘search terms’ in all fields and no 
language or date restrictions were applied to the search strategy in order to maximize 
search sensitivity. A sample full search strategy is provided for the PsycINFO database 
(Supplementary Material 3.1).
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 3.3.3 Study selection and data extraction
One reviewer (SRV) conducted the search, removed duplicates then screened papers by 
title and abstract according to eligibility criteria. Papers retrieved for full evaluation were 
appraised by two reviewers (SRV and SLD) who extracted data into pre-designed, piloted 
tables. Any disagreements were resolved by consensus with two additional reviewers 
(VMF and MAFS). 
Multiple fields were extracted as outlined in our protocol, based on the following 
categories: (1) study design, (2) participant characteristics, (3) intervention 
characteristics, (4) dietary compliance outcomes, (5) cognitive function outcomes, (6) 
brain morphology or function outcomes, (7) study quality, (8) funding source. Cognitive 
outcomes were categorized under their respective domains according to Strauss, et al. 
(40), except for Rey-Osterrieth Complex Figure (ROCF) copy scores which we 
categorized as visuo-spatial.
Additional outcomes relevant to cognition or brain morphology/function were searched 
for in all publications reporting on the same study. Authors were contacted to clarify the 
definition of ‘meat’ (41, 42) and confirm for two publications (43, 44) whether study 
participants and cognitive evaluations overlapped since they were derived from the same 
node of PREDIMED. If data were presented in figures (45), a customized MATLAB 
R2015b script (MathWorks, Natick, Massachusetts, USA) was used to extract data.
Unadjusted means and differences were extracted from papers unless these were 
unavailable, in which case fully adjusted values were extracted and footnoted. Where the 
standard deviation (SD) was unavailable, this was calculated from reported confidence 
intervals (CI):
ܵܦ =  ξܰ × ଽହΨ ஼ூೠ೛೛೐ೝିଽହΨ ஼ூ೗೚ೢ೐ೝଶ×௧ ௩௔௟௨௘ .
When required, change data were calculated as follow-up minus baseline data, or follow-
up data were imputed using baseline plus change data.
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3.3.4 Data synthesis and analysis
Between-group effect sizes (ESs) for various tests within cognitive domains were 
calculated by subtracting the mean change in the control group from the mean 
change in the experimental group and dividing by the pooled SD at baseline:
(ܧܵ = ௫ҧభି௫ҧమ௦ ).
Individual ESs were then corrected for small sample size (Hedges’ g ES) (46) and 95% 
CIs calculated. For post-test comparisons, Cohen’s d ESs were calculated by subtracting 
follow-up data in the control group from follow-up data in the experimental group and 
dividing by the pooled post SD. We used Coe’s calculator (http://www.cem.org/effect-
size-calculator) to generate data from parallel trials in extraction tables. For the cross-
over trial (42) where only change scores were available, we used the F test calculator 
from Campbell’s Collaboration 
(https://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-SMD5.php)
to calculate ESs and CIs and then imputed pooled baseline SD (ܵܦ = ܯܦ/ܧܵ).
Cochrane Review Manager Software, RevMan Version 5.3 (The Cochrane Collaboration, 
Copenhagen) was used to create forest plots when baseline and follow-up data were 
available. A single primary outcome for a given test (e.g., time rather than errors) was 
selected for plotting. The final outcome measure was used where more than two time 
points were provided. The ESs were graphed and described according to Cohen’s 
LQWHUSUHWDWLRQRIµWULYLDO¶µVPDOO¶WRµPRGHUDWH¶ to <0.80) 
DQGµODUJH¶(47). For graphical representation of ESs only, signs were reversed in 
some cases (e.g., processing speed) so that a positive ES represented an improvement 
with Mediterranean diet. We did not plot cognitive composites (e.g., Executive Domain) 
since categorization of cognitive tests within domains varied across studies. However, 
where z scores were available for composites we used these to calculate and discuss ESs.
Where two Mediterranean interventions were compared against one control arm, the 
control number of participants (n) was divided by two, consistent with the 
recommendations of the Cochrane Handbook (48, 49). For the cross-over trial we divided 
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 the n of both groups by two because the authors did not conduct a paired sample analysis 
(50). Statistical heterogeneity was tested using the Chi2 test (significance level: 0.1) and 
I2 statistic (0% to 40%: might not be important; 30% to 60%: may represent moderate 
heterogeneity; 50% to 90%: may represent substantial heterogeneity; 75% to 100%: 
considerable heterogeneity) (51). A random effects model was used as studies included 
in the analysis were assumed to be a random sample of all possible studies that met the 
inclusion criteria for the review (52).
We provided a narrative summary of the standardised mean differences and did not pool 
data within cognitive domains wherever there was: a) a high I2 EDFRPELQDWLRQ
of parallel and cross-over trial data without a paired sample analysis (50), or c) outcomes 
for a given domain were not available from at least three different trials. We considered 
the use of robust variance estimation and multilevel meta-analysis for the cross-over trial 
group, but the number of studies was insufficient (53).
3.3.5 Quality assessment 
Two reviewers (SRV and SLD) independently assessed the quality of included studies 
according to the Physiotherapy Evidence Database (PEDro) scale, designed to assess 
quality of RCTs for major sources of bias (54). However, we modified PEDro criteria as 
follows: a) for studies with multiple publications, a criterion was deemed to be met if 
information was retrievable from any publication; b) for post-test comparisons, the 
criterion for baseline similarity with important prognostic indicators was taken to be 
satisfied if commonly accepted risk factors for cognitive outcomes (e.g., age) were similar 
across groups at baseline.
As there is inconsistency in the definition of the Mediterranean diet in the literature, seven 
additional quality indicators were developed, including 19 unique elements describing 
the ‘traditional’ Mediterranean dietary pattern and cuisine (28). However, these were not 
included in scoring as they have not been validated (See Supplementary Material 3.2 for 
quality rating of Mediterranean diet interventions template). For each of these 19 
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 elements, we rated whether studies: a) prescribed the element, b) specified a quantity, and 
c) met our minimum criterion for a ‘traditional’ pattern. Discrepancies in rating were 
resolved by consensus with a third reviewer (VMF).
3.4 Results
 
3.4.1 Study selection
The initial keyword search identified 6385 titles. Following exclusions based on title or 
abstract and additional hand searching, 30 full text articles were retrieved for evaluation.
One additional RCT was identified after the initial search. Among the 31 selected articles, 
22 were excluded based on eligibility criteria: not RCT design (n=12), not Mediterranean 
diet (n=6), cognitive/brain outcomes not reported (n=3), and secondary intervention 
modality (exercise) not provided to both groups (n=1). The remaining nine articles were 
included for review, representing five RCTs. The largest of these (n=1527), PREDIMED 
(Prevención con Dieta Mediterránea), was a multi-site study that included some cognitive 
outcomes from two sites. One site (Navarra) published four papers (43, 44, 55, 56) and 
correspondence with the authors confirmed that the 2013 publications did not include 
overlap of participants or outcomes, so all were included. The PREDIMED publication 
from Barcelona (57) also did not overlap with the Navarra node participants.
3.4.2 Study characteristics
 
3.4.2.1 Study design and participants
All RCTs were of parallel design, except for one cross-over trial (42) (Supplementary 
Material 3.3). PREDIMED also provided post-test comparisons (43, 44, 55, 56)
(Supplementary Material 3.4). Across the five RCTs, the duration of interventions ranged 
from 10 days to 6.5 years. These community dwelling cohorts (Table 3.1) ranged in size 
from 24 to 1497 (median 166), were 65% female (range 52-100%), with mean age 65.24 
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 years (SD=6.15) (range of individual study mean ages 21.1 to 72.1). Only one trial 
(PREDIMED) was conducted in a Mediterranean region/cultural cohort.
Three studies (42, 58) including one PREDIMED sub-study (57) reported normal 
cognitive status at baseline. Comorbidities were specifically excluded at screening by two 
studies (42, 58) and reported at baseline by another two (45, 57), with the most prevalent 
being hypertension, diabetes and hyperlipidaemia. Relevant medication use was poorly 
reported, with only one PREDIMED sub-study describing medications that were most 
commonly used for hypertension, hyperlipidaemia and diabetes (57). Only PREDIMED, 
in publications for three of its sub-studies, provided data for one or more genotypes 
related to dementia risk (43, 44, 56) (Supplementary Material 3.5).
Four studies (42, 45, 57, 58) reported BMI at baseline, with average overweight status of 
27.78 kg/m2 (SD=3.82). Only PREDIMED reported habitual physical activity and 
educational level at baseline in four of its publications and adjusted for these covariates 
(43, 44, 56, 57) (Supplementary Material 3.5). Reported physical activity level was very 
high in this Spanish study, with up to approximately four times the upper recommended 
MET minutes per week advised for good health to Americans 
(https://health.gov/paguidelines). Educational level was reported, but not adjusted for, in 
the Mediterranean Diet for Cognitive Function and Cardiovascular Health in the elderly 
study (MedLey) (58). The remaining trials did not report measurement or adjustment for 
these factors. 
We attempted to extract habitual sedentary time, size of family unit, whether participant 
was the primary cook, socioeconomic status/financial level and ethnicity but these were 
not reported by any study.
3.4.2.2 Intervention
Behavioural strategies utilised to implement diet. All studies provided individual dietary 
counselling sessions to the intervention group, ranging widely from one session (41, 42)
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 to eight mixed individual and group sessions (45), to both individual and group sessions 
every three months on average, resulting in 12-26 sessions of each type, depending on 
sub-study length (57). Telephone calls or texts for additional supervision were not 
reported by any studies. Logging of dietary intake was reported by four studies with two 
using daily food records (41, 42), one a daily checklist (58) and another (45) a 7-day food 
record but only at baseline and 12 weeks (Supplementary Material 3.6). The use of dietary 
biomarkers to check on dietary compliance was reported by two studies, with 
PREDIMED measuring urinary hydroxytyrosol and plasma alpha linolenic acid (markers 
of specific food intake, namely olive oil and nuts, respectively) and MedLey measuring 
erythrocyte fatty acids, plasma carotenoids and urinary metabolites (markers of the 
dietary pattern, namely monounsaturated to saturated fatty acid ratio, fruit and vegetable 
and mineral intake, respectively) (Supplementary Material 3.7). 
Dietary elements. The prescribed Mediterranean diet varied considerably between the 
five studies, particularly with regards to quantitative advice (Table 3.2). All studies 
provided some advice on the intake of fruit, vegetables, fish/seafood but only 
PREDIMED and MedLey gave quantitative guidance for these foods (57-59). Four
studies advised on the use of fats other than olive oil (41, 42, 45, 57). Four (41, 42, 57-
59) also gave recommendations for the consumption of nuts, dairy, sweets and sweetened 
drinks, but amounts for these foods were variably specified by 2 to 4 of these studies.
Both qualitative and quantitative advice was provided by three studies for the intake of 
wine (42, 57-59) and by four for red/processed meats (41, 42, 57-59). However, only two 
studies provided this level of comprehensive guidance for consumption of olive oil, 
legumes and eggs (57-59). Four out of five studies provided some recommendation on 
poultry (41, 42, 57-59) but only three of these specified how much to consume (41, 42, 
58, 59). PREDIMED was the only study to promote use of sofrito (a rich sauce made with 
tomato and onion simmered in olive oil, widely consumed in the Mediterranean) and 
traditional cooking methods. Despite grain foods, such as bread, playing a major role in 
the Mediterranean diet, only two studies (41, 58, 59) provided any guidance on their 
intake, with MedLey specifying quantities (58, 59), as shown in Table 3.2. Thus, overall, 
most of the experimental diets differed in substantially important ways from the elements 
and quantities of ‘traditional’ Mediterranean diets (28) (Supplementary Material 3.8).
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 Control group intervention. The effect of a Mediterranean diet was compared to either a 
waiting list, usual diet or a low fat control group, depending on the trial (Supplementary 
Material 3.9). A low fat diet was prescribed to controls in PREDIMED based on 
American Heart Association guidelines (57). Three studies (41, 42, 58) from Australia
recommended unspecified ‘usual diet’. One UK study (45) included a waiting list arm, in 
which participants were not discouraged from making dietary changes to their usual diet, 
reporting that some participants elected to do so. A dietitian administered the control 
intervention for only two studies (57, 58). Three of the five studies (41, 42, 45) required 
controls to keep a food record during the intervention period.
Study quality. The overall quality of the included studies according to the modified PEDro 
tool was moderate with four out of five scoring 6 or above (range: 4-8/10). The most 
common limitations were in the areas of subject and therapist blinding, which is 
unavoidable in dietary trials. Three out of five studies (41, 42, 45) did not meet criteria 
for assessor blinding and intention to treat analysis (ITT), despite PEDro being less 
rigorous for ITT compared to CONSORT (60), potentially inflating reported quality. 
With respect to our additional criteria for the intervention itself, only the MedLey study 
met the criterion for participant perception of diet burden or benefit, relevant for 
translating research findings into the public domain. Only PREDIMED and MedLey had 
their diets designed and administered by a dietitian; specified minimum amounts of 
Mediterranean foods to be consumed by participants; or recommended a diet that met at 
least 8/19 of our minimum criterion for the ‘traditional’ Mediterranean diet. Further, just 
two studies reported on diet tolerance (45, 57). However, all studies reported on frequency 
and setting for their diet instruction and assessment of dietary compliance. Figure 3.2
illustrates the percentage of included studies fulfilling the combined quality criteria. 
(Supplementary Material 3.10 and 3.11 show details of quality rating).
When considering the quality of interventions as they relate specifically to the 
‘traditional’ Mediterranean dietary pattern and cuisine, the majority (4/5) (41, 42, 57-59)
met our minimum criterion for sweetened drinks; only three studies (41, 42, 58, 59)
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 achieved this for red/processed meats and sweets; two studies for olive oil, nuts, fruit, 
vegetables and fish/seafood (57-59); two for poultry (41, 42); one study for other fats, 
legumes and sofrito (57) and one for grain foods (58, 59) and wine (42). No studies 
fulfilled our minimum criteria defining the traditionally low intake of dairy products, 
adequate water intake, use of moist cooking methods and eating main meals in company 
as shown in Table 3.2.
Further limitations not captured with the above tools, which could have introduced bias 
or limited robustness of the interventions include: a) use of a waiting list as the control 
group (45), where participants were not discouraged from making dietary or lifestyle 
changes; b) no wash out period for cross-over design (42); and c) outcomes tested only 
in those participants who arrived at scheduled visits for post-test comparisons (43). In 
addition, the MedLey study provided recommendations for dietary serves at four levels 
of energy intake ranging from 6400-9600 kJ per day (59). While the optimal or absolute 
minimum amounts of key Mediterranean foods for cognition and brain function are not 
yet known these, and traditional levels of intake, may not have been reached at the lower 
energy levels for some foods. For example, for energy level 4 (6400 kJ), MedLey 
recommended 1-2 tablespoons of extra virgin olive oil per day, compared to at least 4 
tablespoons reported to have been consumed in the Cretan Mediterranean diet in the 
1960s (61).
Study adherence and tolerance. Only two out of five studies (42, 45) reported participant 
attendance at intervention sessions, ranging from 86-100%, respectively. Dropout rates 
for the RCTs varied from a median of 13.1% (range 0-19.5%) in the experimental groups 
to 10.7% (range 0-33.1%) in the control groups, increasing with trial duration. Adverse 
events were poorly reported, with only 1 out of 5 studies (45) reporting that no 
participants experienced adverse effects from the intervention. PREDIMED authors have 
indicated that such data were collected (62), but this has not yet been published, to our 
knowledge, for the sub-cohorts in the included studies.
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 3.4.3 Cognitive outcomes
 
3.4.3.1 Overview 
The five included studies encompassed 1888 participants and reported on 66 cognitive 
test outcomes. Effect sizes were able to be calculated from reported data or authors’ 
information in 63/66 (95.5%). We extracted mean cognitive scores for all studies and 
outcomes and report these in Supplementary Material 3.12. We plotted the most 
indicative outcomes for those tests, which had both baseline and follow-up data to 
illustrate the scope of current research (Figures 3.3-3.5). Outcomes and original Cohen’s 
d ESs from trials where cognition was measured at only one time point are not plotted 
and can be viewed in Supplementary Material 3.12. However, these are included in the 
text summary of overall ESs within each domain. Overall, only 8/66 (12.1%) of the 
individual cognitive outcomes were statistically significant at the trial level in favour of 
a Mediterranean diet. Two additional cognitive outcomes (3.0%) significantly favoured 
controls, however these were from studies which either had a ‘waiting list’ control group, 
which may have adopted some elements of the experimental diet (45) or did not include 
a washout where the design was cross-over (42). Two studies reported composite domain 
z scores (57, 58) (Supplementary Material 3.12), although component tests were not the 
same. For PREDIMED (57) the three composites included the following tests: 1) Memory 
(Rey Auditory Verbal Learning Test (RAVLT) and Verbal Paired Associates from the 
Wechsler Memory Scale); 2) Frontal (Digit Backward Test from the Wechsler Adult 
Intelligence Scale (DBT) and Color Trail Test (parts 1 and 2); 3) Global (all individual 
tests within study, including the Mini-Mental State Examination). For MedLey, the five 
composites and their included tests were: 1) Executive (Stroop (interference control), 
Initial Letter Fluency (ILF), Excluded Letter Fluency (ELF) and Tower of London 
(TOL)); 2) Memory (RAVLT, Digit Span Forward (DSF); Digit Span Backward (DSB) 
and Letter-Number Sequencing (LNS)); 3) Speed of Processing (Symbol Search and 
Coding); 4) Visual-Spatial Memory (The Benton Visual Retention Test (BVRT)); 5) 
Global (all individual tests within study). The three composites from PREDIMED 
(Memory, Frontal, Global) were significantly improved with the intervention, with ESs 
ranging from small (0.39) to large (1.29), to different degrees by the EVOO or Nuts arm 
77
 of the trial, as described below. By contrast, the MedLey study composites were not 
improved by the Mediterranean diet. No results were able to be pooled for a meta-analysis 
due to pre-defined limitations with regards to heterogeneity and number of studies 
available (see above).
3.4.3.2 Global cognition
Three tests from one study (PREDIMED) reported on global cognition, including one 
parallel (57) (Figure 3.3A) and two post-test (43, 44) (Supplementary Material 3.12) 
comparisons with ESs ranging from 0.15 to 0.63, one being significant. While 
PREDIMED used two experimental groups, only the Mediterranean Nuts group 
performed significantly better than control with a moderate ES (ES=0.63; 0.26, 0.99) for 
MMSE (44) at the 6.5 year time point in the Navarra sub-study site (Supplementary 
Material 3.12). Limited outcomes from this single study precluded data pooling for this 
domain.
In addition to the single tests noted above, two studies (57, 58) provided composite global 
cognition z scores as one of their primary cognitive outcomes. In the PREDIMED sub-
study from Barcelona (57) with participants selected for cardiovascular risk, there were 
large and significant ESs for Global Cognition composite for both Mediterranean diet 
types: ES=1.29 (0.65, 1.92) for Mediterranean EVOO and ES=1.12 (0.44, 1.81) for 
Mediterranean Nuts at 4.1 years. The MedLey study (58) of 24 weeks duration with 
healthy participants, by contrast, did not report benefits for the Mediterranean diet on its 
global (Total Cognitive Function) composite score. Overall, there is evidence of large, 
significant global cognitive benefits for the Mediterranean diet in the most robust trial.
A post-test comparison from the PREDIMED Navarra node (56), at 6.5 years, reported 
for the first time on Mediterranean diet-gene interactions for cognition, pooling the 
EVOO and Nuts Mediterranean groups for this analysis. These investigations were 
undertaken as genome-wide association studies have identified several single nucleotide 
polymorphisms that increase the risk of late-onset AD (63, 64). A significant interaction 
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 was found between the CLU-rs11136000 gene and the Mediterranean diet, with 
significantly improved performance (ES=0.45; 0.12, 0.79) on the MMSE in the 
Mediterranean diet groups only for carriers of the harmful T allele (which occurs at a 
minimum in 40% of the population). By contrast, there was a small significant benefit 
(ES=0.40; 0.09, 0.70) for MMSE scores in the Mediterranean diet group for homozygotes 
with both protective GG alleles for CR1-rs3818361 compared to other genotypes. Finally, 
MMSE scores were significantly better in the Mediterranean group compared to controls 
regardless of ApoE4 status (ApoE4 non-carriers: p=0.007; ApoE4 carriers: p=0.037).
Data were not provided to allow comparison of ESs relative to ApoE status, however.
3.4.3.3 Attention
Seven tests from three studies reported on attention, including four parallel (41, 45) and 
three cross-over (42) comparisons (Figure 3.3B). The ESs ranged widely IURPí15.95 to 
0.63, and no significant benefits were attributed to the Mediterranean diet. Unexpectedly, 
the control group from one 12-week study (45) performed significantly better on one test 
(sustained attention task (SAT)) (45). Non-robust design features may explain these 
results as the control arm was a waiting list where participants were not discouraged from 
making dietary changes, and some elected to do so, suggesting potential contamination.
With limited outcomes and heterogeneity between studies (I2=97%) precluding pooling, 
definitive conclusions about this domain are not possible. 
3.4.3.4 Working memory
Thirteen tests from four studies reported on working memory, including eight parallel 
(41, 57, 58) and three cross-over (42) comparisons (Figure 3.3C) as well as two post-test 
(44) comparisons (Supplementary Material 3.12). These ESs ranged widely IURPí1.49 
to 0.74 with three being significant. There was a moderate ES benefit for Mediterranean 
Nuts on the DSB test (ES=0.74; 0.08, 1.40) (57) (Figure 3.3C) and a small ES benefit for 
Mediterranean EVOO on DSF (ES=0.47; 0.11, 0.83) post-test comparison (44)
(Supplementary Material 3.12) in the PREDIMED study. By contrast, the control group 
performed significantly better on 3-back correct responses test in the cross-over study 
(42), although interpretation is limited by this study design as noted above. Heterogeneity 
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 across studies was moderate (I2=46%) but the number of RCTs was insufficient to warrant 
a multilevel meta-analysis to control for the correlation between subjects in cross-over 
trials and multiple outcomes of each study. Overall, no consistent evidence of 
Mediterranean diet benefit was present.
3.4.3.5 Processing speed
Nine tests from five studies reported on processing speed, including six parallel (41, 45, 
57, 58), two cross-over (42) and one post-test (44) comparison. The ESs ranged from
í0.55 to 0.51, none of which were significant (Figure 3.4A). Heterogeneity across studies 
was low (I2=0%) but the number of studies was insufficient to warrant a multilevel meta-
analysis to control for the correlation between participants in cross-over trials and 
multiple outcomes of each study. A composite z score for Processing Speed from MedLey 
was also non-significant (58). Thus, there is no evidence for benefits of a Mediterranean 
diet intervention on processing speed in the existing literature.
3.4.3.6 Verbal and visual memory
Nineteen tests from five studies reported on verbal and visual memory, including 10
parallel (41, 45, 57, 58) and four cross-over (42) comparisons (Figure 3.4B) and five post-
test (44) comparisons (Supplementary Material 3.12). The ESs ranged from í0.55 to 1.66, 
with only one large ES in the cross-over trial (42) without a wash out period favouring 
the Mediterranean diet for the immediate word recall-correct responses test (ES=1.66; 
0.67, 2.66). Valls-Pedret, et al. (57) also reported in their paper that performance on 
RAVLT total learning test by the Mediterranean EVOO group was significantly different 
to control (p<0.05), which may be likely due to appropriate statistical adjustment which 
we were unable to make. Heterogeneity across studies was moderate (I2=46%) but the 
number of studies was insufficient to warrant a multilevel meta-analysis. There was also 
a small but significant ES for the composite z scores for Memory domain in PREDIMED 
for the Mediterranean Nuts group (ES=0.39; 0.05, 0.73) (57) but not in MedLey. Overall, 
there appears to be limited and inconsistent evidence of benefit of the Mediterranean diet 
for verbal and visual memory.
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 3.4.3.7 Visuo-spatial 
Three tests from one study (44) reported on visuo-spatial domain based on post-test 
comparisons after 6.5 years, with ESs ranging from 0.00 to 0.32 (Supplementary Material
3.12). At this time point, only the Mediterranean EVOO group performed significantly 
better on the Clock Drawing Test (CDT) with a small ES (ES=0.32; 0.04, 0.60). The 
limited outcomes precluded data pooling. A composite of z scores was only available for 
Visual-Spatial Memory domain from MedLey (58) but this was not significant. Overall, 
for visuo-spatial function, there is limited evidence of benefit for a Mediterranean diet.
With respect to genetic predictors of performance on the CDT, in post-test analyses from 
PREDIMED (56), individuals with the harmful T allele for CLU-rs11136000 did 
significantly better on the Mediterranean diet compared to controls, with a small ES 
(ES=0.42; 0.09, 0.75). By contrast, for both CR1-rs3818361 and PICALM-rs3851179, 
those with protective alleles receiving the Mediterranean diet significantly outperformed 
control (ES=0.33; 0.03, 0.64 and ES=0.40; 0.03, 0.76, respectively). Cognitive 
performance on the CDT was only better than control for ApoE4 non-carriers in the 
Mediterranean EVOO group (p<0.001). Notably, these gene interaction patterns were the 
same across both the MMSE and CDT tests for the CLU-rs11136000 and CR1-rs3818361 
genes, where those with harmful and beneficial genotypes, respectively, responded better 
to the Mediterranean diet. However, while APOE4 carrier status had no effect on MMSE 
performance, non-carriers (beneficial genotype with lower risk of dementia) responded 
better on the CDT of visuo-spatial function.
3.4.3.8 Language
Six tests from two studies reported on language, including three parallel (57, 58) (Figure
3.5A) and three post-test (44) (Supplementary Material 3.12) comparisons. The ESs 
UDQJHGIURPí0.48 to 0.45. Only one test (phonemic verbal fluency-letter F, A, S) (44) at 
trial level favoured Mediterranean EVOO with a small ES at 6.5 years follow-up 
(ES=0.45; 0.09, 0.81) (Supplementary Material 3.12). Heterogeneity across studies was 
low (I2=0%) but the number of studies was insufficient to pool data for a meta-analysis. 
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 Thus, there is minimal evidence for a benefit of the Mediterranean diet on language in 
current literature.
3.4.3.9 Executive function 
Five tests from two studies reported on executive function, including three parallel (57, 
58) (Figure 3.5B) and two post-test (44) (Supplementary Material 3.12) comparisons. 
Overall, the ESs for this domain ranged from í0.16 to 0.75 with only one being 
significant. Specifically, the Mediterranean EVOO group performed better than control 
on the Color Trail Test 2 (CTT 2) at 4.1 years in PREDIMED with a moderate ES 
(ES=0.75; 0.14, 1.35) (Figure 3.5B). Heterogeneity across studies was low (I2=29%) but 
the number of studies was insufficient to pool data for a meta-analysis. PREDIMED (57)
also reported a composite of z scores for executive function (described as Frontal 
Cognition), finding a moderate significant ES for Mediterranean Nuts (ES=0.72; 0.06, 
1.38) and large significant ES for Mediterranean EVOO (ES=1.02; 0.40, 1.61). By 
contrast, the ES for the Executive Function composite from MedLey was not significant 
(58). Thus, overall, there is some evidence for moderate to large benefit in this domain, 
although the data supporting this are limited to one study.
3.4.3.10 Motor control
No studies reported on outcomes within this domain. 
3.4.4 Brain morphology/function outcomes
Only one post-test comparison from PREDIMED Navarra (55) (n=243) reported on a 
plasma neuroplasticity biomarker (BDNF), which promotes connectivity between 
neurons, at 3 years in a randomly selected subsample from the original cohort 
(Supplementary Material 3.13). Overall, there were no differences between groups in 
plasma BDNF levels. However, the Mediterranean Nuts group had a 78% decreased risk 
of plasma BDNF levels below the 10th percentile (OR=0.22; 95% CI: 0.05, 0.90) at this 
time point. When analyses were stratified according to prevalence of different diseases at 
baseline there were no significant differences between groups with our calculated ESs 
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 UDQJLQJ IURP í0.17 to 0.11. However, the authors of this PREDIMED comparison 
reported that significantly higher BDNF levels (p<0.05) were found in those with 
depression at baseline assigned to the Mediterranean Nuts diet, compared to control, for 
whom baseline BDNF levels were also available (n=37), presumably due to appropriate 
statistical adjustments, which we were unable to make. Conclusions are limited as plasma 
BDNF was not measured at baseline for most participants, which could have introduced 
bias. 
3.4.5 Incident MCI and dementia
Three PREDIMED post-test comparisons (43, 44, 57) included incidence rates for MCI 
and one for dementia (43) at 4.1 or 6.5 years but these were not significantly different 
between groups. For the smaller cohort from the Navarra node (44) incident MCI was 
7.80%-11.80% in the two Mediterranean diet groups vs. 19.30% in the control group 
whereas a sub-study of a larger cohort from this node (43) reported incident MCI as 
5.13%-5.40% vs. 6.53%, respectively. The latter sub-study however may include 
measurement error, as data were ascertained from medical records rather than actual 
assessment, which could underestimate cases. In the post-test comparison from Barcelona 
(57) incident MCI was 7.1%-13.4% vs. 12.6% (adjusted p=<0.28) in Mediterranean diet 
and control groups, respectively. Incident dementia was reported from the Navarra node 
as 1.70%-3.42% in the Mediterranean diet groups vs. 4.83% in the control (43) but, for 
the reason outlined above, may also underestimate cases, although both MCI and 
dementia outcomes in PREDIMED were blindly assessed, so this bias should have 
affected both groups equally. Thus, there is no experimental evidence at this time to 
corroborate observational data (30) showing an association between followers of a 
Mediterranean dietary pattern and incident dementia.
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 3.5 Discussion
3.5.1 Key findings
This is the first systematic review to our knowledge to evaluate the effect of a 
Mediterranean diet on cognitive function or brain morphology/function exclusively in 
RCTs. Convincing evidence for a significant beneficial effect of the Mediterranean diet 
on cognitive function or brain morphology/function across all available studies and 
outcomes is lacking, and there was a lack of dietary uniformity and trial design precluding 
meta-analysis. However, at the individual trial level, there were significant ESs, ranging 
from 0.32 to 1.66, in favour of a Mediterranean diet for eight test outcomes related to 
global cognition, working memory, verbal and visual memory, visuo-spatial, language 
and executive function domains. 
Importantly, significant ESs were found for composite z scores for Global Cognition, 
Memory and Frontal Cognition domains within PREDIMED (57), ranging from 0.39 to 
1.29. The size of these composite effects may be clinically relevant, as the controls z 
scores declined by íWRí0.38 over the trial, whereas the Mediterranean diet groups 
either remained stable or improved by í0.05 to 0.23 z scores (Supplementary Material
3.12). This suggests the Mediterranean diet may attenuate cognitive decline, or improve
cognition, despite four years of aging.
The success of the PREDIMED sub-study from Barcelona should be interpreted in light 
of its design features and cohort selection. Robust design features include diet design and 
administration by dietitians, prescription and provision of actual quantities of targeted 
foods, consistency with ‘traditional’ Mediterranean dietary patterns, long duration (4.1 
years) and measurement of cognition using gold-standard neuropsychological tests at 
baseline and follow-up. It is likely that the cognitive benefits seen in PREDIMED may 
represent a conservative estimate of potential efficacy, since the two Mediterranean diets 
were compared to a healthy low fat diet, which is an intervention in itself. Additionally, 
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 PREDIMED was conducted in highly active people living within a Mediterranean culture,
so the external generalisability of their results would need to be proven.
There is insufficient evidence relating genotype to Mediterranean diet benefits at this 
time, as mixed results were obtained for four genes only studied in PREDIMED. No 
studies reported brain morphology outcomes, and only one study found a potential benefit 
for BDNF in a subset of participants. Thus, suggestions of protective effects on brain 
morphology from observational studies (15, 65-68) could not be corroborated. Incident 
MCI and dementia rates did not differ significantly, although no study was powered for 
these as primary outcomes and numbers of cases were low. 
To put our findings in perspective, the Finnish Geriatric Intervention Study to Prevent 
Cognitive Impairment and Disability (FINGER), which used a multi-domain intervention 
including diet (non-Mediterranean), exercise, cognitive training and vascular risk 
monitoring over two years reported an ES of 0.13 for overall cognitive performance (69).
Meta-analyses of RCTs on the effect of aerobic exercise (70) and computerized cognitive 
training (71) on cognitive performance have reported ESs from 0.12 to 0.16 and 0.08 to 
0.31, respectively. Thus, the most robust trial of the Mediterranean diet to date compares 
favourably to these other interventions.
Potential reasons for inconsistent efficacy of a Mediterranean diet across RCTs compared 
to more homogeneous benefits seen in previously reviewed observational studies include: 
a) short intervention time to see significant change in physically and cognitively healthy 
cohorts in four of the five studies, b) use of varied Mediterranean diet interventions which 
may not have provided an adequate ‘dose’ of foods important for cognition, and c) lack 
of consistent and sensitive methodologies to measure cognitive change.
3.5.2 Mechanisms
Potential mechanisms for a protective effect of the Mediterranean diet for dementia (30)
as well as cardiovascular disease (CVD) and its risk factors (72), type 2 diabetes (73, 74),
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 breast cancer (75), macular degeneration (76), osteoarthritis (77), and fatty liver (78),
have been extensively reviewed. These include anti-inflammatory, antioxidant and 
microbiome effects, which are also associated with multiple vascular risk factors (16, 79).
The Mediterranean dietary pattern could potentially contribute to better health and
cognition by lowering the glycaemic load (80) and advanced glycation end products 
(AGEs) (81); and increasing dietary fibre, omega-3, polyphenols (16), arginine (82),
nitrate (83) and melatonin (84), which have been suggested to influence mechanistic 
pathways. Unfortunately, none of the trials reviewed reported vascular risk factor 
profiles/biomarkers in relation to cognitive health outcomes, so it is unclear if lack of risk 
factor improvement explains the minimal cognitive benefits observed across the majority 
of outcomes reported. Given that these risk factor profile data are available in other 
reports from PREDIMED (85-87), future exploration of these relationships may be 
possible in these or future trials. 
3.5.3 Implications
In the absence of treatment or cure for dementia, reducing known risk factors takes on 
added importance (2). PREDIMED, the largest RCT testing a Mediterranean diet 
supplemented with EVOO or Nuts, showed significant risk reduction of primary CVD by 
30% after a median follow-up of 4.8 years (72), mainly due to decreased stroke risk. As 
stroke and vascular factors, particularly in mid-life (88), are thought to drive cognitive 
decline with age, such a finding is also of relevance to cognition and brain 
morphology/function. However, despite the CVD evidence being used as a basis for 
recommending this dietary pattern (89-93) it is premature to specifically advise the 
Mediterranean diet for cognition due to the limited empirical evidence at this time. 
PREDIMED PLUS (94) and the BRIDGE trial (95), which also include energy restriction 
and physical activity elements will provide new data on cognitive benefits.
3.5.4 Strengths and limitations
We used a robust and sensitive search strategy with no language or date limitations.
Another strength of our review is that our authors included experienced dietitians 
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specialising in the Mediterranean diet, who undertook an analysis of the dietary 
components and interventions used, which is a novel aspect of our paper and addresses a 
recent criticism on methodologic quality of systematic reviews on the Mediterranean diet 
(96). Further, we attempted to contact authors to clarify poor reporting and increase the 
accuracy of our reporting. However, only one author was responsible for initial study 
selection. Unpublished data were not searched for and we included RCTs with outcomes 
measured only at follow-up or of short duration (10 days).
3.5.5 Future research
Future RCTs should: a) include larger participant numbers and test various cognitive and 
brain morphology/function outcomes, be longer than 1.5 years in duration (97) and have 
a parallel design to avoid potential residual brain structural or connectivity changes in 
cross-over studies (98), b) target at-risk groups, c) characterise relevant genotypes and 
health status/lifestyle factors related to cognition, d) include baseline assessment of 
Mediterranean diet adherence and apply exclusion where this is high; define minimum 
quantities of recommended foods; provide culinary instructions by dietitians, including 
cooking; assess potential impact of chrononutrition, e.g., meal size/frequency and timing; 
use novel technologies to increase compliance; use dietary compliance biomarkers 
including development of a Mediterranean food metabolome (99), e) utilise a usual diet 
as comparator (100), f) undertake standardised neuropsychological assessment at baseline 
and at least one follow-up time point, g) include biomarkers and neuroimaging.
3.5.6 Conclusion
There is currently inconsistent empirical evidence for significant benefits of the 
Mediterranean diet for cognitive function in a small body of literature. No empirical data 
have been reported linking this diet to brain morphology or connectivity. However, 
significant and clinically meaningful effect sizes were found for cognitive composites 
in the largest and most robust trial, indicating promising scope for future well-designed 
trials.
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 Table 3.1. Study characteristics at baseline1
Study Author (yr), 
country
Study design 
& duration 
n (% F) Mean age 
(y) (SD)
Cognitive status Health status Comparative 
condition/s to 
Mediterranean 
diet
1 Wardle (2000), 
Britain (45)
Parallel, 12 wk 176 (52) 53.01 (10.1) Not specified at 
baseline
Selected for 
CV risk: total 
cholesterol 
 mM
Waiting list 
(Exp low fat 
diet also 
compared to 
this)
2 McMillan (2011), 
Australia (41)
Parallel, 10 d 25 (100) 21.1 (3.3) Not specified at 
baseline
Healthy Usual diet
3 PREDIMED sub-studies (2011-2015)
Sanchez-Villegas 
(2011), Spain (55)
Post-test 
comparison at 
3 y
243 (51) 67.85 (6.0) Not specified at 
baseline
Selected for 
CV risk: type 2 
'0RU
major CV risk 
factors
Low fat diet 
3 Martinez-
Lapiscina (2013), 
Spain (43)
Post-test 
comparison at 
6.5 y
285 (55) 67.34 (5.7) Not specified at 
baseline
Selected for 
CV risk: type 2 
'0RU
major CV risk 
factors
Low fat diet
100
Table 3.1. - cont.
Study Author (yr), 
country
Study design 
& duration 
n (% F) Mean age 
(y) (SD)
Cognitive status Health status Comparative 
condition/s to 
Mediterranean 
diet
3 Martinez-
Lapiscina (2013), 
Spain (44)
Post-test 
comparison at 
6.5 y
522 (55) 67.38 (5.7) Not specified at 
baseline
Selected for 
CV risk: type 2 
'0RU
major CV risk 
factors
Low fat diet
3 Martinez-
Lapiscina (2014), 
Spain (56)
Post-test 
comparison at 
6.5 y
522 (56) 67.00 (6.0) Not specified at 
baseline
Selected for 
CV risk: type 2 
'0RU
major CV risk 
factors
Low fat diet
3 Valls-Pedret 
(2015), Spain (57)
Parallel, 4.1 y 447 (51) 66.73 (5.5) Normal (MCI 
excluded at baseline 
with 
neuropsychological
testing)
Selected for 
CV risk: type 2 
'0RU
major CV risk 
factors
Low fat diet
4 Lee (2015), 
Australia (42)
Cross-over,
10 d
24 (100) 25.6 (5.1) Normal (neurological 
& psychiatric disorders 
excluded at baseline)
Healthy Usual diet
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Table 3.1. - cont.
Study Author (yr), 
country
Study design 
& duration 
n (% F) Mean age 
(y) (SD)
Cognitive status Health status Comparative 
condition/s to 
Mediterranean 
diet
5 Knight (2016), 
Australia (58)
2-cohort 
parallel, 24 wk
166 (gender 
for 
completers: 
53)
72.1 (5.0)2 Normal (MCI & 
dementia excluded at 
baseline with 
neuropsychological 
testing)
Healthy Usual diet
1 CV, cardiovascular; DM, diabetes mellitus; Exp, experimental; MCI, Mild Cognitive Impairment; SD, standard deviation; wk, week; y, 
years; yr, year; %, percent.  
2 Mean age and SD for completers only.
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 Table 3.2. Dietary elements prescribed for the Mediterranean diet1
Dietary 
Element
Minimum Criterion2 Wardle 
(2000) (45)
McMillan 
(2011) (41)
PREDIMED 
Study*
Lee (2015) 
(42)
MedLey 
Study (2016) 
(58, 59)
M
e
n
t
i
o
n
e
d
Q
t
y
 
G
i
v
e
n
M
e
t
 
M
i
n
.
M
e
n
t
i
o
n
e
d
Q
t
y
 
G
i
v
e
n
M
e
t
 
M
i
n
.
M
e
n
t
i
o
n
e
d
Q
t
y
 
G
i
v
e
n
M
e
t
 
M
i
n
.
M
e
n
t
i
o
n
e
d
Q
t
y
 
G
i
v
e
n
M
e
t
 
M
i
n
.
M
e
n
t
i
o
n
e
d
Q
t
y
 
G
i
v
e
n
M
e
t
 
M
i
n
.
3
Olive oil 2 TBSP (40 mL)/d or to be used as 
principal fat/oil in diet
X X X X X X
Other fats4 Max allowed: 10 g/d (about 2 tsp) X X5 X6 X X X X 7 X
Nuts 3 serves/wk (1 serve = 30 g) X X X X X X X X
Legumes 2 serves/wk (1 serve = 150 g or 1 cup 
cooked or canned legumes)
X X X X X
Vegetables 2 serves at 2 meals/d or 4 serves/d 
total (1 serve = ½ cup cooked (75 g) 
or 1 cup raw)
X X X X X X X X X
Sofrito 2 times/wk rich tomato sauce with 
onion/garlic simmered in EVOO 
X X X
Fruit 2 serves/d (1 serve = 1 medium or 2 
small pieces or 1 cup diced fruit); 
excludes FJ
X X X X X X X X X
103
Table 3.2. - cont.
 
Dietary 
Element
Minimum Criterion2 Wardle 
(2000) (45)
McMillan 
(2011) (41)
PREDIMED 
Study*
Lee (2015) 
(42)
MedLey 
Study (2016) 
(58, 59)
M
e
n
t
i
o
n
e
d
Q
t
y
 
G
i
v
e
n
M
e
t
 
M
i
n
.
M
e
n
t
i
o
n
e
d
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t
y
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v
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n
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n
.
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e
n
t
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n
e
d
Q
t
y
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i
v
e
n
M
e
t
 
M
i
n
.
M
e
n
t
i
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n
e
d
Q
t
y
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i
v
e
n
M
e
t
 
M
i
n
.
M
e
n
t
i
o
n
e
d
Q
t
y
 
G
i
v
e
n
M
e
t
 
M
i
n
.
3
Grain foods 1-2 serves/meal (or 3-6 serves/d) of 
any, preferably wholegrain; (1 serve 
= 1 slice bread or ½ cup cooked 
pasta, rice, barley, bulgur etc.)
X X X X
Fish or 
shellfish
2 serves/wk unless vegetarian (1 
serve = 1 small fillet or 1 small can 
or 200 g shellfish)
X X X X X X X X X
Poultry Max allowed: 2 serves/wk (1 serve = 
80 g cooked or 100 g raw)
X 8 X 8 X 8 X X 8 X 8 X 8 X X
Red meat & 
processed 
meat
<2 serves/wk red meat & <1 
serve/wk processed meat (1 serve = 
100-150 g)
X 8 X 8 X 8 X X X X X X X X
Eggs Max allowed: 4/wk X X 9 X X
Dairy 
products
Max allowed: 2 serves/d (1 serve = ½ 
cup (120 g) ricotta/cottage, 50 g 
fetta, ¾ cup (200 g) yogurt, 2 slices 
(40 g) cheese, 1 cup (250 mL) milk)
X X X X X X
Sweets Max allowed: 2 times/wk X X X X X X X X X X X
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Dietary 
Element
Minimum Criterion2 Wardle 
(2000) (45)
McMillan 
(2011) (41)
PREDIMED 
Study*
Lee (2015) 
(42)
MedLey 
Study (2016) 
(58, 59)
M
e
n
t
i
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n
e
d
Q
t
y
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e
n
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n
.
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n
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.
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.
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n
.
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v
e
n
M
e
t
 
M
i
n
.
3
Sweetened 
drinks
Max allowed: <1 serve/d; (1 serve = 
1 cup (250 mL))
X X X X X X X X X X X X
Wine Max allowed: 14 std drinks/wk (1 std
drink = 100 mL)
X X X X X X X
Water 5 cups/d
Moist 
cooking 
methods10
)RUPDLQPHDOVZN X11
Main meals 
eaten in 
company 
)RUPDLQPHDOVZN
1 EVOO, extra virgin olive oil; FJ, fruit juice; Max, maximum; Mentioned, element mentioned in study; Met Min., minimum criterion for 
traditional diet was met; Min, minimum; Qty. Given, quantity was specified by authors; std, standard; TBSP, tablespoon; tsp, teaspoon; wk, 
week.
2 Minimum criterion for traditional Mediterranean diet as defined in PROSPERO protocol registration no.: 42015024088.
3 Provided four levels of energy intake ranging from 6400-9600 kJ/d with adjustments made for serves from food groups.  Comparison was 
made with level 2 (8600 kJ/d) recommendations as participants were mostly older men. Advised on discretionary foods as one group.
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 4 Other fats include butter, margarine, cream, refined vegetable oils etc.
5 Paper doesn’t provide quantities but recommended reduce total fat to 30% of energy and swap most saturated fats with monounsaturated 
fats.
6 Paper doesn’t provide quantities but recommended ‘healthy fat (providing essential fatty acids)’.
7 While paper describes recommendation to abstain from butter and margarine, use of other oils is not specified.
8 Correspondence with authors confirmed both red meat and poultry were excluded from eating plan and only fish was permitted.
9 While allowance is not in accordance with minimum criterion the protocol provides quantitative guidance for eggs, i.e. unlimited.
10 Moist cooking methods include boiling, stewing, steaming etc.
11 Recommended traditional cooking methods are assumed to be moist cooking methods.
* Includes (43, 44, 55-57)
 
106
Retrieved for evaluation 
n = 30
Intervention Terms
&UHWDQGLHW0HGLWHUUDQHDQGLHW
0HGLWHUUDQHDQGLHWDU\SDWWHUQ
0HGLWHUUDQHDQW\SHGLHW
0HG'LHW0H'L0H'LHW
Outcome Terms
brain-derived neurotrophic factor, CT scan*, executive 
function, gray matter, grey matter, lumbar puncture, 
magnetic resonance imaging, mild cognitive impairment, 
neurological test*, neuropsychological test*, post-
mortem brain examination, problem solving, reaction 
time, spinal puncture, spinal tap, white matter, 
Alzheimer, BDNF, brain, cerebral, cerebrovascular 
cognition, cognitive, cortical, dement*, fMRS, intellect*, 
intelligen*, IQ, memory, mental, MRI, neural, neuro*, 
neurologic, neurotransmitter*, thinking, tomography, 
visuo-spatial.
Search results 
n = 6385
References fully assessed 
n = 31
Included articles
n = 9
(representing 5 trials) 
Excluded on basis of 
title or abstract 
n = 4603
Added from hand 
searching
n = 1
Excluded on basis of 
eligibility criteria 
n = 22
After removal of duplicates 
n = 4633
Duplicates removed 
n = 1752
FLJXUH 1 35,60$ IORZ FKDUW RI VWXG\ VFUHHQLQJ DQG VHOHFWLRQ SURFHVV
 LQGLFDWHV DOO SRVVLEOH ZRUG H[WHQVLRQV XVHG ZKHQ VHDUFKLQJ
GDWDEDVHV %'1) %UDLQGHULYHG 1HXURWURSKLF )DFWRU &7 FRPSXWHG
WRPRJUDSK\ I056 IXQFWLRQDO PDJQHWLF UHVRQDQFH RI WKH EUDLQ ,4
LQWHOOLJHQFH TXRWLHQW05,PDJQHWLFUHVRQDQFHLPDJLQJ
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FLJXUH 23HUFHQWDJHRIILYHLQFOXGHGVWXGLHVIXOILOOLQJTXDOLW\FULWHULD1RWH±FULWHULRQIRU 'NH\RXWFRPHV!
LQLWLDO VXEMHFWV' LV RXW RI QLQH EHFDXVH LW GLIIHUHG EHWZHHQ SXEOLFDWLRQV IRU D VLQJOH VWXG\ ,77, LQWHQWLRQ WR WUHDW
DQDO\VLV0HG, 0HGLWHUUDQHDQ
20%
100%
100%
40%
40%
40%
40%
100%
100%
40%
78%
40%
0%
0%
80%
80%
100%
80%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Perception of diet burden or benefit reported
Diet compliance assessed
Frequency & setting for diet instruction reported
Diet tolerance reported
Diet meets at least 8 defined minimum criterion
Minimum Med diet foods specified
Diet designed & administered by dietitian
Point & variability measures
Between group statistics
ITT analysis
Key outcomes for >85% initial subjects
Assessors blinding
Therapist blinding
Subject blinding
Baseline similarity
Concealed allocation
Random allocation
Eligibility criteria specified
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A Global cognition
(95% CI lower, upper) (95% CI lower, upper)
B Attention
(95% CI lower, upper) (95% CI lower, upper)
C Working memory
(95% CI lower, upper) (95% CI lower, upper)
(57)
(57)
(41)
(41)
(41)
(57)
(57)
(57)
(57)
(42)
(42)
(42)
(58)
(58)
(58)
(45)
(41)
(41)
(41)
(42)
(42)
(42)
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'JHVSF (IIHFWRI0HGLWHUUDQHDQGLHWRQ$JOREDOFRJQLWLRQ%DWWHQWLRQDQG&ZRUNLQJ
PHPRU\:HXVHGUDQGRPHIIHFWPRGHOV6WDQGDUGLVHGPHDQGLIIHUHQFHVZHUHFDOFXODWHGE\VXEWUDFWLQJWKHPHDQ
FKDQJHLQWKHFRQWUROJURXSIURPWKHPHDQFKDQJHLQWKH0HGGLHWJURXSDQGGLYLGLQJE\WKHSRROHG6'DWEDVHOLQH
'DWDLVSUHVHQWHGDVVWDQGDUGLVHGPHDQGLIIHUHQFHDQG&,)RU/HHHWDOQZDVGLYLGHGE\WZRDVFURVV
RYHU WULDO DQG EDVHOLQH 6' ZDV LPSXWHG WR JHQHUDWH IRUHVW SORWV 9DOOV3HGUHW HW DO  FRQWDLQHG WZR 0HG
H[SHULPHQWDO JURXSV VR WKH FRQWURO JURXSZDV GLYLGHG E\ WZR'6%'LJLW 6SDQ%DFNZDUG'6)'LJLW6SDQ
)RUZDUG (922 H[WUD YLUJLQ ROLYH RLO /16 /HWWHU1XPEHU 6HTXHQFLQJ0HG 0HGLWHUUDQHDQ 006(
0LQL0HQWDO 6WDWH([DPLQDWLRQ57UHDFWLRQ WLPH59,35DSLG9LVXDO,QIRUPDWLRQ3URFHVVLQJ6$76XVWDLQHG
$WWHQWLRQ7DVN6WGVWDQGDUGLVHG:0ZRUNLQJPHPRU\
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A Processing speed
(95% CI lower, upper) (95% CI lower, upper)
B Verbal and visual memory
(95% CI lower, upper) (95% CI lower, upper)
(57)
(57)
(57)
(57)
(57)
(57)
(41)
(41)
(41)
(41)
(42)
(42)
(42)
(42)
(58)
(58)
(41)
(41)
(57)
(57)
(42)
(42)
(58)
(58)
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)LJXUH (IIHFWRI0HGLWHUUDQHDQ GLHW RQ $ SURFHVVLQJ VSHHG DQG % YHUEDO DQG YLVXDOPHPRU\:H XVHG
UDQGRPHIIHFWPRGHOV6WDQGDUGLVHGPHDQGLIIHUHQFHVZHUHFDOFXODWHGE\VXEWUDFWLQJWKHPHDQFKDQJHLQWKHFRQWUROJURXS
IURPWKHPHDQFKDQJHLQWKH0HGGLHWJURXSDQGGLYLGLQJE\WKHSRROHG6'DWEDVHOLQH 'DWDLVSUHVHQWHGDVVWDQGDUGLVHG
PHDQGLIIHUHQFHDQG&, )RU/HHHWDOQZDVGLYLGHGE\WZRDVFURVVRYHUWULDODQGEDVHOLQH6'ZDVLPSXWHG
WRJHQHUDWHIRUHVWSORWV9DOOV3HGUHWHWDOFRQWDLQHGWZR0HGH[SHULPHQWDOJURXSVVRWKHFRQWUROJURXSZDVGLYLGHG
E\ WZR%957, %HQWRQ9LVXDO5HWHQWLRQ7HVW&77, &RORU7UDLO7HVW(922, H[WUDYLUJLQROLYHRLO0HG,0HGLWHUUDQHDQ
5$9/7, 5H\$XGLWRU\9HUEDO/HDUQLQJ7HVW57, UHDFWLRQWLPH6WG, VWDQGDUGLVHG
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A Language
(95% CI lower, upper) (95% CI lower, upper)
B Executive function
(95% CI lower, upper) (95% CI lower, upper)
(57)
(57)
(58)
(58)
(57)
(57)
(58)
(58)
)LJXUH(IIHFWRI0HGLWHUUDQHDQGLHWRQ$ODQJXDJHDQG%H[HFXWLYHIXQFWLRQ:HXVHGUDQGRPHIIHFWPRGHOV
6WDQGDUGLVHGPHDQGLIIHUHQFHVZHUHFDOFXODWHGE\VXEWUDFWLQJWKHPHDQFKDQJHLQWKHFRQWUROJURXSIURPWKHPHDQFKDQJH
LQWKH0HGGLHWJURXSDQGGLYLGLQJE\WKH SRROHG6' DWEDVHOLQH'DWDLVSUHVHQWHGDV VWDQGDUGLVHGPHDQGLIIHUHQFH DQG
&,9DOOV3HGUHWHWDO FRQWDLQHG WZR0HGLWHUUDQHDQ H[SHULPHQWDO JURXSV VR WKH FRQWURO JURXSZDV GLYLGHG E\
WZR&77 &RORU7UDLO7HVW(/) ([FOXGHG/HWWHU)OXHQF\(922 H[WUDYLUJLQROLYH RLO,/) ,QLWLDO /HWWHU )OXHQF\
0HG0HGLWHUUDQHDQ6WGVWDQGDUGL]HG72/7RZHURI/RQGRQ9)79HUEDO)OXHQF\7HVW
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Supplementary Material 3.1. - Sample search strategy for PsycINFO
Database: PsycINFO <1806 to July Week 1 2017>
Search Strategy:
--------------------------------------------------------------------------------
1     "cretan diet".af. (1)
2     "Mediterranean diet".af. (1442)
3     "Mediterranean dietary pattern* ".af. (215)
4     "Mediterranean type diet".af. (43)
5     MedDiet.af. (8)
6     MeDi.af. (1337)
7     MeDiet.af. (1)
8     1 or 2 or 3 or 4 or 5 or 6 or 7 (2835)
9     "brain-derived neurotrophic factor".af. (21890)
10     "CT scan* ".af. (5030)
11     "executive function".af. (44784)
12     "gray matter".af. (28935)
13     "grey matter".af. (12160)
14     "lumbar puncture".af. (1656)
15     "magnetic resonance imaging".af. (122765)
16     "mild cognitive impairment".af. (32190)
17     "neurological test* ".af. (367)
18     "neuropsychological test* ".af. (73150)
19     "post-mortem brain examination".af. (6)
20     "problem solving".af. (120925)
21     "reaction time".af. (91822)
22     "spinal puncture".af. (373)
23     "spinal tap".af. (70)
24     "white matter".af. (47367)
25     Alzheimer.af. (70303)
26     BDNF.af. (25684)
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27     brain.af. (786482)
28     cerebral.af. (255093)
29     cerebrovascular.af. (36294)
30 cognition.af. (492421)
31     cognitive.af. (1003953)
32     cortical.af. (232573)
33     "dement*".af. (150743)
34     fMRS.af. (39)
35     "intellect*".af. (179777)
36     "intelligen*".af. (283243)
37     IQ.af. (55067)
38     memory.af. (491901)
39     mental.af. (1048152)
40     MRI.af. (106385)
41     neural.af. (392217)
42     "neuro*".af. (1233624)
43     neurologic.af. (36100)
44     "neurotransmitter*".af. (52637)
45     thinking.af. (219110)
46     tomography.af. (62312)
47 visuo-spatial.af. (9637)
48     9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 
or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 
or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 (2537049)
49     8 and 48 (2259) (1806-July 2015)
50     limit 49 to yr="2015 -Current" (574)
***************************
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Supplementary Material 3.2. - Quality rating of Mediterranean diet interventions template
Yes (Y) or no (N) rating.
Note – this tool has not been validated.
Quality Indicator Study 1 Study 2 Study 3 Study 4 Study 5 Study 6 Study 7
1. Diet designed and administered by dietitian
2. Minimum amounts specified to participants for 
identified Mediterranean foods 
3. Prescribed diet meets at least 8 out of 19 defined 
minimum criterion*
4. Diet tolerance reported
5. Frequency and setting for diet instruction reported
6. Diet compliance assessed
7. Perception of diet burden or benefit reported
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Definitions for quality indicators
Criterion 1 This criterion is satisfied if the report specifically mentions that the Mediterranean diet was both designed by a 
dietitian and participants were instructed by a dietitian on how to follow this diet.
Criterion 2 Specific daily/weekly quantities are stated for most of the Mediterranean foods recommended.  This criterion is 
not met if only general guidance is provided to include more of certain Mediterranean foods or less of non-
Mediterranean foods without instruction on minimum amounts required for consumption of the Mediterranean 
foods.
Criterion 3 When at least 40% of the minimum criterion* for 19 Mediterranean foods/cuisine aspects are met by the 
experimental diet.
Criterion 4 The study reports any intolerances to specific Mediterranean diet foods or the prescribed Mediterranean diet as a 
whole.
Criterion 5 The frequency or number of dietary instruction sessions provided during the study and the setting for these 
sessions (e.g., individual or group) is reported.
Criterion 6 Dietary compliance to the Mediterranean diet has been assessed in some way, at any time point, during the trial.
This may include food records, FFQ and indices.
Criterion 7 The study collected data from participants on their perception of burden or benefit for the Mediterranean diet.
Note - the original report may cross reference additional protocol papers where criterion is reported.  Criterion may also be satisfied
by citing additional publications from the same study and cohort.
*Minimum criterion for 19 Mediterranean foods/cuisine can be found in Table 3.2 of main paper (1).
FFQ, food frequency questionnaire; %, percent.
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Supplementary Material 3.3. - Study design - randomised controlled trials (RCTs) with pre/post-test comparisons
Author  
(yr)
Country
(city)
Study name Study 
years
Study sizea (n)   Study 
design
Duration of 
intervention
Health 
status of 
participants
Primary 
study 
outcome
Funding source
Wardle 
(2000) (2) 
Britain
(London & 
Southeast 
England)
N/R N/R Exp Med: 61
Exp LF: 59
Con: 56
Parallel 12 wks Selected for 
CV risk: Tot-
cholesterol
>5.2 mM
(198 mg/dL)
Effect of 
cholesterol
lowering 
on mood 
&
cognition
Biotechnology 
and Biological 
Sciences 
Research 
Council 
(BBSRC), UK
McMillan 
(2011) (3)
Australia 
(Melbourne)
N/R N/R Exp: 12
Con: 13
Parallel 10 d Healthy Mood & 
cognition
N/R
Valls-
Pedret 
(2015) (4) 
Spain 
(Barcelona
North sub-
study)
PREDIMED, 
Barcelona
North sub-
study
2003 to 
2009
Exp Med 
EVOO: 155
Exp Med Nuts: 
147
Con: 145
Parallel 4.1 yrs Selected for 
CV risk: type 
'0RU
major CV 
risk factors
Cognition University of 
Navarra,
Instituto de 
Salud Carlos III,
Centros de 
Investigacio´n 
Biome´dica En 
Red)
)LVLRSDWRORJÕD
de la Obesidad y 
Nutricio´n 
(CIBERobn),
donations by 
food companies 
(Patrimonio 
Comunal 
Olivarero, 
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Author  
(yr)
Country
(city)
Study name Study 
years
Study sizea (n)   Study 
design
Duration of 
intervention
Health 
status of 
participants
Primary 
study 
outcome
Funding source
California 
Walnut 
Commission, 
Borges, La 
Morella Nuts, 
Hojiblanca)
Lee (2015)
(5) 
Australia 
(Melbourne)
N/R N/R 24 Crossover 10 d Healthy Mood, 
cognition 
& CV 
outcomes 
Nil
Knight 
(2016) (6) 
Australia 
(Adelaide)
MedLey 2013 to 
2015
Exp: 85
Con: 81
2-cohort 
parallel
24 wks Healthy Cognition National Health 
Medical 
Research 
Council; 
University of 
South Australia 
Postgraduate 
Award
a study n reported as randomised except for McMillan (2011) (3) who report baseline n for each group after n=2 excluded/dropped out from originally 
randomised n=27 as not specified whether both of these were from Med group.
Con, control group; CV, cardiovascular; d, days; DM, diabetes mellitus; Exp, experimental group; LF, low fat intervention; Med, Mediterranean 
intervention; n, number; N/R, outcome measured but not reported; PREDIMED, Prevención con Dieta Mediterránea, translated to PREvention with 
MEDiterranean Diet; wks, weeks; yr, year; yrs, years.
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Supplementary Material 3.4. - Study design – PREDIMED RCT with only post-test comparisons
Author  
(yr)
Country
(city)
Study name Sub-study size (n) Follow 
up time 
point
Health status of 
participants 
Primary 
study 
outcome
Funding source
Sanchez-
Villegas 
(2011) (7) 
Spain
(Navarra 
region sub-
study)
PREDIMED, 
NAVARRA
sub-study
Exp Med EVOO: 91
Exp Med Nuts: 75
Con: 77
Randomly selected
23% of cohort
3 yrs Selected for CV 
risk: type 2 DM 
RUPDMRU&9
risk factors
Plasma 
BDNF
Department of Health of the 
Navarra government, Linea 
Especial of the University of 
Navarra & Instituto de Salud 
Carlos III
Martinez-
Lapiscina 
(2013) (8) 
Spain
(Navarra 
region sub-
study)
PREDIMED, 
NAVARRA
sub-study
Exp Med EVOO: 95
Exp Med Nuts: 95
Con: 95
Randomly selected 
27% of cohort, of 
which 95% agreed to 
participate
6.5 yrs Selected for CV 
risk: type 2 DM 
RUPDMRU&9
risk factors
Cognition Official agency for funding 
biomedical
research of the Spanish 
Government, Thematic 
Network
Nutrition & Cardiovascular 
disease, Thematic
Network PREDIMED, 
FEDER (FondoEuropeo de 
Desarrollo Regional), 
CIBERobn (Virtual Center 
for Biomedical Research on
Obesity and Nutrition) & 
Government of Navarra
Martinez-
Lapiscina 
(2013) (9) 
Spain
(Navarra 
region sub-
study)
PREDIMED, 
NAVARRA
sub-study
Exp Med EVOO: 224
Exp Med Nuts: 166 
Con: 132
6.5 yrs Selected for CV 
risk: type 2 DM 
RUPDMRU&9
risk factors
Global 
cognition
Official agency for funding 
biomedical
research of the Spanish 
Government, Thematic 
Network
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Author  
(yr)
Country
(city)
Study name Sub-study size (n) Follow 
up time 
point
Health status of 
participants 
Primary 
study 
outcome
Funding source
Non-randomly 
selected 49.5% of 
cohort
Nutrition & Cardiovascular 
disease, Thematic
Network PREDIMED, 
CIBERobn (Virtual Center 
for Biomedical Research on
Obesity and Nutrition) & 
Government of Navarra 
Martinez-
Lapiscina 
(2014)
(10) 
Spain
(Navarra 
region sub-
study)
PREDIMED, 
NAVARRA
sub-study
Exp Med EVOO: 224
Exp Med Nuts: 166 
Con: 132
Non-randomly 
selected 49.5% of 
cohort
6.5 yrs Selected for CV 
risk: type 2 DM 
RUPDMRU&9
risk factors
Effect of 
Med diet on 
cognition 
across 
different 
gene 
variants
Official agency for funding
biomedical research of the 
Spanish Government, 
Thematic Network Nutrition 
& Cardiovascular
disease, Thematic Network
PREDIMED, FEDER (Fondo 
Europeo de Desarrollo 
Regional), CIBERobn
(Virtual Center for 
Biomedical Research on 
Obesity and
Nutrition) & Government of 
Navarra
BDNF, brain derived neurotrophic factor; Con, control group; CV, cardiovascular; DM, diabetes mellitus; Exp, experimental group; Med,
Mediterranean intervention; n, number; PREDIMED, Prevencion con Dieta Mediterranea, translated to PREvention with MEDiterranean Diet; yr,
year; yrs, years; %, percent.
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Supplementary Material 3.5. - Participant characteristics
Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
Wardle 
(2000) (2) 
Exp 
Med: 54 
(11)
Exp LF: 
52 (11)
Con: 53 
(8)
Exp 
Med: 
56
Exp 
LF: 42
Con: 57
Free living Not 
specified 
at baseline
Mildly or 
moderately 
raised serum 
cholesterol
(100)
N/R Exp Med: 
29 (6)
Exp LF: 27 
(5)
Con: 27 (4)
N/A N/A
McMillan 
(2011) (3) 
21.1
(3.26), 
19-30
100 Free living Not 
specified 
at baseline
N/R N/R N/R N/A N/A
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7) 
Exp Med 
EVOO:
68.1
(6.1)
Exp Med 
Nuts:
67.4
(5.7)
Con:
68.0
(6.1)
Exp 
Med 
EVOO:
53.8
Exp 
Med 
Nuts:
48.0
Con: 
51.9
Free living Not 
specified 
at baseline
Exp Med 
EVOO:
Hypertension 
(83.5); 
diabetes 
(25.3);
hypercholester
olaemia (79.1); 
depression 
(15.4)
N/R Exp Med 
EVOO:
29.7 (3.6)
Exp Med 
Nuts: 29.1
(2.7)
Con: 28.5 
(3.4)
N/R N/R
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
Exp Med Nuts:
Hypertension 
(86.7); 
diabetes 
(42.7); 
hypercholester
olaemia (50.7); 
depression 
(18.7)
Con: 
Hypertension 
(84.4); 
diabetes 
(31.2); 
hypercholester
olaemia (66.2); 
depression 
(11.7)
Martinez-
Lapiscina 
(2013)b (8) 
Exp Med 
EVOO: 
67.18
(5.61)
Exp 
Med 
EVOO:
58.2
Free living Not 
specified 
at baseline
Exp Med 
EVOO:
Hypertension 
(74.7); 
diabetes 
N/R Exp Med 
EVOO:
28.68 (3.6)
Exp Med 
EVOO: 302
(219) 
Exp Med 
EVOO: 8.87 
(2.08)
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
Exp Med 
Nuts: 
67.33
(5.96)
Con: 
67.52
(5.67)
Exp 
Med 
Nuts:
60.2
Con: 
47.2
(31.9);
dyslipidaemia
(79.1); ApoE4 
genotype 
(13.2)
Exp Med Nuts:
Hypertension 
(79.5); 
diabetes 
(34.1); 
dyslipidaemia
(76.1); ApoE4 
genotype 
(19.3)
Con: 
Hypertension 
(79.8); 
diabetes
(32.6); 
dyslipidaemia
(66.3); ApoE4 
Exp Med 
Nuts: 28.83
(3.2)
Con: 29.12 
(3.5)
Exp Med 
Nuts: 249
(188) 
Con: 276 
(220)
Exp Med 
Nuts: 8.57 
(2.84) 
Con: 8.75 
(3.34)
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
genotype 
(15.7)
Martinez-
Lapiscina 
(2013)c (9) 
Exp Med 
EVOO: 
67.35
(5.65) 
Exp Med 
Nuts: 
67.30
(5.77)
Con: 
67.55
(5.54) 
Exp 
Med 
EVOO:
54.5
Exp 
Med 
Nuts:
57.2
Con: 
54.5
Free living Not 
specified 
at baseline
Exp Med 
EVOO:
Hypertension 
(77.7); 
diabetes 
(37.1); 
dyslipidaemia
(70.5); family 
Hx cognitive 
decline (18.8); 
ApoE4 
genotype 
(12.5)
Exp Med Nuts:
Hypertension 
(83.1); 
diabetes
(34.9); 
dyslipidaemia
(69.3); family
Hx cognitive 
decline (22.8); 
N/R Exp Med 
EVOO:
29.30 (3.4)
Exp Med 
Nuts: 28.96
(3.1)
Con: 29.94 
(3.4)
Exp Med 
EVOO: 282
(200) 
Exp Med 
Nuts: 280
(194) 
Con: 253 
(197)
Exp Med 
EVOO: 8.50 
(2.79)
Exp Med 
Nuts: 8.45 
(3.00) 
Con: 8.54 
(3.38)
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
ApoE4
genotype 
(13.9)
Con: 
Hypertension 
(81.8); 
diabetes 
(26.5); 
dyslipidaemia
(67.4); family
Hx cognitive 
decline (20.8); 
ApoE4 
genotype 
(14.4)
Martinez-
Lapiscina 
(2014)d
(10) 
Exp Med 
EVOO: 
67 (6)
Exp Med 
Nuts: 67 
(6)
Con: 67 
(6)
Exp 
Med 
EVOO:
54
Exp 
Med 
Nuts:
58
Free living Not 
specified 
at baseline
Exp Med 
EVOO:
Hypertension 
(77.3); 
diabetes 
(37.7); 
dyslipidaemia
(70.5); family 
N/R Exp Med 
EVOO:
29.3 (3.4)
Exp Med 
Nuts: 28.9
(3.2)
Con: 29.0
(3.4)
Exp Med 
EVOO: 283
(199) 
Exp Med 
Nuts: 279
(196) 
Con: 252 
(198)
Exp Med 
EVOO: 8.50
(2.8)
Exp Med 
Nuts: 8.40
(2.9)
Con: 8.50
(3.4)
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
Con: 55 Hx cognitive 
decline (15.9); 
ApoE4 
genotype 
(13.6);  CLU 
MAF (0.37); 
CR1 MAF 
(0.17); 
PICALM 
(0.39)
Exp Med Nuts:
Hypertension 
(82.6); 
diabetes 
(36.0); 
dyslipidaemia
(69.6); family
Hx cognitive 
decline 
(13.04); 
ApoE4 
genotype 
(15.1); CLU 
MAF (0.37); 
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
CR1 MAF
(0.11); 
PICALM 
(0.30)
Con: 
Hypertension 
(81.4); 
diabetes 
(27.1); 
dyslipidaemia
(66.7); family 
Hx cognitive 
decline (14.7); 
ApoE4 
genotype 
(15.6); CLU 
MAF (0.39); 
CR1 MAF 
(0.14); 
PICALM 
(0.34)
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
Valls-
Pedret 
(2015)e (4) 
Exp Med 
EVOO: 
67.9
(5.4)
Exp Med 
Nuts: 
66.7
(5.3)
Con: 
65.5
(5.8)
Exp 
Med 
EVOO: 
52.8
Exp 
Med 
Nuts: 
48.2
Con: 
51.6
Free living Normal 
(MCI 
excluded 
at 
baseline)
Exp Med 
EVOO: 
hypertension 
(77.2%); 
diabetes 
(55.1%); 
dyslipidaemia
(75.6%)
Exp Med Nuts: 
hypertension 
(68.8%); 
diabetes 
(58.9%); 
dyslipidaemia
(74.1%)
Con:
hypertension 
(76.8%); 
diabetes 
Exp Med 
EVOO:
antihypertensive 
(67.7%); 
antidiabetic 
(26.8%); 
hypolipidaemic 
(52.8%); 
anticholinergic 
(15.7%)
Exp Med Nuts:
antihypertensive 
(63.4%); 
antidiabetic 
(36.6%); 
hypolipidaemic
(47.3%); 
anticholinergic 
(11.6%)
Con: 
antihypertensive 
(66.3%); 
Exp Med 
EVOO: 
28.5 (3.3)
Exp Med 
Nuts: 28.4 
(3.2)
Con: 28.5 
(3.3)
Exp Med 
EVOO: 541 
(358)
Exp Med 
Nuts: 554 
(339)
Con: 516 
(349)
Exp Med 
EVOO: 6.8 
(3.0)
Exp Med 
Nuts: 7.6 
(3.3)
Con: 7.1 
(2.8)
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Author 
(yr)
Age 
(y) mean 
(SD), 
range 
Sex
(% 
female)
Residential 
setting
Cognitive 
status 
Relevant 
chronic
diseasesa (%)
Relevant 
medications or 
supplements
(%)
BMI
(kg/m2) 
(SD)
Habitual 
physical 
activity 
mean (SD), 
MET-
min/d
Educational 
level mean 
(SD), yrs  
(50.5%); 
dyslipidaemia
(71.6%)
antidiabetic 
(37.9%); 
hypolipidaemic
(49.5%); 
anticholinergic 
(15.8%)
Lee 
(2015) (5) 
25.6
(5.14), 
20-38
100 Free living Normal 
(neurologi
cal & 
psychiatric 
disorders 
excluded 
at 
baseline)
Excluded at 
screening
N/A 23.01 (2.33) N/A N/A
Knight 
(2016)f (6) 
Exp: 
72.1
(4.9)
Con: 
72.0
(5.0)
Exp: 
24.1
Con: 
29.2
Free living Normal 
(MCI &
dementia 
excluded 
at 
baseline)
Excluded at 
screening
N/R Exp: 26.5 
(3.5)
Con: 26.9 
(4.1)
N/A Exp: 19.7% 
only 
secondary
Con: 21.2% 
only 
secondary
a Relevant chronic diseases refer to any diseases (or risk factors) shown in the literature to impair cognition or modify brain function/morphology 
or interfere with the ability to adopt and adhere to the dietary intervention. 
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b Baseline data for age, sex, relevant chronic diseases, BMI, habitual physical activity and education relates to participants analysed: Exp Med 
EVOO=91, Exp Med Nuts=88, Con=89.
c Baseline data for age, sex, relevant chronic diseases, BMI, habitual physical activity and education relates to participants analysed: Exp Med 
EVOO=224, Exp Med Nuts=166, Con=132.
d Baseline data for age, sex, relevant chronic diseases, BMI, habitual physical activity and education relates to n=510 in total: Exp Med EVOO=220,
Exp Med Nuts=161, Con=129.
e Baseline data for age, sex, relevant chronic diseases, BMI, habitual physical activity and education relates to participants analysed: Exp Med 
EVOO=127, Exp Med Nuts=112, Con=95.
f Baseline data for age, sex, relevant chronic diseases, BMI and education relates to participants analysed: Exp Med=70, Con=67.
BMI, body mass index; CLU, CR1, PICALM & ApoE4, genotypes previously identified as related to cognitive decline; Con, control group; 
EVOO, extra virgin olive oil; Exp, experimental group; LF, low fat intervention; MAF, minimum allele frequency; Med, Mediterranean 
intervention; MET-min, minutes at a given metabolic equivalent level (units of energy expenditure in physical activity, 1 MET-min roughly 
equivalent to 1 kCal); MCI, mild cognitive impairment; n, number; neuropsych, neuropsychological; N/A, not available as not collected during 
study; N/R, outcome measured but not reported; PREDIMED, Prevencion con Dieta Mediterranea, translated to PREvention with MEDiterranean 
Diet; SD, standard deviation; yr, year; yrs, years; %, percent.
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Supplementary Material 3.6. - Intervention characteristics: means of implementation of the experimental Mediterranean and control 
condition
Author  (yr) Food provided Diet 
developed by
dietitian
Diet 
administered by 
dietitian & mode 
of 
administration
Individual 
counselling
Group 
counselling
Telephone 
calls, texts 
etc.
Logging 
of dietary 
intake 
Assessment 
of tolerance 
Experimental
Wardle
(2000) (2) 
Y, high PUFA 
spread & oil
N/R Y, in person (also 
psychologist)
Y, 8 
sessions of 
mixed 
individual 
& group
Y, 8 
sessions of 
mixed 
individual 
& group
N Y, 7-d
food 
record at 
baseline & 
12 wks
Y
McMillan 
(2011) (3)
N, $75 
supermarket 
voucher provided
N/R N Y, 1 session N N Y, daily 
food 
record 
N
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
Y, Med EVOO: 1 
liter EVOO/wk;
Med Nuts: 30g/d 
raw unprocessed 
nuts (15 g walnuts 
& 15 g almonds) 
Y Y, in person Y, 12 
sessions on
average 
(every 3 
MThs)
Y, 12 
sessions on
average 
(every 3 
MThs)
N N Y
Martinez-
Lapiscina 
(2013) (8)
Y, Med EVOO: 1
liter EVOO/wk;
Med Nuts: 30g/d 
raw unprocessed
nuts (15 g walnuts,
Y Y, in person Y, 26
sessions on 
average 
(every 3 
MThs)
Y, 26
sessions on 
average 
(every 3 
MThs)
N N Y
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Author  (yr) Food provided Diet 
developed by
dietitian
Diet 
administered by 
dietitian & mode 
of 
administration
Individual 
counselling
Group 
counselling
Telephone 
calls, texts 
etc.
Logging 
of dietary 
intake 
Assessment 
of tolerance 
7.5 g almonds &
7.5 g hazelnuts)
Martinez-
Lapiscina 
(2013) (9)
Y, Med EVOO: 1
liter EVOO/wk;
Med Nuts: 30g/d 
raw unprocessed
nuts (15 g walnuts,
7.5 g almonds &
7.5 g hazelnuts)
Y Y, in person Y, 26
sessions on
average 
(every 3 
MThs)
Y, 26
sessions on
average
(every 3 
MThs)
N N Y
Martinez-
Lapiscina 
(2014) (10)
Y, Med EVOO: 1
liter EVOO/wk;
Med Nuts: 30g/d 
raw unprocessed
nuts (15 g walnuts,
7.5 g almonds &
7.5 g hazelnuts)
Y Y, in person Y, 26
sessions on
average
(every 3 
MThs)
Y, 26
session on
average
(every 3 
MThs)
N N Y
Valls-Pedret 
(2015) (4) 
Y, Med EVOO: 1
liter EVOO/wk;
Med Nuts: 30g/d 
raw unprocessed
nuts (15 g walnuts,
7.5 g almonds &
7.5 g hazelnuts)
Y Y, in person Y, 16 
sessions on
average 
(every 3 
MThs)
Y, 16 
sessions on
average 
(every 3 
MThs)
N N Y
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Author  (yr) Food provided Diet 
developed by
dietitian
Diet 
administered by 
dietitian & mode 
of 
administration
Individual 
counselling
Group 
counselling
Telephone 
calls, texts 
etc.
Logging 
of dietary 
intake 
Assessment 
of tolerance 
Lee (2015)
(5)
N, $150 
supermarket 
voucher provided
N/R N Y, 1 session N N Y, daily 
food 
record
N
Knight 
(2016) (6)
Y, canned 
legumes, yoghurt 
(natural/flavored
Greek), EVOO, 
canned tuna, 
unsalted nuts 
(walnuts, almonds, 
peanuts)
Y Y, in person Y, 14 
sessions
N N Y, daily
food 
checklist
N
Control
Wardle 
(2000) (2) 
N N N N N N Y, 7-d
food 
record 
baseline 
only
N
McMillan 
(2011) (3)
N, $75 
supermarket 
voucher provided
N N N N N Y, daily 
food 
record 
N
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N N Y, in person Y, 1 session N N N Y
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Author  (yr) Food provided Diet 
developed by
dietitian
Diet 
administered by 
dietitian & mode 
of 
administration
Individual 
counselling
Group 
counselling
Telephone 
calls, texts 
etc.
Logging 
of dietary 
intake 
Assessment 
of tolerance 
Martinez-
Lapiscina 
(2013) (8)
N N Y, in person Y, 1 session N N N Y
Martinez-
Lapiscina 
(2013) (9)
N N Y, in person Y, 1 session N N N Y
Martinez-
Lapiscina 
(2014) (10)
N N Y, in person Y, 1 session N N N Y
Valls-Pedret 
(2015) (4) 
N N Y, in person Y, 3 
sessions 
over first 3 
yrs (1/yr) + 
4 sessions 
for last yr = 
7 sessions 
total
Y, 4 
sessions 
during last 
yr only
N N Y
Lee (2015)
(5)
N, $150 
supermarket 
voucher provided
N N N N N Y, daily 
food 
record
N
Knight 
(2016) (6)
N, $10 
supermarket 
voucher provided 
per fortnight
N Y, in person Y, 14 
sessions
N N N N
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d, days; EVOO, extra virgin olive oil; Med, Mediterranean intervention; MThs, months; MUFA, monounsaturated fatty acids; N, no; N/R, outcome 
measured but not reported; PREDIMED, Prevencion con Dieta Mediterranea, translated to PREvention with MEDiterranean Diet; PUFA,
polyunsaturated fatty acids; wks, weeks; Y, yes; yr, year; years, years.
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Supplementary Material 3.7. - Dietary compliance outcomes
Author  (yr) Attendance 
at 
intervention 
sessions (% 
cohort)
Dietary log 
completion 
(% cohort)
Consumed 
free foods 
provided 
(% cohort)
Diet 
compliance 
assessment 
tool (score)
Dietary 
biomarkers
Perceptions 
of burden 
or benefit
Dropout
rate 
(%)a
Reason for 
dropout
Experimental
Wardle 
(2000) (2) 
86.9% 
completed 12
wk follow up 
& attended 
 Tx
sessions
N/R N/A 7-d food 
record; score 
N/R
N/A N/A 13.1 Moving, taking 
new job, no time 
to attend sessions
McMillan 
(2011) (3)
N/R 11/12 
(91.7%)
N/A 10-d food 
record; 93% 
of meals & 
95% of 
snacks
N/A N/A 3.7b 1 participant 
withdrew & 1 was 
excluded in 
analysis due to 
failure to comply 
with eating plan
PREDIMED 
publicationsc
(2011-2015): 
Sanchez-
Villegas 
(2011) (7),
Martinez-
Lapiscina 
(2013) (8),
Martinez-
N/R N/A N/R 137-item 
FFQ; score 
N/R
14-item 
screener
score
Pre Med 
EVOO:
8.6/14
(SD:1.91)
Y, Med EVOO: 
increase in 
urinary
hydroxytyrosold
(mean increase 
= 49.6 μg/L); 
Y, Med Nuts: 
sig. increase in 
plasma ALAe
Y, yrly Med 
EVOO:
16.1
Med 
Nuts:
23.1
Med EVOO: 2 
deceased, 4 
illness, 15 
declined to 
participate, 4 lost 
contact 
Med Nuts: 1 
deceased, 3 
illness, 29 
declined to 
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Author  (yr) Attendance 
at 
intervention 
sessions (% 
cohort)
Dietary log 
completion 
(% cohort)
Consumed 
free foods 
provided 
(% cohort)
Diet 
compliance 
assessment 
tool (score)
Dietary 
biomarkers
Perceptions 
of burden 
or benefit
Dropout
rate 
(%)a
Reason for 
dropout
Lapiscina 
(2013) (9),
Martinez-
Lapiscina 
(2014) (10),
Valls-Pedret 
(2015) (4) 
Post Med 
EVOO: 
10.47/14
Change Med 
EVOO:
1.87/14
(SD:2.22)
Pre Med 
Nuts: 8.3/14
(SD:2.17)
Post Med 
Nuts: 
10.68/14
Change Med 
Nuts: 2.38/14
(SD:2.13)
(mean increase 
= 0.19%) 
participate, 1 lost 
contact
Lee (2015)
(5)
100% 100% N/A 10-d food 
record; 80% 
compliance 
to 
experimental 
diet
N/A N/A 0 No drop outs
Knight 
(2016) (6)
N/R N/R N/R Daily food 
check list, 3-
day weighed 
Erythrocyte 
fatty acids, 
plasma 
N/A 17.6 5 withdrew before 
commencement, 1 
had other 
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Author  (yr) Attendance 
at 
intervention 
sessions (% 
cohort)
Dietary log 
completion 
(% cohort)
Consumed 
free foods 
provided 
(% cohort)
Diet 
compliance 
assessment 
tool (score)
Dietary 
biomarkers
Perceptions 
of burden 
or benefit
Dropout
rate 
(%)a
Reason for 
dropout
food record 
& FFQ at 
baseline, 2 & 
4 MThs; 92%
compliance 
reported but 
score N/R
carotenoids, 
urinary 
metabolites
(potassium, 
sodium, 
magnesium, 
calcium)
commitments, 2 
did not comply 
with diet, 4 had 
family/personal 
issues, 3 had 
health reasons 
(unrelated to trial)
Control
Wardle 
(2000) (2) 
89.3% 
completed 12 
wk follow up
N/A N/A N/A N/A N/A 10.7 Moving, taking 
new job, no time 
to attend sessions
McMillan 
(2011) (3)
N/R 11/13 
(84.6%)
N/A 10-d food 
record; 71%
of meals & 
68% of 
snacks not
adhered to 
Med
N/A N/A 3.7b 1 participant 
withdrew & 1 was 
excluded in 
analysis due to 
failure to comply 
with eating plan
PREDIMED 
publicationsc
(2011-2015): 
Sanchez-
Villegas 
(2011) (7),
Martinez-
N/R N/A N/A 137-item 
FFQ; score 
N/R
14-item 
screener 
score Pre: 
Y, decrease in 
urinary 
hydroxytyrosold
(mean decrease 
= 8.9 μg/L); 
Y, sig. increase 
in plasma ALAe
Y, yrly 33.1 1 deceased, 6 
illness, 41 
declined to 
participate 
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Author  (yr) Attendance 
at 
intervention 
sessions (% 
cohort)
Dietary log 
completion 
(% cohort)
Consumed 
free foods 
provided 
(% cohort)
Diet 
compliance 
assessment 
tool (score)
Dietary 
biomarkers
Perceptions 
of burden 
or benefit
Dropout
rate 
(%)a
Reason for 
dropout
Lapiscina 
(2013) (8),
Martinez-
Lapiscina 
(2013) (9),
Martinez-
Lapiscina 
(2014) (10),
Valls-Pedret 
(2015) (4) 
8.7/14 
(SD:2.15)
Post: 9.1/14
Change: 
0.40/14 
(SD:2.27) 
(mean increase 
= 0.03%)
Lee (2015)
(5)
100% 100% N/A 10-d food 
record; 76% 
compliance 
to control
N/A N/A 0 No drop outs
Knight 
(2016) (6)
N/R N/R N/A 3-d weighed 
food record 
& FFQ at 
baseline, 2 & 
4 MThs;
score N/R
Erythrocyte 
fatty acids, 
plasma 
carotenoids, 
urinary 
metabolites
(potassium, 
sodium, 
magnesium, 
calcium)
N/A 17.3 9 withdrew before 
commencement, 2 
had other 
commitments, 2 
had 
family/personal 
issues, 1 had 
health reasons 
(unrelated to trial)
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a Dropout rate includes those randomised who withdrew, were deceased, didn’t complete the study and therefore lost to analysis. It does not 
include those excluded for analysis due to low adherence. 
b Percent refers to overall dropout rate as paper does not specify which group drop outs relate to.
c Diet compliance assessment tool, dietary biomarkers, dropout rate and reason for drop out relate to Valls-Pedret (2015) (4). 
d Hydroxytyrosol measured in n=65 (Med EVOO=20; Med Nuts=21; Con=24).
e ALA measured in n=75 (Med EVOO=24; Med Nuts=28; Con=23).
ALA, alpha linolenic acid; d, day; EVOO, extra virgin olive oil; FFQ, food frequency questionnaire; Med, Mediterranean intervention; MThs,
months; N/A, not available as not collected during study; N/R, outcome measured but not reported; PREDIMED, Prevencion con Dieta 
Mediterranea, translated to PREvention with MEDiterranean Diet; SD, standard deviation; sig., significant; Tx, treatment; wk, week; Y, yes; yr,
year; yrly, yearly; %, percent.
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Supplementary Material 3.8. - Intervention characteristics: dietary elements/nutritional behaviours prescribed for experimental 
Mediterranean condition
Dietary 
Element
Minimum
criteriona
Wardle (2000)
(2) 
McMillan 
(2011) (3)
PREDIMED 
publications (2011-
2015): Sanchez-
Villegas (2011) (7),
Martinez-Lapiscina 
(2013) (8), Martinez-
Lapiscina (2013) (9),
Martinez-Lapiscina 
(2014) (10), Valls-
Pedret (2015) (4) 
Lee (2015) (5) Knight (2016)b
(6)
Olive oil 2 TBSP (40 
ml)/d or to be 
used as principal 
fat/oil in diet
1ĻWRWDOIDWWR
30% E 
N; combine 
healthy fat with 
protein & CHO
<7%63GZLWK
‘abundant use for 
cooking & dressing of 
dishes’
N; focus on foods 
providing source 
of healthy fats
Y; 2-3 TBSP/d
Other fats 
(e.g., butter, 
margarine, 
cream, refined 
vegetable oils)
Max. allowed: 
10 g/d (about 2 
tsp)
1ĻWRWDOIDWWR
30% E &  swap 
most SFA with 
MUFA
N Y; ‘eliminate or limit’ 
with <1 serve/d spread 
fats
~Y; no butter or 
margarine
N
Nuts 3 serves/wk
1 serve = 30 g
N 1ĹQXWVVHHGV <VHUYHVZNQXWVRU
seeds (30 g/serve)
1ĹQXWV <VHUYHVZN
(35 g/serve)
Legumes 2 serves/wk
1 serve = 150 g 
(1 cup cooked or 
canned legumes)
N N <VHUYHVZN N 1VHUYHVZN
(75 g/serve)
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Dietary 
Element
Minimum
criteriona
Wardle (2000)
(2) 
McMillan 
(2011) (3)
PREDIMED 
publications (2011-
2015): Sanchez-
Villegas (2011) (7),
Martinez-Lapiscina 
(2013) (8), Martinez-
Lapiscina (2013) (9),
Martinez-Lapiscina 
(2014) (10), Valls-
Pedret (2015) (4) 
Lee (2015) (5) Knight (2016)b
(6)
Vegetables 2 serves at 2 
meals/d or 4 
serves/d total
1 serve = ½ cup 
cooked (75 g) or 
1 cup raw
1ĹYHJ 1ĹYHJ <VHUYHVGwith at 
least 1 as salad (125 
g/serve)
1ĹYHJ <serves/d 
(75 g/serve)
Sofrito 2x/wk rich 
tomato sauce 
with 
onion/garlic 
simmered in 
EVOO 
N N <WLPHVZN N N
Fruit 2 serves/d 
1 serve = 1 
medium or 2 
small pieces or 1 
cup diced fruit; 
excludes FJ
1ĹIUXLW 1ĹIUXLW <VHUYHVG
including natural juice 
(125 g/serve)
1ĹIUXLW Y; 2-3 serves/d 
(150 g/serve)
Grain foods 1-2 serves/meal 
(or 3-6 serves/d)
N 1ĹZKROHJUDLQV N N <VHUYHVG
(30-120 g/serve)
144
Supplementary Material 3.8. - cont.
Dietary 
Element
Minimum
criteriona
Wardle (2000)
(2) 
McMillan 
(2011) (3)
PREDIMED 
publications (2011-
2015): Sanchez-
Villegas (2011) (7),
Martinez-Lapiscina 
(2013) (8), Martinez-
Lapiscina (2013) (9),
Martinez-Lapiscina 
(2014) (10), Valls-
Pedret (2015) (4) 
Lee (2015) (5) Knight (2016)b
(6)
of any, 
preferably 
wholegrain
varieties 
including intact, 
cracked or rolled 
grains;
1 serve = 1 slice 
bread or ½ cup 
cooked pasta, 
rice, barley, 
polenta, bulgur 
etc.
Fish or 
shellfish
2 serves/wk
unless 
vegetarian
1 serve = 1
small fillet or 1 
small can or 200
g shellfish
1ĹRLO\ILVK 1ĹRLO\ILVK <VHUYHVZNZLWK
VHUYHoily fish; (100-
150 g/serve fish & 200 
g/serve shellfish) 
1ĹRLO\ILVK <VHUYHVZN
(150 g/serve)
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Dietary 
Element
Minimum
criteriona
Wardle (2000)
(2) 
McMillan 
(2011) (3)
PREDIMED 
publications (2011-
2015): Sanchez-
Villegas (2011) (7),
Martinez-Lapiscina 
(2013) (8), Martinez-
Lapiscina (2013) (9),
Martinez-Lapiscina 
(2014) (10), Valls-
Pedret (2015) (4) 
Lee (2015) (5) Knight (2016)b
(6)
Poultry Max allowed: 2 
serves/wk
1 serve = 100-
150 g
N Y N; preference for white 
meat, e.g., poultry 
without skin or rabbit
Y; abstain from 
white meat
N
Red meat & 
processed meat
<2 serves/wk 
red meat & <1 
serve/wk
processed meat
1 serve = 100-
150 g
N Y N; <1 serve/d with 
preference for white 
meat, e.g., poultry 
without skin or rabbit 
Y; abstain from 
all red meats
<Verve/wk 
red meat (100 
g/serve); 2
serves/wk 
processed meat 
(50 g/serve)
Eggs Max allowed: 4 
/wk
N N N; permitted ad lib N N
Dairy products Max allowed: 2 
serves/d
1 serve = ½ cup 
(120 g) 
ricotta/cottage 
cheese, 50 g 
fetta, ¾ cup 
(200 g) yoghurt, 
N 1DGYLVHGWRĹ
LF dairy
N; LF cheese permitted 
ad lib
1DGYLVHGWRĹ
LF dairy
N
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Dietary 
Element
Minimum
criteriona
Wardle (2000)
(2) 
McMillan 
(2011) (3)
PREDIMED 
publications (2011-
2015): Sanchez-
Villegas (2011) (7),
Martinez-Lapiscina 
(2013) (8), Martinez-
Lapiscina (2013) (9),
Martinez-Lapiscina 
(2014) (10), Valls-
Pedret (2015) (4) 
Lee (2015) (5) Knight (2016)b
(6)
2 slices (40 g) 
hard cheese, 1 
cup (250 ml) 
milk
Sweets Max. allowed: 2 
times/wk
N Y N; eliminate or limit to 
<3 serves/wk
Y <VHUYHVZN
of total 
discretionary 
foods (600 
kJ/serve)
Sweetened 
drinks
Max. allowed: 
<1 serve/d;
1 serve = 1 cup 
(250 ml)
N Y Y; <1 drink/d Y <VHUYHVZN
of total 
discretionary 
foods (600 
kJ/serve)
Wine Max. allowed: 
14 standard 
drinks/wk             
1 standard drink 
= 100 ml
N N 1JODVses red 
wine/wk if wine 
consumed
Y; abstain from 
all alcohol
N
Water 5 cups/d N N N N N
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Dietary 
Element
Minimum
criteriona
Wardle (2000)
(2) 
McMillan 
(2011) (3)
PREDIMED 
publications (2011-
2015): Sanchez-
Villegas (2011) (7),
Martinez-Lapiscina 
(2013) (8), Martinez-
Lapiscina (2013) (9),
Martinez-Lapiscina 
(2014) (10), Valls-
Pedret (2015) (4) 
Lee (2015) (5) Knight (2016)b
(6)
Moist cooking 
methods used,
e.g., boiling, 
stewing, 
steaming
For PDLQ
meals/wk
N N N; recommended 
‘traditional’ cooking 
methods
N N
Main meals
eaten in 
company 
)RUPDLQ
meals/wk
N N N N N
a Our set minimum criterion to describe compliance to the traditional Mediterranean diet.
b MedLey study provided recommendations for serves for four levels of energy intake ranging from 6400-9600 kJ/d. Comparison was made with 
level 2 (8600 kJ/d) recommendations as participants were mostly older men.  MedLey study also advised on discretionary foods as one group. 
ad lib, ad libitum; CHO, carbohydrate; d, day; E, energy; EVOO, extra virgin olive oil; FJ, fruit juice; kJ, kilojoules; LF, low fat; Max., maximum; 
MUFA, monounsaturated fatty acids; N, no; N/R, outcome measured but not reported; PREDIMED, Prevencion con Dieta Mediterranea, translated 
to PREvention with MEDiterranean Diet; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids; TBSP, tablespoon; tsp, teaspoon; veg,
vegetables; wk, week; Y, yes; ~Y, partially meets specified criteria; %, percent.
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Supplementary Material 3.9. - Intervention characteristics: dietary elements/nutritional behaviours prescribed for control/comparative
condition
Author  (yr) Type of diet Macronutrient
recommendations
Micronutrient 
recommendations
Other recommendations
Wardle (2000) (2) Waiting list (Tx offered end of 
period)
Nil Nil Not discouraged from making 
dietary changes and some 
elected to do so
McMillan (2011) (3) Usual diet Nil Nil Nil
PREDIMED publications 
(2011-2015): Sanchez-
Villegas (2011) (7),
Martinez-Lapiscina 
(2013) (8), Martinez-
Lapiscina (2013) (9),
Martinez-Lapiscina 
(2014) (10), Valls-Pedret 
(2015) (4) 
LF based on guidelines from AHA 
National Cholesterol Education 
Program Adult Treatment Panel III
Nil Nil Nil; no energy restriction
Lee (2015) (5) Usual diet Nil Nil Nil
Knight (2016) (6) Usual diet Nil Nil Maintain current diet, physical 
activity and dietary 
supplements unless instructed 
otherwise by medical 
professional
AHA, American Heart Association; LF, low fat intervention; PREDIMED, Prevencion con Dieta Mediterranea, translated to PREvention with 
MEDiterranean Diet; Tx, treatment; yr, year.
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Supplementary Material 3.10. - Quality review of five included studies according to modified PEDro scale
Quality Indicator Wardle 
(2000) (2)
McMillan 
(2011) (3)
PREDIMED Study Lee 
(2015) (5)
MedLey 
Study 
Sanchez-
Villegas 
(2011) (7)
Martinez-
Lapiscina 
(2013) (8)
Martinez-
Lapiscina 
(2013) (9)
Martinez-
Lapiscina 
(2014) (10)
Valls-
Pedret 
(2015) (4)
Knight 
(2016) (6)
1. Eligibility criteria 
specified
1 0 1 1 1 1 1 1 1
2. Random allocation 1 1 1 1 1 1 1 1 1
3. Concealed allocation 1 1 1 1 1 1 1 0 1
4. Baseline similarity with 
important prognostic 
indicators
1 1 1 1 1 1 1 0 1
5. Blinding of all subjects 0 0 0 0 0 0 0 0 0
6. Blinding of all therapists 0 0 0 0 0 0 0 0 0
7. Blinding of all assessors 0 0 1 1 1 1 1 0 1
8. Measures of key 
outcomes (>85% of 
initial subjects)
1 1 1 1 1 1 0 1 0
9. Intention to treat analysis 0 0 1 1 1 1 1 0 1
10. Between group statistics 1 1 1 1 1 1 1 1 1
11. Point measures & 
measures of variability
1 1 1 1 1 1 1 1 1
Final score ( /10) 6 6 8 8 8 8 7 4 7
Quality indicator met: 0=no; 1=yes. N.B. number 1 indicator is not included in PEDro scoring. It measures external validity or generalisability 
of the trial and is retained so the Delphi list is complete.
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Supplementary Material 3.11. - Quality review of five included studies for Mediterranean diet intervention
Quality Indicator Wardle (2000) (2) McMillan (2011) 
(3)
PREDIMED 
Study Sanchez-
Villegas (2011)
(7), Martinez-
Lapiscina (2013)
(8), Martinez-
Lapiscina (2013)
(9), Martinez-
Lapiscina (2014)
(10), Valls-Pedret 
(2015) (4)
Lee 
(2015) (5)
MedLey Study 
Knight (2016) (6),
Davis (2015) (11), 
Davis (2017) (12)
1. Diet designed and
administered by dietitian
N N Y N Y
2. Minimum amounts 
specified to participants 
for identified 
Mediterranean foods
N N Y N Y
3. Prescribed diet meets at 
least 8 out of 19 defined 
minimum criterion*
N N Y N Y
4. Diet tolerance reported Y N Y N N
5. Frequency and setting 
for diet instruction 
reported
Y Y Y Y Y
6. Diet compliance
assessed
Y Y Y Y Y
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Quality Indicator Wardle (2000) (2) McMillan (2011) 
(3)
PREDIMED 
Study Sanchez-
Villegas (2011)
(7), Martinez-
Lapiscina (2013)
(8), Martinez-
Lapiscina (2013)
(9), Martinez-
Lapiscina (2014)
(10), Valls-Pedret 
(2015) (4)
Lee 
(2015) (5)
MedLey Study 
Knight (2016) (6),
Davis (2015) (11), 
Davis (2017) (12)
7. Perception of diet 
burden or benefit 
reported
N N N N Y
Y=yes or N=no rating is provided for each indicator.
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Definitions for quality indicators
Criterion 1 This criterion is satisfied if the report specifically mentions that the Mediterranean diet was both designed by a 
dietitian and participants were instructed by a dietitian on how to follow this diet.  
Criterion 2 Specific daily/weekly quantities are stated for most of the Mediterranean foods recommended.  This criterion is 
not met if only general guidance is provided to include more of certain Mediterranean foods or less of non-
Mediterranean foods without instruction on minimum amounts required for consumption of the Mediterranean 
foods.  
Criterion 3 When at least 40% of the minimum criterion* for 19 Mediterranean foods/cuisine aspects are met by the 
experimental diet.  
Criterion 4 The study reports any intolerances to specific Mediterranean diet foods or the prescribed Mediterranean diet as a 
whole.  
Criterion 5 The frequency or number of dietary instruction sessions provided during the study and the setting for these 
sessions (e.g., individual or group) is reported.  
Criterion 6 Dietary compliance to the Mediterranean diet has been assessed in some way, at any time point, during the trial.  
This may include food records, FFQ and indices.  
Criterion 7 The study collected data from participants on their perception of burden or benefit for the Mediterranean diet.  
*Minimum criterion for 19 Mediterranean foods/cuisine can be found in Table 3.2 of main paper (1).
FFQ, food frequency questionnaire; %, percent.
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Supplementary Material 3.12. - Cognitive function outcomes
Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Global cognition
Wardle 
(2000) (2) 
N/A N/A N/A N/A N/A N/A N/A N/A
McMillan 
(2011) (3)
N/A N/A N/A N/A N/A N/A N/A N/A
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
MMSEc 6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 28.14 
(2.02)
Post Med 
Nuts: 28.83
(2.22)
Change Med 
EVOO: N/A 
Pre: N/A
Post: 27.48
(1.97)
Change: N/A
Med EVOO: 
0.66 (-0.06,
1.38)
Med Nuts: 1.35 
(0.57, 2.13)
Med EVOO: 0.33 
(-0.03, 0.69)
Med Nuts: 0.63 
(0.26, 0.99)
0.130 N
Y
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Incident MCI 
cases (%)d,e
Change Med 
Nuts: N/A
Exp Med 
EVOO: 7 
(7.80%)
Exp Med 
Nuts: 10 
(11.80%)
17 (19.30%) N/A Exp Med EVOO: 
-0.57 (-5.44, 4.30)
Exp Med Nuts: -
0.32 (-4.65, 4.01)
0.024
0.171
N
N
Martinez-
Lapiscina 
(2013) (9)
MMSEf 6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 28.00 
(2.18)
Post Med 
Nuts: 27.96 
(2.12)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre: N/A
Post: 27.40 
(2.38)
Change: N/A
Med EVOO: 
0.60 (-0.01,
1.21)
Med Nuts: 0.56 
(-0.07, 1.19)
Med EVOO: 0.27 
(-0.01, 0.54)
Med Nuts: 0.25 (-
0.03, 0.54)
0.030 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Incident MCI 
cases (%)e,g
Incident 
dementia 
cases (%)e,g
Exp Med 
EVOO: 18 
(5.13%)
Exp Med 
Nuts: 19 
(5.40%)
Exp Med 
EVOO: 12 
(3.42%)
Exp Med 
Nuts: 6 
(1.70%)
23 (6.53%)
17 (4.83%)
N/A
N/A
Med EVOO: -
0.14 (-6.71, 6.43)
Med Nuts: -0.11
(-6.59, 6.37)
Med EVOO: -
0.20 (-7.99, 7.60)
Med Nuts: -0.59
(-10.35, 9.17)
N/R
N/R
N/R
N/R
N
N
N
N
Martinez-
Lapiscina 
(2014) (10)
MMSEh,i,j 6.5 yrs CLU
CT/TT: 28.20 
(2.15)
CLU 
CC: 27.74 
(2.00)
CR1
GG: 28.12 
(1.87)
CLU
CT/TT: 27.23 
(2.02)
CLU 
CC: 27.56 
(2.01)
CR1
GG: 27.37 
(1.89)
0.97 (0.45, 1.49)
0.18 (-0.52,
0.88)
0.76 (0.32, 1.20)
0.45 (0.12, 0.79)
0.09 (-0.35, 0.53)
0.40 (0.09, 0.70)
<0.001
0.612
0.001
Y
N
Y
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
CR1
GA/AA: 
27.66 (2.30)
PICALM
CT/TT: 28.11 
(1.73)
PICALM
CC: 27.89 
(2.20)
ApoE4 non-
carriers: N/R
ApoE4 
carriers: N/R
CR1
GA/AA: 
27.51 (2.30)
PICALM
CT/TT: 27.61 
(1.75)
PICALM
CC: 27.18 
(2.21)
ApoE4 non-
carriers: N/R
ApoE4 
carriers: N/R
0.15 (-0.83,
1.13)
0.51 (0.01, 1.00)
0.76 (0.10, 1.43)
0.56 (0.15, 0.97)
1.61 (0.10, 3.13)
0.06 (-0.46, 0.59)
0.29 (-0.08, 0.65)
0.32 (-0.06, 0.71)
N/A
N/A
0.762
0.046
0.024
0.007
0.037
N
N
N
N/A
N/A
Valls-Pedret 
(2015) (4) 
MMSEk,l Baseline,  
as close to 
study 
termination 
date as 
possible 
(average 
4.1 yrs)
Pre Med 
EVOO: 28.01 
(1.28)
Pre Med 
Nuts: 28.11 
(1.28)
Post Med 
EVOO: 28.17
Pre: 28.38 
(1.30)
Post: 28.12
Med EVOO: 
0.42 (-0.01,
0.85)
Med Nuts: 0.19 
(-0.25, 0.63)
Med EVOO: 0.32
(-0.01, 0.66)
Med Nuts: 0.15 (-
0.19, 0.49)
Overall: 
0.15u
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Global 
cognition 
compositel,m
Post Med 
Nuts: 28.04
Change Med 
EVOO: 0.16 
(1.59)
Change Med 
Nuts: -0.07
(1.58)
Pre Med 
EVOO: -0.07
(0.33)
Pre Med 
Nuts: -0.05
(0.27)
Post Med 
EVOO: -0.02
Post Med 
Nuts: -0.10
Change Med 
EVOO: 0.05 
(0.51)
Change: -
0.26 (1.55)
Pre: -0.07
(0.32)
Post: -0.45
Change: -
0.38 (0.52)
Med EVOO: 
0.43 (0.23, 0.63)
Med Nuts: 0.33
(0.14, 0.52)
Med EVOO: 1.29
(0.65, 1.92)
Med Nuts: 1.12
(0.44, 1.81)
<0.01
<0.25
Overall: 
0.005u
Y
Yx
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Incident MCI 
cases (%)e,n
Change Med 
Nuts: -0.05
(0.55)
Exp Med 
EVOO: 17 
(13.4%)
Exp Nuts: 8 
(7.1%)
12 (12.6%) N/A Med EVOO:
0.04 (-4.51, 4.58)
Med Nuts:
-0.35 (-5.67, 4.97)
0.28 N
N
Lee (2015)
(5)
N/A N/A N/A N/A N/A N/A N/A N/A
Knight 
(2016)t (6)
Total age-
related 
cognitive 
function 
score 
composite
Baseline, 3 
MThs, 6 
MThs
Pre: N/R
3 MThs:
Post: -0.76
(5.37)
6 MThs:
Post: -0.37
(5.14)
Pre: N/R
3 MThs:
Post: 0.82
(5.43)
6 MThs:
Post: 0.40 
(5.23)
-1.58 (-3.41,
0.25)
-0.77 (-2.52,
0.98)
-0.29 (-0.63, 0.05)
-0.15 (-0.48, 0.19)
0.10v
N
N
Attention
Wardle 
(2000) (2) 
Sustained 
attention task
(SAT) 
adapted from 
Baker 
Baseline, 6 
wks, 12 
wks
Pre: 34.86
(0.62)
6 wks:
Post: 
32.81 (0.50)
Pre:
34.31 (0.54)
6 wks:
Post:
34.34 (0.55)
6 wks:
-2.08 (-2.31, -
1.85)
6 wks:
-3.54 (-4.16, -
2.92)
Overall: 
<0.001w
Y
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
vigilance
paradigma,b
Change: -
2.05
12 wks:
Post: 
33.80 (0.48)
Change: -
1.06
Change: 0.03
12 wks:
Post:
42.57 (0.47)
Change: 8.26
12 wks:
-9.32 (-9.55, -
9.09)
12 wks:
-15.86 (-18.06, -
13.66)
Y
McMillan 
(2011) (3)
Serial 3 RT 
(ms)
Serial 3
accuracy (%)
Serial 7 RT 
(ms)
Baseline, 
10 d
Pre: 4094 
(1010)
Post: 3762 
(1467)
Change: -
332.00
Pre: 88.01 
(12.12)
Post: 91.46 
(9.18)
Change: 3.45
Pre: 7813 
(5043)
Post: 6700
(2854)
Pre: 3983 
(1273)
Post: 3429 
(1103)
Change: -
554.00
Pre: 91.95 
(11.67)
Post: 89.68 
(13.23)
Change: -
2.27
Pre: 5981 
(2105)
Post: 6536 
(2689)
222.00 (-734.25,
1178.25)
5.72 (-4.12,
15.56)
-1668.00 (-
4818.68,
1482.68)
0.19 (-0.60, 0.97)
0.47 (-0.33, 1.26)
-0.42 (-1.22, 0.37)
0.34
0.27
0.09
N
N
N
160
Supplementary Material 3.12. - cont.
 
Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Serial 7 
accuracy (%)
RVIP RT 
(ms)
RVIP 
accuracy 
(100%)
Change: -
1113.00
Pre: 80.15 
(20.04)
Post: 83.58 
(10.16)
Change: 3.43
Pre: 467 (56)
Post: 453 
(37)
Change: -14
Pre: 39.96 
(24.05)
Post: 54.55 
(20.69)
Change: 
14.59
Change: 
555.00
Pre: 89.96 
(12.90)
Post: 83.77 
(23.86)
Change: -
6.19
Pre: 471 (57)
Post: 478 
(61)
Change: 7.0
Pre: 46.32 
(25.44)
Post: 56.65 
(20.24)
Change: 
10.33
9.62 (-4.21,
23.45)
-21 (-67.81,
25.81)
4.26 (-16.27,
24.79)
0.56 (-0.24, 1.36)
-0.36 (-1.15, 0.43)
0.17 (-0.62, 0.95)
0.29
0.35
0.58
N
N
N
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Martinez-
Lapiscina 
(2013) (8)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014) (10)
N/A N/A N/A N/A N/A N/A N/A N/A
Valls-Pedret 
(2015) (4) 
N/A N/A N/A N/A N/A N/A N/A N/A
Lee (2015)
(5)
Serial 3 –
correct
responseso,p
Serial 3 RT 
(ms)o,p
Serial 3 –
total 
responseso,p
Baseline, 
11 d
Pre: N/R
Post: N/R
Change: 0.86 
(7.69)
Pre: N/R
Post: N/R
Change: -
348.35
(948.92)
Pre: N/R
Post: N/R
Change: 2.17 
(5.48)
Pre: N/R
Post: N/R
Change: 3.87 
(5.84)
Pre: N/R
Post: N/R
Change: -
501.76
(595.79)
Pre: N/R
Post: N/R
Change: 4.3 
(5.34)
-3.01
153.41
-2.13
-0.69 (-1.85, 0.48)
0.95 (-0.25, 2.14)
-0.59 (-1.75, 0.56)
0.25
0.61
0.31
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Serial 7 –
correct 
responseso,p
Serial 7 RT 
(ms)o,p
Serial 7 –
total 
responseso,p
RVIP RT 
(ms)o,p
RVIP 
accuracy 
(100%)o,p
Pre: N/R
Post: N/R
Change: 1.48 
(4.96)
Pre: N/R
Post: N/R
Change: -
707.96
(2374.76)
Pre: N/R
Post: N/R
Change: 0.87 
(4.61)
Pre: N/R
Post: N/R
Change: -
5.38 (72.50)
Pre: N/R
Post: N/R
Change: 4.08 
(14.23)
Pre: N/R
Post: N/R
Change: 1.22 
(4.11)
Pre: N/R
Post: N/R
Change: 
192.17
(1515.71)
Pre: N/R
Post: N/R
Change: -
0.57 (3.49)
Pre: N/R
Post: N/R
Change: -
11.92 (89.59)
Pre: N/R
Post: N/R
Change: 8.42 
(16.52)
0.26
-900.13
1.44
6.54
-4.34
0.65 (-0.51, 1.81)
-0.74 (-1.91, 0.43)
0.57 (-0.58, 1.73)
0.57 (-0.58, 1.73)
-0.57 (-1.73, 0.58)
0.72
0.21
0.82
0.48
0.39
N
N
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
RVIP – false 
alarm 
responseso,p
Pre: N/R
Post: N/R
Change: -
0.74 (6.70)
Pre: N/R
Post: N/R
Change: -
0.52 (5.81)
-0.22 -0.57 (-1.73, 0.58) 0.97 N
Knight 
(2016) (6)
N/A N/A N/A N/A N/A N/A N/A N/A
Working memory
Wardle 
(2000) (2) 
N/A N/A N/A N/A N/A N/A N/A N/A
McMillan 
(2011) (3)
Corsi blocks 
RT (ms)
Corsi blocks 
score
N-Back RT 
(ms)
Baseline, 
10 d
Pre: 3109 
(683)
Post: 2689 
(557)
Change: -420
Pre: 5.57 
(1.24)
Post: 6.25 
(98)
Change: 0.68
Pre: 990 
(346)
Post: 1025 
(746)
Change: 35
Pre: 3088 
(536)
Post: 3925 
(1129)
Change: 837
Pre: 5.77 (87)
Post: 6.00 
(92)
Change: 0.23
Pre: 1045 
(549)
Post: 741 
(439)
Change: -304
-1257 (-1762.77,
-751.23)
0.45 (-51.6,
52.5)
339 (-44.55,
722.55)
-1.99 (-2.95, -
1.03)
0.01 (-0.78, 0.79)
0.71 (-0.10, 1.52)
<0.001
0.28
0.11
Y
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
N-Back 
accuracy (%)
Numeric WM 
RT (ms)
Numeric WM 
RT accuracy 
(%)
Pre: 86.85 
(7.55)
Post: 86.85 
(9.96)
Change: 0
Pre: 782 
(114)
Post: 797 
(191)
Change: 15
Pre: 88.98 
(25.99) 
Post: 95.58 
(4.59)
Change: 6.60
Pre: 85.64 
(7.40)
Post: 82.90 
(11.63)
Change: -
2.74
Pre: 860 (16)
Post: 738 
(116)
Change: -122
Pre: 96.33 
(3.64)
Post: 92.39 
(13.39)
Change: -
3.94
2.74 (-3.45,
8.93)
137 (71.01,
202.99)
10.54 (-4.50,
25.58)
0.35 (-0.44, 1.15)
1.66 (0.75, 2.57)
0.56 (-0.24, 1.36)
0.38
0.04
0.21
N
Y
N
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
Digit, 
forwardc
6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Pre: N/A Med EVOO: 
0.90 (0.21, 1.59)
Med EVOO: 0.47 
(0.11, 0.83)
0.01 Y
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Digit, 
backwardc
Post Med 
EVOO: 7.80 
(2.02)
Post Med 
Nuts: 7.40 
(1.84)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 4.44
(1.99)
Post Med 
Nuts: 4.51 
(2.01)
Change Med 
EVOO: N/A 
Post: 6.90
(1.64)
Change: N/A
Pre: N/A
Post: 4.20
(1.38)
Change: N/A
Med Nuts: 0.50 
(-0.14, 1.14)
Med EVOO: 
0.24 (-0.41,
0.89)
Med Nuts: 0.31 
(-0.35, 0.97)
Med Nuts: 0.28 (-
0.08, 0.64)
Med EVOO: 0.13 
(-0.23, 0.49)
Med Nuts: 0.17 (-
0.19, 0.53)
0.49
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Change Med 
Nuts: N/A
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014) (10)
N/A N/A N/A N/A N/A N/A N/A N/A
Valls-Pedret 
(2015) (4) 
Digit span 
forwardl,m
Baseline,  
as close to 
study 
termination 
date as 
possible 
(average 
4.1 yrs)
Pre Med 
EVOO: 5.33 
(0.95)
Pre Med 
Nuts: 5.20 
(0.86)
Post Med 
EVOO: 5.44
Post Med 
Nuts: 5.56
Change Med 
EVOO: 0.11 
(0.86)
Change Med 
Nuts: 0.36 
(0.90)
Pre: 5.23 
(0.91)
Post: 5.15
Change: -
0.08 (0.87) 
Med EVOO: 
0.19 (-0.38,
0.76)
Med Nuts: 0.44 
(-0.14, 1.02)
Med EVOO: 0.20
(-0.39, 0.79)
Med Nuts: 0.49 (-
0.16, 1.14)
Overall: 
0.28u
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Digit span 
backwardl,m
Pre Med 
EVOO: 3.76 
(0.84)
Pre Med 
Nuts: 3.83 
(0.75)
Post Med 
EVOO: 4.01
Post Med 
Nuts: 4.17
Change Med 
EVOO: 0.25 
(1.09)
Change Med 
Nuts: 0.34 
(1.13)
Pre: 3.95 
(0.79)
Post: 3.71
Change: -
0.24 (1.08) 
Med EVOO: 
0.49 (-0.01,
0.99)
Med Nuts: 0.58 
(0.07, 1.09)
Med EVOO: 0.58
(-0.02, 1.19)
Med Nuts: 0.74
(0.08, 1.40)
Overall: 
0.14u
N
Y
Lee (2015)
(5)
Corsi blocks 
RT (ms)o,p
Corsi blocks 
spano,p
Baseline, 
11 d
Pre: N/R
Post: N/R
Change: 
603.26
(1254.19)
Pre: N/R
Post: N/R
Pre: N/R
Post: N/R
Change: -
322.00
(1368.18)
Pre: N/R
Post: N/R
925.26
0.15
1.18 (-0.05, 2.40)
0.57 (-0.58, 1.73)
0.054
0.70
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
3-Back 
reaction -
time (ms)p,q
3-Back -
correct 
responsesp,q
Numeric WM 
RT (ms)o,p
Numeric WM 
accuracyo,p
Change: 0.28 
(1.10)
Pre: N/R
Post: N/R
Change: -
374.77
(499.25)
Pre: N/R
Post: N/R
Change: -
2.32 (5.80)
Pre: N/R
Post: N/R
Change: -
85.96
(181.35)
Pre: N/R
Post: N/R
Change: 1.11 
(5.54)
Change: 0.13 
(0.84)
Pre: N/R
Post: N/R
Change: -
123.50
(426.18)
Pre: N/R
Post: N/R
Change: 4.14 
(7.27)
Pre: N/R
Post: N/R
Change: -
75.49 (59.80)
Pre: N/R
Post: N/R
Change: -
0.92 (6.36)
-251.27
-6.46
-10.47
2.03
-1.03 (-2.28, 0.23)
-1.55 (-2.90, 0.21)
-0.57 (-1.73, 0.58)
0.57 (-0.58, 1.73)
0.1
0.02
0.75
0.87
N
N
N
N
Knight 
(2016)t (6)
Digit span 
forward
Baseline, 3 
MThs, 6 
MThs
Pre: 11.2 
(2.0)
Pre: 10.9 
(2.1)
0.20u
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Digit span 
backward
3 MThs:
Post: 11.18
(1.99)
Change: -
0.02
6 MThs:
Post: 11.04 
(2.26)
Change: -
0.16
Pre: 9.2 (2.2)
3 MThs:
Post: 9.49 
(1.85)
Change: 0.29
6 MThs:
Post: 9.41 
(2.26)
Change: 0.21
3 MThs:
Post: 11.44
(2.03)
Change: 0.54
6 MThs:
Post: 10.74 
(2.30)
Change: -
0.16
Pre: 9.3 (2.1)
3 MThs:
Post: 9.38
(1.89)
Change: 0.08
6 MThs:
Post: 9.51 
(2.28)
Change: 0.21
-0.56 (-1.25,
0.13)
0.00 (-0.69,
0.69)
0.21 (-0.52,
0.94)
0.00 (-0.73,
0.73)
-0.27 (-0.61, 0.06)
0.00 (-0.33, 0.33)
0.10 (-0.24, 0.43)
0.00 (-0.33, 0.33)
0.84u
N
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Letter-
number 
sequencing 
(LNS)
Pre: 20.5 
(2.5)
3 MThs:
Post: 20.40
(2.47)
Change: -
0.10
6 MThs:
Post: 20.68 
(3.15)
Change: 0.18
Pre: 20.9 
(2.8)
3 MThs:
Post: 20.92 
(2.52)
Change: 0.02
6 MThs:
Post: 20.88
(3.24)
Change: -
0.02
-0.12 (-1.02,
0.78)
0.20 (-0.70,
1.10)
-0.05 (-0.38, 0.29)
0.08 (-0.26, 0.41)
0.85u
N
N
Processing speed
Wardle 
(2000) (2) 
Choice 
reaction time 
(modification 
of Erikson & 
Erikson task)
Baseline, 6 
wks, 12 
wks
N/R N/R N/A N/A 6 wks & 
12 wks: 
>0.05u
N
McMillan 
(2011) (3)
Simple RT 
(ms)
Baseline, 
10 d
Pre: 277 (59)
Post: 253.33 
(32)
Change: -
23.67
Pre: 289.04 
(56)
Post: 274 
(46)
Change: -
15.04
-8.63 (-56.21,
38.95)
-0.15 (-0.93, 0.64) 0.66 N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Choice RT 
(ms)
Choice RT 
accuracy (%)
Pre: 392 (86)
Post: 375
(37)
Change: -
17.00
Pre: 97.22 
(2.24)
Post: 94.20 
(4.19)
Change: -
3.02
Pre: 377 (45)
Post: 378 
(57)
Change: 1.00
Pre: 96.16 
(3.79)
Post: 96.15 
(3.79)
Change: -
0.01
-18 (-74.13,
38.13)
-3.01 (-5.61, -
0.41)
-0.26 (-1.04, 0.53)
-0.93 (-1.75, -
0.10)
0.30
0.13
N
Y
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
TMT-Ac 6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 65.50
(31.98)
Post Med 
Nuts: 71.57 
(32.94)
Pre: N/A
Post: 70.79
(34.13)
Med EVOO: -
5.29 (-17.08,
6.50)
Med Nuts: 0.78 
(-11.31, 12.87)
Med EVOO: -
0.16 (-0.52, 0.20)
Med Nuts: 0.02 (-
0.34, 0.38)
0.41 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Change: N/A
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014) (10)
N/A N/A N/A N/A N/A N/A N/A N/A
Valls-Pedret 
(2015) (4) 
Color Trail 
test part 1l,m
Baseline,  
as close to 
study 
termination 
date as 
possible 
(average 
4.1 yrs)
Pre Med 
EVOO: 62.60 
(19.99)
Pre Med 
Nuts: 61.15 
(18.39)
Post Med 
EVOO: 56.83
Post Med 
Nuts: 63.63
Change Med 
EVOO: -5.77
(17.38)
Pre: 57.00 
(19.78)
Post: 61.53
Change: 4.53 
(17.78) 
Med EVOO: -
10.30 (-22.36,
1.76)
Med Nuts: -2.05
(-14.55, 10.45)
Med EVOO: -
0.51 (-1.11, 0.09)
Med Nuts: -0.11
(-0.75, 0.53)
Overall: 
0.045u
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Change Med 
Nuts: 2.48 
(18.84)
Lee (2015)
(5)
Simple RT 
(ms)o,p
Choice RT 
(ms)o,p
Choice RT -
correct 
responseso,p
Baseline, 
11 d
Pre: N/R
Post: N/R
Change: 8.79 
(21.88)
Pre: N/R
Post: N/R
Change: 0.47 
(28.61)
Pre: N/R
Post: N/R
Change: 0.78 
(1.68)
Pre: N/R
Post: N/R
Change: 3.55 
(64.84)
Pre: N/R
Post: N/R
Change: -
5.02 (23.57)
Pre: N/R
Post: N/R
Change: -
0.26 (2.98)
5.24
5.49
1.04
0.57 (-0.58, 1.73)
0.57 (-0.58, 1.73)
0.57 (-0.58, 1.73)
0.78
0.53
0.35
N
N
N
Knight 
(2016)t (6)
Symbol 
search
Baseline, 3 
MThs, 6 
MThs
Pre: 19.3 
(4.1)
3 MThs:
Post: 21.39
(5.07)
Change: 2.09
6 MThs:
Pre: 19.5 
(4.5)
3 MThs:
Post: 22.13
(5.12)
Change: 2.63
6 MThs:
-0.54 (-1.99,
0.91)
-0.54 (-1.99,
0.91)
-0.12 (-0.46, 0.21)
-0.12 (-0.46, 0.21)
0.78u
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Coding
Processing 
speed 
composite
Post: 24.83 
(5.20)
Change: 5.53
Pre: 40.7 
(9.3)
3 MThs:
Post: 46.07
(9.88)
Change: 5.37 
6 MThs:
Post: 52.34 
(9.90)
Change: 
11.64
Pre: N/R
3 MThs:
Post: -0.20
(1.61)
Post: 25.57 (-
12.26)
Change: 6.07
Pre: 42.8
(10.8)
3 MThs:
Post: 48.82
(9.94)
Change: 6.02
6 MThs:
Post: 54.73 
(9.96)
Change: 
11.93
Pre: N/R
3 MThs:
Post: 0.21
(1.64)
-0.65 (-4.05,
2.75)
-0.29 (-3.69,
3.11)
-0.41 (-0.96,
0.14)
-0.06 (-0.40, 0.27)
-0.03 (-0.36, 0.31)
-0.25 (-0.59, 0.09)
0.92u
0.81u
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
6 MThs:
Post: -0.18
(1.57)
6 MThs:
Post: 0.19 
(1.60)
-0.37  (-0.91,
0.17)
-0.23 (-0.57, 0.10) N
Verbal & visual memory
Wardle 
(2000) (2) 
Verbal 
immediate 
free recall
Baseline, 6 
wks, 12 
wks
N/R N/R N/A N/A 6 wks & 
12 wks: 
>0.05u
N/A
McMillan 
(2011) (3)
Immediate 
word recall
Delayed word 
recall
Word recog 
accuracy (%)
Baseline, 
10 d
Pre: 7.67
(2.00)
Post: 8.92 
(2.39)
Change: 1.25
Pre: 6.33 
(2.38)
Post: 7.83 
(2.36)
Change: 1.5
Pre: 81.95 
(14.03)
Post: 85.28 
(8.46)
Change: 3.33
Pre: 7.67 
(2.10)
Post: 8.54 
(2.18)
Change: 0.87
Pre: 7.00 
(2.08)
Post: 6.85 
(2.64)
Change: -
0.15
Pre: 88.72 
(6.02)
Post: 88.46 
(7.28)
Change: -
0.26
0.38 (-1.32,
2.08)
1.65 (-0.2, 3.5)
3.59 (-5.22,
12.40)
0.18 (-0.61, 0.97)
0.72 (-0.09, 1.53)
0.33 (-0.46, 1.12)
0.13
0.17
0.31
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Word recog 
RT (ms)
Delayed 
picture recog 
(%)
Delayed 
picture recog 
RT
Pre: 894 
(150)
Post: 865 
(210)
Change: -29
Pre: 88.75 
(7.65)
Post: 86.66 
(7.92)
Change: -
2.09
Pre: 742 
(223)
Post: 852 
(199)
Change: 110
Pre: 945 
(227)
Post: 754 
(152)
Change: -191
Pre: 90.00 
(10.26)
Post: 87.69 
(12.35)
Change: -
2.31
Pre: 752 (97)
Post: 719 
(104)
Change: -33
162 (1.32,
322.68)
0.22 (-7.32,
7.76)
143 (2.72,
283.28)
0.81 (-0.01, 1.62)
0.02 (-0.76, 0.81)
0.82 (0.00, 1.63)
0.04
0.95
0.16
N
N
Y
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
RAVLT, 
immediate 
recallc
6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Pre: N/A Med EVOO:
2.28 (-0.99,
5.55)
Med EVOO: 0.25
(-0.11, 0.61)
0.27 N
N
177
Supplementary Material 3.12. - cont.
 
Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
RAVLT, 
delayed 
recallc
Post Med 
EVOO: 32.90 
(8.83)
Post Med 
Nuts: 31.28 
(10.60)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 5.81
(2.69)
Post Med 
Nuts: 5.17 
(3.02)
Change Med 
EVOO: N/A 
Post: 30.62
(9.54)
Change: N/A
Pre: N/A
Post: 5.21
(2.97)
Change: N/A
Med Nuts: 0.66
(-3.06, 4.38)
Med EVOO:
0.60 (-0.40,
1.60)
Med Nuts: -0.04
(-1.13, 1.05)
Med Nuts: 0.06 (-
0.30, 0.42)
Med EVOO: 0.21
(-0.14, 0.57)
Med Nuts: -0.01
(-0.37, 0.35)
0.25 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Verbal paired 
associatesc
ROCF, 
immediatec
Change Med 
Nuts: N/A
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 13.43 
(3.70)
Post Med 
Nuts: 12.05 
(3.75)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Pre: N/A
Post: 12.81
(3.80)
Change: N/A
Pre: N/A
Med EVOO:
0.62 (-0.73,
1.97)
Med Nuts: -0.76
(-2.13, 0.61)
Med EVOO:
1.93 (-0.18,
4.04)
Med EVOO: 0.17
(-0.19, 0.52)
Med Nuts: -0.20
(-0.56, 0.16)
Med EVOO: 0.33
(-0.03, 0.69)
0.05
0.01
N
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
ROCF, 
delayedc
Post Med 
EVOO: 13.88
(6.67)
Post Med 
Nuts: 10.94 
(6.61)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 13.27
(7.54)
Post Med 
Nuts: 10.83 
(6.56)
Change Med 
EVOO: N/A 
Post: 11.95
(3.70)
Change: N/A
Pre: N/A
Post: 11.13
(6.15)
Change: N/A
Med Nuts: -1.01
(-3.11, 1.09)
Med EVOO:
2.14 (-0.42,
4.70)
Med Nuts: -0.30
(-2.63, 2.03)
Med Nuts: -0.17
(-0.53, 0.19)
Med EVOO: 0.30
(-0.06, 0.66)
Med Nuts: -0.05
(-0.41, 0.31)
0.03 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Change Med 
Nuts: N/A
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014) (10)
N/A N/A N/A N/A N/A N/A N/A N/A
Valls-Pedret 
(2015) (4) 
RAVLT, total 
learningk,l
Baseline,  
as close to 
study 
termination 
date as 
possible 
(average 
4.1 yrs)
Pre Med 
EVOO: 39.31 
(7.92)
Pre Med 
Nuts: 39.46 
(7.90)
Post Med 
EVOO: 43.81
Post Med 
Nuts: 43.72
Change Med 
EVOO: 4.50 
(7.20)
Change Med 
Nuts: 4.26 
(7.18)
Pre: 39.24 
(7.90)
Post: 41.34
Change: 2.10 
(7.19)
Med EVOO: 
2.40 (-0.25,
5.05)
Med Nuts: 2.16 
(-0.53, 4.85)
Med EVOO: 0.30 
(-0.03, 0.64)
Med Nuts: 0.27 (-
0.07, 0.61)
<0.05
>0.05
Overall: 
0.04u
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
RAVLT, 
delayed 
recallk,l
Paired 
associatesk,l
Pre Med 
EVOO: 6.61 
(2.96)
Pre Med 
Nuts: 6.48
(2.94)
Post Med 
EVOO: 8.08
Post Med 
Nuts: 8.28
Change Med 
EVOO: 1.47 
(2.56)
Change Med 
Nuts: 1.80 
(2.56)
Pre Med 
EVOO: 15.25 
(3.22)
Pre Med 
Nuts:  15.25 
(3.20)
Pre: 6.37 
(2.92)
Post: 7.32
Change: 0.95 
(2.55)
 
Pre: 14.89 
(3.19)
Med EVOO: 
0.52 (-0.47,
1.51)
Med Nuts: 0.85 
(-0.15, 1.85)
Med EVOO: 
0.34 (-0.73,
1.41)
Med Nuts: 0.50 
(-0.59, 1.59)
Med EVOO: 0.18
(-0.16, 0.51)
Med Nuts: 0.29 (-
0.05, 0.63)
Med EVOO: 0.11
(-0.23, 0.44)
Med Nuts: 0.16 (-
0.18, 0.49)
Overall: 
0.06u
Overall: 
0.56u
N
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Memory 
compositek,l
Post Med 
EVOO: 15.5
Post Med 
Nuts: 15.66
Change Med 
EVOO: 0.25 
(3.30)
Change Med 
Nuts: 0.41
(3.31)
Pre Med 
EVOO: 0.02 
(0.74)
Pre Med 
Nuts: 0.013 
(0.77)
Post Med 
EVOO: 0.06
Post Med 
Nuts: 0.10
Change Med 
EVOO: 0.04 
Post: 14.8
Change: -
0.09 (3.29) 
Pre: -0.04
(0.22)
Post: -0.21
Change: -
0.17 (0.76)
Med EVOO: 
0.21 (0.00, 0.42)
Med Nuts: 0.26 
(0.04, 0.48)
Med EVOO: 0.33
(-0.01, 0.66)
Med Nuts: 0.39
(0.05, 0.73)
<0.25
>0.05
Overall: 
0.04u
N
Y
183
Supplementary Material 3.12. - cont.
 
Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
(0.77) 
Change Med 
Nuts: 0.09 
(0.75)
Lee (2015)
(5)
Immediate 
word recall –
correct 
responsesp,q,s
Immediate 
word recall –
incorrect 
responsesp,q,s
Delayed word 
recall –
correct 
responsesp,r,s
Delayed word 
recall –
incorrect 
responsesp,r,s
Baseline, 
11 d
Pre: N/R
Post: N/R
Change: 1.14 
(2.01) 
Pre: N/R
Post: N/R
Change: -
0.32 (0.95) 
Pre: N/R
Post: N/R
Change: 0.67 
(2.46)
Pre: N/R
Post: N/R
Change: -
0.33 (1.15) 
Pre: N/R
Post: N/R
Change: -
0.64 (1.97) 
Pre: N/R
Post: N/R
Change: 0.36 
(0.79) 
Pre: N/R
Post: N/R
Change: -
0.48 (2.42)
Pre: N/R
Post: N/R
Change: 0.71 
(1.38) 
1.78
-0.68
1.15
-1.04
1.73 (0.34, 3.11)
-1.33 (-2.63, -
0.02)
0.85 (-0.38, 2.09)
-1.29 (-2.59, 0.01)
0.01
0.04
0.17
0.046
Y
Y
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Word recog 
accuracy 
(%)o,p
Word recog 
RT (ms)o,p
Picture recog 
– correct 
responseso,p
Picture recog 
RT (ms)o,p
Pre: N/R
Post: N/R
Change: -
8.87 (9.11)
Pre: N/R
Post: N/R
Change: -
49.09
(123.81)
Pre: N/R
Post: N/R
Change: -
0.14 (5.17)
Pre: N/R
Post: N/R
Change: -
5.04 (131.30)
Pre: N/R
Post: N/R
Change: -
0.14 (9.51)
Pre: N/R
Post: N/R
Change: -
33.39 (93.63)
Pre: N/R
Post: N/R
Change: -
2.52 (6.96)
Pre: N/R
Post: N/R
Change: -
117.22
(530.47)
-8.73
-15.7
2.38
112.18
-0.57 (-1.73, 0.58)
-0.57 (-1.73, 0.58)
0.72 (-0.44, 1.89)
0.57 (-0.58, 1.73)
0.78
0.69
0.23
0.36
N
N
N
N
Knight 
(2016)t (6)
Benton 
Visual 
Retention 
Test (BVRT)
Baseline, 3 
MThs, 6 
MThs
Pre: 6.2 (1.5)
3 MThs:
Post: 5.21
(1.66)
Pre: 6.1 (1.3)
3 MThs:
Post: 5.45
(1.68)
-0.34 (-0.82,
0.14)
-0.24 (-0.58, 0.10)
0.55u
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
RAVLT 
(total score)
Memory 
composite
Change: -
0.99
6 MThs:
Post: 6.07 
(1.78)
Change: -
0.13
Pre: 76.7 
(14.9)
3 MThs:
Post: 79.70
(14.66)
Change: 3.0
6 MThs:
Post: 86.18 
(13.73)
Change: 9.48
Pre: N/R
Change: -
0.65
6 MThs:
Post: 6.29
(1.80)
Change: 0.19
Pre: 75.7 
(13.8)
3 MThs:
Post: 78.88
(14.86)
Change: 3.18
6 MThs:
Post: 87.54 
(15.44)
Change: 
11.84
Pre: N/R
-0.32 (-0.80,
0.16)
-0.18 (-5.04,
4.68)
-2.36 (-7.22,
2.50)
-0.23 (-0.56, 0.11)
-0.01 (-0.35, 0.32)
-0.16 (-0.50, 0.17)
0.24u
0.44u
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
3 MThs:
Post: -0.22
(2.45)
6 MThs:
Post: -0.05
(2.56)
3 MThs:
Post: 0.23
(2.50)
6 MThs:
Post: 0.05 
(2.58)
-0.45 (-1.29,
0.39)
-0.10 (-0.97,
0.77)
-0.18 (-0.52, 0.15)
-0.04 (-0.37, 0.30)
N
N
Visuo-spatial
Wardle
(2000) (2) 
N/A N/A N/A N/A N/A N/A N/A N/A
McMillan 
(2011) (3)
N/A N/A N/A N/A N/A N/A N/A N/A
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
Clock 
Drawing Test 
(CDT)c
6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 5.53
(1.61)
Post Med 
Nuts: 5.20 
(1.68)
Pre: N/A
Post: 5.07
(1.66)
Med EVOO: 
0.46 (-0.13,
1.05)
Med Nuts: 0.13
(-0.48, 0.74)
Med EVOO: 0.28
(-0.08, 0.64)
Med Nuts: 0.08 (-
0.28, 0.44)
0.160 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
ROCF, copyc
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A 
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 29.87 
(5.98)
Post Med 
Nuts: 28.13 
(7.06)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Change: N/A
Pre: N/A
Post: 28.13
(6.08)
Change: N/A
Med EVOO:
1.74 (-0.43,
3.91)
Med Nuts: 0.00
(-2.45, 2.45)
Med EVOO: 0.29
(-0.07, 0.65)
Med Nuts: 0.00 (-
0.36, 0.36)
0.11 N
N
Martinez-
Lapiscina 
(2013) (9)
Clock 
Drawing Test 
(CDT)f
6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Pre: N/A Med EVOO: 
0.50 (0.07, 0.93)
Med Nuts: 0.32 
(-0.16, 0.80)
Med EVOO: 0.32 
(0.04, 0.60)
Med Nuts: 0.19 (-
0.09, 0.48)
0.020 Y
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Post Med 
EVOO: 5.45 
(1.53)
Post Med 
Nuts: 5.27 
(1.66)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Post: 4.95 
(1.66)
Change: N/A
Martinez-
Lapiscina 
(2014) (10)
Clock 
Drawing Test 
(CDT)h,i,j
6.5 yrs CLU
CT/TT: 5.50 
(1.42)
CLU 
CC: 5.24 
(1.47)
CR1
GG: 5.43 
(1.40)
CR1
GA/AA: 5.24 
(1.47)
CLU
CT/TT: 4.90 
(1.40)
CLU 
CC: 4.83 
(1.36)
CR1
GG: 4.96 
(1.41)
CR1
GA/AA: 4.92 
(1.46)
0.60 (0.24, 0.96)
0.40 (-0.11,
0.92)
0.46 (0.13, 0.79)
0.31 (-0.30,
0.93)
0.42 (0.09, 0.75)
0.28 (-0.16, 0.72)
0.33 (0.03, 0.64)
0.22 (-0.31, 0.74)
0.001
0.126
0.006
0.762
Y
N
Y
N
189
Supplementary Material 3.12. - cont.
 
Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
PICALM
CT/TT: 5.36 
(1.46)
PICALM
CC: 5.41 
(1.35)
ApoE4 non-
carriers: N/R
ApoE4 
carriers: N/R
PICALM
CT/TT: 4.78 
(1.46)
PICALM
CC: 5.19 
(1.35)
ApoE4 non-
carriers: N/R
ApoE4 
carriers: N/R
0.59 (0.18, 1.00)
0.27 (-0.13,
0.68)
0.55 (0.25, 0.85)
0.33 (-0.60,
1.27)
0.40 (0.03, 0.76)
0.16 (-0.22, 0.55)
N/A
N/A
0.005
0.186
<0.001
0.477
Y
N
N/A
N/A
Valls-Pedret 
(2015) (4) 
N/A N/A N/A N/A N/A N/A N/A N/A
Lee (2015)
(5)
N/A N/A N/A N/A N/A N/A N/A N/A
Knight 
(2016) (6)
Visual-spatial 
score 
composite
Baseline, 3 
MThs, 6 
MThs
Pre: N/R
3 MThs:
Post: -0.07
(1.03)
6 MThs:
Post: -0.06
(0.94)
Pre: N/R
3 MThs:
Post: 0.07 
(0.96)
6 MThs:
Post: 0.06 
(0.98)
-0.14 (-0.48,
0.20)
-0.12 (-0.44,
0.20)
-0.14 (-0.48, 0.20)
-0.12 (-0.46, 0.21)
0.10u
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Language
Wardle 
(2000) (2) 
N/A N/A N/A N/A N/A N/A N/A N/A
McMillan 
(2011) (3)
N/A N/A N/A N/A N/A N/A N/A N/A
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
Semantic 
Verbal 
Fluency-
Animalsc
6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 13.05
(4.11)
Post Med 
Nuts: 12.17 
(4.25)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre: N/A
Post: 12.16
(3.96)
Change: N/A
Med EVOO:
0.89 (-0.57,
2.35)
Med Nuts: 0.01
(-1.50, 1.52)
Med EVOO: 0.22
(-0.14, 0.58)
Med Nuts: 0.00 (-
0.36, 0.36)
0.24 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Phonemic 
Verbal 
Fluency-
FASc
Boston 
Naming Testc
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 25.66 
(9.99)
Post Med 
Nuts: 23.34 
(10.38)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 47.27 
(7.73)
Pre: N/A
Post: 21.29
(8.78)
Change: N/A
Pre: N/A
Post: 47.19
(6.10)
Med EVOO:
4.37 (0.91, 7.83)
Med Nuts: 2.05
(-1.53, 5.63)
Med EVOO:
0.08 (-2.53,
2.69)
Med Nuts: -1.76
(-4.50, 0.98)
Med EVOO: 0.45
(0.09, 0.81)
Med Nuts: 0.21 (-
0.15, 0.57)
Med EVOO: 0.01
(-0.35, 0.37)
Med Nuts: -0.23
(-0.59, 0.13)
0.01
0.18
Y
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Post Med 
Nuts: 45.43 
(8.21)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Change: N/A
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014) (10)
N/A N/A N/A N/A N/A N/A N/A N/A
Valls-Pedret 
(2015) (4) 
Verbal 
fluencyl,m
Baseline,  
as close to 
study 
termination 
date as 
possible 
(average 
4.1 yrs)
Pre Med 
EVOO: 18.44 
(3.99)
Pre Med 
Nuts: 20.33 
(3.55)
Post Med 
EVOO: 18.97
Post Med 
Nuts: 18.82
Pre: 19.02 
(3.99)
Post: 19.32
Med EVOO: 
0.23 (-2.18,
2.64)
Med Nuts: -1.81
(-4.27, 0.65)
Med EVOO: 0.06
(-0.53, 0.65)
Med Nuts: -0.48
(-1.13, 0.17)
Overall: 
0.13u
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Change Med 
EVOO: 0.53 
(4.15)
Change Med 
Nuts: -1.51
(3.80)
Change: 0.30 
(4.20)
Lee (2015)
(5)
N/A N/A N/A N/A N/A N/A N/A N/A
Knight 
(2016)t (6)
Initial letter 
fluency (ILF)
Excluded 
letter fluency 
(ELF)
Baseline, 3 
MThs, 6 
MThs
Pre: 24.7 
(8.5)
3 MThs:
Post: 24.37
(7.63)
Change: -
0.33
6 MThs:
Post: 25.60 
(8.03)
Change: 0.90
Pre: 23.3 
(9.4)
3 MThs:
Pre: 25.4 
(8.5)
3 MThs:
Post: 27.10
(7.75)
Change: 1.70
6 MThs:
Post: 27.25 
(8.14)
Change: 1.85
Pre: 21.9 
(7.8)
3 MThs:
-2.03 (-4.90,
0.84)
-0.95 (-3.82,
1.92)
-0.24 (-0.57, 0.10)
-0.11 (-0.45, 0.22)
-0.32 (-0.66, 0.02)
0.34u
0.18u
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Post: 22.39 
(7.21)
Change: -
0.91
6 MThs:
Post: 24.26 
(8.89)
Change: 0.96
Post: 23.77 
(7.32)
Change: 1.87
6 MThs:
Post: 25.18 
(9.04)
Change: 3.28
-2.78 (-5.71,
0.15)
-2.32 (-5.25,
0.61)
-0.27 (-0.60, 0.07) N
Executive function
Wardle 
(2000) (2) 
N/A N/A N/A N/A N/A N/A N/A N/A
McMillan 
(2011) (3)
N/A N/A N/A N/A N/A N/A N/A N/A
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
Similaritiesc 6.5 yrs Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 10.90
(5.40)
Pre: N/A
Post: 10.11
(4.37)
Med EVOO: 
0.79 (-1.04,
2.62)
Med Nuts: 0.53
(-1.37, 2.43)
Med EVOO: 0.15
(-0.20, 0.51)
Med Nuts: 0.10 (-
0.26, 0.46)
0.58 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
TMT-Bc
Post Med 
Nuts: 10.64 
(5.64)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Pre Med 
EVOO: N/A
Pre Med 
Nuts: N/A
Post Med 
EVOO: 
199.58
(134.95)
Post Med 
Nuts: 232.41 
(120.35)
Change Med 
EVOO: N/A 
Change Med 
Nuts: N/A
Change: N/A
Pre: N/A
Post: 220.19
(117.18)
Change: N/A
Med EVOO: -
20.61 (-67.25,
26.03)
Med Nuts: 12.22
(-31.03, 55.47)
Med EVOO: -
0.16 (-0.52, 0.20)
Med Nuts: 0.10 (-
0.26, 0.46)
0.21 N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014) (10)
N/A N/A N/A N/A N/A N/A N/A N/A
Valls-Pedret 
(2015) (4) 
Color Trail 
test part 2l,m
Baseline,  
as close to 
study 
termination 
date as 
possible 
(average 
4.1 yrs)
Pre Med
EVOO: 
136.55
(42.31)
Pre Med 
Nuts: 131.59 
(39.88)
Post Med 
EVOO: 
142.21
Post Med 
Nuts: 155.82
Change Med 
EVOO: 5.66 
(50.34)
Change Med 
Nuts: 24.23 
(55.40)
Pre: 129.99 
(41.79)
Post: 167.55
Change: 
37.56 (52.00) 
Med EVOO: -
31.90 (-57.42, -
6.38)
Med Nuts: -
13.33 (-40.17,
13.51)
Med EVOO: -
0.75 (-1.35, -0.14)
Med Nuts: -0.32
(-0.97, 0.32)
<0.05
>0.05
Overall: 
0.045u
Y
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Frontal 
cognition 
compositel,m
Pre Med 
EVOO: -0.06
(0.60)
Pre Med 
Nuts: 0.04 
(0.57)
Post Med 
EVOO: 0.17
Post Med 
Nuts: 0.07
Change Med 
EVOO: 0.23 
(0.63)
Change Med 
Nuts: 0.03 
(0.68)
Pre: 0.12 
(0.31)
Post: -0.21
Change: -
0.33 (0.64)
Med EVOO: 
0.56 (0.23, 0.89)
Med Nuts: 0.36 
(0.04, 0.68)
Med EVOO: 1.02
(0.40, 1.64)
Med Nuts: 0.72
(0.06, 1.38)
<0.01
<0.25
Overall: 
0.003u
Y
Yx
Lee (2015)
(5)
N/A N/A N/A N/A N/A N/A N/A N/A
Knight 
(2016)t (6)
Stroop test 
(interference 
control)
Baseline, 3 
MThs, 6 
MThs
Pre: 2.5 (0.5)
3 MThs:
Post: 2.33
(0.52)
Change: -
0.17
Pre: 2.5 (0.6)
3 MThs:
Post: 2.33 
(0.53)
Change: -
0.17
0.00 (-0.19,
0.19)
0.00 (-0.33, 0.33)
0.82u
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Tower of 
London 
(TOL)
Executive 
function 
composite
6 MThs:
Post: 2.28 
(0.40)
Change: -
0.22
Pre: 15.4 
(3.4)
3 MThs:
Post: 16.20
(3.06)
Change: 0.80
6 MThs:
Post: 17.49 
(3.21)
Change: 2.09
Pre: N/R
3 MThs:
Post: -0.28
(2.08)
6 MThs:
Post: 2.26
(0.43)
Change: -
0.24
Pre: 15.9 
(3.3)
3 MThs:
Post: 16.52
(3.12)
Change: 0.62
6 MThs:
Post: 17.51 
(3.24)
Change: 1.61
Pre: N/R
3 MThs:
Post: 0.82 
(5.43)
0.02 (-0.17,
0.21)
0.18 (-0.95,
1.31)
0.48 (-0.65,
1.61)
-1.10 (-2.48,
0.28)
0.04 (-0.30, 0.37)
0.05 (-0.28, 0.39)
0.14 (-0.19, 0.48)
-0.27 (-0.60, 0.07)
0.67u
0.11u
N
N
N
N
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
6 MThs:
Post: -0.09
(1.89)
6 MThs:
Post: 0.30 
(2.11)
-0.39 (-1.07,
0.29)
-0.19 (-0.53, 0.14) N
Motor control
Wardle 
(2000) (2) 
Tapping 
speed
Baseline, 6 
wks, 12 
wks
N/R N/R N/A N/A 6 wks & 
12 wks: 
>0.05u
N
McMillan 
(2011) (3)
N/A N/A N/A N/A N/A N/A N/A N/A
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (8)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014) (10)
N/A N/A N/A N/A N/A N/A N/A N/A
Valls-Pedret 
(2015) (4) 
N/A N/A N/A N/A N/A N/A N/A N/A
Lee (2015)
(5)
N/A N/A N/A N/A N/A N/A N/A N/A
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Cognitive 
function test
Follow up 
time points
Exp mean 
(SD)
Control 
mean (SD)
Between group 
MD (95% CIs)
Between group 
ES (95% CIs)
Between 
group p-
value
ES 
significant
Knight 
(2016) (6)
N/A N/A N/A N/A N/A N/A N/A N/A
We used random-effect models.  Standardised mean differences were calculated by subtracting the mean change in the control group from the 
mean change in the Med diet group and dividing by the pooled SD at baseline. Data is presented as standardised mean difference and 95% CI.
For PREDIMED studies with two Med Exp groups (4, 7-10) we divided Con by two to calculate ES. For post-test comparisons, ESs were calculated 
by subtracting the Con post-test from the Exp post-test and dividing by the pooled post SD (7-10). Values for PREDIMED and MedLey composites 
(4, 6) relate to z scores.
a All measures extracted from Figure 2 in Wardle (2000) (2) using Matlab and number of correct responses across 10 trials summed at each time 
point. 
b Outcomes reported for n=155 in total (Med n=53; Con n=50; LF n=52).
c Outcomes reported for n=268 in total (Med EVOO n=91; Med Nuts n=88; Con n=89).
d Outcomes available for n=263 in total (Med EVOO n=90; Med Nuts n=85; Con n=88).
e ES and CI calculated from incident percentage using Campbell Collaboration calculator: https://www.campbellcollaboration.org/effect-size-
calculato.html  
f Outcomes available for n=522 in total (Med EVOO n=224; Med Nuts n=166; Con n=132).
g Incident MCI and dementia obtained from review of medical records for total n=1055 as randomised.
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h For this test the intervention group gathers two Med diet groups, i.e., Med Diet EVOO and Med Diet Nuts merged to evaluate effect of Med as 
whole dietary pattern.
i Multivariable adjusted means and differences extracted from paper as unadjusted N/R.
j Outcomes for genotypes reported for variable n’s. CLU CT/TT total=309 (Med=226; Con=83); CLU CC total=198 (Med=153; Con=45); CR1
GG total=375 (Med=278; Con=97); CR1 GA/AA total=133 (Med=101; Con=32); PICALM CT/TT total=248 (Med=179; Con=69); PICALM CC 
total=256 (Med=196; Con=60).
k Outcomes reported for n=334 in total (Med EVOO n=127; Med Nuts n=112; Con n=95).
l Multivariable adjusted means and differences extracted as reported in main paper (although unadjusted values available in author suppl. tables).
m Outcomes reported for n=96 in total (Med EVOO n=41; Med Nuts n=25; Con n=30).
n Incident MCI cases reported for completers n=334. No dementia cases documented.
0 Change score reported for n=23 in cross-over RCT.
p ES and CI calculated from F test and n divided by two, as cross-over trial, using Campbell Collaboration calculator: 
https://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-SMD5.php
q Change score reported for n=22 in cross-over RCT.
r Change score reported for n=21 in cross-over RCT.
s Missing cases reported but number unclear.
t Outcomes reported for n=137 completers (Med=70; Con=67).
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u p value by analysis of covariance.
v Interaction effect from mixed factorial repeated measures ANCOVA.
w p value by analysis of covariance of three groups.  However, post hoc tests indicated Con did better than either Med or LF.
x The p value is discordant with the CI. We note the ANCOVA used a small n with a very large number of co-variates and may therefore have 
suffered from reduced statistical power. 
CIs, confidence intervals; CLU, CR1, PICALM & ApoE4, genotypes previously identified as related to cognitive decline; Con, control group; d,
days; ES, effect size; EVOO, extra virgin olive oil; Exp, experimental group; FAS, letters used in phonemic verbal fluency test; MCI, mild cognitive 
impairment; Med, Mediterranean intervention; MD, mean difference; MMSE, mini mental state examination; MThs, months; N, no; N/A, not 
available as not collected during study; N/R, outcome measured but not reported; PREDIMED, Prevencion con Dieta Mediterranea, translated to 
PREvention with MEDiterranean Diet; RAVLT, Rey auditory verbal learning test; recog, recognition; ROCF, Rey–Osterrieth complex figure; RT,
reaction time; RVIP, rapid visual information processing; SAT, sustained attention task; SD, standard deviation; suppl., supplementary; TMT-A,
trail making test part A; TMT-B, trail making test part B; wks, weeks; WM, working memory; Y, yes; yrs, years; %, percent.
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Supplementary Material 3.13. - Brain morphology or function outcomes
Author  
(yr)
Brain 
markers  
Follow up 
time 
points
Exp  mean (SD) Control mean 
(SD)
Between 
group MD 
(95% CIs)
Between 
group ES 
(95% CIs)
Between 
group p-
value
ES 
significant
Functional outcomes
Wardle 
(2000) (2)
N/A N/A N/A N/A N/A N/A N/A N/A
McMillan 
(2011) (3)
N/A N/A N/A N/A N/A N/A N/A N/A
PREDIMED publications (2011-2015)
Sanchez-
Villegas 
(2011) (7)
Plasma 
BDNF
Risk of 
plasma 
BDNF below 
Baseline 
only for 
participant
s with 
prevalent 
depression, 
3 yrs for 
entire 
cohort
Pre Med EVOO: 
N/R 
Pre Med Nuts: N/R 
Post Med EVOO: 
24.66 (38.32)
Post Med Nuts: 
24.87 (34.21)
Change Med 
EVOO: N/R
Change Med Nuts: 
N/R
Pre Med EVOO: 
N/R
Pre Med Nuts: N/R
Pre: N/R
Post: 23.37 (33.66)
Change: N/A
Pre: N/R
Med EVOO: 
1.29 (-12.72,
15.30)
Med Nuts: 
1.50 (-11.81,
14.81)
Med EVOO:
0.03 (-0.34,
0.41)
Med Nuts: 
0.04 (-0.34,
0.43)
0.68
0.97
N
N
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Author  
(yr)
Brain 
markers  
Follow up 
time 
points
Exp  mean (SD) Control mean 
(SD)
Between 
group MD 
(95% CIs)
Between 
group ES 
(95% CIs)
Between 
group p-
value
ES 
significant
10th
percentile
Plasma 
BDNF when 
hypertension 
prevalent at 
baselinea
Post Med EVOO: 
N/R
Post Med Nuts: N/R
Change Med 
EVOO: N/R
Change Med Nuts: 
N/R
Pre Med EVOO: 
N/R
Pre Med Nuts: N/R
Post Med EVOO: 
27.20 (34.94)
Post Med Nuts: 
26.05 (31.56)
Change Med 
EVOO: N/R
Change Med Nuts: 
N/R
Post: N/R 
Pre: N/R
Post: 25.77 (30.61)
Change: N/R
N/A
Med EVOO: 
1.43 (-12.50,
15.36)
Med Nuts:
0.28 (-12.98,
13.54)
Med EVOO:  
OR=1.02 
(0.38, 2.76)
Med Nuts: 
OR=0.22 
(0.05, 0.90)
Med EVOO:
0.04 (-0.37,
0.45)
Med Nuts:
0.01 (-0.41,
0.43)
0.04
0.74
N
Y
N
N
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Author  
(yr)
Brain 
markers  
Follow up 
time 
points
Exp  mean (SD) Control mean 
(SD)
Between 
group MD 
(95% CIs)
Between 
group ES 
(95% CIs)
Between 
group p-
value
ES 
significant
Plasma 
BDNF when 
diabetes 
prevalent at 
baselineb
Plasma 
BDNF when 
hypercholest
erolaemia
prevalent at 
baselinec
Pre Med EVOO: 
N/R
Pre Med Nuts: N/R
Post Med EVOO: 
26.89 (20.71)
Post Med Nuts: 
28.34 (25.25)
Change Med 
EVOO: N/R
Change Med Nuts: 
N/R
Pre Med EVOO: 
N/R
Pre Med Nuts: N/R
Post Med EVOO: 
23.31 (40.96)
Post Med Nuts: 
23.81 (29.60)
Change Med 
EVOO: N/R
Change Med Nuts: 
N/R
Pre: N/R
Post: 30.54 (22.63)
Change: N/R
Pre: N/R
Post: 23.52 (33.07)
Change: N/R
Med EVOO:
-3.65 (-19.13,
11.83)
Med Nuts: -
2.20 (-19.00,
14.60)
Med EVOO:
-0.21 (-17.95,
17.53)
Med Nuts:
0.29 (-15.51,
16.09)
Med EVOO:
-0.17 (-0.87,
0.53)
Med Nuts: -
0.09 (-0.75,
0.58)
Med EVOO:
-0.01 (-0.45,
0.44)
Med Nuts:
0.01 (-0.49,
0.51)
0.51
0.98
N
N
N
N
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Author  
(yr)
Brain 
markers  
Follow up 
time 
points
Exp  mean (SD) Control mean 
(SD)
Between 
group MD 
(95% CIs)
Between 
group ES 
(95% CIs)
Between 
group p-
value
ES 
significant
Plasma 
BDNF when 
depression 
prevalent at 
baselined
Pre Med EVOO: 
N/R
Pre Med Nuts: N/R
Post Med EVOO: 
24.16 (13.80)
Post Med Nuts: 
32.37 (11.59)
Change Med 
EVOO: N/R
Change Med Nuts: 
N/R
Pre: N/R
Post: 22.72 (9.68)
Change: N/R
Med EVOO:
1.44 (-12.79,
15.67)
Med Nuts:
9.65 (-2.63,
21.93)
Med EVOO:
0.11 (-0.92,
1.13)
Med Nuts:
0.83 (-0.23,
1.88)
0.007
N
N
Martinez-
Lapiscina 
(2013) (8)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2013) (9)
N/A N/A N/A N/A N/A N/A N/A N/A
Martinez-
Lapiscina 
(2014)
(10)
N/A N/A N/A N/A N/A N/A N/A N/A
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Author  
(yr)
Brain 
markers  
Follow up 
time 
points
Exp  mean (SD) Control mean 
(SD)
Between 
group MD 
(95% CIs)
Between 
group ES 
(95% CIs)
Between 
group p-
value
ES 
significant
Valls-
Pedret 
(2015) (4)
N/A N/A N/A N/A N/A N/A N/A N/A
Lee 
(2015) (5)
N/A N/A N/A N/A N/A N/A N/A N/A
Knight 
(2016) (6)
N/A N/A N/A N/A N/A N/A N/A N/A
We used random-effect models.  Standardised mean differences were calculated by subtracting the mean change in the control group from the
mean change in the Med diet group and dividing by the pooled SD at baseline.  Data is presented as standardised mean difference and 95% CI.  
a Outcome available for n=206 of total cohort.
b Outcome available for n=79 of total cohort.
c Outcome available for n=161 of total cohort.
d Outcome available for n=37 of total cohort.
BDNF, brain derived neurotrophic factor; CIs, confidence intervals; ES, effect size; EVOO, extra virgin olive oil; Med, Mediterranean intervention; 
MD, mean difference; N, no; N/A, not available as not collected during study; N/R, outcome measured but not reported; OR, odds ratio; 
PREDIMED, Prevencion con Dieta Mediterranea, translated to PREvention with MEDiterranean Diet; SD, standard deviation; Y, yes; yr, year; 
%, percent.
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CHAPTER FOUR 
Development of the Mediterranean Diet and Culinary 
Index (MediCul) tool
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4.1 Introduction 
Existing Mediterranean diet index tools have various limitations. For example, Chapters 
Two and Three within this thesis identified that previous Mediterranean diet interventions 
and index tools used to assess adherence to the dietary pattern did not necessarily 
represent the ‘traditional’ diet. In order to conduct well-designed trials in the future to test 
the effect of the ‘traditional’ Mediterranean diet on brain health, as well as other 
outcomes, a new tool is required.  
 
The aim of this chapter was to describe the development of a new Mediterranean diet 
index tool to assess adherence to the ‘traditional’ dietary pattern and aspects of cuisine, 
which can be used within Western populations including among individuals at higher risk 
of cognitive decline. 
 
4.1.1 Rationale for use of diet index tools 
Diet index tools are widely used in research as they allow for a combined measure of 
dietary factors (e.g., foods, food groups, habits related to eating) that can be conveniently 
summarised in a single score (Bach et al., 2006; Hernández Ruiz et al., 2015). Index tools 
were originally developed to assess overall diet quality in relation to dietary guidelines, 
such as with the Diet Quality Index (DQI) (Patterson, Haines, & Popkin, 1994), Healthy 
Eating Index (HEI) (Kennedy, Ohls, Carlson, & Fleming, 1995), Alternative Healthy 
Eating Index (AHEI) (McCullough et al., 2002) and, more recently, the Australian 
Recommended Food Score (ARFS) (Collins et al., 2015), Healthy Eating Index for 
Australian Adults (HEIFA-2013) (Roy, Hebden, Rangan, & Allman-Farinelli, 2016) and 
Dietary Guideline Index (DGI) (McNaughton, Ball, Crawford, & Mishra, 2008) now 
adapted for use also with food records (Ward, Coates, & Hill, 2019). Latter indexes, such 
as those based on the Dietary Approaches to Stop Hypertension (DASH) (Kwan et al., 
2013), Mediterranean-Dietary Approaches to Stop Hypertension (MIND) (Morris et al., 
2015a), Nordic (Hillesund, Bere, Haugen, & Øverby, 2014) and the popular 
Mediterranean diet (Trichopoulou et al., 1995) aimed to assess adherence to a particular 
dietary pattern and relate the scores to various outcomes. The Dietary Inflammatory Index 
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(DII) aims to capture the inflammatory potential across any eating pattern and may 
therefore be relevant to multiple diets, including the Mediterranean diet (Shivappa, Steck, 
Hurley, Hussey, & Hébert, 2014). 
 
4.1.2 Mediterranean diet index tools 
Since 1995 at least 30 original Mediterranean diet index tools and their variants have been 
developed and used, many of which remain unnamed (see Appendix Five). Adherence 
scores from these tools have been associated with survival/mortality (Bonaccio et al., 
2018; Sofi, Macchi, Abbate, Gensini, & Casini, 2014; Trichopoulou, Costacou, Bamia, 
& Trichopoulos, 2003); multiple chronic diseases (see Chapter One); risk factors such as 
inflammation, lipids, blood pressure, coagulation markers (Panagiotakos, Pitsavos, & 
Stefanadis, 2006), body weight/waist circumference (Estruch et al., 2016); the 
microbiome (De Filippis et al., 2016); diet quality (Mariscal-Arcas et al., 2007); and the 
degree of adherence to a Mediterranean diet (Trichopoulou et al., 1995). Surprisingly, 
most index tools to date have studied adherence to a Mediterranean dietary pattern within 
countries outside the Mediterranean region, such as the US, Canada, Northern Europe, 
Australia, Middle East and China. 
 
The most widely used Mediterranean diet index tool (Hoffman & Gerber, 2013; 
Zaragoza-Martí, Cabañero-Martínez, Hurtado-Sánchez, Laguna-Pérez, & Ferrer-
Cascales, 2018), frequently modified by researchers to better suit various populations and 
cohorts, is the Mediterranean Diet Score (MDS). This has also been called the 
Mediterranean Diet Pattern Score (MDPS) (Kouris-Blazos & Itsiopoulos, 2014). The 
MDS was originally developed, and later updated, by Trichopoulou (Trichopoulou et al., 
1995; Trichopoulou et al., 2003) to include fish. More recently, the Mediterranean Diet 
Score (MedDietScore) (Panagiotakos, Milias, Pitsavos, & Stefanadis, 2006) and the 
Mediterranean Diet Adherence Screener (MEDAS) (see Appendix Six) (Schroder et al., 
2011) have become increasingly popular. MEDAS has also been adapted for use in other 
populations, such as with the development of the Mediterranean Eating Pattern for 
Americans (MEPA) screener, which incorporates selected elements protective for brain 
health (Cerwinske, Rasmussen, Lipson, Volgman, & Tangney, 2017). 
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While most Mediterranean diet index tools aim to assess adherence to a Mediterranean 
dietary pattern among the general adult population, it is worth noting that some tools 
focus on specific stages of the life cycle, cohorts with particular conditions, or even 
specific meal occasions. Examples include the Mediterranean Diet Score for Pregnancy 
(MDS-P) (Mariscal-Arcas et al., 2009), KIDMED (Serra-Majem et al., 2004), one 
unnamed Mediterranean diet index tool used in relation to peripheral artery disease risk 
in people with type 2 diabetes (Ciccarone et al., 2003) and the Breakfast Quality Index 
(BQI) (Monteagudo et al., 2013).  
 
The Mediterranean Lifestyle (MEDLIFE) index (Sotos-Prieto et al., 2014; Sotos-Prieto 
et al., 2015), which is based on the Spanish Mediterranean diet pyramid (Bach-Faig et al., 
2011), was devised to more broadly assess adherence to the Mediterranean lifestyle as it 
includes physical activity, rest, social interaction and conviviality elements. This tool also 
assesses some unique Mediterranean dietary habits, e.g., infrequent snacking, which have 
rarely been captured within the Mediterranean context. Most recently, the Total Lifestyle 
Index (TLI) was constructed to measure adherence to the overall Mediterranean lifestyle 
pattern, including the Mediterranean diet, physical activity, sleep and daily living 
activities with social/intellectual aspects (Anastasiou et al., 2018). While the whole 
Mediterranean lifestyle may be of greatest importance for health, this has not yet been 
well studied, and is beyond the scope of this thesis. 
 
4.1.3 Limitations of existing tools 
Existing Mediterranean diet index tools and/or resulting scores show variation (Milà-
Villarroel et al., 2011) based on:  
a) their construction (a priori versus a posteriori; see Chapter One); 
b)  the number and type of elements included (typical range: 6-28 main elements); 
c)  cut-off points used for scoring; 
d)  total score (typical range: 0-130), which can also have variable weighting applied 
to the elements. 
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Scores for tools constructed a priori may better reflect the ‘traditional’ Mediterranean 
diet as the dietary elements are informed by historical intake data from Mediterranean 
populations at that time period (D'Alessandro & De Pergola, 2015) as compared to scores 
derived using data-driven models such as Principal Component Analysis (PCA).  
 
However, while the original MDS index (Trichopoulou et al., 1995; Trichopoulou et al., 
2003) was based on elements developed a priori, the cut-off points used to generate 
scoring were arbitrarily based on gender- and population-specific median intakes within 
Greece at that time. The use of such cut-off points may have been appropriate within a 
Mediterranean population which has maintained a traditional diet until the 1990s 
(Trichopoulou et al., 1995). However, this approach has been identified as a limitation 
when used in other countries or cohorts since such cut-off points will differ according to 
population characteristics (Martinez-Gonzalez, Hershey, Zazpe, & Trichopoulou, 2017; 
Sofi et al., 2014). For example, in some cohorts within the studies evaluated in a recent 
review of Mediterranean diet indexes, median intakes of meat and dairy were very high 
(D'Alessandro & De Pergola, 2018). Nevertheless, the use of medians, means and tertiles, 
derived from food frequency questionnaires has been common in research when deriving 
a score, even though these cut-off points may not necessarily represent levels related to 
‘traditional’ Mediterranean intakes. Indeed, such cut-off points may simply delineate 
participants with more desirable versus undesirable intakes of the elements assessed.  
 
Mediterranean diet index tools have also been criticised for lacking critical elements that 
characterise the ‘traditional’ Mediterranean diet and cuisine (D'Alessandro & De Pergola, 
2015; Hoffman & Gerber, 2013) (see Chapter Two). For example, while a 
monounsaturated fatty acid (MUFA) to saturated fatty acid ratio may be appropriate for 
use within the Mediterranean region where MUFA predominantly comes from the high 
intake of extra virgin olive oil (EVOO), in Australia the major source of MUFA in the 
diet reported is meat (Baghurst, 1999), which has different and usually opposing health 
effects, compared to olive oil. More recently, meat products were also found to be the 
highest contributors to dietary MUFA among older Australians from the Blue Mountains 
Eye Study (BMES) (Flood, Webb, Rochtchina, Kelly, & Mitchell, 2007), and for adults 
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aged 19 years and older, when compared to other food groups, based on the Australian 
Health Survey 2011-12 (Australian Bureau of Statistics, 2014). However, very recent data 
are lacking and may be different due to the rise in popularity of olive oil. In addition, not 
all existing tools adequately assess the contribution of modern, ultra-processed foods to 
the diet, which is important if they are intended for use within Western populations. 
Further, to derive scores for some tools involves complex computations, so the tools 
cannot be easily used in clinical practice. 
 
From a reliability and validity viewpoint, a recent systematic review of Mediterranean 
diet index tools found that few fulfilled quality criteria, especially with regards to test-
retest reliability and concurrent validity against another diet reference method (Zaragoza-
Martí et al., 2018). For example, relatively few tools have been compared for performance 
against a 24-hour food recall (Benitez-Arciniega et al., 2011), food record (Ciccarone et 
al., 2003), food frequency questionnaire (FFQ) (Schroder et al., 2011) or dietary 
biomarkers (Gerber et al., 2000; Panagiotakos et al., 2009). Tool validation against 
another diet reference method, particularly one that is not limited by the same recall bias, 
is now considered benchmark practice to determine whether a tool accurately measures 
what it intends to measure. Also, many existing index tools are not in the form of a dietary 
survey so a score cannot be directly derived, sometimes requiring assumptions to be made 
when deriving the score from a FFQ. Finally, to the author’s knowledge, no 
Mediterranean diet index tool has been specifically developed for, and validated within, 
the Australian context including among individuals diagnosed with mild cognitive 
impairment (MCI), which is a precursor to dementia (Petersen, 2004). This is an 
important research gap, given the emerging evidence that a Mediterranean dietary pattern 
may reduce rates of cognitive decline among high risk populations (Psaltopoulou et al., 
2013; Scarmeas et al., 2009; Tangney et al., 2011). 
 
4.1.4 Ideal characteristics for a new tool 
Patterson et al. (1994) who developed the original Diet Quality Index (DQI) (not for a 
Mediterranean diet), identified that “the most serious limitation to research in nutrition 
epidemiology has been the lack of accurate and practical methods to measure diet”. This 
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concern is relevant also for clinical studies. However, ‘gold standard’ assessment 
methods such as a FR can be burdensome for the participant, as well as expensive and 
labour-intensive for the researcher (Collins, Watson, & Burrows, 2010). The use of diet 
index tools may overcome some of the limitations of using a FR. However, individuals 
may still misrepresent their diets in line with their optimistic biases about food 
benefits/risks (Miles & Scaife, 2003) and social desirability bias (Hebert, Clemow, Pbert, 
Ockene, & Ockene, 1995). 
 
Nevertheless, diet index tools can capture the multi-dimensional nature of individual diets 
(Waijers, Feskens, & Ocké, 2007) as well as the cumulative impact of the elements 
measured (Golley et al., 2012) with reduced participant burden. An ideal diet index tool 
would: a) address known limitations of existing index tools, b) assess the whole of diet, 
c) be relatively simple to use, and d) be tested for reliability and validity in target 
populations, including against a dietary reference method that is not limited by the same 
recall bias.  
 
Therefore, the aim of this Chapter was to describe the development of a new diet index 
tool to assess adherence to the ‘traditional’ Mediterranean dietary pattern and aspects of 
cuisine which: 
a) is suitable for use in the Australian context; 
b) lends itself to various administrations, including online and in-person; 
c) can be used among adults with mild cognitive impairment (MCI); 
d) can be used to also indirectly derive a MEDAS score; 
e) has potential utility for research and clinical practice, without complex 
mathematical computations. 
 
4.2 Method 
The new Mediterranean diet index tool, which is in the form of a survey, was developed 
using guidelines (Passmore, Dobbie, Parchman, & Tysinger, 2002) and general 
recommendations (Cade, Thompson, Burley, & Warm, 2002) for survey construction and 
refined at multiple stages, as outlined below.
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4.2.1 Identification of ‘traditional’ elements 
A literature review was first conducted (see Chapter Two) and the ‘traditional’ 
Mediterranean cuisine was described from original data sources to improve current 
understanding. This was used to check against elements already included in existing 
Mediterranean tools from various countries (see Appendix Five) and to identify any gaps 
or potentially important elements that should also be included in the new tool to assess 
adherence to the ‘traditional’ diet. Further, consideration was given to definitions of the 
‘traditional’ Mediterranean diet from various educational Mediterranean diet pyramids 
(Bach-Faig et al., 2011; Oldways, 2008; Willett et al., 1995) to inform the final selection 
of elements for the new index tool using professional judgement.  
 
4.2.2 Tool naming  
To reduce confusion in future with other Mediterranean tools, which can sometimes be 
difficult to discern, a name was devised. The new diet index tool was called the 
Mediterranean Diet and Culinary Index (MediCul) in an attempt to link together concepts 
of the Mediterranean diet, cuisine/culinary matters and a ‘food as medicine’ philosophy.  
 
4.2.3 Tool development 
It was intended that the MediCul tool approximate a short diet survey (defined as <50 
items) (Calfas, Zabinski, & Rupp, 2000). Hence, short questions were developed using 
simple language, appropriate for an Australian and Western context. Expert dietetic 
knowledge was employed to minimise the use of leading questions since people tend to 
over-report what they perceive as good foods and under-report bad foods. 
 
Both frequency and serve questions were developed to reduce participant burden, as 
frequency questions tend to be easier to answer. Frequency data can also explain much of 
the variation in dietary intake or be a greater contributor to variation than serve size for 
most foods (Collins et al., 2014; Thompson & Subar, 2017). Questions were worded in a 
systematic way. For example, “How often do you usually…” was stated for frequency 
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questions, and consistent response options were offered for “times per day, times per 
week, times per month and I don’t eat…”. For serve questions, “How many serves of X 
do you usually eat..?” was stated with relevant serve size examples being provided, as 
well as consistent response options.  
 
Care was taken to ensure the final tool addressed gaps identified in existing tools. In 
particular, questions were devised, and checked, to ensure the tool assesses: 
1. intake of unique Mediterranean foods and cuisine aspects. For example, typical 
food combinations such as sofrito; high moisture, lower heat cooking methods; 
growing of own vegetables; wholegrain/low glycaemic index (GI) bread 
preference (as a proxy for wholegrains); wine in small amounts and only with 
meals; meals frequently home cooked; fasting practice; napping after the midday 
meal; 
2. discretionary foods, as these are frequently consumed in Western countries and 
make up approximately 35% of the energy intake in Australian diets (Australian 
Bureau of Statistics, 2014), e.g., hot chips, takeaway and sugary drinks; 
3. foods consumed in the ‘traditional’ Mediterranean diet, which have more recently 
been specifically associated with cognitive function, e.g., dark green leafy 
vegetables (Morris et al., 2015a; Morris et al., 2015b), nuts (Barbour, Howe, 
Buckley, Bryan, & Coates, 2014; O'Brien et al., 2014) and EVOO (Valls-Pedret 
et al., 2015). 
 
To be able to derive a MEDAS score, the 14 MEDAS questions optimised for the English 
language (or their substance) were included within the MediCul tool. Guidelines were 
developed to convert participant responses, if necessary, to the relevant frequency for 
MEDAS scoring. This was considered valuable due to the importance in research of the 
Prevencion con Dieta Mediterranea (PREDIMED) randomised controlled trial, which 
also includes cognitive outcomes (Valls-Pedret et al., 2015), and the recent popularity of 
the MEDAS tool, also in studies outside of Spain, such as the AUSMED Heart Trial 
(Mayr et al., 2018; Mayr, Tierney, Kucianski, Thomas, & Itsiopoulos, 2019).  
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The sequence of questions within MediCul was determined following common sense 
principles such as, assessing the total intake from a food group prior to assessing 
individual elements of that food group and grouping related questions together. 
 
4.2.4 Tool piloting 
A 40-item draft MediCul tool was pilot-tested (Passmore et al., 2002) among five healthy 
consumers from the general public and three participants from an existing cohort of older 
individuals with MCI (Singh et al., 2014) for readability, comprehension and timing. The 
Flesch Reading Ease and Flesch-Kincaid Grade Level were computed with Microsoft 
Word and employed to assess readability and comprehension as these are well established 
methods and have been previously used to assess consent forms (Priestley, Campbell, 
Valentine, Denison, & Buller, 1992) and patient information leaflets (Williamson & 
Martin, 2010). These indexes check the number of syllables per word (a measure of word 
difficulty) and sentence length (indicates syntactic complexity). Responses were sought 
to the following questions: length of time for completion of MediCul, any unclear 
questions, recommendations for tool improvement and perceived benefits of having a 
dietitian present to clarify questions. Feedback on MediCul was also obtained from 
several scientific experts on the Mediterranean diet before the MediCul tool was refined 
and finalised. 
 
The revision process resulted in evolutionary changes to MediCul instructions and some 
questions to improve their clarity and sensitivity. Additional questions were added 
(increasing the items from 40 to 50) to ensure the ‘traditional’ Mediterranean dietary 
pattern and aspects of cuisine could be adequately assessed. For example, a separate 
question was introduced for onion/garlic exposure, which is lacking in existing tools, yet 
the allium family of vegetables is consumed almost daily in the Mediterranean in cooked 
and/or raw forms. Images were added for less well-known foods such as dark green leafy 
vegetables, legumes, nuts/seeds and standard alcoholic drink quantities. See Chapter Six, 
Supplementary Material 6.2, for the final 50-item MediCul tool.  
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4.2.5 Tool cut-off points 
Absolute cut-off points for scoring were determined based on ‘traditional’ intakes. For 
some questions, multiple cut-off points were allocated to provide greater discernment, 
e.g., intake of nut serves. Maximum points were awarded for the highest level of 
adherence compared to ‘traditional’ intakes or exposures, and minimum points to the 
lowest.  
 
Cut-off points were informed by considering a combination of information sources: the 
traditional Cretan diet described in the Seven Countries Study (SCS), which gave rise to 
the ‘Mediterranean diet’ terminology and is considered the archetypal Mediterranean diet 
(Hatzis et al., 2013; Kromhout et al., 1989); popular Mediterranean diet index tools, such 
as MEDAS, which was itself informed by dose-response relationships between each food 
item and risk of myocardial infarction (Martinez-Gonzalez, Fernandez-Jarne, Serrano-
Martinez, Wright, & Gomez-Gracia, 2004; Schroder et al., 2011); Mediterranean diet 
pyramids such as the original pyramid by Willett et al. (1995), Oldways pyramid 
(Oldways, 2008), Spanish Mediterranean Diet Foundation pyramid (Bach-Faig et al., 
2011) and National Health and Medical Research Council Australian dietary guidelines 
and alcohol guidelines (National Health and Medical Research Council, 2001, 2013) for 
limits on alcohol. Although considered, the current dietary guidelines from the Greek 
Ministry of Health and Welfare (Ministry of Health and Welfare: Supreme Scientific 
Health Council, 1999) were not used as a basis for cut-off points, except for legumes, as 
these do not all reflect ‘traditional’ intakes. For example, these guidelines recommend 
red/white meat products 4-5 times per week, whereas ‘traditional’ intakes of such animal 
products were considerably lower. See Chapter Six, Supplementary Material 6.1, for the 
cut-off points used for each MediCul question. 
 
4.2.6 Tool weighting 
The weighting of points for various elements was based on the significance of the 
component to the ‘traditional’ Mediterranean cuisine in terms of quantity and frequency 
of intake and guided by weighting used in existing tools, particularly MEDAS, which has 
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been associated with health outcomes including cognitive function (Valls-Pedret et al., 
2015). While some tools provide equal weighting for each element, assuming all 
contribute equally to outcomes, this approach was avoided as it has been identified as a 
potential weakness which may affect a tools accuracy and predictive ability for future 
health outcomes (Panagiotakos et al., 2009). 
 
With regards to weighting for specific food groups, the MEDAS tool awards the highest 
weighting to foods with high fat content, i.e., EVOO and nuts, followed by a lower but 
equal weighting to vegetables, animal protein and discretionary foods, with the lowest 
weighting given to all other foods. This hierarchy was also used when weighting the 
scoring for MediCul food groups. Overall, MediCul awards the highest weighting to 
healthy Mediterranean foods. The remainder of MediCul points are distributed to 
unhealthy Western foods followed by cuisine elements, which have been less studied in 
relation to health outcomes. 
 
4.2.7 Tool scoring 
MediCul was designed to be scored in three steps: 
1. convert raw responses for all questions to the relevant frequency required for 
scoring. See Table 4.1 for conversions; 
2. score each item based on its cut-off point/s; 
3. sum the scores for all items to derive a total MediCul score. 
 
The scoring process can be done manually or automated for convenience using software 
such as Microsoft Excel. See Chapter Six, Supplementary Material 6.1, for the maximum 
score possible for each MediCul question.
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Table 4.1. Conversions prior to scoring 
 
 
4.2.8 Tool adaptation for online use  
In order for MediCul to be administered online (e.g., offered to participants via the 
SurveyMonkey platform as used in Chapter Five) the following adaptations were made: 
1. overall instructions were slightly modified to reflect online use, e.g., 
Next/Previous buttons, use of drop down menus, etc.; 
2. the number of questions per page was limited for ease of viewing on screen and 
to minimise required scrolling; 
3. drop down menus were added to offer frequency/quantity options; 
4. some questions were slightly re-worded to better fit the response options in drop 
down menus. 
See Appendix Seven for screen shots of sample MediCul questions formatted for online 
administration. 
Convert from Convert to Calculation 
Serves or frequencies per 
month 
Serves or frequencies per day Divide by 30 
Serves or frequencies per 
month 
Serves or frequencies per week Divide by 30 then 
multiply by 7 
Serves or frequencies per week Serves or frequencies per day Divide by 7 
Serves or frequencies per day Serves or frequencies per week Multiply by 7 
Days per month Days per year Divide by 30 then 
multiply by 365 
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4.2.9 Scoring for MEDAS 
The MEDAS score, used in PREDIMED, can be indirectly derived from responses 
provided to MediCul using a similar 3-step process for tool scoring discussed above (see 
Chapter Five, Supplementary Material Table S1). 
 
4.3 Results 
A new 50-item Mediterranean diet index tool named MediCul was developed a priori to 
capture the ‘traditional’ dietary pattern and certain aspects of cuisine. It measures some 
unique elements, not assessed by previous Mediterranean diet index tools. For example, 
the use of a home garden to grow vegetables, dark green leafy vegetable consumption, 
and the intake of olives and other traditional fermented foods. It also assesses exposure 
to discretionary foods, enabling it to be suitable for use within Western populations where 
such foods contribute significantly to energy intakes. 
 
MediCul includes 17 main food groups/elements: olive oil, vegetables, fruit, nuts, 
wholegrains, legumes, fish/shellfish, eggs, dairy products, white meat, red/processed 
meats, sweets and sugary drinks, takeaway, water, alcohol, coffee, cuisine. Nine of these 
elements cover desirable features of a ‘traditional’ Mediterranean diet and aspects of 
cuisine, and six cover undesirable elements of a Western diet.  
 
MediCul is scored out of 100, with a higher score representing increased adherence to the 
‘traditional’ dietary pattern and aspects of cuisine. However, it is presently difficult to 
categorise the level of adherence, e.g., low, moderate, high, without further testing the 
tool in association with health outcomes. This is beyond the scope of this thesis, but is 
planned for future research. 
 
MediCul takes approximately 20 minutes to complete and is relatively simple to use. It 
has good readability as confirmed by the Flesch Reading Ease = 76.4 and Flesch-Kincaid 
Grade Level = 5.4, where text with scores of at least 60-70, and at least 7-8, respectively, 
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is considered to be well written. MediCul is designed to be suitable for online and in-
person administration. 
 
4.4 Discussion 
It is commonly assumed that all Mediterranean diet index tools assess adherence to the 
‘traditional’ diet. This is a misconception since such tools, with both elements and 
absolute cut-off points determined a priori and based on traditional intakes have been 
reported far less in the literature (see Appendix Five). 
 
MediCul is a newly developed diet index tool that has avoided the identified risks of 
moving towards a modernised Mediterranean model, far away from the ‘traditional’ one 
originally described in the SCS (Ciancarelli, Di Massimo, De Amicis, & Ciancarelli, 
2017). During the development of MediCul some previous criticisms of Mediterranean 
diet research were also addressed as MediCul gathers information on cooking styles and 
certain food combinations, as well as various cuisine practices. Therefore, MediCul may 
assist in future research by enabling greater discernment between the ‘traditional’ 
Mediterranean dietary pattern and other plant-based dietary patterns. However, the 
strengths and limitations of MediCul should be considered.  
 
4.4.1 Strengths  
 
4.4.1.1 Original data sources used for cut-off points 
MediCul uses cut-off points based on ‘traditional’ intakes (circa 1950s to early 1960s in 
Crete, Greece, and Southern Italy), which have been associated with reduced risks of 
chronic diseases now prevalent in Western society, including dementia (Hatzis, Sifaki-
Pistolla, & Kafatos, 2015).
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4.4.1.2 Novel Mediterranean elements assessed 
Aspects of ‘traditional’ cuisine or habits related to eating, not captured by other index 
tools, are measured by MediCul. These include use of lemon/vinegar in food 
preparation; frequent home cooked main meals; exposure to moist, lower temperature 
cooking methods; eating main meals in company; fasting practice and napping after the 
midday meal. 
 
4.4.1.3 Exposure to Western foods assessed 
MediCul includes a range of questions that assess exposures to commonly consumed 
Western foods that have been associated with health risks, e.g., sugary drinks and 
takeaways. Although such foods were not part of the ‘traditional’ Mediterranean diet, 
Westernisation of dietary habits is occurring globally, including within Mediterranean 
countries (D'Alessandro & De Pergola, 2018).  
 
4.4.1.4 Foods associated with cognition assessed 
MediCul includes elements that have been related to cognitive function, e.g., dark green 
leafy vegetables (Mewborn, Terry, Renzi-Hammond, Hammond, & Miller, 2017), water 
(Lieberman, 2007), coffee (Santos, Costa, Santos, Vaz-Carneiro, & Lunet, 2010) and 
fasting practice (Brandhorst et al., 2015). Some of these elements are not measured by 
other tools. 
 
4.4.1.5 Zero alcohol intake not penalised 
Unlike most existing Mediterranean diet index tools, MediCul does not penalise 
participants if they avoid alcohol, for two of its alcohol questions. This is based on the 
following rationale: a) not all women consumed alcohol in the ‘traditional diet’, b) even 
small to moderate, but regular amounts of alcohol are now appreciated to increase cancer 
risk (Winstanley et al., 2011) with previously reported health benefits now believed to 
have been overstated due to confounding (Knott, Coombs, Stamatakis, & Biddulph, 2015) 
and, c) alcohol contributes to adverse brain morphology and function outcomes, 
particularly at high levels (Guest, Grant, Mori, & Croft, 2014; Topiwala et al., 2017; 
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Verbaten, 2009). While some observational studies show an association for low 
exposures to alcohol and reduced risk of cognitive decline and dementia, especially in 
older adults, systematic reviews have been criticised for not categorising former drinkers 
separately from lifetime abstainers in their analyses (Ilomaki, Jokanovic, Tan, & 
Lonnroos, 2015). Hence, MediCul is similar to HEIFA-2013 (Roy et al., 2016), a non-
Mediterranean index tool based on the updated Australian Dietary Guidelines (National 
Health and Medical Research Council, 2013), which awards maximum points for no or 
low alcohol intakes. 
 
4.4.1.6 Practical serves and images used 
For foods where quantity is assessed, MediCul uses practical serve sizes informed partly 
by MEDAS serves, as well as the commonly consumed portions in Australia (Zheng et 
al., 2016) and the Australian Guide to Healthy Eating (AGTHE), as appropriate. The tool 
also includes images for some less well-known foods in Western populations. 
 
4.4.1.7 More comprehensive than a screener 
While short screener tools may be useful to elicit behaviour change within an 
intervention, MediCul provides a comprehensive assessment of adherence to the 
‘traditional’ dietary pattern and aspects of cuisine with less participant burden than an 
extensive FFQ.  
 
4.4.1.8 Complex computations not required 
A MediCul score can be derived without further statistical analyses. It can be determined 
manually or calculation can be automated using software, such as Microsoft Excel. 
 
4.4.1.9 MEDAS score can be derived 
Responses to MediCul questions allow for indirect derivation of a MEDAS score, which 
is ideal for comparison to other studies that have used, or may use this screener in future. 
 
227
4.4.2 Limitations  
 
4.4.2.1 Limited dietary assessment period 
Inquiring about the last six months could be a limitation of MediCul, as this period doesn’t 
cover the impact of all seasons. Also, it is in contrast to many FFQs which typically ask 
about periods of 12 months. However, the time period of dietary assessment for MediCul 
could be adjusted to suit research needs. Also, the shorter time frame of dietary 
assessment selected for MediCul was deliberate as it may be difficult to assess diet over 
extended periods, especially among individuals with MCI. It is known that recall errors 
increase with time (Livingstone, Robson, & Wallace, 2004), increasing the chance of 
recall bias. This possibility was flagged by comments made when piloting the tool, where 
some individuals with MCI reported they could only consider the last month when 
answering questions about their diet. MediCul does, however, ask about cooking methods 
related to both warmer and cooler weather, as these can vary substantially.  
 
4.4.2.2 Healthiness of ‘traditional’ diet assumed 
The SCS gave rise to the Mediterranean diet terminology, as the ‘traditional’ Cretan diet 
consumed during the time of the study has been associated with the lowest coronary heart 
disease, cancer and dementia mortality, compared to the diets from 15 other cohorts 
(Hatzis et al., 2013; Hatzis et al., 2015). While the Mediterranean diet is the most 
extensively studied dietary pattern to date, with similar high quality evidence not 
available for any other dietary patterns (Martinez-Gonzalez et al., 2017), it is well-known 
that changes have occurred to what is now consumed in the Mediterranean. For example, 
there has been an increase in consumption of animal products and ultra processed foods. 
Since such foods have been associated with chronic disease, it was decided that MediCul 
should be based on the ‘traditional’ cuisine (see Chapter Two), which may represent a 
healthier time point in consumption of the Mediterranean diet.
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4.4.2.3 Combined quantity and frequency questions used 
A few questions within MediCul include the simultaneous assessment of both quantity 
and frequency variables, e.g., serves of vegetables consumed. Such questions tend to be 
more difficult to answer and may reduce accuracy (Passmore et al., 2002). However, these 
questions were based on standard questions within use in Australian dietary surveys, so 
this was unavoidable.  
 
4.4.2.4 Less common Western foods not assessed 
MediCul does not assess foods that are used less commonly within the general Western 
population, but which may contribute significantly to the diets of individuals. For 
example, there is no response category for coconut oil, coconut yoghurt, probiotic shots, 
margarine containing olive oil, dairy blend or paleo bread. However, no dietary 
assessment tool can measure everything, which is why study purpose is an important 
consideration in tool selection. 
 
4.4.2.5 Food preparation methods uncertain if not primary cook  
Food preparation methods may be unknown by respondents who are not the primary cook 
within their household. However, this is a limitation across all tools where it is not 
compulsory for the partner/carer to be present during an assessment.  
 
4.4.2.6 Food avoidance due to intolerance/allergy affects scoring 
Some individuals may have a food intolerance/allergy to particular foods/nutrients, which 
could influence their MediCul score. For example, a nut allergy or fructan intolerance. 
However, this is unavoidable, if the intake of certain ‘traditional’ foods is to be assessed. 
 
4.4.2.7 Sex and energy-adjusted cut-off points unavailable  
Due to the paucity of data for traditional intakes according to gender and energy intake 
level, MediCul uses non-gender specific cut-off points, as does MEDAS and the various 
Mediterranean diet pyramids.
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4.4.2.8 Not designed to calculate nutrient intakes  
Few diet index tools are used to estimate the intake of nutrients or phytochemicals 
(Hernández Ruiz et al., 2015) and MediCul is no exception. For example, while MediCul 
includes a short question to assess intake of total coffee cups, this cannot be used to 
accurately calculate caffeine intake since coffee cup sizes vary. Also, the type of coffee 
beans used and method of preparation can impact the caffeine content of coffee. Hence, 
multiple questions are required to accurately assess caffeine intake. This is beyond the 
scope of MediCul and best done using specialised tools, such as the caffeine food 
frequency questionnaire (C-FFQ) recently developed for the Australian population 
(Watson, Kohler, Banks, & Coates, 2017).  
 
4.4.2.9 Timing of food intake not assessed 
Traditionally, most eating within the Mediterranean occurred during the day with the 
main meal being a cooked lunch followed by a light supper (Hoffman & Gerber, 2013). 
Emerging research suggests late night eating, common in Western countries, disrupts the 
circadian rhythm and is associated with multiple chronic diseases (Grant et al., 2017; St-
Onge et al., 2017). While the timing of food intake over a 24-hour period may also be an 
important consideration for health, this is not assessed by MediCul due to the complexity 
of chrononutrition, which also considers meal size/frequency and timing. 
 
Finally, although MediCul provides the opportunity to comprehensively assess adherence 
to a ‘traditional’ Mediterranean dietary pattern and aspects of cuisine, it should be noted 
that previous studies using various Mediterranean diet index tools, which did not include 
measures of cuisine, nor Mediterranean specific cut-off points, have still found benefits 
for a Mediterranean-style dietary pattern. These include a reduced risk of mortality and 
chronic disease (Kouris-Blazos et al., 1999; Trichopoulou et al., 1995). However, higher 
scores from some of these tools, particularly when applied to Western populations, may 
simply be reflecting increased adherence to a prudent plant-based dietary pattern, rather 
than being discerning for the ‘traditional’ Mediterranean diet. 
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4.5 Conclusion  
A new 50-item diet index tool, MediCul, has been developed to assess adherence to the 
‘traditional’ Mediterranean dietary pattern and aspects of cuisine. MediCul is intended 
for online and in-person use within a Western context, including among adults with risk 
factors for cognitive decline and those diagnosed with MCI. Validation of the MediCul 
tool against a dietary reference method, within two such cohorts, is reported in Chapters 
Five and Six.  
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PREFACE 
 
In order for research tools to be used, they should first be validated. This is to ensure they 
are measuring what is intended, and can do so with reliability among the population of 
interest. While there are various types of validity of interest within research, it is now 
generally accepted that diet index tools should be tested for concurrent validity against a 
reference dietary method that is not limited by the same recall bias. 
 
The aim of this chapter was to test the reliability and validity of the newly developed 
Mediterranean Diet and Culinary Index (MediCul) against a 3-day food record, when 
administered online to middle-aged and older Australian adults with risk factors for 
cognitive decline, but no current diagnosis of dementia or neurodegenerative disease, 
representing a Western population. 
 
This chapter was published in the journal Nutrients:  
• Radd-Vagenas, S., Fiatarone Singh, M., Daniel, K., Noble, Y., Jain, N., O’Leary, 
F., . . . Flood, V. (2018). Validity of the Mediterranean Diet and Culinary Index 
(MediCul) for online assessment of adherence to the ‘traditional’ diet and aspects 
of cuisine in older adults. Nutrients, 10(12), 1913. doi:10.3390/nu10121913 
 
The chapter includes two published supplementary materials: 
- How to derive a MEDAS score from MediCul 
- Kappa statistics for percent agreement within the same category of 17 MediCul 
groups, between survey A and survey B   
 
Further information related to this chapter is presented in Appendices Seven to Eleven 
and includes: screen shots of sample MediCul questions formatted for online 
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administration, ethics letter, Research Food Diary app instructions, dietitian assisted food 
record checklist, front sheet for validation and reliability testing of MediCul.  
 
Part of the work produced in this chapter has been presented at the following conference: 
• Radd-Vagenas, S., Fiatarone Singh, M. A., Daniel, K., Noble, Y., O’Leary, F., 
Mavros, Y., Brodaty, H., Flood, V. M. Reliability and validity of MediCul 
(Mediterranean Diet & Culinary Index) in older Australian adults. 42nd Nutrition 
Society of Australia (Inc.) Annual Scientific Meeting, Canberra, Australia, 27-
30th November 2018. 
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Abstract: The Mediterranean diet is associated with multiple health benefits. Yet, no tool has
been specifically developed to assess adherence to the ‘traditional’ Mediterranean diet and cuisine
within a Western cohort, and validated for online use. We tested the reliability and validity of
online administration of the Mediterranean Diet and Culinary Index (MediCul) among middle-aged
and older adults. Participants were recruited in January–March 2017 from the 45 and Up Study,
completing MediCul twice. Test-retest reliability was assessed using the paired t-test, intra-class
correlation coefficient (ICC) and Bland-Altman plot. Validity was tested against a three-day food
record (FR)-derived MediCul score using Bland-Altman and nutrient trends across the MediCul score
tertiles. Participants (n = 84; 60% female; 65.4 years (SD = 5.9)), were overweight (BMI 26.1; SD = 4.0)
with 1.7 (SD = 1.5) chronic illnesses/conditions. Sequential MediCul tool scores were 56.1/100.0 and
56.8/100.0, respectively (t = −1.019; p = 0.311). Reliability via ICC (ICC = 0.86, 95% CI: 0.789, 0.910,
p < 0.0001) and Bland-Altman was good. In Bland-Altman validity analyses, the tool over-reported
FR MediCul score by 5.6 points with no systematic bias ((y = 8.7 − 0.06*x) (95% CI: −0.278, 0.158,
p = 0.584)). Nutrient trends were identified for MediCul consistent with expected Mediterranean
patterns. Online MediCul administration demonstrated good reliability and moderate validity for
assessing adherence to a ‘traditional’ Mediterranean pattern among older Australians.
Keywords: validity; reliability; repeatability; dietary assessment; index tool; score; Mediterranean
diet; Mediterranean dietary pattern; traditional
Nutrients 2018, 10, 1913; doi:10.3390/nu10121913 www.mdpi.com/journal/nutrients
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1. Introduction
The Mediterranean diet is a focus of research interest worldwide, as it has been associated with
multiple health benefits. These include a reduced risk of premature death, cardiovascular disease
(CVD), metabolic syndrome, cancer, liver disease, type 2 diabetes, depression, cognitive decline with
ageing, mild cognitive impairment (MCI) and dementia, in particular Alzheimer’s disease [1–11].
However, there has been inconsistency in the literature with regards to the definition used for
the Mediterranean diet [12,13]. Also, variable or inadequately reported Mediterranean interventions
have been used in clinical trials, which may not represent the ‘traditional’ diet [7]. The ‘traditional’
Mediterranean diet has been described as the dietary pattern existing in Greece and Southern Italy
during the late 1950s and early 1960s [13]. Briefly, it pertains to a more frugal, plant-based pattern with
higher intakes of unrefined foods, such as grains, vegetables, fruits, legumes and extra virgin olive oil,
and lower levels of exposure to meats, dairy and modern discretionary foods.
While the benefits ascribed to a Mediterranean diet parallel those of other plant-based diets,
such as vegetarian diets and the Dietary Approaches to Stop Hypertension (DASH) diet [14,15],
the ‘traditional’ Mediterranean diet also includes some unique cuisine aspects. For example,
low advanced glycation end products (AGEs) cooking methods [16], such as boiling and stewing,
and the use of acidic ingredients in cooking, such as lemon or vinegar; particular food combinations,
e.g., onions sautéed in olive oil with tomato as the basis for many cooked dishes; regular inclusion
of fermented foods, e.g., olives, feta cheese; limited snacking between meals; and water as the main
beverage. Such elements may contribute to increased antioxidant bioavailability, reduced chronic
systemic inflammation and positively influence the microbiome, but they have been rarely captured
in existing tools [13]. Hence, previous Mediterranean diet index tools may not have been sufficiently
nuanced to assess adherence to the ‘traditional’ Mediterranean diet and cuisine [17–19]. This may partly
explain differences in reported health outcomes, associated with a Mediterranean diet score across
various studies [12,20,21]. Some findings in the literature ascribed to the ‘traditional’ Mediterranean
diet may simply represent increased adherence to healthier plant-based dietary patterns, which have
also been associated with benefits, such as reduced risk of type 2 diabetes and mortality, outside the
context of a particular diet [20,21].
Additional limitations of existing Mediterranean diet index tools, especially when used within
a Western population, include the type and number of elements assessed, source of cut-off points used,
score derivation methodology and lack of validation against a dietary reference method, which is
not limited by the same recall biases [22]. For example, the number of components assessed in
reported indexes has ranged from only six [23] to 28 in the MEDiterranean LIFEstyle index (MEDLIFE),
which evaluates the Mediterranean diet and lifestyle more broadly [24]. Studies in Western countries
have used sex-specific median values from their respective populations as cut-off points for the
elements detailed in the first Mediterranean Diet Score (MDS) [11,25], originally developed for use
in a Greek population. This is problematic, since the median intakes for certain foods, such as
meat and dairy, are high in some Western cohorts [12]. Most Mediterranean diet adherence scores,
including multiple variants of the MDS, the MedDietScore [26] and Mediterranean Style Dietary
Pattern Score (MSDPS) [27], require derivation from a food frequency questionnaire (FFQ) rather
than being calculated directly from responses to an administered index tool. Notable exceptions are
MEDLIFE [24], the Mediterranean Diet Adherence Screener (MEDAS) [28] from the PREvencion
conDIeta MEDiterranea (PREDIMED) study in Spain and the Mediterranean Eating Pattern for
Americans (MEPA) screener adapted from MEDAS [29].
Only some Mediterranean diet index tools attempt to adjust for Western dietary habits or non-typical
Mediterranean foods, such as discretionary foods [24,28–31], which were not part of the ‘traditional’ diet
and may provide different health effects. Finally, in the era of e-Health, which opens the potential for wider
tool administration including regional and remote areas, to the best of our knowledge, no Mediterranean
diet index tool based on the ‘traditional’ diet and cuisine has been validated for online administration.
Such a tool could assist with broad population-based and longitudinal studies.
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We recently developed the Mediterranean Diet and Culinary Index (MediCul) tool, to overcome
these common limitations. We have tested the performance of MediCul when administered in-person,
to a cohort of older Australians with MCI [22]. As MediCul has the potential for wider use, the purpose
of the present study was to test its reliability and validity when administered online to middle-aged
and older people in the general population, living in the same Western country.
2. Materials and Methods
2.1. Participants
We aimed to recruit a cross-sectional sample of 100 [32,33] community-dwelling participants
living in Sydney from January to March 2017, from the Sax Institute’s 45 and Up Study [34], as part
of a validation study for various tools to be used in the Maintain Your Brain (MYB) trial administered
within an online platform [35]. The 45 and Up Study is a large prospective cohort in New South Wales
(NSW), Australia (n = 267,153) of participants recruited from the Department of Human Services
(formerly Medicare) enrolment database representing diverse socio-demographic, geographic and
cultural backgrounds, investigating healthy ageing [34]. Participants initially joined the study by
completing the baseline questionnaire (between January 2006 and December 2009) and giving their
consent for follow-up and linkage of their information to routine health databases.
Inclusion criteria for the MYB validity study were: (1) Previously enrolled in the 45 and Up Study
and agreeable to further contact with email on record, (2) aged 55–75 years in 2016, (3) absence of
dementia, Parkinson’s disease and multiple sclerosis, (4) home internet/computer access, (5) access
to iPad or iPhone (for activity and diet logging), and (6) residing in postcode within 30 km radius of
Lidcombe, NSW (site of clinic visit in Sydney).
Exclusion criteria were: (1) Unable to use a computer, (2) life threatening condition, (3) inability
to write/converse in English, (4) serious psychiatric condition, on antipsychotics or suicidal ideation,
and (5) unstable medical condition.
A potentially eligible subset of the 45 and Up Study cohort (n = 27,848) was identified by the Sax
Institute, which administers the 45 and Up Study [34], based on above inclusion criteria except for home
internet/computer access and access to iPad/iPhone, details which were unavailable to the Sax Institute.
Based on an estimated recruitment rate of 30%, 300 invitations were initially sent by the Sax Institute to
a random sample of participants. A further 303 invitations were sent later to achieve the target sample.
Participation in the MYB validity study was voluntary and electronic informed consent was
obtained before starting any data collection. This was followed by full online screening for study
eligibility, using both the inclusion and exclusion criteria. Ethics approval for MYB was obtained from
the University of New South Wales Human Research Ethics Committee (#16252) and NSW Population
and Health Services Ethics Committee (#2016/03/636). Ethical conduct for the 45 and Up Study was
approved by the University of New South Wales Human Research Ethics Committee (HREC).
2.2. Assessments
The MYB validity study included four assessment time points relevant to the validation of the
MediCul tool. MediCul was administered twice online utilizing SurveyMonkey® (www.surveymonkey.
com), at least one week apart (survey A and survey B), with an invitation for a clinic visit in between.
The clinic visit was used to measure: (a) Weight in light clothing, without shoes, using calibrated
digital scales (AND HW-100K and Avery Berkel HL122), (b) height using a wall-mounted Harpenden
stadiometer (Holtain Limited, Crymmych, Pembrokeshire, UK), (c) waist circumference taken at the
umbilicus with a flexible tape measure (Grafco®, Graham-Field, Model # 17-1340-2), and (d) resting
heart rate, taken manually, after a five-minute seated resting period. All anthropometric measurements
were made in triplicate with the mean being used. Body mass index (BMI) was calculated by dividing
weight (kg) by height2 (m). Data relating to demographics, self-reported medical conditions, number of
medications taken and supplement use were also collected as part of a suite of surveys during the first
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MediCul (survey A) administration. Composite medications were counted according to the number of
active ingredients they contained. Prevalence of nutrition supplement use was based on any reported
vitamin/mineral/botanical supplements, excluding probiotics. Vitamin B12 injections were counted
as medication. At the end of the clinic visit, or via email if a clinic visit was not possible, participants
were asked to keep a three-day food record (FR) as soon as they had completed MediCul survey B,
selecting one weekend and two weekdays, which needed to be within a seven-day period, but did not
need to be consecutive. Participants were instructed to use the ‘Research Food Diary’ app [36] as this
may reduce participant and researcher burden. This app has previously been reported to have a high
level of acceptance by adults compared to a 24-hour dietary recall [37] and mobile nutrition apps,
in general, have been shown in healthy populations to be comparable to traditional dietary assessment
methods [38]. The Research Food Diary app is based on Australian food composition data, and entries
can be directly imported into FoodWorks 8 Professional Edition software: 8.0.3553 (Xyris Software
Pty Ltd., Brisbane, Australia). We provided detailed downloadable instructions for the Research Food
Diary app, including color screen shots. Some participants however, declined to use the app so a hard
copy FR template was provided. The FR instructions provided to all participants advised them to log
typical days (not to change dietary intake), record any recipes, enter foods as consumed throughout
the day, and estimate serve sizes using household measures (spoons, cups) or weights (grams (g)),
if preferred, using kitchen scales. Participants were advised to expect a call from a dietitian shortly
after submitting their FR. A phone call was made to each participant within 24–48 hours of receiving
their FR to query unusual quantities and confirm entries were complete using a checklist for potentially
forgotten foods, based on principles from the ASA24 Automated Self-Administered 24-hour Dietary
Assessment Tool [39,40].
Where MediCul survey A or survey B was not completed within one week of administration,
an email reminder was sent with a direct link to prompt participants to complete their surveys. If either
survey still remained incomplete 1–2 weeks later, a second email reminder was sent. If FRs were not
submitted within one week, participants also received a reminder email. If FRs were not submitted
within two weeks, telephone reminders were made.
2.3. The MediCul Tool
MediCul is a 50-item short dietary survey developed empirically to assess adherence to
a ‘traditional’ Mediterranean dietary pattern and aspects of cuisine [13] within a Western population.
It applies reverse scoring for high exposures to foods that were not part of the ‘traditional’ pattern,
such as modern discretionary foods, which now account for approximately 35% of the total energy
intake of Australians [41]. A score for the popular MEDAS screener can also be derived from MediCul
(Supplementary Table S1).
MediCul is scored between 0 and 100, with a higher score representing greater adherence,
and takes approximately 20 minutes to complete. Details about MediCul development, elements,
cut-off points, scoring and rationale have previously been reported as Supplementary Materials in
the British Journal of Nutrition and this tool is freely available for download and use in research and
education [22].
For the present validity study, MediCul was modified for online administration using
SurveyMonkey with drop-down response options, logic and data limits applied to facilitate correct
dietary reporting without a dietitian being present. These backend adjustments were tested for accurate
performance by five researchers.
2.4. Dietary Analysis
We used Excel (MS Office Professional Plus 2013) to derive scores for both the MediCul and
MEDAS tools [22]. The FRs were coded and entered into FoodWorks 8 and we selected AusBrands
2015 and AusFoods 2015 data sources which map to the AUSNUT 2011–2013 Food Standards Australia
New Zealand (FSANZ) nutrient database for analysis by S.R.-V. As the food groups within FoodWorks
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draw on the concept of the USDA Food Patterns Equivalents Database (FPED), which counts hot
chips/fries/crisps and legumes in the vegetable group, we manually adjusted serves for the FoodWorks
vegetable group to exclude these discretionary and legume foods. We also manually added some
legume serves to the legume protein foods group, which were not counted by FoodWorks. We did not
analyze the nutrient contribution from supplements as our focus was on validating a dietary pattern.
2.5. Statistical Analysis
Statistical analyses were conducted using the Statistical Package for Social Sciences (SPSS) for
Windows version 24 (SPSS, Inc., Chicago, IL, USA). Histograms, skewness, kurtosis and minimum
and maximum values were used to examine distributions for normality and identify potential data
entry errors for index scores, nutrients and foods groups. Means and standard deviations (SD) were
calculated and reported for normally distributed nutrients whereas medians and the interquartile
range was reported for non-normally distributed nutrients.
The derived MEDAS score from survey A (n = 84) was compared to the baseline MEDAS
score reported for participants in PREDIMED, being the largest randomized controlled trial (RCT) of
a Mediterranean diet [42]. Further, we estimated the percent of our cohort that reached previously defined
Mediterranean thresholds [22] for selected foods/’traditional’ aspects of cuisine, determined by their FRs.
Test-retest reliability for MediCul was assessed using the paired t-test and intra-class correlation
coefficient (ICC), which was classified as poor (<0.40), fair to good (≥0.4 and <0.75), and very good
(≥0.75) [43]. A Bland-Altman plot was also used to determine the level of agreement between survey
A and survey B time points, since a high correlation does not necessarily mean good agreement [44].
Kappa was utilized to check percent agreement within the same category [32] for 17 major food groups
within MediCul and values were interpreted using cut-offs proposed by Landis and Koch [45]. We used
Spearman’s correlation coefficient to assess whether the lag time between survey A and survey B was
correlated with the difference in MediCul scores at the two time points. We also investigated whether
selected categorical (i.e., sex, supplement use, primary grocery shopper, primary cook) or continuous
(i.e., age, BMI) variables might be driving the improved performance for survey B, using Chi-square,
linear regression and paired t-tests, as appropriate.
Concurrent validity for MediCul was determined by examining the Bland-Altman plot of the
difference in MediCul scores between the survey tool and the FR versus the mean of the scores from
the two assessment methods, with limits of agreement (LOA) being ±2 standard deviations (SD) from
the mean difference. Bias was assessed using linear regression analysis. A paired t-test was conducted
for scores from the survey at time points A, B, and the mean of AB versus the FR, to check the mean
differences and confidence intervals (CI) across these comparisons.
We also indirectly validated MediCul by examining whether expected (Mediterranean) nutrient
trends from the FR were associated with tertiles of the MediCul score. For positively or negatively
skewed nutrients, we conducted a log 10 transformation, then re-checked their distribution for
normality to determine whether parametric or non-parametric statistical tests should be applied.
Normally distributed and normalized nutrients were compared across tertiles of the MediCul score
derived from both survey A and the FR, using one-way ANOVA, while non-normally distributed
nutrients were analyzed using the Kruskal-Wallis test. Variances were checked for equality using the
Levene’s test; the Bonferroni post hoc test was applied for equal variances and the Games-Howell for
unequal variances. First (linear)- and second (quadratic)-order polynomial contrasts were applied to
test for nutrient trends across tertiles, as well as the line of best fit for normally distributed/normalized
nutrients. The Jonckheere trend test was used for non-normally distributed nutrients.
As the FR did not include details for three MediCul questions (i.e., growing of own vegetables,
weekly main meals eaten alone and fasting frequency), the validation of MediCul was based on scoring
out of 97 whereas reliability analysis was based on scoring out of 100.
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3. Results
We received 175 responses to the 603 invitations sent by the Sax Institute to potentially eligible
participants from the 45 and Up Study. Of these, 93 participants were eligible after full screening
(Figure 1). A total of 84/93 (90%) completed the first administration of MediCul (survey A) and
65 participants elected to make a clinic visit for physical measurements. Seventy-six participants
completed MediCul on two occasions. The final number included for reliability testing was 74,
since two participants started their FR prior to completing MediCul survey B and were excluded.
Validity testing was conducted with 71 participants who completed both survey A and the FR, with 69%
of these using the app and submitting an electronic FR. Data collection for all participants was
completed by mid-May 2017.
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tool; iCul survey B, second administration of MediCul tool; MS, multiple sclerosis; n, number of
participants; Sax, the Sax Institute.
The majority of the recruited participants were female, and reported taking at least one nutritional
supplement, with about one-half being the primary grocery shopper and primary cook at home
(Table 1). Participants ranged in age from 56 to 76 years, were overweight on average (BMI = 26.1;
SD = 4.0), with approximately one-half having a waist circumference associated with high chronic
disease risk [46] (Table 1). They had 1.7 (SD = 1.5) chronic illnesses/conditions, on average, with the
most prevalent being osteoarthritis, followed by hypercholesterolemia and hypertension. The median
number of medications taken was 1.5 (IQR: 0.0, 3.0).
The mean MediCul score from survey A (n = 84) was 55.2/100.0 (SD = 11.6; range: 27.5, 75.5).
The derived mean MEDAS score for the same time point was 6.5/14.0 ( 1.7; range: 2.0, 10.0),
which was approximately two points lower than the baseline MEDAS score of 8.6 (SD = 2) [42] reported
in the Spanish PREDIMED population, prior to intervention with a Mediterranean diet supplemented
with extra virgin olive oil or nuts or a reduced fat control diet. However, it was one point higher than
reported recently for a Western UK cohort [47]. Only 3/84 (4%) of our participants achieved a MEDAS
score of ≥10, which has been classified as high adherence to a Mediterranean diet and associated with
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better health outcomes in PREDIMED (2, 48–50). All of these participants were in the highest tertile of
the MediCul score from survey A (cut-off = 59.0 for tertile 3) when compared to nutrients from the FR.
Few participants reached defined Mediterranean thresholds for selected foods/’traditional’ aspects of
cuisine [22], especially for olive oil (0%), legumes (6%), sofrito, a sauce made with tomato, onion/garlic
and olive oil, used as the base for many dishes (10%), vegetables (11%) and fruit (18%) (Figure 2).
However, the majority reported cooking most of their main meals at home (73%), limiting snacking
occasions (79%), limiting sugary drinks (83%) and consuming raw vegetables/salads most days of the
week (86%). Almost half included an adequate intake of nuts (44%) and fish/shellfish (48%).
Table 1. Participant characteristics at baseline (n = 84).
Descriptive Statistics (Mean (SD) or Proportion)
Age (years) 65.4 (5.9)
Females (%)
BMI * (kg/m2)
60
26.1 (4.0)
<18.5 (%) 1.5
18.5 to 24.9 (%) 35.4
25.0 to 29.9 (%) 47.7
≥30 (%) 15.4
Waist circumference *—females (cm) 91.4 (12.4)
≥88 cm (%) 56.4
Waist circumference *—males (cm) 100.2 (8.2)
≥102 cm (%) 46.2
Resting heart rate * (beats per minute) 66 (8)
Primary cook at home (%) 49
Primary grocery shopper at home (%) 51
Supplement use (%) 63
Number of chronic illnesses/conditions 1.7 (1.5)
Osteoarthritis (%) 36
Hypercholesterolemia (%) 30
Hypertension (%) 24
Gastro-esophageal reflux disease (%) 16
Depression (%) 7
Diabetes (%) 4
Number of medications (median (IQR)) 1.5 (0.0, 3.0)
Abbreviations: IQR, interquartile range representing the 25th and 75th percentiles; n, number of participants;
SD, standard deviation; BMI, body mass index (calculated as weight in kilograms divided by height in meters
squared). * measured at clinic visit (n = 65).
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Figure 2. Percent of participants who reached Mediterranean diet thresholds according to three-day
food records (n = 71). Thresholds defined by highest cut-offs used in MediCul tool for the relevant
questions [22]. Abbreviations: n, number of participants; d, day; Prep, preparation; Sofrito, a sauce
made with tomato, onion/garlic and olive oil, used as a base for savory dishes; TBSP, tablespoon;
wk, week.
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3.1. Reliability
There was a considerable lag time between MediCul survey A and survey B for some participants,
so the time between surveys was non-normally distributed (median = 16 days; IQR: 13, 20). As we
did not have an a priori criterion for the length of time between surveys, we did not exclude any
participants for reliability testing based on the time between surveys.
MediCul B score was similar to MediCul A 56.8/100 and 56.1/100.0, respectively (t = −1.019;
p = 0.311). The MediCul tool was highly reliable as assessed by ICC and 95% CI, (ICC = 0.86, 95% CI:
0.789, 0.910, p < 0.0001). Using the Bland-Altman test for repeated measures, the mean difference
between the scores at the two time points was −0.69 with lower and upper LOA being −12.09 and
10.71, respectively. Seventy of the 74 participants (95%) fell within the LOA representing ±2 SD,
with a reasonably even distribution of the mean difference in scores. There was no indication of bias
according to the regression coefficient ((y= −2.95 + 0.04*x) (95% CI: −0.088, 0.168; p = 0.535)), further
supporting the null hypothesis that the scores were equally variable at the two time points. The slightly
higher mean score from survey B was unrelated to age, BMI, sex, supplement use, being the primary
grocery shopper or primary cook. The lag time between repeated tool administration was unrelated to
the difference between MediCul scores (Spearman’s p = −0.102; p = 0.385), suggesting that MediCul is
a stable index for usual intakes across the time spans in this study.
Percent agreement within the same category of the 17 main MediCul food groups for survey A
and survey B, determined by Kappa, was ‘almost perfect’ for coffee; ‘substantial’ for fruit, wholegrains,
fish/shellfish, eggs, dairy products, takeaway and water; ‘moderate’ for olive oil, nuts, legumes,
white meat preference, red/processed meat, sweets and sugary drinks and alcohol; and ‘fair’ for
vegetables and cuisine (Supplementary Table S2). No groups were found to have poor agreement
within the same category between the two time points of MediCul tool administration.
3.2. Validity
Analysis of the paired t-tests for MediCul scores from the survey administered at time points A, B
and mean of AB versus the FR (n = 68) indicated a similar mean difference and 95% CI across the three
comparisons, which were all statistically significant (p < 0.0001) (Table 2). We thus decided to proceed
with survey A for the remaining validity testing, because this time point included most data points
(n = 71) and represented first time MediCul use, which could be applied in future research.
The Bland-Altman plot showed a mean difference of 5.6 between the MediCul score derived from
survey A (54.6/97.0, SD = 11.2, range: 26.5, 73.5) and the FR (49.0/97.0, SD = 11.7, range: 25.0, 80.0),
and the mean difference was lower among participants who provided a paper version of their FR
compared to the electronic version (supplied through the app), although both were similarly checked
by the dietitian (Table 2). The scores for 69/71 participants (97%) fell within or on the 95% LOA with
lower and upper LOA being −13.0 and 24.2, respectively, with reasonably even distribution across
mean scores. There was no significant linear trend for the fitted regression line ((y = 8.7 − 0.06*x)
(95% CI: −0.278, 0.158, p = 0.584)), indicating no systematic bias between the two measurement
methods (Figure 3).
Table 2. Mean difference from paired samples t-test for the Mediterranean Diet and Culinary Index
(MediCul) scores from surveys A, B, mean AB versus three-day food record (n = 68).
Mean Difference 95% CI of the Difference p Value
A versus FR * 5.32 3.03, 7.62 <0.0001
B versus FR 6.38 4.16, 8.59 <0.0001
Mean AB versus FR 5.85 3.70, 8.00 <0.0001
Abbreviations: A, first administration of MediCul; B, second administration of MediCul; mean AB, mean of A
and B MediCul administrations; n, number of participants; FR, three-day food record; CI, confidence intervals.
* When compared to Survey A with maximum data points (n = 71), participants using a paper FR (n = 22) had
a mean difference of 2.6 points (95% CI:−2.36, 7.63; t = 1.10; p = 0.285), whereas those using the electronic FR (n = 49)
had a mean difference of 6.9 points (95% CI: 4.50, 9.30; t = 5.77; p < 0.0001).
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e hypothesized that a higher intake of certain nutrients (determined by FR analysis) would
be associated with the higher tool (survey A) and FR-derived MediCul scores, categorized as tertiles.
This was true for: Polyunsaturated fatty acids (PUFA) as fat, n-3 long chain (LC) PUFA ( g),
eicosapentaenoic acid (EPA) ( g), docosahexaenoic acid (D A) ( g), and ratio of unsaturated to
saturated fatty acids (SFA), supporting increased adherence to a Mediterranean dietary pattern (Table 3).
Additionally, we hypothesized that a lower intake of some other nutrients would be associated with
the higher MediCul score tertiles from both sources. This was true for SFA as % fat, alcohol (g) and the
sodium to potassium ratio, being consistent with the plant based, minimally processed, nature of the
‘traditional’ Mediterranean diet, which is proportionally lower in SFA and includes only a moderate
amount of alcohol. For the sodium to potassium ratio, a significant difference (p = 0.004) was observed
between MediCul score tertiles 1 and 3, derived from the FR.
For so e nutrients, the expected relationship as observed only ith the ediCul score tertiles
fro the FR e.g., P F (g), alpha linolenic acid ( L ) ( g), ratio of onounsaturated fatty acids
( UFA) to SFA, dietary fiber (g), vitamin E (mg), potassium ( g), magnesium ( g) and selenium (µg).
For magnesium, not only was there a positive linear trend across tertiles of the MediCul score from the
FR, but a significant difference was observed between tertiles 1 and 3 (p = 0.015) and tertiles 2 and 3
(p = 0.016). PUFA % fat, EPA and DHA are nutrient examples for which significant differences were
found between tertiles 1 and 3 of the MediCul score, derived from both the tool and FR (Table 3).
In all cases linear trends were significant and there were no significant deviations from normality
except for retinol equivalents (µg), beta-carotene (µg) and iron (mg), where a quadratic trend was
a better fit for these nutrients in relation to the MediCul score tertiles from survey A.
There was no relationship between tertiles for either of the MediCul scores and intake of energy
(kJ), protein (g), total fat (g), SFA (g), MUFA (g), cholesterol (mg), carbohydrate (g), total sugars (g) and
folate (µg).
256
Nutrients 2018, 10, 1913 10 of 17
Table 3. Nutrient intakes compared with tertiles of the Mediterranean Diet and Culinary Index (MediCul) score from FR and survey A (n = 71) *.
Nutrients from Food
Record
Source of the MediCul
Score Tertile Cut-Off
Points
Nutrient Intake for Tertile 1
of the MediCul Score
Nutrient Intake for Tertile 2
of the MediCul Score
Nutrient Intake for Tertile 3
of the MediCul Score
Comparison of Nutrient
Intakes across Tertiles of
the MediCul Score p Value
Test for Trend p Value,
Direction ↑ ↓ †
Mean/median SD/IQR Mean/median SD/IQR Mean/median SD/IQR
Energy kJ/d
FR 9206 2322 8330 2323 9054 2342 0.386 0.810
Survey 9326 2450 8526 2124 8733 2435 0.468 0.380
Protein g/d
FR 97 25 89 22 101 20 0.190 0.548
Survey 100 24 89 26 97 16 0.200 0.605
Protein % energy
FR 18 3 19 4 19 3 0.474 0.224
Survey 19 3 18 4 20 4 0.208 0.301
Fat g/d
FR 87 31 77 24 93 33 0.189 0.491
Survey 85 27 83 28 89 37 0.790 0.661
Fat % energy
FR 34 6 34 6 38 7 0.129 0.083
Survey 34 5 36 6 37 8 0.242 0.097
SFA g/d
FR 32 11 26 11 29 13 0.266 0.412
Survey 30 11 30 12 27 12 0.613 0.411
SFA % energy
FR 13 2 12 3 12 4 0.428 0.269
Survey 12 2 13 3 11 3 0.191 0.588
SFA % fat
FR 41 a 6 38 8 33 8 0.004 0.001 ↓
Survey 39 7 39 b 7 34 8 0.024 0.030 ↓
PUFA g/d
FR 12 9, 16 11 b 9, 16 14 12, 22 0.017 0.018 ↑
Survey 11 9, 15 12 10, 15 15 11, 22 0.146 0.087
PUFA % fat
FR 16 a 5 18 5 21 7 0.021 0.007 ↑
Survey 17 a 5 17 5 21 7 0.026 0.013 ↑
MUFA g/d
FR 35 14 31 10 39 14 0.169 0.300
Survey 35 11 33 12 37 16 0.594 0.559
MUFA % fat
FR 43 4 45 6 45 6 0.242 0.099
Survey 45 5 43 5 45 7 0.453 0.721
n-3 LC PUFA mg/d
FR 242 a 125, 459 261 b 97, 606 891 290, 1725 0.004 0.006 ↑
Survey 241 112, 409 290 176, 670 858 291, 1583 0.035 0.025 ↑
ALA mg/d
FR 1499 a 851, 1808 1445 966, 2005 1643 1437, 2757 0.027 0.012 ↑
Survey 1539 908, 2112 1489 992, 1758 1591 1308, 2757 0.064 0.069
EPA mg/d
FR 70 a 24, 138 72 b 29, 200 372 78, 665 0.005 0.006 ↑
Survey 66 a 24, 117 74 b 42, 243 275 81, 567 0.023 0.009 ↑
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Table 3. Cont.
Nutrients from Food
Record
Source of the MediCul
Score Tertile Cut-Off
Points
Nutrient Intake for Tertile 1
of the MediCul Score
Nutrient Intake for Tertile 2
of the MediCul Score
Nutrient Intake for Tertile 3
of the MediCul Score
Comparison of Nutrient
Intakes across Tertiles of
the MediCul Score p Value
Test for Trend p Value,
Direction ↑ ↓ †
Mean/median SD/IQR Mean/median SD/IQR Mean/median SD/IQR
DPA mg/d
FR 69 47,129 55 29, 117 136 67, 312 0.054 0.083
Survey 57 37, 129 70 49, 113 130 48, 308 0.141 0.123
DHA mg/d
FR 109 a 43, 235 124 b 30, 345 391 149, 751 0.005 0.004 ↑
Survey 109 a 42,197 149 b 47, 328 409 162, 640 0.023 0.009 ↑
MUFA:SFA ratio
FR 1.1 a 0.9, 1.2 1.1 0.9, 1.6 1.4 1.1, 1.7 0.010 0.003 ↑
Survey 1.2 1.0, 1.4 1.1 0.9, 1.2 1.6 1.0, 1.7 0.053 0.082
Unsaturated:SFA ratio
FR 1.5 a 0.3 1.8 0.6 2.1 0.7 0.002 <0.001 ↑
Survey 1.7 a 0.5 1.6 b 0.5 2.1 0.8 0.007 0.010 ↑
Cholesterol mg/d
FR 333 155 264 105 322 130 0.153 0.761
Survey 333 128 281 150 306 120 0.400 0.488
Carbohydrate g/d
FR 205 55 192 69 196 63 0.782 0.618
Survey 208 63 197 58 187 66 0.500 0.241
Carbohydrate %
energy
FR 37 7 38 6 35 7 0.448 0.461
Survey 37 6 38 6 35 8 0.265 0.339
Sugars g/d
FR 96 34 98 41 94 39 0.948 0.851
Survey 98 34 98 40 91 39 0.772 0.545
Alcohol g/d
FR 21 a 8, 31 13 1, 26 7 1, 15 0.035 0.010 ↓
Survey 27 a 12, 34 8 2, 17 8 1, 15 0.014 0.008 ↓
Water g/d
FR 2878 517 3106 692 3089 827 0.447 0.293
Survey 2995 466 2856 690 3245 837 0.148 0.229
Dietary fiber g/d
FR 27 8 30 10 33 9 0.064 0.019 ↑
Survey 29 10 28 7 34 10 0.080 0.073
Vitamin C mg/d
FR 128 43, 151 120 82, 198 120 79, 166 0.156 0.084
Survey 113 64, 166 128 73, 158 123 95, 202 0.190 0.092
Vitamin E mg/d
FR 12 11, 15 14 11, 18 17 12, 22 0.083 0.042 ↑
Survey 13 12, 18 13 11, 15 18 11, 23 0.089 0.222
Vitamin B12 µg/d
FR 4.8 3.7, 5.9 4.2 3.1, 5.2 4.5 3.6, 6.3 0.215 0.793
Survey 4.9 3.7, 6.5 4.4 3.5, 5.7 4.4 3.6, 5.0 0.524 0.472
Folate µg/d ‡
FR 381 119 379 122 403 112 0.732 0.516
Survey 389 123 363 108 414 119 0.321 0.484
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Table 3. Cont.
Nutrients from Food
Record
Source of the MediCul
Score Tertile Cut-Off
Points
Nutrient Intake for Tertile 1
of the MediCul Score
Nutrient Intake for Tertile 2
of the MediCul Score
Nutrient Intake for Tertile 3
of the MediCul Score
Comparison of Nutrient
Intakes across Tertiles of
the MediCul Score p Value
Test for Trend p Value,
Direction ↑ ↓ †
Mean/median SD/IQR Mean/median SD/IQR Mean/median SD/IQR
Retinol equivalents
µg/d
FR 1092 557 1193 568 1266 587 0.577 0.298
Survey 1153 404 972 b 557 1454 637 0.012 0.016
Beta carotene µg/d
FR 4567 3307 5619 3245 6047 3273 0.285 0.125
Survey 5043 2477 4167 b 3112 7196 3593 0.004 0.013
Sodium mg/d
FR 2330 753 2021 750 1920 688 0.141 0.058
Survey 2298 836 2064 699 1901 652 0.190 0.071
Potassium mg/d
FR 3513 813 3690 1057 4105 945 0.096 0.036 ↑
Survey 3691 860 3520 939 4124 1028 0.089 0.135
Sodium:Potassium
ratio
FR 0.7 a 0.3 0.6 0.2 0.5 0.2 0.006 0.001 ↓
Survey 0.6 0.2 0.6 0.2 0.5 0.2 0.072 0.031 ↓
Magnesium mg/d
FR 390 a 349, 500 361 b 321, 466 470 440, 525 0.006 0.005 ↑
Survey 418 333, 489 393 365, 469 466 365, 557 0.154 0.148
Iron mg/d
FR 12.1 3.3 11.7 3.4 13.2 3.5 0.288 0.254
Survey 12.9 3.6 11.1 2.7 13.1 3.7 0.091 0.030
Zinc mg/d
FR 12.1 4.0 10.7 3.2 11.9 3.1 0.336 0.868
Survey 11.8 4.2 11.1 3.1 11.8 3.1 0.721 0.960
Selenium µg/d
FR 89 70, 109 91 76, 105 103 92, 134 0.035 0.017 ↑
Survey 96 81, 117 92 68, 109 96 83, 110 0.435 0.751
Abbreviations: n, number of participants; SD, standard deviation; IQR, interquartile range (representing the 25th and 75th percentiles); kJ, kilojoules; d, day; FR, food record;
g, grams; SFA, saturated fatty acids; PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids; n-3, omega 3; LC, long chain; mg, milligrams; ALA, alpha linolenic acid;
EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid. * MediCul index score tertiles are derived from FR and survey A (first administration of MediCul).
For survey A, the cut-off points for tertiles 2 and 3 were 50.0 and 59.0, respectively. Values are presented as mean (SD) for normally distributed data or median (IQR) for non-normally
distributed data. These data were normalized by logarithmic transformation for use in ANOVA models with the exception of alcohol, selenium, EPA and DHA, which were unable to be
normalized and therefore analyzed using the Kruskal-Wallis model. When ANOVA F ratio was significant, variances were checked for equality using the Levene’s test, and Bonferroni
was applied for equal variances or Games-Howell post hoc t test for unequal variances. First (linear)- and second (quadratic)-order polynomial contrasts were applied to test for trends
across tertiles, as well as the line of best fit for normally distributed/normalized nutrients. The Jonckheere trend test was used for non-normally distributed nutrients. In all cases linear
trends were significant and there were no significant deviations from normality, except for retinol equivalents, beta carotene and iron when compared with tertiles from survey A, where
the quadratic trend was positive and the most significant. Significant differences (p < 0.05) between tertiles denoted as: a = 1 vs. 3; b = 2 vs. 3. † Linear trend direction indicated as ↑
(increasing) or ↓ (decreasing). ‡ Naturally occurring food folates only.
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4. Discussion
Our study indicates that online administration of MediCul has good reliability and moderate
validity, as an assessment of adherence to a ‘traditional’ Mediterranean dietary pattern and aspects
of cuisine among the middle-aged and older individuals studied who live in a Western country.
These findings are consistent with those reported for in-person administration among older individuals
with MCI [22].
The participants included in our study were Australians aged 55–75 years, living in suburban
Sydney. Only 4% had high adherence to a Mediterranean diet based on their derived MEDAS
scores. Higher MEDAS scores have been related to positive health outcomes in PREDIMED [2,48–50].
Similarly, a very small proportion reached thresholds for ‘traditional’ Mediterranean foods or exposures.
For example, 11% reported adequate vegetable intake, 6% had adequate legumes, and 49% limited
their exposure to red meat, in accordance with ‘traditional’ levels. These participants represented
a fairly homogenous group in regards to their dietary intakes, with few people achieving a high
MediCul score. Such a cohort may be at higher chronic disease risk. Education on the Mediterranean
diet, which is already recommended by dietary guidelines, may be prudent. Targets for ‘traditional’
Mediterranean foods and cuisine aspects can be viewed in previously published Supplementary
Materials that describe cut-off points used in the MediCul tool [22]. For example, four tablespoons of
extra virgin olive oil per day; one serve (30 g) of nuts, five or more days per week; inclusion of dark
green leafy vegetables (e.g., spinach, kale, silverbeet), four or more times per week.
Concurrent validity of MediCul has therefore been demonstrated within a cohort that is almost
entirely Western in their eating habits. Further research is required to validate MediCul use among
other population groups, including those with broader dietary habits (particularly at the high
end), and in relation to biomarkers of dietary intake. The MYB trial, a three-year randomized
controlled trial of a fully online multi-modal intervention targeting modifiable dementia risk factors in
6236 participants, will utilize MediCul at baseline and annual follow up. This will generate data on
change in MediCul score over time and its association with chronic disease risk factors, which will
provide external validity, since clinical end points were not available from this validation study [35].
Given the good reliability of the MediCul tool shown here, we anticipate that changes in the index
score, in the context of the MYB trial and similar dietary interventions, would represent true dietary
change, and could potentially serve as a marker of positive health outcomes related to the ‘traditional’
diet and cuisine.
Strengths and Limitations
The MediCul tool assesses the overall dietary pattern within a Western context, capturing the
multi-dimensional nature of individual diets. With 50 items being assessed, it provides a comprehensive
score for adherence to a ‘traditional’ Mediterranean dietary pattern and aspects of cuisine. Many of these
elements are lacking from most other index tools. MediCul also enables derivation of a MEDAS score for
comparison with studies that have used this short screener. Importantly, it is relatively simple to use and
compute its scoring and MediCul can be administered online and in-person [22], increasing its potential
utility, feasibility in large cohorts and cost-effectiveness.
Our study has some limitations. Data are currently lacking to support external validity for
MediCul, which is of clinical relevance. Generalizability may also have been tempered by selection
bias as our participants came from the 45 and Up Study, thus representing individuals who are
better educated, more health aware and who may respond differently to dietary surveys compared
to non-volunteers [32]. Our participants had less obesity and diabetes compared to the general
Australian population for a similar age group [51,52]. MediCul was also administered within a suite of
surveys, which may have caused fatigue, impacting on responses and scores. This was unavoidable
as we wished to simulate the online testing experience of the subsequent MYB trial. Our testing,
nevertheless, confirmed good reliability and moderate validity. It is also well known that food records
may under-report intake or include atypical days [53] and there were some limitations specifically
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related to use of the Research Food Diary app. For example, certain recipes entered into the app by
participants included some scanned foods that did not exist in the FoodWorks data source available
to us, and needed to be re-entered by the dietitian, which was done by selecting nutritionally similar
foods. If participants selected composite dishes within the app or reported a composite meal in a paper
FR (e.g., stir fry chicken and vegetables), the dietitian checked all entries similarly during the phone call
by probing for potentially missed foods and ingredients, such as oil. While the MediCul tool performed
well overall, it performed better against a traditional (paper) FR, as compared to an electronic FR
(using an app). However, it was not our intention to compare methods of keeping an FR, and we
therefore did not exclude any participants who provided a paper FR as we did not have an a priori
criterion to do so.
In some participants, the approximately 20 point difference in MediCul score between the new
tool and the FR, could be clinically meaningful. However, it has been suggested that a certain degree
of disagreement is to be expected when instruments assessing usual diet are validated against food
records, due to within-person variations that typically occur over the shorter reference period of
an FR [32]. Also, the lower and upper LOA (13% and 25%, respectively) were similar to findings for
MediCul from our validity study among individuals with MCI [22] and well within the 50% and 200%
LOA suggested by Ambrosini et al. [54] to classify agreement between an FFQ and food record as
being acceptable. Furthermore, the new MediCul tool appears to be closer to the reference method,
as compared to MEDAS. MEDAS under- and overestimated scores by 43% and 53%, respectively,
when validated in a Spanish population against an FFQ [28], or by 16% and 36% when validated
within a UK cohort against an FR [47].
5. Conclusions
MediCul is a highly reliable and moderately valid Mediterranean diet index tool for online
administration among health aware, better educated, middle-aged and older individuals living in
a Western country, which can be used to assess adherence to a ‘traditional’ dietary pattern and aspects
of cuisine relevant to many important health outcomes.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/12/1913/
s1, Table S1: How to derive a MEDAS score from MediCul and Table S2: Kappa statistics for percent agreement
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Supplementary Material Table S1. - How to derive a MEDAS score from MediCul 
Aim: To derive a Mediterranean Diet Adherence Screener (MEDAS) score out of 14 from the responses provided to the 50-item 
Mediterranean Diet and Culinary Index (MediCul) tool. 
Instructions: 
1. Check the participant responses to the relevant MediCul question numbers listed in column three below. 
2. Convert these responses to the relevant frequency for scoring, where required*.  
3. Follow the instructions in columns four and five below to score each MEDAS question either 1 or 0 (zero) points; if a 
response cannot be awarded 1 point, it is automatically awarded a 0 (zero) point as there are no intermediate points. 
4. Add up the points for the 14 MEDAS questions to provide the total MEDAS score. 
Note – some MEDAS questions used within MediCul have been optimised for the English language. 
 
1. MEDAS question [1] 2. MEDAS 
criteria for 1 
point 
3. Relevant 
MediCul 
Question/s [2] 
4. MediCul response category 5. MEDAS scoring 
instructions 
1. Do you use olive oil as 
main culinary fat? 
Yes Q. 29 This MediCul question is only used to 
score for MEDAS, hence no 
adjustment is required 
This MediCul 
question is only used 
to score for 
MEDAS, hence no 
adjustment is 
required 
2. How much olive oil do 
you consume in a given 
day (including oil used 
for frying, salads, out-of-
house meals, etc.)?  
≥ 4 TBSP/d  Q. 28 First check that response to Q. 28 is 
given per day or convert to per day* 
Apply MEDAS 
criteria (column 2) 
and score 
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1. MEDAS question [1] 2. MEDAS 
criteria for 1 
point 
3. Relevant 
MediCul 
Question/s [2] 
4. MediCul response category 5. MEDAS scoring 
instructions 
3. How many vegetable 
servings do you consume 
per day? [1 serving: 200 
g (consider side dishes as 
half a serving)] 
≥ 2 (≥ 1 
portion raw 
or as a salad) 
 
Q. 1  First check that response to Q. 1 is 
given per day or convert to per day* 
Take total MediCul 
serves/d and 
multiply by 75 g 
then divide by 200 g;  
Apply MEDAS 
criteria (column 2) 
and score 
4. How many fruit units 
(including natural fruit 
juices) do you consume 
per day? 
 3 serve/d 
 
 
Q. 12 and Q. 34 First check that responses given in Q. 
12 and Q. 34 are expressed as per day 
or convert to per day*; 
Finally, add together responses from 
Q. 12 and Q. 34 
Apply MEDAS 
criteria (column 2) 
and score 
5. How many servings of 
red meat, hamburger or 
meat products (ham, 
sausage, etc.) do you 
consume per day? 
< 1 serve/d Q. 13 and Q. 14 First check that responses given in Q. 
13 and Q. 14 are expressed as per day 
or convert to per day*; 
Add together responses for Q. 13 and 
14 
Apply MEDAS 
criteria (column 2) 
and score 
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1. MEDAS question [1] 2. MEDAS 
criteria for 1 
point 
3. Relevant 
MediCul 
Question/s [2] 
4. MediCul response category 5. MEDAS scoring 
instructions 
6. How many servings of 
butter, margarine, or 
cream do you consume 
per day? (1 serving: 12 g) 
< 1 serve/d 
 
 
Q. 26 and Q. 27 First check that responses given in Q. 
26 and Q. 27 are expressed as per day 
or convert to per day*; 
Add together daily serves for Q. 26 
and Q. 27 
Divide total for Q. 
26 & Q. 27 by 2 to 
correct for MEDAS 
serve size; 
Apply MEDAS 
criteria (column 2) 
and score 
7. How many 
sweet/carbonated 
beverages do you drink 
per day? 
< 1/d Q. 33 First check that response given in Q. 
33 is expressed as per day or convert 
to per day* 
Apply MEDAS 
criteria (column 2) 
and score 
8. How much wine do 
you drink per week? 
≥ 7 
glasses/wk 
Q. 41c First check that response given in Q. 
41c is expressed as per week or 
convert to per week* 
Apply MEDAS 
criteria (column 2) 
and score 
9. How many servings of 
legumes do you consume 
per week? (1 serving: 
150 g) 
≥ 3/wk Q. 19 First check that response given in Q. 
19 is expressed as per week or convert 
to per week* 
Apply MEDAS 
criteria (column 2) 
and score 
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1. MEDAS question [1] 2. MEDAS 
criteria for 1 
point 
3. Relevant 
MediCul 
Question/s [2] 
4. MediCul response category 5. MEDAS scoring 
instructions 
10. How many servings 
of fish or shellfish do 
you consume per week? 
(1 serving: 100-150 g of 
fish or 4-5 units or 200 g 
shellfish) 
≥ 3/wk Q. 16 First check that response given in Q. 
16 is expressed as per week or convert 
to per week* 
Apply MEDAS 
criteria (column 2) 
and score 
11. How many times per 
week do you consume 
commercial sweets or 
pastries (not homemade), 
such as cakes, cookies, 
biscuits or custard? 
< 3/wk 
 
 
Q. 31, Q. 32a  ASSUMPTION: serves/wk for 
cakes/biscuits = times/wk;  
First check that response  given in Q. 
31 is  expressed as per week or 
convert to per week*; 
Add Q. 31 response +  Q.32a response 
(custard only) 
Apply MEDAS 
criteria (column 2) 
and score 
12. How many servings 
of nuts (including 
peanuts) do you consume 
per week? (1 serving: 30 
g) 
≥ 3/wk Q. 24 First check that response given in Q. 
24 is expressed as per week or convert 
to per week* 
Apply MEDAS 
criteria (column 2) 
and score 
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1. MEDAS question [1] 2. MEDAS 
criteria for 1 
point 
3. Relevant 
MediCul 
Question/s [2] 
4. MediCul response category 5. MEDAS scoring 
instructions 
13. Do you preferentially 
consume chicken, turkey 
or rabbit meat instead of 
veal, pork, hamburger or 
sausage? 
Yes Q. 17 Assume Yes = if ‘chicken, turkey or 
rabbit’ OR ‘I don’t eat chicken or 
meat’ options ticked; 
Assume No = if ‘beef, pork, 
hamburgers or sausages’ ticked 
Apply MEDAS 
criteria (column 2) 
and score 
14. How many times per 
week do you consume 
vegetables, pasta, rice or 
other dishes seasoned 
with sofrito (sauce made 
with tomato and onion, 
leek or garlic and 
simmered with olive oil)? 
≥ 2/wk Q. 6 First check that response given in Q. 6 
is expressed as per week or convert to 
per week* 
Apply MEDAS 
criteria (column 2) 
and score 
Q, question; TBSP, tablespoons; d, day; g, grams; wk, week. 
*As the MediCul questions may include daily, weekly and monthly response options, some conversions are required to ensure 
responses relate to the same time period as in the MEDAS questions: 
 To convert responses given for serves/frequency per month to serves/frequency per week: divide by 30 then multiply by 7. 
 To convert responses given for serves/frequency per week to serves/frequency per day: divide by 7. 
 To convert responses given for serves/frequency per month to serves/frequency per day: divide by 30. 
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Supplementary Material Table S2. - Kappa statistics for percent agreement within 
the same category of 17 MediCul groups between survey A and survey B 
 
MediCul group Percent (%) 
agreement 
within same 
category 
Kappa value Level of agreement [1] 
1. Olive oil 59.5% 0.47 (p<0.0001) Moderate 
2. Vegetables 32.4% 0.21 (p<0.0001) Fair 
3. Fruit 81.1% 0.63 (p<0.0001) Substantial 
4. Nuts 64.9% 0.50 (p<0.0001) Moderate 
5. Wholegrains 93.2% 0.77 (p<0.0001) Substantial 
6. Legumes 67.6% 0.49 (p<0.0001) Moderate 
7. Fish/shellfish 82.4% 0.69 (p<0.0001) Substantial 
8. Eggs 90.5% 0.74 (p<0.0001) Substantial 
9. Dairy products 86.5% 0.63 (p<0.0001) Substantial 
10. White meat 
preference 
70.3% 0.50 (p<0.0001) Moderate 
11. Red/processed meat 63.5% 0.53 (p<0.0001) Moderate 
12. Sweets & sugary 
drinks 
59.5% 0.51 (p<0.0001) Moderate 
13. Takeaway 82.4% 0.64 (p<0.0001) Substantial 
14. Water 78.4% 0.71 (p<0.0001) Substantial 
15. Alcohol 66.2% 0.58 (p<0.0001) Moderate 
16. Coffee 100.0% 1.00 (p<0.0001) Almost perfect 
17. Cuisine 39.2% 0.23 (p<0.0001) Fair 
survey A, first administration of MediCul tool; survey B, second administration of 
MediCul tool. 
 
Reference for interpretation of Kappa values 
1. Landis, J.R.; Koch, G.G. The measurement of observer agreement for categorical data. 
Biometrics 1977, 33, 159-174. 
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CHAPTER SIX
Reliability and validity of the Mediterranean Diet and 
Culinary Index (MediCul) tool in an older population 
with mild cognitive impairment
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PREFACE
Diet research tools should be tested for reliability and concurrent validity against a 
reference dietary method within all populations where they are intended to be used. 
The aim of this chapter was to test the reliability and validity of the newly developed 
Mediterranean Diet and Culinary Index (MediCul) against a 3-day food record, when 
administered in-person to older Australian adults with mild cognitive impairment, 
representing a Western population at high risk of dementia.
This chapter was published in the British Journal of Nutrition by Cambridge University 
Press (© The Authors 2018):
x Radd-Vagenas, S., Fiatarone Singh, M. A., Inskip, M., Mavros, Y., Gates, N., 
Wilson, G. C., . . . Flood, V. M. (2018). Reliability and validity of a Mediterranean 
diet and culinary index (MediCul) tool in an older population with mild cognitive 
impairment. British Journal of Nutrition, 120(10), 1189-1200.
doi:10.1017/S0007114518002428
The chapter includes three published supplementary materials:
- MediCul tool elements, cut-off points, scoring and rationale
- MediCul index tool
- Kappa statistics for percent agreement within the same category of 17 MediCul 
elements between survey A and B
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Further information related to this chapter is presented in Appendices Eight, and Ten to 
Thirteen and includes: ethics letter, dietitian assisted food record checklist, front sheet for
validation and reliability testing of MediCul, 3-day paper food record template and FAQ
on completing the 3-day food record.
Part of the work produced in this chapter has been presented at the following conference:
x Radd-Vagenas, S., Daniel, K., Noble, Y., Fiatarone Singh, M., & Flood, V. 
Reliability of new index tool to assess adherence to Mediterranean diet among 
people with mild cognitive impairment. Dietitians Association of Australia 35th
National Conference, Sydney, Australia, 17-19th May 2018.
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6.1 Abstract 
Dementia is a leading cause of morbidity and mortality without pharmacologic prevention
or cure. Mounting evidence suggests adherence to a Mediterranean dietary pattern may 
slow cognitive decline, and is important to characterise in at-risk cohorts. Thus, we
determined the reliability and validity of Mediterranean Diet and Culinary Index 
(MediCul), a new tool, among community-dwelling individuals with mild cognitive 
impairment (MCI). Sixty-eight participants (66% female) aged 75.9 years (6.6), from the 
Study of Mental and Resistance Training study MCI cohort completed the 50-item 
MediCul at two time points, followed by a 3-day food record (FR). MediCul test-retest 
reliability was assessed using intraclass correlation coefficients (ICC), Bland-Altman 
plots and Kappa agreement within 17 dietary element categories. Validity was assessed 
against the FR using the Bland-Altman method and nutrient trends across MediCul score 
tertiles. The mean MediCul score was 54.6/100.0 with few participants reaching 
thresholds for key Mediterranean foods. MediCul had very good test-retest reliability 
(ICC=0.93, 95 CI% 0.884, 0.954, p<0.0001) with fair-to-almost-perfect agreement for 
classifying elements within the same category. Validity was moderate with no systematic 
bias between methods of measurement, according to the regression coefficient
\ í30+0.17*x) (95% CI íP=0.091). MediCul overestimated the mean
FR score by 6%, with limits of agreement (LOA) being under- and overestimated by 11% 
and 23%, respectively. Nutrient trends were significantly associated with increased 
MediCul scoring, consistent with a Mediterranean pattern. MediCul provides reliable and 
moderately valid information about Mediterranean diet adherence among older 
individuals with MCI, with potential application in future studies assessing relationships
between diet and cognitive function.
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6.2 Introduction
The Mediterranean diet has been associated with many health benefits such as a reduced 
risk of cardiovascular disease (CVD) (Estruch et al., 2018; Gardener et al., 2011; Gates 
et al., 2011; Martinez-Gonzalez & Bes-Rastrollo, 2014; Tong, Wareham, Khaw, 
Imamura, & Forouhi, 2016), cancer (Couto et al., 2011; Toledo et al., 2015), type 2 
diabetes (Esposito, Maiorino, Ceriello, & Giugliano, 2010; Salas-Salvadó et al., 2014)
and neurodegenerative diseases (Psaltopoulou et al., 2013; Sofi, Macchi, Abbate, Gensini, 
& Casini, 2014). The latter includes a slower rate of cognitive decline with age (Tangney 
et al., 2011), reduced risk of dementia (particularly Alzheimer’s disease (AD)) (Scarmeas, 
Stern, Mayeux, & Luchsinger, 2006) and reduced risk of mild cognitive impairment 
(MCI) and conversion of MCI to AD (Scarmeas et al., 2009). These findings are important 
since dementia is now a leading cause of morbidity and mortality globally with no 
pharmacologic options available to prevent, slow or reverse its course (World Health 
Organization, 2017).
More than 30 Mediterranean diet indexes and their variations (Bach et al., 2006; 
D'Alessandro & De Pergola, 2015; Milà-Villarroel et al., 2011; Radd-Vagenas, Kouris-
Blazos, Fiatarone Singh, & Flood, 2017; Ruiz et al., 2015) (including short screeners)
(Cerwinske, Rasmussen, Lipson, Volgman, & Tangney, 2017; Schroder et al., 2011) have 
been reported in the literature for use in assessing adherence to a Mediterranean dietary 
pattern. Indexes are popular as they can assess overall dietary patterns, while reducing 
participant and researcher burden associated with more classical methods of dietary 
measurement such as long food frequency questionnaires (FFQs) and weighed food 
records (Thompson & Subar, 2017).
However, limitations exist with the currently available Mediterranean diet indexes. For 
example, while the original and widely used Mediterranean Diet Score (MDS), and its 
many iterations (Trichopoulou et al., 1995; Trichopoulou, Costacou, Bamia, & 
Trichopoulos, 2003), includes elements determined a priori, the cut-off points used for 
this tool vary between the populations studied as they are related to mean or median 
intakes, which may not reflect ‘traditional’ Mediterranean or optimal intakes. Also, 
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relatively few Mediterranean diet indexes have been validated directly against an 
alternate dietary assessment method (Hebestreit et al., 2017; Schroder et al., 2011; Sotos-
Prieto et al., 2015), especially one not limited by the same recall biases. Further, most
Mediterranean diet index scores reported in the literature have been derived indirectly 
from FFQs (which may or may not be validated), then used to look for associations with 
health outcomes. Direct validation of dietary tools is now appreciated to be important to 
reliably interpret results (Freedman et al., 2015).
Importantly, to our knowledge, no existing Mediterranean diet index tools have been 
validated for use among individuals at various stages of cognitive decline, such as MCI.
MCI is considered a pre-dementia stage, defined by subjective concern and mild objective 
cognitive changes without significant changes in daily functioning related to cognition
(Petersen, 2004). In terms of prevention, MCI has been identified as a potential window 
of opportunity for lifestyle or other interventions since approximately 12% of individuals
with MCI convert to AD per year, compared to an annual conversion rate of 1-2% in the
general population (Petersen et al., 1999). It is therefore important to be able to accurately 
measure adherence to a Mediterranean dietary pattern in older adults who may have 
already begun to manifest memory difficulties, or are diagnosed with MCI. A
Mediterranean diet index tool, which has been validated in such at-risk populations,
would be useful for future interventions investigating the potential of nutrition to slow 
progression of cognitive decline.
A short Spanish Mediterranean Diet Adherence Screener (MEDAS) used in the largest 
randomised controlled trial of the Mediterranean diet, that is, PREvencion con DIeta 
MEDiterranea (PREDIMED) in cognitively normal but high CVD risk participants, is the 
only tool, to our knowledge, which has been associated with clinically demonstrated 
cognitive benefits. In a sub-cohort of these PREDIMED participants, their MEDAS score 
(out of 14) increased over a four-year period by approximately two points from a baseline 
of 8.3 and 8.6 in the groups supplemented with extra virgin olive oil and nuts, 
respectively, to 10.7 and 10.5 (Radd-Vagenas et al., 2017; Valls-Pedret et al., 2015). Also, 
an increase in MEDAS scoring has been associated with other benefits, such as reduced 
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risk of obesity and breast cancer (Martínez-González et al., 2012; Toledo et al., 2015).
However, it is unclear exactly what the cut-off points in MEDAS mean for cognitive and 
other health outcomes. Also, the score interpretations for what is considered low, medium 
and high adherence to the diet in relation to studied outcomes, vary for this tool
(Hernandez-Galiot & Goni, 2017; Martínez-González et al., 2012).
In summary, deficiencies in existing Mediterranean diet index tools may reduce their 
ability to predict health outcomes and guide lifestyle interventions. In addition, no tools 
have been developed for, and tested in, a cohort with pre-existing cognitive impairment 
at higher risk of conversion to dementia. Our aim was to test the reliability and validity 
of a more comprehensive, newly constructed, Mediterranean diet index tool including 
elements and cut-off points based on the ‘traditional’ Mediterranean diet, within a cohort 
of older people with MCI living in a non-Mediterranean country, in order to facilitate
clinical research in various at-risk populations.
6.3 Methods
 
6.3.1 Participants
We recruited a convenience sample of community-dwelling participants from Sydney, 
Australia, who fulfilled MCI criteria (Gates et al., 2011; Petersen et al., 1999) from an 
existing clinical trial cohort (Singh et al., 2014), The Study of Mental and Resistance 
Training (SMART). The flow of participants from the original SMART trial into this
validity study can be seen in Figure 6.1. SMART participants had been diagnosed with 
MCI but without dementia, and 100 were randomised between 2008 and 2011 to 
resistance training and/or cognitive training for six months, with follow-up at 18 months
and then annually, where possible, to confirm their ongoing cognitive and health status
(Singh et al., 2014). All SMART participants, except those who were deceased, dropped 
out, uncontactable, involved in piloting the Mediterranean Diet and Culinary Index 
(MediCul) tool or known to have reverted to normal cognition or progressed to dementia
were invited to participate in this validity study during one of their annual re-assessment 
283
visits, which occurred, on average, 78 months from the time they were originally recruited 
to SMART with the diagnosis of MCI.
6.3.2 Data administration and collection 
The new Mediterranean diet index tool named MediCul was administered at the 
University clinic site as a paper survey (survey), twice, one week apart (time points A, 
B), with a dietitian observing and available to clarify questions (S. R-V.). The dietitian 
also checked responses to ensure no question was missed. Immediately following survey
B, participants were instructed to keep a 3-day food record (FR) on any two weekdays 
and one weekend day within a seven day period, representing usual intake. They were 
asked to specify brands of foods/drinks, preparation methods and recipes, as well as to 
use the supplied Australian standard household measures (i.e., metric cups, spoons, jug),
to estimate quantities. Participants were not required to weigh foods, although some
elected to do so. Returned FRs were queried with the participant by the dietitian for 
potentially missed food categories using a checklist.
Anthropometric data was collected at time point A using calibrated digital scales and a 
wall-mounted stadiometer at the clinic (in light clothing and no shoes) or portable scales 
and stadiometer (UC-321PBT (A&D Company Limited) and Seca 213, respectively), if 
a home visit was required. Body mass index (BMI) was calculated by dividing weight 
(kg) by height (m2).
Additional participant characteristics including education level, marital status, number of 
chronic diseases, cognitive and physical function scores were sourced from original or 
follow-up SMART data, selecting the closest time point available for the entire cohort in
our validity study. On average, this was 78 months prior to the validity study for education 
and marital status, and 59 months prior for number of chronic diseases, Alzheimer’s 
Disease Assessment Scale-Cognitive subscale (ADAS-Cog), Katz Activities of Daily 
Living (Katz ADL) and Bayer Informant Activities of Daily Living (Bayer-IADL) scores.
ADAS-Cog (Rosen, Mohs, & Davis, 1984) and Bayer-IADL (Hindmarch, Lehfeld, de 
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Jongh, & Erzigkeit, 1998) were used as primary outcomes in SMART for global cognitive 
function and functional independence, respectively (Singh et al., 2014).
The study was approved by the Ethics Review Committee (RPAH Zone) of the Sydney
Local Health District (Protocol No. X08-0064 & HREC/08/RPAH/106).
6.3.3 Tool development
The 50-item MediCul index tool was developed empirically in the form of a short 
question survey (See Supplementary Material 6.1 for elements, cut-off points, scoring
and rationale) to a) reflect a ‘traditional’ Mediterranean dietary pattern and certain aspects
of cuisine not assessed by previous tools (Bach-Faig et al., 2011; Oldways, 2008; Radd-
Vagenas et al., 2017; Willett et al., 1995), b) include 14 questions from the validated 
MEDAS screener optimised for the English language (Schroder et al., 2011), and c) 
incorporate discretionary foods, commonly consumed in Western populations (Australian 
Bureau of Statistics, 2014).
After conducting a literature review to identify important Mediterranean dietary elements 
and existing tools (Radd-Vagenas et al., 2017) draft questions were developed in 
consultation with Mediterranean diet and survey tool experts. The tool was pilot-tested 
with five healthy people from the general public aged 50-80 and three SMART 
participants with MCI for readability, ambiguity and completion timing, which is 20
minutes on average, before being finalised.
MediCul includes a blend of frequency and serve questions spanning 17 main elements
and assesses their exposure over the past six months: olive oil, vegetables, fruit, nuts, 
wholegrains, legumes, fish/shellfish, eggs, dairy products, white meat, red/processed 
meats, sweets and sugary drinks, takeaway, water, alcohol, coffee and certain aspects of 
Mediterranean cuisine. In all, nine of these elements cover desirable features of the
‘traditional’ Mediterranean diet and four cover undesirable features of a Western diet.
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MediCul is scored from 0-100, with a higher score representing increased adherence to a 
‘traditional’ dietary pattern (Supplementary Material 6.2).
6.3.4 Nutritional analysis
Scoring for both the MediCul and MEDAS tools was operationalised using Excel (MS 
Office Professional Plus 2013). The FRs were coded and entered into FoodWorks 8
Professional Edition: 8.0.3553 (Xyris Software Pty Ltd, Brisbane, Australia) selecting 
AusBrands 2015 and AusFoods 2015 data sources which map to the AUSNUT 2011-13
Food Standards Australia New Zealand (FSANZ) nutrient database for analysis by S. R-
V. Average intakes for food group outputs were adjusted manually, where required, as 
FoodWorks draws on the concept of USDA Food Patterns Equivalents Database (FPED), 
which is sometimes contrary to current nutrition guidelines that also consider diet quality 
(e.g., hot chips are counted in the vegetable group). Missing foods that have become 
popular in recent times (e.g., paleo bread), were entered into FoodWorks using data from 
nutrition panels on packaging, and by basing such foods on similar products. Nutrient 
intakes from supplements were not included as the aim was to test validity of MediCul 
based on foods alone (Margetts & Nelson, 1997).
6.3.5 Statistical analysis
The Statistical Package for Social Sciences (SPSS) for Windows version 24 (SPSS Inc.) 
was used for all analyses. We aimed to have a minimum of 50 participants as 
recommended by Peat (2001) for adequate assessment of repeatability and agreement.
The distribution of MediCul scores, nutrients and food groups was examined for 
plausibility with the aid of histograms and by considering minimum and maximum 
values, to identify potential data entry errors. We did not use cut-offs for potential 
outlying values in reported dietary intake as we were specifically testing the tool among 
participants with MCI and did not want to subjectively exclude clinically conceivable 
answers for possible cognitive influences in reporting. As people with MCI are known to 
be clinically and neurologically heterogeneous (Livingston et al., 2017), a range of
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cognitive performances, and thereby accuracy of recall for dietary intake within such a 
cohort, were therefore able to be captured.
A comparison was made of MediCul and the derived MEDAS scores, relevant to
cognitive outcomes reported in the literature (Valls-Pedret et al., 2015). In addition, we
estimated the percent of MCI participants that reached Mediterranean diet thresholds for 
selected foods/aspects of ‘traditional’ cuisine presumed to be health promoting, and those 
rarely used traditionally but consumed at significant levels in Western populations and 
known to be harmful at high or frequent levels of exposure. This was done using cut-off 
points for the highest score for relevant questions, from the MediCul index tool
(Supplementary Material 6.1).
Reliability for MediCul across the two administrations, one week apart, was assessed 
using the intraclass correlation coefficient (ICC) and classified as poor (<0.40), fair to 
good 0.4 and <0.75), and YHU\JRRG (Rosner, 2015). A Bland-Altman plot was 
used to assess the level of agreement between survey A and B time points, since a high 
correlation does not necessarily mean good agreement (Bland & Altman, 1986). Kappa 
was also used to check percentage agreement within the same category for the 17 dietary
elements. The Kappa values were characterised as showing almost perfect agreement
(0.81-1.00), substantial agreement (0.61-0.80), moderate agreement (0.41-0.60), fair 
agreement (0.21-0.40), slight agreement (0.00-0.20) and poor agreement (<0.00) (Landis 
& Koch, 1977).
Validity was assessed by comparing MediCul scores derived from survey A versus
MediCul scores from the FR using the Bland-Altman method. The differences between
the two methods were plotted against the means of the methods, with limits of agreement 
(LOA) as two standard deviations (SD) above, and below, the mean difference. Linear 
regression analysis was used to indicate the direction of bias and whether it was constant 
across mean scores.
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A total of three questions from MediCul relating to growing own vegetables, main meal 
eaten alone and fasting frequency, were unable to be validated as the FR did not include 
these details. We chose not to score for napping (traditionally conducted immediately 
after lunch in the Mediterranean), hence this question was also not validated. Finally, the 
validation of the MediCul index tool was based on scoring out of 97 whereas the 
reliability analysis was out of 100.
Indirect validity was investigated by examining if MediCul scores were associated with 
expected trends in nutrient intakes extracted from the FR. Nutrient values from the FR 
were checked for normal distribution using graphical methods and skewness, and log 10 
transformed where positively/negatively skewed, then re-checked for normality to inform 
the statistical tests to be used. Normally distributed or normalised nutrients from the FR 
were compared across tertiles of MediCul score derived from both survey A and the FR
using parametric tests (one-way ANOVA), whereas non-normally distributed nutrients 
were analysed using non-parametric tests (Kruskal-Wallis). When the ANOVA F ratio 
was significant, variances were checked for equality, and Bonferroni’s test was applied 
for equal variances or the Games-Howell post hoc test was applied for unequal variances.
In addition, first (linear)- and second (quadratic)-order polynomial contrasts were applied 
to test for nutrient trends across tertiles, as well as the line of best fit.
Means and SD were calculated from FR values for normally distributed nutrients: 
kilojoules, protein, fat, fat as percentage energy, saturated fatty acids (SFA), SFA as
percentage energy, SFA as percentage fat, polyunsaturated fatty acids (PUFA) as 
percentage fat, monounsaturated fatty acids (MUFA), MUFA as percentage fat, 
cholesterol, carbohydrate, carbohydrate as percentage energy, sugars, water, dietary fibre, 
vitamin C, vitamin A, beta carotene, sodium, potassium, magnesium, iron and zinc.
Medians and the interquartile range, representing tertiles 1 and 3 of the MediCul score, 
were calculated for non-normally distributed nutrients: protein as percentage energy, 
PUFA, n-3 long chain (LC) PUFAĮ-linolenic acid (ALA), EPA, docosapentaenoic acid, 
DHA, ratio of MUFA to SFA, ratio of total unsaturated fatty acids to SFA, vitamin E, 
vitamin B12, total folate, selenium and alcohol.
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Linear regression analysis was undertaken to assess precision of the MediCul tool across 
ADAS-Cog scores, being an index of global cognition (n=67).
6.4 Results
We recruited 68 participants from the 100 originally randomised to the SMART trial 
(Figure 6.1). All were included in the reliability study and 65 participated in the validity 
study. A total of two participants did not complete the FR and one had an incomplete FR.
The majority of the recruited participants were female (65%), married/de facto (56%) and 
the primary cook at home (71%). On average, they were aged 75.9 years (SD=6.6), 
overweight (BMI=27.3 kg/m2; SD=5.2), well educated (13 years; SD=4), had 2.8 chronic 
diseases (SD=1.6), good physical function and a confirmed MCI diagnosis based on the
most recently available ADAS-Cog scores (Table 6.1).
The mean MediCul score for survey A was 54.6/100.0 (SD=13.0; range: 32.5, 85.5) with 
4.4% of participants VFRULQJ.0. The mean derived MEDAS score for survey A was 
6.1/14.0 (SD=2.2; range: 1.0, 11.0). All those with 0('$6VFRUHVRI.0 (Valls-Pedret 
et al., 2015) had a MediCul score of 81.5.
Based on their FR, few participants reached thresholds for Mediterranean foods 
considered to be protective for cognitive or vascular function, such as olive oil (2%), 
legumes (3%), fruit (14%) and water (15%) (Figure 6.2). Fewer than half had minimal 
exposure to potentially harmful foods, used at low levels in the ‘traditional’ diet, such as 
processed meat (43%) and red meat (46%). However, three-quarters of the participants 
did report they mostly cooked their main meals at home and 89% kept sugary drinks to a 
minimum.
6.4.1 Reliability
The reliability of the MediCul index tool, based on single measures and 95% confidence 
intervals of the ICC, was very good (ICC=0.93, 95 CI% 0.884, 0.954, p<0.0001), 
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indicating the total score was measured similarly at the two time points (A and B). The 
Bland-Altman test for repeated measures showed a mean difference between the two 
scores of -0.04 with a lower LOA of í9.7 and an upper LOA of 9.6. Sixty-six of the 68 
(97%) participants fell within or on the lower and upper LOA with a fairly even 
distribution across mean scores. There was also no indication of bias according to the 
regression coefficient (y=í0.79+0.01*x) (95% CI: í0.082, 0.109; p=0.778), supporting 
the null hypothesis that the scores at two time points were equally variable. 
Groups that performed well for percentage agreement within the same category at time 
points A and B were as follows: wholegrains and coffee (almost perfect agreement); fruit, 
nuts, fish/shellfish, eggs, white meat preference, water and alcohol (substantial 
agreement); olive oil, dairy products, red/processed meats, sweets and sugary drinks 
(moderate agreement). Groups with fair agreement within the same category were: 
vegetables, legumes, takeaway and cuisine (Landis & Koch, 1977) (Supplementary 
Material 6.3). No groups had poor agreement for the proportion within each category at 
the two time points.
6.4.2 Validity
We assessed paired t-tests for scores from the survey administered at time points A, B
and the mean of AB versus the FR (n=65). This analysis indicated a very similar mean 
difference and CI across the three comparisons, which were all significant (p<0.0001) 
(Table 6.2). We therefore used survey A time point for the remaining validity testing,
given that this represented first time MediCul use, as could be applied in future research.
Bland-Altman analysis showed a positive mean difference of 6.0 between the MediCul 
score derived from survey A (52.8/97.0, SD=12.4, range: 31.5, 83.5) and the FR
(46.8/97.0, SD=10.8, range: 21.5, 72.0). Scores for all but one participant fell within or 
on the 95% limits of agreement ZLWKDORZHU/2$RIí10.7 and an upper LOA of 22.6.
There was also no significant linear trend for WKHILWWHGUHJUHVVLRQOLQH\ í2.30+0.17*x) 
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(95% CI: í0.027, 0.358; p=0.091), indicating no systematic bias between the two 
methods of measurement (Figure 6.3).
Significant linear trends in relation to tertiles of MediCul score were identified for the 
following nutrients, consistent with what would be expected for a Mediterranean dietary 
pattern: total fat (grams and %), including PUFA and MUFA (grams), which increased 
across tertiles of MediCul score from both the survey and FR (Table 6.3). This also 
translated into highly significant trends for ratios of MUFA to SFA and total unsaturated 
fatty acids to SFA (p<0.0001). Further, dietary fibre, vitamin C, vitamin E and 
magnesium all increased with increasing tertiles of MediCul score from both methods.
Conversely, a significant trend for the reduction in carbohydrate as percent of energy was 
observed across tertiles of MediCul score from both methods. Protein was either unrelated 
(grams) or significantly decreased (percentage energy) when comparing tertiles from the 
survey (p=0.041), consistent with the fact that a Mediterranean diet is not a high protein 
diet. In some instances, there was a trend for nutrients by tertiles of scores from the FR 
but not the survey (and vice versa), e.g., n-3 LC PUFA. There was no trend observed for 
total folate. In all cases, linear trends were significant, except for sodium when compared 
to tertiles from the FR and sugars when compared to tertiles from survey A, where the 
quadratic trend provided a better fit for the data.
MediCul precision was stable across a range of cognition IURPQRUPDOWR0&,-
12)) using ADAS-Cog as a measure of global cognitive performance.
6.5 Discussion
MediCul is a short survey index tool (takes 20 minutes to complete, on average), 
developed to assess adherence to a ‘traditional’ Mediterranean dietary pattern and certain 
aspects of cuisine, within a Western population. It also assesses some cultural (fasting) 
and lifestyle factors (gardening, napping) that can impact on dietary intake or are uniquely 
related to consumption of the main (midday) meal. On the basis of our analyses, MediCul 
has very good reliability and moderate validity relative to a FR, among older individuals 
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with MCI. To our knowledge, this is the first Mediterranean diet index tool to be validated 
in a group at higher risk of dementia. Our results cannot be generalised to younger or 
cognitively unimpaired individuals without further testing. Also, our participants were
originally volunteers for a randomised clinical trial and well educated, which may have 
influenced our results. Although we chose not to exclude participants based on extreme
energy intakes, these were nevertheless all within plausible limits (Willett, 1998).
The MediCul index tool overestimated the mean total score compared to its reference 
method by 6%, and this was similar to the findings for MEDAS in Spanish (5%) and 
German (9%) cohorts (Hebestreit et al., 2017; Schroder et al., 2011). However, it is well-
known that questionnaires tend to overestimate intakes compared with FRs (Klipstein-
Grobusch et al., 1998). Although there was a considerable range for LOA from the Bland-
Altman method when comparing scores from the MediCul index tool versus the FR, and 
it is unknown if this may have clinical implications, no systematic bias was found across 
mean scores. Hence, while the new index tool may be under and overestimating the FR-
derived MediCul score by 11% and 23%, respectively, the Spanish cohort MEDAS scores 
were under and overestimated by 43% and 53%, respectively, compared with FFQ
estimates (Schroder et al., 2011). Further, the under- and overestimates for the MediCul 
index tool are of a similar range reported for an alternate diet quality index score
(Huybrechts et al., 2010), and well within limits proposed by Ambrosini et al. (2003) who 
classified agreement between a FFQ and FR as being acceptable when LOA were between 
50% and 200%.
MediCul captures wide elements of the Mediterranean dietary pattern as a continuous 
measure. The cut-off points used and nutrient patterns identified suggest that diet quality
may be improving with an increased MediCul score. For example, with increasing tertiles 
of the MediCul score there is a significant increase in healthy fats (and ratios of MUFA 
or total unsaturated fats to SFA), as well as dietary fibre, vitamin C and vitamin E,
whereas carbohydrate as percentage energy declines correspondingly, and protein 
remains the same or decreases slightly. These directions are as anticipated for a
‘traditional’ Mediterranean diet, and macronutrient levels in the third tertile approximate 
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a Mediterranean diet model proposed in Australia (George et al., 2018). For example, the 
macronutrient proportions in the third tertile of MediCul score from the index tool were: 
fat, 41% of energy; protein, 15% of energy; carbohydrate, 36% of energy; MUFA, 47% 
of total fat. No trend was observed for total folate, probably a result of fortification in the 
Australian food supply, making interpretation of folate intakes difficult without additional 
and specific questions to assess this nutrient.
In our cohort of MCI participants, few reached Mediterranean diet thresholds for adequate 
intake of certain protective foods, such as olive oil, legumes, fruit and water and under 
half met our criterion for high vegetable variety, adequate fish intake and limited 
red/processed meat intake (Figure 6.2). The mean scores from the MediCul index tool 
and the derived MEDAS were also moderately low: 54.6/100.0 (SD=13.0) and 6.1/14.0
(SD=2.2), respectively. As a 0HGL&XOVFRUHRI.5 was equivalent to a MEDAS score 
RI.0, a level associated with cognitive benefit in the PREDIMED trial (Valls-Pedret 
et al., 2015), it is of concern that only 3/68 (4.4%) of older participants with MCI included
in our study scored in this range. These findings suggest that individuals with MCI living 
in Western countries, even those well-educated, may not be optimally protected by a 
Mediterranean dietary pattern, which is recommended for chronic disease prevention by 
US (US Department of Health and Human Services and US Department of Agriculture, 
2015) and Australian (National Health and Medical Research Council, 2013) dietary 
guidelines and the National Health Service (NHS, 2017) in the UK. Future studies,
however, are required to determine the direction of this relationship, as reverse causality 
is possible.
6.5.1 Limitations
Individual diets are complex and tend to vary over time, making measurement errors 
inevitable for all dietary methods (Willett, 2001). The best methods for assessing 
populations at risk of dementia are yet to be elucidated (Bowman et al., 2011). The 
MediCul index tool relies on self-reported data that could bias our results, especially 
given the cohort investigated. Yet there is limited research on cognitive status impact on 
the integrity of self-reported dietary data (Zuniga & McAuley, 2015). One small study,
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including MCI participants of a similar age to our participants, found cognitive 
impairment may inflate reliability and decrease validity of a FFQ (Bowman et al., 2011),
which may also be the case with our findings. Further, MediCul has not yet been validated 
against disease risk factors and health outcomes or using biochemical measures of food 
intake, as has been reported for MEDAS (Díez-Espino et al., 2011; Hebestreit et al., 2017; 
Sánchez-Taínta et al., 2008; Schröder, Marrugat, Vila, Covas, & Elosua, 2004), and there 
has generally been limited use of biomarkers to investigate the relationship between diet 
and cognitive function (Zuniga & McAuley, 2015). However, this type of validation may
be most relevant for assessment of absolute nutrient intakes rather than an index for an
overall dietary pattern. While most FFQs solicit information about intake over the past 
year (Thompson & Subar, 2017) the MediCul index tool asks participants about their last 
six months, which together with specific questions relating to cooking methods for both 
warmer and cooler weather, may address some seasonal variation. However, this time 
period may still be problematic for information retrieval among individuals with MCI, 
although it has been reported that if the information recalled is considered inadequate, 
respondents rely on general knowledge of what they routinely eat (Zuniga & McAuley, 
2015). We also had a dietitian present, available to answer questions and check responses 
were complete, limiting conclusions about other types of administrations or if the tool is 
entirely self-administered. Finally, the primary measure of global cognition (ADAS-
Cog), assessed at the same time point for the whole cohort in our validity study, was 
taken, on average, 59 months earlier and it is possible that some participants may have 
reverted to normal cognition, inflating our results.
To reduce participant burden we required only a 3-day food record using household 
measures, which is not ideal for foods that are not consumed daily. However, 3- to 4-day 
records appear acceptable as it has been reported that the validity of collected information 
decreases in the latter days of a 7-day record with recording periods of more than four 
days thought to be unsatisfactory owing to fatigue/disinterest, creating reactivity bias
(Thompson & Subar, 2017). In common with most other indexes, no energy adjustment 
was made for age or sex, which is unavoidable with tools designed for easy use. The 
FoodWorks nutritional analysis program has some limitations, with missing foods and 
categorisation used for some food groups, however, we adjusted for this manually.
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FoodWorks also contains Australian compositional data but this is unlikely to vary in 
ways that would influence reliability and validity of MediCul for use in other countries.
6.5.2 Strengths
Small scale indexes such as screeners may not capture extreme levels of intakes, leading 
to overestimation of associations with health outcomes (Panagiotakos, Pitsavos, & 
Stefanadis, 2006). More comprehensive surveys may also have higher validity (Martinez-
Gonzalez et al., 2002), although a ceiling of validity may exist (Willett, 2001). MediCul 
may be likened more to the larger scale modified MedDietScore index tool, which has 
scoring from 0-130 (Panagiotakos et al., 2009), yet it is relatively quick to complete and 
compute scoring for, compared to a typical FFQ. MediCul also measures some unique
aspects of Mediterranean cuisine such as high moisture, lower temperature cooking 
methods; frequent use of herbs and spices; and exposure to fermented foods like olives.
Such elements have been recommended to improve calculation of Mediterranean diet 
scores (Hoffman & Gerber, 2013). In its development, MediCul considered various best 
practice guidelines for dietary assessment (Cade, Burley, Warm, Thompson, & Margetts, 
2004) now advised by The DIETary Assessment Tool NETwork (Cade et al., 2017). The 
fact that a MEDAS score can also be derived from MediCul improves its utility so that 
comparisons with different studies, for various outcomes, can also be made.
6.5.3 Conclusions
Preventing or slowing cognitive decline may have a significant impact on the lives of 
individuals, families and carers, as well as future public health budgets. The 
Mediterranean diet is a promising lifestyle modality based on current evidence. Accurate 
measurement of adherence to the ‘traditional’ dietary pattern, among at-risk individuals
or those with existing cognitive impairment is vital to progress the field. We found that 
MediCul is a reliable and moderately valid tool to assess adherence to a Mediterranean 
dietary pattern among individuals with MCI who are at higher risk of converting to 
dementia. In our cohort of older Australians with MCI, the mean MediCul score was 
moderately low, suggesting poor compliance to this dietary pattern. MediCul may be a 
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useful tool for future studies testing a Mediterranean diet intervention for various stages 
of cognitive decline, including MCI.
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Table 6.1. Characteristics of study participants (n=68)
(Mean values and standard deviations; medians, ranges and percentages)
Mean SD 
Age (years)* 75.9 6.6
Females (%) 64.7 -
BMI (kg/m2)* 27.3 5.2
Education level (years)† 13.2 3.7
Married/de facto (%)† 55.9 -
Number of chronic diseases‡ 2.8 1.6
Primary cook at home (%)* 70.6 -
ADAS-Cog score (0-70)‡ 5.2 2.5
ADAS-&RJ 0.0 -
Katz ADL score (0-12)‡
Median 0.0
Range 0.0-0.0
Bayer-IADL score (1-10)‡§
Median 0.1
Range 0.0-0.2
Bayer-IADL >3 (%) 0.0
ADAS-Cog, Alzheimer’s Disease Assessment Scale-Cognitive subscale, used as the
primary test for global cognitive function in Study of Mental and Resistance Training 
(SMART, higher scores indicate more impairment; cut-off for GHPHQWLD LV; Katz 
ADL, Katz Index of Independence in Activities of Daily Living (higher scores indicate
more impairment; cut-off for significant functional impairment is >0); Bayer-IADL, 
Bayer Informant Activities of Daily Living (higher scores indicate more impairment; cut-
off for significant functional impairment is >3).
* Assessed at time point A of validity study.
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† Assessed at baseline of SMART study (Singh et al., 2014), on average, 78 months 
before validity study.
‡ Assessed at 18 months of SMART study (Singh et al., 2014), on average, 59 months 
before validity study with n=67 as missing tests for one participant.
§ Participant score substituted for informant score for n=3.
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Table 6.2. Mean difference from paired samples t-tests for Mediterranean diet and 
culinary index (MediCul) scores from surveys A, B, mean AB versus 3-day food record
(FR) (n=65)
(Mean difference and 95 % confidence intervals)
Mean difference 95% CI P value
A versus FR 5.95 3.85, 8.05 <0.0001
B versus FR 6.29 3.95, 8.64 <0.0001
AB versus FR 6.12 3.97, 8.28 <0.0001
A, first administration of MediCul; B, second administration of MediCul; AB, mean of A 
and B MediCul administrations.
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Table 6.3. Nutrient intakes compared with tertiles of Mediterranean diet and culinary index (MediCul) score (n=65)*
(Mean values and standard deviations; medians and interquartile ranges (IQR))
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
Energy (kJ/d) FR 8317 2362 8413 2286 8571 2355 0.973 0.722
Survey 8326 2632 8043 2079 8932 2167 0.442 0.400
Protein (g/d) FR 85 19 85 19 82 19 0.855 0.695
Survey 85 21 84 17 83 19 0.884 0.622
Protein (% energy) FR 0.516 0.310
Median 18 17 16
IQR 16-20 15-19 15-18
Survey 0.057 Ļ
Median 18 18 15
IQR 15-20 15-20 14-18
Fat (g/d) FR 75 31 82 25 97 44 0.109 Ĺ
Survey 75 33 79 30 100 38 0.041 Ĺ
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Table 6.3. - cont.
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
Fat (% energy) FR 33§ 7 37 10 40 10 0.027 Ĺ
Survey 32§ 7 36 8 41 12 0.008 Ĺ
SFA (g/d) FR 32 15 27 11 28 13 0.377 0.292
Survey 32 16 26 11 30 12 0.418 0.757
SFA (% energy) FR 14 4 12 5 12 3 0.156 0.081
Survey 14 4 12 3 13 4 0.367 0.421
SFA (% fat) FR 47‡§ 8 36 7 33 7 <0.0001 Ļ
Survey 46‡§ 10 37 7 34 6 <0.0001 Ļ
PUFA (g/d) FR 0.001 Ĺ
Median 9‡§ 14 17
IQR 7-14 11-15 11-25
Survey 0.006 Ĺ
Median 11§ 11 14
IQR 6-15 9-15 11-20
PUFA (% fat) FR 15§ 5 19 6 21 6 0.003 Ĺ
Survey 17 7 19 5 19 5 0.341 0.214
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Table 6.3. - cont.
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
MUFA (g/d) FR 26§ 11 34 13 42 22 0.006 Ĺ
Survey 25§ 12 32 15 43 19 0.001 Ĺ
MUFA (% fat) FR 38‡§ 5 45 7 46 6 <0.0001 Ĺ
Survey 37‡§ 5 44 6 47 6 <0.0001 Ĺ
n-3 LC PUFA 
(mg/d)
FR 0.075 Ĺ
Median 133 270 469
IQR 83-379 153-887 215-1228
Survey 0.778 0.484
Median 159 379 286
IQR 109-600 76-1348 176-872
ALA (mg/d) FR 0.273 0.108
Median 1017 1202 1842
IQR 820-1866 1001-2230 1094-2382
Survey 0.151 0.082
Median 1074 1828 1492
IQR 863-1642 921-2524 1001-1854
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Table 6.3. - cont.
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
EPA (mg/d) FR 0.070 Ĺ
Median 35 104 163
IQR 18-90 47-312 63-530
Survey 0.682 0.394
Median 59 101 87
IQR 29-222 14-549 47-344
DPA (mg/d) FR 0.579 0.378
Median 59 84 79
IQR 40-91 51-124 50-173
Survey 0.907 0.943
Median 65 73 66
IQR 50-111 34-192 51-86
DHA (mg/d) FR 0.022 Ĺ
Median 42§ 144 256
IQR 20-212 48-447 99-646
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Table 6.3. - cont.
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
Survey 0.359 0.268
Median 53 212 155
IQR 25-300 27-662 49-333
MUFA:SFA ratio FR <0.0001 Ĺ
Median 0.8‡§ 1.2 1.4
IQR 0.7-0.9 1.1-1.5 1.2-1.6
Survey <0.0001 Ĺ
Median 0.8‡§ 1.2 1.4
IQR 0.7-1.1 1.0-1.4 1.1-1.6
Unsaturated:SFA 
ratio
FR <0.0001 Ĺ
Median 1.1‡§ 1.8 2.1
IQR 1.0-1.3 1.5-2.2 1.8-2.4
Survey <0.0001 Ĺ
Median 1.1‡§ 1.8 1.9
IQR 0.9-1.6 1.3-2.2 1.7-2.1
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Table 6.3. - cont.
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
Cholesterol (mg/d) FR 288 101 260 84 261 135 0.613 0.397
Survey 297 89 265 125 249 103 0.334 0.149
Carbohydrate (g/d) FR 211 59 203 96 182 46 0.376 0.176
Survey 215 68 183 58 200 83 0.329 0.459
Carbohydrate (% 
energy)
FR 42 6 38 11 36 8 0.057 Ļ
Survey 42 7 38 8 36 11 0.050 Ļ
Sugars (g/d) FR 109 35 96 51 99 29 0.480 0.348
Survey 113 42 88 26 104 45 0.097 0.046
Alcohol (g/d) FR 0.505 0.294
Median 3.6 5.4 0.0
IQR 0.0-17.4 0.0-10.9 0.0-10.6
Survey 0.472 0.757
Median 0.0 6.6 0.5
IQR 0.0-18.1 0.0-16.6 0.0-8.0
Water (g/d) FR 2420 592 2547 560 2649 715 0.479 0.228
Survey 2412 665 2427 446 2766 687 0.108 0.063
314
Table 6.3. - cont.
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
Dietary fibre (g/d) FR 25§ 8 30 11 34 8 0.004 Ĺ
Survey 24§ 7 30 8 35 11 0.001 Ĺ
Vitamin C (mg/d) FR 106‡§ 57 160 85 170 57 0.004 Ĺ
Survey 103§ 62 141 64 186 69 <0.001 Ĺ
Vitamin E (mg/d) FR <0.0001 Ĺ
Median 11§ ۅ 19
IQR 8-13 11-18 15-32
Survey <0.0001 Ĺ
Median 11‡§ 15 16
IQR 8-12 10-21 14-24
9LWDPLQ%ȝJG FR 0.588 0.337
Median 4.3 4.1 4.1
IQR 3.5-5.2 3.1-4.9 3.4-5.2
Survey 0.768 0.588
Median 4.3 4.5 4.1
IQR 3.4-4.9 3.3-5.0 3.3-5.2
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Table 6.3. - cont.
Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
)RODWHWRWDOȝJG FR 0.236 0.110
Median 665 575 595
IQR 576-797 498-757 459-665
Survey 0.496 0.395
Median 631 641 590
IQR 574-743 489-789 439-684
9LWDPLQ$ȝJG FR 1184 785 1019 582 1242 370 0.484 0.803
Survey 1044 606 1249 723 1154 498 0.550 0.554
ȕ-&DURWHQHȝJG FR 4473 3582 4521 3457 5955 2389 0.248 0.144
Survey 3957 2858 5496 3732 5401 2961 0.215 0.142
Na (mg/d) FR 2308 842 2656 1029 1994 677 0.056 0.032
Survey 2354 851 2403 859 2209 989 0.766 0.605
K (mg/d) FR 3128 662 3264 945 3516 800 0.285 0.120
Survey 3117 756 3128 605 3646 954 0.048 Ĺ
Mg (mg/d) FR 332§ 90 358 103 449 160 0.006 Ĺ
Survey 335 102 371 131 426 136 0.061 Ĺ
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Nutrients from food 
record
Source of 
MediCul score 
tertile cut-off 
points
Nutrient intake for tertile 1 
of MediCul score
Nutrient intake for tertile 2 of 
MediCul score
Nutrient intake for tertile 3 
of MediCul score
Comparison 
of nutrient 
intakes 
across 
tertiles of 
MediCul 
score P
value
Test for 
trend P 
value, 
direction 
ĹĻ
Mean SD Mean SD Mean SD
Fe (mg/d) FR 11.2 2.5 12.8 4.9 12.9 4.4 0.287 0.162
Survey 10.9 2.4 12.2 3.6 13.7 5.3 0.076 Ĺ
Zn (mg/d) FR 10.7 3.1 10.6 3.5 11.2 4.1 0.850 0.647
Survey 10.8 3.3 10.5 3.6 11.3 3.7 0.770 0.664
6HȝJG FR 0.120 Ĺ
Median 72 89 91
IQR 57-89 68-97 69-124
Survey 0.504 0.771
Median 82 81 90
IQR 62-101 64-92 66-119
n, number of participants; SD, standard deviation; IQR, interquartile range; kJ, kilojoules; d, day; FR, food record; g, grams; %, percentage; SFA, 
saturated fatty acids; PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids; n-3, omega 3; LC, long chain; mg, milligrams; 
ALA, alpha linolenic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; mcg, micrograms.
* Tertiles are derived for MediCul index scores from both the FR and survey A (first administration of MediCul). For survey A, the cut-offs for 
tertiles 2 and 3 were 47.0 and 58.0, respectively. Values are presented as means and standard deviations for normally distributed data or medians 
and IQR for non-normally distributed data. These data were normalised by logarithmic transformation for use in ANOVA models with the exception 
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of alcohol and DHA, which were not able to be normalized and were therefore analysed using Kruskal-Wallis model. When ANOVA F ratio was 
significant, variances were checked for equality, and Bonferroni was applied for equal variances or Games-Howell post hoc t-test for unequal 
variances. First (linear)- and second-(quadratic) order polynomial contrasts were applied to test for trends across tertiles, as well as line of best fit.
In all cases linear trends were significant, and there were no significant deviations from normality, except for sodium when compared to tertiles 
from the FR and sugars when compared to tertiles from survey A, where the quadratic trend was positive and the most significant.
7UHQGGLUHFWLRQLQGLFDWHGDVĹLQFUHDVLQJRUĻGHFUHDVLQJ
‡ Significant differences between tertiles 1 versus 2.
§ Significant differences between tertiles 1 versus 3.
ۅ6LJQLILFDQWGLIIHUHQces between tertiles 2 versus 3.
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SMART recruitment pool n=2094
Randomised to SMART RCT n=100
Assessed for eligibility n=195
Baseline assessment n=101
Recruited to validity study n=68
Deceased n=2
Dementia n=7
Drop out n=12
Not MCI n=1
Pilot for tool n=3
No contact n=7
Ineligible n=56
On hold n=200
Not interested n=1582
No contact n=61
Ineligible n=1
(medical)
Withdrawals n=0
On hold n=0
Ineligible n=60
On hold n=17
Withdrawals n=17
)LJXUH3DUWLFLSDQWIORZFKDUW7KH6WXG\RI0HQWDODQG5HVLVWDQFH7UDLQLQJ60$57IURP
ZKLFKSDUWLFLSDQWVZHUHUHFUXLWHGWRWKH0HGL&XOYDOLGLW\VWXG\QQXPEHURISDUWLFLSDQWV5&7
UDQGRPLVHGFRQWUROOHGWULDO0&,PLOGFRJQLWLYHLPSDLUPHQW
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89%
74%
72%
71%
60%
58%
55%
48%
46%
43%
42%
42%
29%
29%
29%
23%
22%
15%
14%
11%
3%
2%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Sugary drinks <1 cup/week
Meals home cooked ≥5 times/week
Raw vegetables ≥4 times/week
Eggs ≤4/week
Dairy products ≤2 serves/d
Snacking ≤2 times/d
Herbs & spices ≥4 times/week
Moist cooking methods ≥4 times/week
Red meat ≤1 serve/week
Processed meat <0.5 serves/week
Fish or shellfish ≥3 serves/week
Vegetable variety ≥10 types/week
Biscuits & cakes <1 times/week
High lutein vegetables ≥4 times/week
Nuts ≥5 serves/week
Vegetables ≥5 serves/d
Lemon or vinegar in food prep ≥4 times/week
Water ≥5 cups/d
Fruit ≥3 serves/d
Sofrito ≥2 times/week
Legumes ≥3 serves/week
Olive oil ≥4 TBSP/d
)LJXUH3HUFHQWDJHRISDUWLFLSDQWVZKRUHDFKHG0HGLWHUUDQHDQGLHWWKUHVKROGVDFFRUGLQJWRGD\IRRGUHFRUGV
Q 7%63WDEOHVSRRQSUHSSUHSDUDWLRQ
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Mean MediCul score [(survey A+FR)]
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Upper LOA=22.6
Mean=6.0
Lower LOA=-10.7
)LJXUH%ODQG$OWPDQSORWRIWKHGLIIHUHQFHEHWZHHQ0HGLWHUUDQHDQGLHWDQGFXOLQDU\
LQGH[0HGL&XOVFRUHPHDVXUHGE\VXUYH\$ILUVWDGPLQLVWUDWLRQRI0HGL&XODQGGD\
IRRGUHFRUG)5DQGWKHPHDQ0HGL&XOVFRUHRIWKHWZRPHWKRGVQ 7KHVROLGOLQH
LQWKHFHQWUHLQGLFDWHVWKHPHDQGLIIHUHQFHEHWZHHQWKHWZRPHWKRGVDQGWKHGRWWHGOLQHV
DERYH DQG EHORZ LQGLFDWH WKH OLPLWV ZLWKLQ ZKLFK  RI WKH GLIIHUHQFHV EHWZHHQ WKH
PHWKRGV DUH H[SHFWHG WR IDOO 6' DERYH DQG EHORZ WKH PHDQ GLIIHUHQFH 7KH ILWWHG
UHJUHVVLRQ OLQH LV \ í[  &, í  S  LQGLFDWLQJ QR
V\VWHPDWLFELDV6'VWDQGDUGGHYLDWLRQ/2$OLPLWVRIDJUHHPHQW
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Supplementary Material 6.1. - MediCul tool elements, cut-off points, scoring and rationale
Elements Sub-elements Description of 
Measure
Cut-off Points Total 
Score 
Rationale
1. Olive oil Q25 Fat types 
frequency
Days/wk 0 = No added 
fats used               
0 = Total other 
fats > olive oil
3 = Total other 
fats = olive oil
6 = Total other 
fats < olive oil
6 Olive oil was the primary culinary fat used in the 
‘traditional’ Med diet (Radd-Vagenas, Kouris-
Blazos, Fiatarone Singh, & Flood, 2017).
The relative frequency of exposure to various fat 
types is easier to rate than quantifying amounts.  
This also avoids scoring for MediCul using the 
leading MEDAS Q (Schroder et al., 2011)
Q26 Butter/cream 
intake
Serves/d N/R
Q included for 
MEDAS score 
only
N/R As below for Q27 (Zheng et al., 2016).
Q27 Margarine 
intake
Serves/d N/R
Q included for 
MEDAS score 
only
N/R Not scored in MediCul as difficult to accurately 
quantitate serves.
For purposes of MEDAS scoring, MediCul defines 
1 serve=1 tsp (5g), and makes an adjustment (as 
MEDAS 1 serve=12g), as this amount is easier to 
visualise and more consistent with typical food 
portions consumed by Australian adults (5-7g 
margarine for 31-71+ years) (Zheng et al., 2016).
Q28 Olive oil 
quantity
TBSP/d
(1 Australian 
0 = 0-1.99
TBSP/d
3 = 2-3.99
6 High olive oil intake (i.e., 60g/d) is consistent with 
‘traditional’ Cretan use (e.g., 95g/d edible fats in 
1960s; mostly olive oil) (Kromhout et al., 1989) and 
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Elements Sub-elements Description of 
Measure
Cut-off Points Total 
Score 
Rationale
TBSP = 15 g or 
20 ml)
TBSP/d
 7%63G
meets or exceeds MEDAS cut-off SRLQW7%63G
(Kromhout et al., 1989).
Note MEDAS 1 TBSP=13.5 g, hence 53 g/d 
required.
Q29a Olive oil as 
main culinary fat
Subjective 
response as to 
whether olive 
oil is main fat in 
diet: no or yes
N/R
Q included for 
MEDAS score 
only
N/R Not scored in MediCul as leading Q.
Original MEDAS Q (Schroder et al., 2011), slightly 
improved for inclusion within MediCul by 
prompting to consider use of all fats/oils, including 
spreads.  
Also, this Q follows others on various fat serves 
consumed, to help participant identify more 
correctly whether olive oil is the main culinary fat.
Q29b Olive oil 
type
N/R 0 = lite, classic, 
other                     
4 = extra virgin
4 Traditionally, olive oil was all extra virgin, which 
contains polyphenols. Research shows polyphenols 
are key to the efficacy of olive oil (Casamenti & 
Stefani, 2017; Cicerale, Conlan, Sinclair, & Keast, 
2009).  Many olive oils are refined and do not 
contain significant polyphenols (Aiello, Guccione, 
Accardi, & Caruso, 2015) so it is important to know 
which type is used.
No other Med diet tools assess this, likely because 
in the past the role of the minor constituents of olive 
oil was underappreciated.
2. Vegetables Q1 Vegetable
intake
Serves/d 0 = 0-2.99
serves/d 
1 = 3-4.99
2 Based on validated Q in Australia for national 
monitoring.  Measures all vegetables/salads 
including potato, which was included in original 
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Cut-off Points Total 
Score 
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serves/d
 VHUYHVG
Med diet index tool as traditionally consumed 
cooked as a vegetable (not fast food) (Trichopoulou 
et al., 1995).
Consistent with AGTHE serves (National Health 
and Medical Research Council, 2013). AGTHE 1 
VHUYH òFXSJKHQFHVHUYHVG J
MEDAS cut-off SRLQWVHUYHVGZKHUHVHUYH 
JKHQFHJG
AGTHE recommends 375 g/d, which approximates 
400 g/d cut-off point in MEDAS (National Health 
and Medical Research Council, 2013; Schroder et 
al., 2011).
Q2 Vegetable 
variety
Types/wk 0 = <10 
types/wk
 
types/wk
1 Dietary guidelines promote increased dietary 
variety. Increased vegetable variety is associated 
with higher diet quality (Keim, Forester, Lyly, 
Aaron, & Townsend, 2014).  Vegetable variety is 
also associated more strongly with reduced cancer 
risk than vegetable quantity (Jansen et al., 2004).
Simply assessing vegetable quantity may therefore 
not fully capture the mechanisms whereby 
vegetables decrease disease risk. Keim et al. (2014)
used cut-off SRLQWGLIIHUent vegetables/wk for 
high variety. 
CSIRO Healthy Diet Score includes multiple Qs on 
vegetable variety (Hendrie & Noakes, 2017).
No other Med diet tools assess this.
325
Supplementary Material 6.1. - cont.
 
 
Elements Sub-elements Description of 
Measure
Cut-off Points Total 
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Q3 Vegetable raw 
frequency
Times/wk 0 = 0-3.99
times/wk
 WLPHVZN
1 The ‘traditional’ Med diet regularly included raw 
vegetables in the form of salads, e.g., cabbage 
salad, village salad (mixed), dakos (grated tomato 
on rusks with EVOO). Hence frequency of raw 
vegetable exposure over most days per week is 
assessed. Research suggests raw vs. cooked 
vegetables are associated with better mental health 
and reduced mortality (Brookie, Best, & Conner, 
2018; Masala et al., 2007).
Ciccarone et al. (2003) in their Med tool used cut-
off SRLQWIRUH[SRVXUHWRUDZYHJHWDEOHVRI
times/wk.
CSIRO Healthy Diet Score assesses salad 
vegetables (Hendrie & Noakes, 2017).
Higher lutein 
vegetable 
frequency:
Q4a Other green 
vegetables
Q4b Dark green 
leafy vegetables
Times/wk 0 = 0-1.99
times/wk
1 = 2-3.99
times/wk
 WLPHVZN
2 Dark green leafy vegetables were consumed in the 
‘traditional’ Med diet, mostly picked wild from the 
mountains (Allbaugh, 1953; Keys, 1995).  These
are rich in lutein, nitrate and vitamin K, which 
provide vascular and cognitive benefits (Bolton-
Smith, Price, Fenton, Harrington, & Shearer, 2000; 
Lidder & Webb, 2013; Mohn & Johnson, 2017).
Higher plasma lutein levels and green leafy 
vegetable intake is associated with decreased 
dementia risk, slowing of cognitive decline and age-
related macular degeneration (Morris et al., 2015a; 
Morris et al., 2015b; Tan et al., 2008).
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Cut-off Points Total 
Score 
Rationale
Two questions are asked about different types of 
green vegetables to minimise response bias.  Cut-
off point relates to frequency of exposure for most 
days per week, which is simpler to estimate than 
quantity consumed.
MIND study (Morris et al., 2015a) cut-off SRLQWLV
6 serves/wk. 
No other Med diet tools assess this except Italian 
Mediterranean Index (IMI) (Agnoli et al., 2011).
Q5 Onions/garlic 
frequency
Times/wk 0 = 0-3.99
times/wk
 WLPHVZN
1 The allium family of vegetables is regularly 
consumed (mostly daily) in the ‘traditional’ Med 
diet in salads and cooked dishes and contributes to 
polyphenol intake (Fidanza & Alberti, 2005).  Cut-
off point relates to frequency of exposure for most 
days per week, which is simpler to estimate than 
quantity consumed.
No other Med diet tools assess this except Italian 
Mediterranean Index (IMI) (Agnoli et al., 2011).
Q8 Grow own 
vegetables
N/R 0 = No
1 = Yes
1 Having a home garden was traditional and is 
positively correlated with a high Med diet score in 
the Australian arm of the MEDIS Study (Darmos-
Thodis, 2013).  Growing any vegetables may 
promote an increased intake, physical activity and 
higher vitamin D levels (Kouris-Blazos & 
Itsiopoulos, 2014).
No other Med diet tools assess this.
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3. Fruit Q12 Fruit intake Serves/d 0 = 0-0.99
serves/d
3 = 1-2.99
serves/d
 VHUYHVG
6 Q based on standard Q from national surveys in 
Australia. Examples of dried fruit also provided 
since consumed in the Mediterranean (Kromhout et 
al., 1989).
Cut-off point is consistent with MEDAS (Schroder 
et al., 2011) GEXW0('$6DOVRcounts fruit 
juice), Greek dietary guidelines (Ministry of Health 
and Welfare: Supreme Scientific Health Council, 
1999) and high traditional (1960s) Cretan intake of 
464 g/d (Kromhout et al., 1989).
Higher fruit intake is associated with reduced stroke 
risk (Dauchet, Amouyel, & Dallongeville, 2005; 
Hu, Huang, Wang, Zhang, & Qu, 2014; Mizrahi et 
al., 2009).
MediCul cut-off point exceeds 2 serves/d 
recommended by AGTHE (National Health and 
Medical Research Council, 2013).
MediCul excludes juice as this increases the 
glycaemic load, thereby providing different effects 
to whole fruit.  Also, juice was not regularly 
consumed in the ‘traditional’ Med diet.
4. Nuts Q24 Nuts intake Serves/wk
(1 serve = 30g 
or 1.5 TBSP 
nut/seed butter)
0 = 0-0.99
serves/wk
2 = 1-2.99
serves/wk
4 = 3-4.99
serves/wk
6 Nuts were regularly consumed in the ‘traditional’
diet (Allbaugh, 1953). Observational studies show 
greater CVD proWHFWLRQZLWKH[SRVXUHWRQXWV
times/wk (Aune et al., 2016; Sabaté & Ang, 2009).
Clinical and observational studies show improved 
cognition or reduced cognitive decline with age 
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 
serves/wk
with nut consumption (Barbour, Howe, Buckley, 
Bryan, & Coates, 2014; O'Brien et al., 2014; Pribis 
et al., 2011).
MediCul uses wider range of cut-off points then 
MEDAS for increased discernment.  
MEDAS (Schroder et al., 2011) cut-off SRLQW
serves/wk.
Goulet, Nadeau, and Lemieux (2003) cut-off point 
>2 portions/d is for legumes and nuts/seeds 
combined.
5. Wholegrains Q20 
Wholegrain/lower 
GI bread frequency
Frequency 0 = No bread 
used 
0 = White > 
(wholegrain + 
wholemeal + rye 
+ sourdough)        
3 = White = 
(wholegrain + 
wholemeal + rye 
+ sourdough)        
6 = White < 
(wholegrain + 
wholemeal + rye 
+ sourdough)
6 Grain foods were an important part of the 
‘traditional’ Med diet and mostly unrefined (intact, 
cracked or coarsely milled) (Trichopoulou & 
Lagiou, 1997).  Bread was made using a sourdough 
culture (Pes et al., 2015). Such forms result in a 
lower GI, which is associated with health benefits 
(Barclay et al., 2008; Brand-Miller, Hayne, Petocz, 
& Colagiuri, 2003; Goff, Cowland, Hooper, & 
Frost, 2013).
This Q uses bread as a proxy for quality of grains
most frequently consumed.
MIND diet (Morris et al., 2015a) uses cut-off point 
VHUYHVGEXWVHUYHVIRUGLIIHUHQWJUDLQIRRGVYDU\
and are difficult to estimate, hence not used in 
MediCul.
MEDLIFE criteria (Sotos-Prieto et al., 2014) for 
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wholegrains = fibre >25 g/d, which requires 
nutritional calculations. 
6. Legumes Q19 Legume 
intake
Serves/wk
(1 serve = 1 cup 
cooked dry 
beans or 150g)
0 = 0-0.99
serves/wk
3 = 1-2.99
serves/wk
 
serves/wk
6 Legumes were a core food in ‘traditional’ peasant 
Med diets in the 19th century, used as a meat 
replacement (Matalas, 2006; Ministry of Health and 
Welfare: Supreme Scientific Health Council, 1999).
MediCul cut-off point is consistent with MEDAS
(Schroder et al., 2011) VHUYHVZNDQGVHUYHVL]H
The AGTHE protein serve (1 cup cooked), rather 
than vegetable serve (1/2 cup cooked), is used as 
more consistent with ‘traditional’ food use
(National Health and Medical Research Council, 
2013).
GLNC recommends legumes are consumed 2-3
times/wk (Grains & Legumes Nutrition Council, 
2013).
7. Fish/shellfish Q16 Fish/shellfish 
intake
Serves/wk
(1 serve= 1 
small fish fillet 
or 1 small can 
of fish or 200 g 
shellfish)
0 = 0-0.99
serves/wk
3 = 1-2.99
serves/wk
 
serves/wk
6 Fish was part of the ‘traditional’ Med diet but 
intake depended on proximity to the sea (Radd-
Vagenas et al., 2017).  Research shows fish may 
contribute to brain structure benefits and 
consumption is associated with reduced risk of 
AD/dementia (Barberger-Gateau et al., 2007; Gu et 
al., 2015).
MediCul is consistent with MEDAS (Schroder et 
al., 2011) serves and cut-off SRLQWVHUYHVZN
The Heart Foundation recommends 2-3 serves oily 
fish/wk for all Australians in their position 
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statement on fish and CV health (Heart Foundation, 
2015).
8. Eggs Q18 Egg intake Eggs/wk  HJJVZN
1 = >4-6.99
eggs/wk
2 = 0-4 eggs/wk
2 Eggs were consumed in moderation in the 
‘traditional’ Med diet (Radd-Vagenas et al., 2017).
Some studies have associated egg intake with a 
higher risk of type 2 diabetes, and stroke in those 
with existing type 2 diabetes (Djoussé & Gaziano, 
2008; Djoussé, Khawaja, & Gaziano, 2016).
MediCul cut-off point is based on the original Med 
diet pyramid (Willett et al., 1995).
Goulet et al. (2003) cut-off point 0-4 eggs/wk with 
D]HURVFRUHIRUHJJVZN
Ciccarone et al. (2003) cut-off point 0-2 eggs/wk.
MEDLIFE (Sotos-Prieto et al., 2014) cut-off point 
2-4 eggs/wk.
Spanish Med pyramid cut-off point 2-4/wk (Bach-
Faig et al., 2011).
Eggs are not commonly assessed by Med diet index
tools.
9. Dairy products Q21 Dairy product 
intake
Serves/d
(1 serve = half a 
cup (120 g) 
ricotta/cottage 
cheese, 50 g 
fetta, ¾ cup 
(200 g) yoghurt, 
2 slices (40 g) 
0 = >2 serves/d
2 = 0-2 serves/d
2 Dairy intake was moderately low in the ‘traditional’
diet and did not focus on low fat products, popular 
in Western countries (Ministry of Health and 
Welfare: Supreme Scientific Health Council, 1999; 
Pes et al., 2015; Willett et al., 1995).
MediCul cut-off point relates to maximum exposure 
for total dairy of any type, i.e., cow, sheep, goat, 
full fat, low fat, reduced fat.
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hard yellow 
cheese)
Serve size for fetta is provided based on calcium 
equivalence. 
Q22 Milk type Response to 
which type of 
milk usually 
consumed
N/R
Q included for 
qualitative 
purpose only
N/R Not used in MediCul scoring.
10. White meat Q15 White meat 
calculated 
preference
Serves/wk 0 = Q13 + Q14 
serves/wk > 
Q15 + Q16 
serves/wk
1 = Q13 + Q14 
serves/wk = 
Q15 + Q16 
serves/wk
2 = Q15 + Q16 
serves/wk > 
Q13 + Q14 
serves/wk OR 
Q13 + Q14 + 
Q15 + Q16 
serves/wk = 0 
(vegetarian)
2 Exposure to meat was low in the ‘traditional’ Med 
diet (Radd-Vagenas et al., 2017).  Red meat in
particular is associated with chronic disease risk, 
and may be related to risk of dementia (Bellavia, 
Stilling, & Wolk, 2016; Giem, Beeson, & Fraser, 
1993).
MEDAS (Schroder et al., 2011) includes a leading 
Q to assess white meat preference.  While that
MEDAS Q is embedded within MediCul (Q17) for 
the purpose of calculating a MEDAS score, this 
particular MediCul Q is designed to assess whether 
serves of white meat are consumed more frequently 
than serves of red meat.  MediCul does not score 
for number of chicken serves.
Q17 White meat 
subjective 
preference
Subjective 
response as to 
which is 
preferentially 
N/R
Q included for 
MEDAS score 
only
N/R Included to derive MEDAS (Schroder et al., 2011)
score, but not scored in MediCul as leading Q.
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eaten: white, 
red or no meats
11.
Red/processed 
Q13 Red meat 
intake
Serves/wk
(1 serve= 100-
150 g)
0 = >3 
serves/wk
1.5 = >1-3
serves/wk
3 = 0-1 serve/wk
3 Exposure to red meat was low in the ‘traditional’
Med diet (Martinez-Gonzalez, Hershey, Zazpe, & 
Trichopoulou, 2017; Ministry of Health and 
Welfare: Supreme Scientific Health Council, 1999).
Red meat in particular is associated with chronic 
disease risk, and may be related to risk of dementia
(Bellavia et al., 2016; Giem et al., 1993).
This Q is based on MEDAS (Schroder et al., 2011)
and the original Willett Med pyramid (Willett et al., 
1995).  However, serves are based on commonly 
consumed portions in Australia rather than 65 g as 
defined in AGTHE (Zheng et al., 2016).
MedDietScore (Panagiotakos et al., 2009) uses cut-
off SRLQWZN
MEDLIFE (Sotos-Prieto et al., 2014) uses cut-off
point <2/wk.
MIND diet (Morris et al., 2015a) allows higher 
exposure to red meat and meat products <4 
meals/wk.
AGTHE (National Health and Medical Research 
Council, 2013) recommends not > 455 g/wk.
Q14 Processed 
meat intake
Serves/wk
(1 serve= 1 ½ 
thick or 2 
thinner 
0 = >1 serve/wk
1.5 = 0.5-1
serve/wk
3 Exposure to processed meat was low in the 
‘traditional’ Med diet (Radd-Vagenas et al., 2017).
Processed meat is strongly associated with chronic 
disease risk and mortality (Larsson & Orsini, 2014).
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sausages; 2
rashers bacon; 4
slices processed 
meats (100 g);
1 meat pie,
pastie, sausage 
roll; 6 chicken 
nuggets)
3 = 0-<0.5 
serve/wk
Q is based on MEDAS (Schroder et al., 2011) Q.
However, cut-off point is consistent with 
MEDLIFE (Sotos-Prieto et al., 2014) VHUYHZN
and Ciccarone et al. (2003) 0 times/wk, which is 
closer to traditional intakes.  This Q uses a similar 
serve size to that for fresh red meat so responses 
can be summed for MEDAS scoring.
MEDAS cut-off point <7 serves/wk.
Goulet et al. (2003) cut-off point <1 portion (50-
100g)/wk.
MIND diet (Morris et al., 2015a) allows higher 
exposure to red meat and meat products <4 
meals/wk.
12. Sweets & 
sugary drinks
Q31 Biscuits/cakes 
frequency
Times/wk  WLPHVZN
1 = 1-1.99
times/wk
2 = 0-0.99
times/wk
2 Sugar containing foods were rare in the ‘traditional’
Med diet (Radd-Vagenas et al., 2017; Willett et al., 
1995).  High sugar foods can increase insulin 
resistance, which is associated with significantly 
lower regional cerebral glucose metabolism and 
Alzheimer’s disease (Willette et al., 2015).
This Q is based on MEDAS (Schroder et al., 2011)
Q but includes examples of more typical sweets in 
Australia and includes all sweets, not just 
‘commercial’ types as in MEDAS. It excludes 
custard.
MEDLIFE (Sotos-Prieto et al., 2014) cut-off point 
VHUYHVZNIRUDOOVZHHWV
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MEDAS cut-off point <3 times/wk for all 
sweets/pastries.
MediCul scoring takes into account the effect of 
added sugars from additional sources assessed in 
other relevant Qs, i.e., Q32b, Q33.
Q32a Custard 
frequency
Times/wk N/R
Q included for 
MEDAS score 
only
N/R This is not scored in MediCul but included to obtain 
a MEDAS (Schroder et al., 2011) score for 
sweets/pastries.  MEDAS includes custard as part of 
sweets/pastries.
Q32b Ice cream 
frequency
Times/wk  WLPHVZN
1= 1-1.99
times/wk
2 = 0-0.99
times/wk
2 Ice cream was not part of the ‘traditional’ Med diet 
but is a popular dessert or snack in Australia
(Willett et al., 1995).
MediCul scoring takes into account the effect of 
added sugars from additional sources assessed in 
other relevant Qs, i.e., Q31, Q33.
No other Med diet tools assess this.
Q33 Sugary drinks 
intake
Cups/wk  FXSVZN
1 = 1-1.99
cups/wk
2 = 0-0.99
cups/wk
2 Sugary drinks were rare in the ‘traditional’ Med diet
(Radd-Vagenas et al., 2017).  They can increase 
insulin resistance, which is associated with 
significantly lower regional cerebral glucose 
metabolism and Alzheimer’s disease (Willette et al., 
2015).
Q based on MEDAS (Schroder et al., 2011) Q but
provides standardised serves, whereas MEDAS 
simply asks re number of sugary drinks consumed 
per day.
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MediCul scoring takes into account the effect of 
added sugars from additional sources assessed in 
other relevant Qs, i.e., Q31, Q32b.
Q34 Fruit juice 
intake
Cups/wk 0 = >7 cups/wk     
2 = 0-7 cups/wk
2 Intake of fruit juice was rare in the ‘traditional’
Med diet, although some fruit syrups were home-
made to offer to guests, diluted with water (Radd-
Vagenas et al., 2017).
Q is included to assess excessive exposure to fruit 
juice which, like other sugary drinks, may increase 
the glycaemic load and promote weight gain and 
insulin resistance (Sharma, Chung, Kim, & Hong, 
2016; Xi et al., 2014).
Q also allows fruit juice to be counted in total 
serves of fruit to derive a MEDAS (Schroder et al., 
2011) score. 
Q35 Fruit juice 
type
Response to 
type usually 
consumed: 
commercial or 
freshly 
squeezed
N/R
Q included for 
MEDAS score 
only
N/R This Q is not scored in MediCul.
Type required for MEDAS scoring only, since 
‘natural fruit juices’ counted as fruit.  Natural fruit 
juices assumed to be freshly squeezed juices. 
13. Takeaway Q7 Hot chips 
frequency
Times/wk  WLPHVZN
1 = 1-1.99
times/wk
2 = 0-0.99
times/wk
2 Hot chips were not part of the ‘traditional’ Med diet 
but are common in Western diets.  Hot chips may 
be a proxy for takeaway (fast food) consumption. 
Unlike boiled potato, fried potato contains 
significant acrylamide and AGEs content, 
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associated with inflammation and negative health 
outcomes, such as cancer and neurotoxicity (Cai et 
al., 2014; Kellow & Coughlan, 2015; Shojaee-
Aliabadi et al., 2013; Uribarri et al., 2010).
Previous Med diet tools have grouped all potato 
products either with vegetables or grains. 
No other Med diet tools assess this. 
Q30 Takeaway 
frequency
Times/wk  WLPHVZN
1 = 1-1.99
times/wk               
2 = 0-0.99
times/wk
2 The ‘traditional’ Med diet did not include takeaway
(fast food) yet this is common in modern society 
and associated with negative health outcomes
(Cahill et al., 2014; Martinez-Gonzalez et al., 
2017).
MIND diet cut-off point <1 times/wk for fast fried 
foods (Morris et al., 2015a).
14. Water Q36 Pure water 
intake
Cups/d 0 = 0-2.99
cups/d
2 = 3-4.99
cups/d
 FXSVG
4 Water was the main drink consumed traditionally
(Radd-Vagenas et al., 2017).  Adequate intake is 
associated with reduced risk of fatal coronary heart 
disease (Chan, Knutsen, Blix, Lee, & Fraser, 2002)
and dehydration with impaired cognitive 
performance (Lieberman, 2007; Wilson & Morley, 
2003).
Upper MediCul cut-off point is based on 
observational data and exceeds findings from 
MEDIS cross sectional analysis where estimated 
plain water intake by Greek-born Australians (from 
Med islands) is 947 ml/d (Tsindos, Itsiopoulos, & 
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Kouris-Blazos, 2015).
No other Med diet tools assess this.
Q38 Herbal tea 
intake
Cups/d 0 = Other teas or 
herbal tea <4 
cups/wk
1  KHUEDOWHD
cups/wk
1 Wild herbs were picked from the mountains and 
herbal tea was regularly consumed in the 
‘traditional’ diet (Matalas, 2006).  Greek mountain 
tea is rich in polyphenols and may benefit cognition 
(Hofrichter et al., 2016; Samanidou, Tsagiannidis, 
& Sarakatsianos, 2012).
Green/black tea was not traditionally consumed so 
it is not scored, despite providing polyphenols.
No other Med diet tools assess this. 
Q39 Tea type Response to tea 
type mostly 
consumed
N/R N/R Included for qualitative purposes and to inform 
scoring for Q38.
Although green/black tea contain polyphenols, they 
were not part of the ‘traditional’ Med diet (Radd-
Vagenas et al., 2017).
15. Alcohol Q40 Alcohol 
drinking days 
frequency
Days/wk 0 = >5 days/wk
2 = 0-5 days/wk
2 Alcohol was consumed in the ‘traditional’ Med diet 
but only with meals and in low amounts (usually 
diluted with water) (Trichopoulou et al., 1995).
MediCul cut-off point is based on NHMRC 
guidelines (National Health and Medical Research 
Council, 2001) which recommend 2 alcohol free 
days per week, as frequency is associated with 
increased intake. 
Alcohol standard 
drinks intake:
Standard 
drinks/wk
0 = >14 std 
drinks/wk 
2 Alcohol is associated with cancer risk, all-cause 
mortality and promotes excessive energy intake
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Q41a F/S beer
Q41b Light beer
Q41c Wine
Q41d Spirits
1 = >7-14 std 
drinks/wk
2 = 0-7 std 
drinks/wk
(Knott, Coombs, Stamatakis, & Biddulph, 2015; 
National Health and Medical Research Council, 
2009; Winstanley et al., 2011).
Q assesses whether total alcohol intake is low, 
consistent with traditional intakes (Trichopoulou et 
al., 1995).  The upper cut-off point is deliberately 
conservative compared to other Med diet index 
tools as the negative effects of even small amounts 
of alcohol are now better appreciated, especially for 
cancer (Bagnardi et al., 2013).
Most alcohol is 
wine and
consumed only 
with meals:
Q42a Wine type
Q42b With meals
N/R 0 = Wine not 
main drink or 
not exclusively 
consumed with 
meals                    
2 = Wine main 
drink & 
exclusively 
consumed with 
main meals 
2 Drinking wine only with meals was customary in 
the Med diet (Martinez-Gonzalez & Martin-Calvo, 
2016) and may reduce negative effects of alcohol 
by slowing absorption rate.  Both red and white 
wines were traditionally consumed and contain 
antioxidants (Trichopoulou, Bamia, & 
Trichopoulos, 2009).  Type is assessed in MediCul 
for qualitative purposes.  
MEDLIFE (Sotos-Prieto et al., 2014) cut-off point 
1-2 serves/d (1 serve=1 cup); also awards points for 
both red/white wine.
MEDAS (Schroder et al., 2011) only scores for red 
wine and does not require consumption with meals.
16. Coffee Q37a Coffee intake Cups/d 0 = >2 cups/d 
unless de-
caffeinated
 FXSVGRU
1 Caffeinated coffee was part of the ‘traditional’ Med 
diet but at lower levels than commonly believed 
since coffee beans were not grown in the region and 
expensive to buy (Allbaugh, 1953; Matalas, 2006).
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Elements Sub-elements Description of 
Measure
Cut-off Points Total 
Score 
Rationale
any quantity de-
caffeinated
This Q is a crude measure of coffee/caffeine 
exposure since it is difficult to assess intake without 
multiple Qs to determine variety of beans, roasting 
and brewing type, and volume of beverage 
consumed.  
Although some observational studies suggest higher 
intakes of coffee may benefit cognition and 
dementia risk, there is large methodological 
heterogeneity across studies precluding conclusions 
for these outcomes (Santos, Costa, Santos, Vaz-
Carneiro, & Lunet, 2010).
MediCul uses a conservative cut-off point as higher 
intakes of coffee are associated with increased
myocardial infarction risk in individuals with the 
commonly observed risk variant of the CYP1A2 
gene (Cornelis, El-Sohemy, Kabagambe, & 
Campos, 2006).
No other Med diet tools assess this.
Q37b Caffeinated 
vs. non-caffeinated
Response to 
type of coffee 
mostly 
consumed
N/R N/R The response for this Q is included to inform 
scoring for Q37a.
17. Cuisine & 
lifestyle 
Q6 Sofrito 
frequency
Times/wk 0 = 0-0.99
times/wk
1 = 1-1.99
times/wk
 WLPHVZN
2 Sofrito is a combination of tomato, olive oil and 
onion/garlic (Estruch et al., 2013), used as basis of 
multiple Med dishes.  It is high in phytonutrients 
including quercetin and lycopene, important for 
vascular function (Rodriguez-Rodriguez et al., 
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2017). Because it is in a lipid matrix, sofrito 
facilitates increased bioavailability of 
phytonutrients contained in the vegetables and 
EVOO.  Increased plasma lycopene is associated 
with decreased plasma and CSF IL-6 (an 
inflammatory marker) (Guest et al., 2014).
Q based on MEDAS (Schroder et al., 2011) Q with 
cut-off SRLQWWLPHVZN
Q9 Herbs and
spices frequency
Times/wk 0 = 0-3.99
times/wk
 WLPHVZN
1 Seasonings, particularly herbs, were used in 
‘traditional’ Med cuisine (Radd-Vagenas et al., 
2017).  These provide antioxidants and anti-
inflammatory phytonutrients and may reduce the 
formation of noxious chemicals during high 
temperature cooking, e.g., AGEs, HCAs (Dearlove, 
Greenspan, Hartle, Swanson, & Hargrove, 2008; 
Murkovic, Steinberger, & Pfannhauser, 1998).
MediCul scoring rewards if exposure occurs on 
more than half the days per week.  
MEDLIFE (Sotos-Prieto et al., 2014) cut-off point 
VHUYHVGEXWDOVRLQFOXGHVRQLRQDQGJDUOLF
Q10 
Lemon/vinegar 
frequency
Times/wk 0 = 0-3.99
times/wk
 WLPHVZN
1 These condiments were regularly used in 
‘traditional’ cuisine. They may reduce the 
glycaemic load and retard formation of AGEs 
during/after cooking (Chen, Chen, Giudici, & Chen, 
2016; Uribarri et al., 2010), as well as positively 
influence the microbiome to retard formation of 
TMA, a novel CVD risk factor (Wang et al., 2015).
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Cut-off Points Total 
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Rationale
A score for exposure to more than half the days per 
week is awarded.
No other Med diet tools assess this.
Fermented foods:
Q11 Olives 
frequency
Q23a Yoghurt 
frequency
Q23b Fetta cheese 
frequency
Times/wk 0 = Q11 + Q23a 
+ Q23b = 0-3.99
times/wk
1 = Q11 + Q23a 
4E 
times/wk
1 Fermented foods were regularly consumed as part 
of Med cuisine and may provide benefits for the 
microbiome (Fidanza & Alberti, 2005; Iriti & 
Vitalini, 2012; Kushi, Lenart, & Willett, 1995; 
Peres, Peres, Hernández-Mendoza, & Malcata, 
2012).
A novel combined exposure score for three 
fermented foods is calculated.
MIND diet (Morris et al., 2015a) criteria for total 
cheese <1 serve/wk.
No other Med diet tools assess exposure to 
fermented foods. 
Q43 Main meal 
home cooked 
frequency
Times/wk 0 = <5 
Times/wk
 
Times/wk
1 The ‘traditional’ Med cuisine involved home 
cooked meals (Radd-Vagenas et al., 2017). In 
Western society, diet quality improves when 
cooking at home more often (Monsivais, Aggarwal, 
& Drewnowski, 2014; Tiwari, Aggarwal, Tang, & 
Drewnowski, 2017).
No other Med diet tools assess this. 
Q44 Main meal 
eaten alone 
frequency
Times/wk  
Times/wk
1 = <5 
Times/wk
1 Main meals were usually eaten in company, which 
provides social connectedness (Altomare et al., 
2013; Serra-Majem, Bach-Faig, & Raido-Quintana, 
2012). This Q rewards when main meals for most 
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days per week are consumed in company rather 
than alone.
No other Med diet tools assess this.
Lower vs. higher 
AGEs cooking 
methods 
frequency:
Q45 Warmer 
weather 
Q46 Cooler 
weather
Frequency 0 = Total higher 
AGEs (Q45 + 
4WRWDO
lower AGEs 
(Q45 + Q46)
1 = Total higher 
AGEs (Q45 + 
Q46) < total 
lower AGEs 
(Q45 + Q46)
1 Traditional cooking methods generally used high 
moisture and lower temperature (Radd-Vagenas et 
al., 2017).  High temperature, dry heat, cooking 
methods common in Western countries promote 
formation of AGEs (Uribarri et al., 2010).  AGEs 
are associated with dementia and other chronic 
diseases and their complications (Kellow & 
Coughlan, 2015; Takeuchi & Yamagishi, 2008).
This novel Q assesses frequency of high vs. low 
AGEs cooking methods during warmer and cooler 
weather and awards a score when the majority of 
cooking is done using lower AGEs methods.
Higher AGEs methods = a) grill, BBQ, dry fry b) 
shallow/deep fry c) roast/bake.
Lower AGEs methods = d) boil/stew e) steam f) stir 
fry.
Q47 Snacking 
frequency
Times/d 0 = >2 Times/d
 7LPHVG
1 Frequent snacking was uncommon in the 
‘traditional’ Med diet.  In Western countries 
frequent snacking is associated with increased 
energy intake and obesity (Hoffman & Gerber, 
2013; Murakami & Livingstone, 2015).
Q48 Fasting 
frequency
Days/yr 0 = no fasting
1 = any days/yr
1 The ‘traditional’ Med diet was frugal and fasting 
from animal foods was regularly undertaken due to 
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Elements Sub-elements Description of 
Measure
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Score 
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religious reasons (Kafatos, Verhagen, 
Moschandreas, Apostolaki, & Westerop, 2000; 
Sarri, Linardakis, Bervanaki, Tzanakis, & Kafatos, 
2004). The main meal was taken at lunch and 
eating late at night was uncommon, supporting a 
more time-restricted feeding pattern, which aligns 
better with circadian rhythms and may provide 
metabolic advantages (Sutton et al., 2018).
Increasing dietary fibre from plant foods and 
limiting exposure to animal products may 
beneficially influence the microbiome (Kouris-
Blazos & Itsiopoulos, 2014).  Energy restriction is 
associated with improvement of multiple risk 
factors, e.g., insulin resistance (Mattson, Longo, & 
Harvie, 2017).
Q assesses any deliberate fasting which may 
involve energy restriction or avoidance of animal 
products.
No other Med diet tools assess this.
Q49 Fasting type Response to 
indicate type 
usually 
practised
N/R N/R Included for qualitative purposes only.
As regular fasting is generally uncommon in 
Western countries, no scoring is provided for type 
of fasting.
No other Med diet tools assess this.
Q50a Napping 
frequency
Days/wk N/R N/R Napping after the midday meal was common in the 
traditional lifestyle and some studies in 
Mediterranean countries suggest short naps reduce 
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risk of CVD (Naska, Oikonomou, Trichopoulou, 
Psaltopoulou, & Trichopoulos, 2007; Trichopoulos 
et al., 1988).
Q is included for qualitative purposes and not 
scored in MediCul.
No other Med diet tools assess this.
Q50b Napping 
duration
Less than 30 
mins
30 mins or 
longer
N/R N/R Q is included for qualitative purposes and not 
scored in MediCul.
No other Med diet tools assess this.
Q, question; wk, week; Med, Mediterranean; MEDAS, Mediterranean Diet Adherence Screener used in PREDIMED study; d, day; N/R, not 
relevant or not scored for in MediCul; TBSP, tablespoon; g, grams; ml, millilitres; AGTHE, Australian Guide to Healthy Eating; CSIRO, 
Commonwealth Scientific and Industrial Research Organisation; EVOO, extra virgin olive oil; MIND, Mediterranean-DASH diet intervention for 
neurodegenerative delay diet; IMI, Italian Mediterranean Index; MEDIS, MEDiterranean ISlands study; CVD, cardiovascular disease; GI,
glycaemic index; MEDLIFE, MEDiterranean LIFEstyle index; GLNC, Grains Legumes Nutrition Council; AD, Alzheimer’s disease; 
MedDietScore, Mediterranean diet score; F/S, full strength; NHMRC, National Health Medical Research Council; std, standard; CSF, 
cerebrospinal fluid; TMA, trimethylamine; AGEs, advanced glycation end products; HCAs, heterocyclic amines.
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Name:__________________________ 
 Assessment:_____________________ 
Date:___________________________ 
Administrator:___________________ 
Short Dietary Survey 
This is a survey about the food you eat.  Read it carefully and identify the amounts that best 
describe your usual intake over the last six months.  It’s important that the answers you 
provide reflect what you personally eat, rather than what you think you should or shouldn’t be 
having, or what someone else wants you to eat.  When there are options, please choose one 
response most relevant to you.  This survey will take around 20 minutes to complete. 
But first, here are two sample questions with sample answers to give you an idea of how the 
survey works. 
Sample Question 1:  How often do you eat jelly beans?  (Jelly beans of all colours are included). 
Sample Response 1: If you usually don’t eat any eat jelly beans, or do this rarely, you would skip the first two 
options and tick the last option box, like this. 
_______ times per day 
OR 
_______ times per week 
OR 
I don’t eat jelly beans 
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Sample Question 2:  How many serves specifically of Lebanese bread do you usually eat each day?  (1 serve 
is one quarter of a large Lebanese bread, which is the size of a dinner plate). 
Sample Response 2: If you usually eat one whole Lebanese bread for lunch and another half a Lebanese bread 
for dinner, you would write 6 serves in the first option, like this. 
___6____ serves per day
OR 
________ serves per week 
OR 
________serves per month 
OR 
 I don’t eat Lebanese bread 
359
Supplementary Material 6.2. MediCul index tool 
Now it’s over to you.  Please start with the first question below. 
Remember, your answers should represent your 
usual intake over the last six months.
1. How many serves of vegetables do you usually eat each day?  (1 serve is ½ cup cooked vegetables or 1
cup of salad vegetables).  Please choose one response most relevant to you.
_______ serves per day
OR
_______ serves per week
OR
_______ serves per month
I don’t eat vegetables or salad 
2. How many different types of vegetables do you usually eat in one week?  Count each type only once.
_______ different vegetables are eaten over the week
3. How often do you usually eat raw vegetables such as salads, carrot sticks, and sprouts?  Don’t count
small garnishes.  Please choose one response most relevant to you.
_______ times per day
OR
_______ times per week
OR
_______ times per month
OR
 I don’t eat raw vegetables 
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4. How many times per week do you usually eat raw or cooked green vegetables?  Write a number next
to each of the two groups below.  Place a ‘0’ (zero) on the line if you don’t usually eat any greens on a
weekly basis.  SEE PICTURE BELOW FOR EXAMPLES OF DARK GREEN LEAFY VEGETABLES.
______ times per week of broccoli, peas, beans, zucchini, Brussels sprouts, cabbage, bok choy
AND
______ times per week of dark green leafy varieties such as kale, spinach, silverbeet, amaranth,
dandelion, chicory, endive, rocket
5. How often do you usually eat onions, garlic, spring onions or shallots?  Count those used in cooking
and eaten raw in salads.  Please choose one response most relevant to you.
________ times per day
OR
________ times per week
OR
________ times per month
OR
  I don’t eat onions, garlic, spring onions or shallots 
6. How many times per week do you usually eat dishes cooked in a sauce made with tomato and onion
simmered in olive oil?  The sauce may also include garlic and herbs.  (Exclude canned/bottled tomato
sauces if onion and olive oil are not used).  Please choose one response most relevant to you.
________ times per week
OR
________ times per month
OR
  I don’t eat dishes cooked in a sauce made with tomato and onion simmered in olive oil 
361
Supplementary Material 6.2. MediCul index tool 
7. How often do you usually eat hot chips, French fries, wedges or fried potatoes?  Please choose one
response most relevant to you.
_______ times per day
OR
_______ times per week
OR
_______ times per month
OR
 I don’t eat hot chips, French fries wedges or fried potatoes 
8. Do you grow any of your own vegetables?
No 
 OR 
Yes 
9. How often do you usually use herbs or spices?  For example, in cooking, salad or dessert.  This includes
fresh or dried varieties such as parsley, oregano, cinnamon, cumin, pepper etc.  Please choose one
response most relevant to you.
________ times per day
OR
________ times per week
OR
________ times per month
OR
  I don’t use herbs or spices 
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10. How often do you usually use lemon or vinegar when preparing food?  For example, to make salad
dressing, stirred into soup or for basting meat or seasoning vegetables before roasting.  Please choose
one response most relevant to you.
________ times per day
OR
________ times per week
OR
________ times per month
OR
  I don’t use lemon or vinegar when preparing food 
11. How often do you usually eat olives?  This includes black, green, kalamata or stuffed olives and
tapenade (a paste) made from olives.  Please choose one response most relevant to you.
_______ times per day
OR
_______ times per week
OR
_______ times per month
OR
I don’t eat olives or tapenade 
12. How many serves of fruit do you usually eat each day?  Do not count juice.  (1 serve is 1 medium piece
or 2 small pieces of fruit or 1 cup of diced/canned fruit or 30 g dried fruit e.g. 4 dried apricot halves, 1
½ tablespoons sultanas).  Please choose one response most relevant to you.
______ serves per day
OR
______ serves per week
OR
______ serves per month
OR
 I don’t eat fruit 
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13. How many serves of red meat such as beef, veal, lamb, kangaroo or pork do you usually eat each day?
Include all steaks, chops, roasts, mince, stir-fries and casseroles.  (1 serve equals 100-150 g).  Please
choose one response most relevant to you.
________ serves per day
OR
________ serves per week
OR
________ serves per month
OR
 I don’t eat red meat 
14. How many serves of processed meat such as sausages, bacon, ham, devon, frankfurts, salami,
luncheon meats or meat pies do you usually eat each day?  (1 serve equals 1 ½ thick or 2 thinner
sausages, 2 rashers bacon, 4 slices processed meats (100 g), 1 meat pie/pastie/sausage roll, 6 chicken
nuggets).  Please choose one response most relevant to you.
________ serves per day
OR
________ serves per week
OR
________ serves per month
OR
I don’t eat processed meat 
15. How many serves of white meat such as chicken, turkey or rabbit do you usually eat each day?  Include
all fillets, pieces, roasts, mince, stir-fries and casseroles.  (1 serve is 100-150 g).  Please choose one
response most relevant to you.
________ serves per day
OR
________ serves per week
OR
________ serves per month
OR
I don’t eat white meat 
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16. How many serves of fish or shellfish do you usually eat each week?  Include fresh and canned.  (1 serve
is 1 small fish fillet or 1 small can of fish or 200 g shellfish).  Please choose one response most relevant
to you.
________ serves per day
OR
_________ serves per week
OR
_________ serves per month
OR
  I don’t eat fish or shellfish 
17. Which do you usually eat more often?  Please choose one response most relevant to you.
Chicken, turkey or rabbit 
OR 
Beef, pork, hamburgers or sausages 
OR 
I don’t eat chicken or meat 
18. How many eggs do you usually eat each day?  Please choose one response most relevant to you.
________per day
OR
________per week
OR
________ per month
OR
I don’t eat eggs 
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19. How many serves of legumes do you usually eat each day?  Legumes include baked beans, canned 4-
bean mix, lentils, split peas, chickpeas and any other canned or dried beans.  (1 serve is 1 cup (150 g)
cooked or canned beans).  They do not include fresh peas and green beans.  Please choose one
response most relevant to you.  SEE PICTURE BELOW FOR EXAMPLES.
________ serves per day
OR
________ serves per week
OR
________ serves per month
OR
I don’t eat legumes 
20. How many times per week do you usually eat each of the following types of bread or wraps?  Don’t
worry about amounts.  Place a ‘0’ (zero) on the line if you don’t usually eat certain types of bread or
wraps.
________ times per week white e.g. Tip Top, Wonder White, Molenberg
________ times per week wholegrain e.g. Burgen, Helga’s, Schwob’s Swiss Bakery
________ times per week wholemeal e.g. Buttercup, Glicks, Bill’s, Lawson’s
________ times per week rye e.g. Country Life, Abbott’s Village Bakery, Van Der Meulin
________ times per week sourdough e.g. Coles Bakery, Bill’s, Macro, Woolworths
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21. How many serves of dairy products do you usually eat each day?  (1 serve is 1 cup milk (250 ml), 2
slices hard cheese (40 g), ½ cup (120 g) ricotta/cottage, 80 g fetta cheese or 200 g (¾ cup) yoghurt).
Don’t count dairy alternatives such as rice milk or soy yoghurt.  Please choose one response most
relevant to you.
________ serves per day
OR
________ serves per week
OR
________ serves per month
OR
I don’t eat dairy products 
22. What type of milk do you usually have?  Please choose one response most relevant to you.
Regular dairy milk (whole or full cream) 
OR 
Low or reduced fat dairy milk 
OR 
Skim dairy milk 
OR 
Other (please specify) ______________________ 
OR 
I don’t have milk 
23. How often do you usually eat the fermented dairy products below?  Please choose one response most
relevant to you.
a) Yoghurt?  This includes low fat, full cream, Greek yoghurt, probiotic yoghurt, fruit yoghurt and kefir.
________ times per day 
OR 
________ times per week 
OR 
________ times per month 
OR 
  I don’t eat yoghurt 
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b) Fetta cheese?
________ times per day 
OR 
________ times per week 
OR 
________ times per month 
OR 
 I don’t eat fetta cheese 
24. How many serves of nuts do you usually consume per day or per week?  Nuts include peanuts, walnuts,
Brazil nuts, cashews etc.  (1 serve is 30 g nuts or a small handful, or 1 ½ tablespoons nut paste/peanut
butter).  SEE PICTURE FOR EXAMPLES.
________ serves per day
OR
________ serves per week
OR
________ serves per month
OR
  I don’t eat nuts 
25. How many days per week do you usually use each of the following fats and oils?  Fats and oils may be
used in your cooking, as spreads or on salads.  Don’t worry about amounts.  Place a ‘0’ (zero) on the
line if you don’t usually eat certain types of fats/oils.
________ days per week butter
________ days per week margarine
________ days per week mayonnaise
________ days per week vegetable oil e.g. sunflower, grapeseed, canola, rice bran
________ days per week olive oil
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26. How many serves of butter or cream do you usually eat each day?  (1 serve is 1 teaspoon).  Please
choose one response most relevant to you.
________ serves per day
OR
________ serves per week
OR
________serves per month
OR
I don’t eat butter or cream 
27. How many serves of margarine do you usually eat each day?  (1 serve is 1 teaspoon).  This includes all
types/brands of margarine such as those formulated with olive oil, plant sterols and omega-3.  For
example, Flora, Meadow Lea, Olive Grove, Bertolli, Gold N Canola, Logical.  Please choose one response
most relevant to you.
________ serves per day
OR
________ serves per week
OR
________serves per month
OR
I don’t eat margarine 
28. How many tablespoons of olive oil do you usually eat each day?  This includes oil used in cooking,
drizzled on salads or bread and food eaten away from home)?  (1 tablespoon = 20 ml).  Please choose
one response most relevant to you.
______ tablespoons per day
OR
______ tablespoons per week
OR
_____ tablespoons per month
OR
I don’t use olive oil 
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29. a) Do you use olive oil as the main fat in your diet when considering all the types of fats/oils/spreads
used in your cooking, food preparation and on your bread?
No 
OR 
Yes 
b) If yes, what type of olive oil do you usually use?  Please choose one response most relevant to you.
Light 
OR 
Classic/Mild/Pure 
OR 
Extra Virgin 
OR 
Other (please specify)______________________ 
You are over half way through the survey – we really appreciate your time - 
30. How often do you usually have meals or snacks from takeaway food stores?  Examples include
McDonalds, Hungry Jacks, Pizza Hut, KFC, Red Rooster, fish/chicken shop or local take away food places
and foods such as burgers, pizza, hot dogs, battered chicken or fish and chips.
________ times per day
OR
________ times per week
OR
________ times per month
OR
  I don’t eat takeaway foods 
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31. How many times per day do you eat biscuits or cakes of any type?  This includes sweet biscuits,
muffins, sponge cakes, sweet buns, doughnuts and Danish pastries.  Please choose one response most
relevant to you.
________ times per day
OR
________ times per week
OR
________ times per month
OR
 I don’t eat biscuits or cakes 
32. How many times per week do you usually consume custard or ice cream?  Place a ‘0’ (zero) on the line
if you don’t usually consume any.
________ times per week custard
________ times per week ice cream
33. How many cups of sugar sweetened/carbonated beverages do you usually drink each day?  This
includes soft drink, cordial, sports drink, vitamin water and energy drink.  Don’t forget any used to mix
with spirits.  (1 cup is 250 ml, 1 can of soft drink is 1.5 cups).  Do not count ‘diet’ drinks.  Please choose
one response most relevant to you.
________ cups per day
OR
________ cups per week
OR
________ cups per month
OR
I don’t drink sugar sweetened/carbonated beverages 
371
Supplementary Material 6.2. MediCul index tool 
34. How many cups of fruit juice do you usually drink each day?  Fruit juice includes all types of fruit juices,
fresh or commercial.  (1 cup is 250 ml).  Please choose one response most relevant to you.
_______ cups per day
OR
_______ cups per week
OR
_______ cups per month
OR
I don’t drink fruit juice (if so, skip the next question) 
35. What type of fruit juice do you usually drink?  Please choose one response most relevant to you.
Fruit juice commercially packaged in bottles or tetra paks. 
OR 
Freshly squeezed fruit juice 
36. How many cups of water do you usually drink each day?  (1 cup is 250 ml; 1 litre equals 4 cups).  Please
choose one response most relevant to you.
________ cups per day
OR
________ cups per week
OR
________ cups per month
OR
 I don’t drink water 
37. How many cups of coffee do you usually drink each day?  Please choose one response most relevant to
you.
________ cups per day
OR
________ cups per week
OR
________ cups per month
OR
I don’t drink coffee 
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b) If you drink coffee, which type do you mostly drink?
Caffeinated 
OR 
De-caffeinated 
38. How many cups of tea do you usually drink each day?  Please choose one response most relevant to
you.
________ cups per day
OR
________ cups per week
OR
________ cups per month
OR
I don’t drink tea (if so, skip the next question) 
39. What type of tea do you mostly drink?  Please choose one response most relevant to you.
Black tea, with milk 
OR 
Black tea, no milk 
OR 
Green tea 
OR 
Herbal tea (this contains no caffeine) 
40. How often do you usually drink alcoholic beverages?  Please choose one response most relevant to
you.
________days per week
OR
________days per month
OR
I don’t drink alcoholic beverages (if so, skip the next two questions) 
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41. a) If you drink full strength beer, how many stubbies/cans (375 ml) do you usually have?  Please choose
one response most relevant to you.
________ stubbies/cans per day
OR
________ stubbies/cans per week
OR
________ stubbies/cans per month
OR
I don’t drink full strength beer 
b) If you drink lite beer, how many stubbies/cans (375 ml) do you usually have?  Please choose one
response most relevant to you.
________ stubbies/cans per day 
OR 
________ stubbies/cans per week  
OR 
________ stubbies/cans per month 
OR 
I don’t drink lite beer 
c) If you drink wine, how many glasses (150 ml) do you usually have?  Please choose one response
most relevant to you.
________ glasses per day 
OR 
________ glasses per week  
OR 
________ glasses per month 
OR 
I don’t drink wine 
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d) If you drink spirits, how many pub-sized nips (30 ml) do you usually have?  Please choose one
response most relevant to you.
________ nips per day 
OR 
________ nips per week  
OR 
________ nips per month 
OR 
I don’t drink spirits 
42. a) If you drink wine, what type do you usually have?  (If not, skip this question).
White wine 
OR 
Red wine 
b) When do you usually drink the wine?
Only with main meals 
OR 
With meals and /or at other times, outside of main meal occasions 
Finally, we’d like to ask you a few questions about your personal eating and lifestyle habits as well as 
the cooking methods used to prepare your food. 
43. How often is your main or evening meal cooked at home?  This may be prepared by you, your family
or your friends.
_________ times per week
OR
_________ times per month
OR
I don’t eat home cooked meals 
44. How many of your main or evening meals do you eat alone (without company)?
_________ meals per week
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45. During the warmer weather how many times per week do you usually eat foods/meals prepared using
each of the following cooking methods?  Place a ‘0’ (zero) on the line if you don’t use a certain cooking
method.
_________ times per week prepared by grilling, BBQing or dry frying in a pan
_________ times per week prepared by shallow or deep frying
_________ times per week prepared by roasting or baking
_________ times per week prepared by boiling or stewing
_________ times per week prepared by steaming
_________ times per week prepared by stir frying
46. During the cooler weather how many times per week do you usually eat foods/meals prepared using
each of the following cooking methods?  Place a ‘0’ (zero) on the line if you don’t use a certain cooking
method.
_________ times per week prepared by grilling, BBQing or dry frying in a pan
_________ times per week prepared by shallow or deep frying
_________ times per week prepared by roasting or baking
_________ times per week prepared by boiling or stewing
_________ times per week prepared by steaming
_________ times per week prepared by stir frying
47. a). How many times per day do you usually snack?  Snacking is an eating occasion that occurs between
main meals.  Count snacks such as morning/afternoon tea, supper, eating while driving or while
watching TV.  If you snack multiple times between meals, count each occasion once if it is separated by
15 minutes.
________times per day
OR
I don’t usually snack between meals or I snack less often than daily 
b). If you do snack daily, name the three most frequent types of snacks you usually have. 
______________________________ 
______________________________ 
______________________________ 
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48. How often do you usually fast?  Fasting means deliberately abstaining from eating all foods or avoiding
certain types of foods for given periods.  For example Lent, Ramadan, 5:2 diet.  It does not mean
occasionally skipping meals or missing breakfast.
________ days per week
OR
________ days per month
OR
________ days per year
OR
I don’t fast   (if so, skip the next question and go straight to the last question) 
49. What option would best describe the type of fasting you usually practise?  Please choose one response
most relevant to you.
I avoid certain types of foods when I fast e.g. avoid meat and dairy 
OR 
I restrict the amount of food for a given period e.g. reduce portion sizes or calories 
OR 
I avoid all foods for a given time period e.g. don’t eat at all during the day 
OR 
Other (please specify)_______________________________________ 
50. a). How many days per week do you usually take a nap after lunch?
_________ days per week
OR
I don’t take a nap after lunch (if so, you are finished the survey) 
b). If you nap after lunch three days per week or more often, how long do you usually nap for?  Please 
pick one option. 
Less than 30 minutes 
OR 
30 minutes or longer 
Thank you for completing this survey - 
377
Supplementary Material 6.2. MediCul index tool 
© Sue Radd-Vagenas, Advanced APD 2018.  
The MediCul tool may be used, reproduced and distributed without permission.  It should be made available 
free of charge to patients.  Written permission is required for any form of commercial or pharma use. 
Acknowledgement: Nuts for Life for image of handful of nuts www.nutsforlife.com.au; National Health and 
Medical Research Council for images of standard drinks of alcohol https://www.nhmrc.gov.au/health-
topics/alcohol-guidelines. 
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Supplementary Material 6.3. Kappa statistics for percent agreement within the same 
category of 17 MediCul elements between survey A and B
MediCul elements Percent (%)
agreement 
within same 
category
Kappa value Level of 
agreement
(Landis & Koch, 
1977)
1. Olive oil 66.2% 0.53 (p<0.0001) Moderate
2. Vegetables 44.1% 0.35 (p<0.0001) Fair
3. Fruit 82.4% 0.71 (p<0.0001) Substantial
4. Nuts 72.1% 0.61 (p<0.0001) Substantial
5. Wholegrains 98.5% 0.93 (p<0.0001) Almost perfect
6. Legumes 52.9% 0.27 (p=0.002) Fair
7. Fish/shellfish 76.5% 0.62 (p<0.0001) Substantial
8. Eggs 86.8% 0.66 (p<0.0001) Substantial
9. Dairy products 83.8% 0.46 (p<0.0001) Moderate
10. White meat preference 79.4% 0.63 (p<0.0001) Substantial
11. Red/processed meat 61.8% 0.51 (p<0.0001) Moderate
12. Sweets and sugary drinks 73.5% 0.50 (p<0.0001) Moderate
13. Takeaway 70.6% 0.39 (p<0.0001) Fair
14. Water 82.4% 0.74 (p<0.0001) Substantial
15. Alcohol 83.8% 0.79 (p<0.0001) Substantial
16. Coffee 97.1% 0.86 (p<0.0001) Almost perfect
17. Cuisine 41.2% 0.31 (p<0.0001) Fair
survey A, first administration of MediCul; survey B, second administration of MediCul.
Reference for interpretation of Kappa values
Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical 
data. Biometrics, 33(1), 159-174. doi:10.2307/2529310 
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CHAPTER SEVEN 
 
Discussion and conclusions 
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7.1 Overview and outcomes 
This thesis set out to improve understanding of the ‘traditional’ Mediterranean cuisine; 
investigate the relationship of a Mediterranean diet to cognitive health; and to advance 
the measurement of adherence to the ‘traditional’ Mediterranean dietary pattern and 
aspects of cuisine for use in future studies within Western populations. This final chapter 
discusses the key findings and their implications. It describes the contribution this thesis 
makes to the body of knowledge and delineates remaining gaps in the evidence base. 
 
7.1.1 Improved understanding of ‘traditional’ Mediterranean cuisine 
The findings in this thesis support the premise that the ‘traditional’ Mediterranean diet is 
more complex than just a list of foods – it is a cuisine rooted in a way of life (Trichopoulou 
& Lagiou, 1997; United Nations Educational Scientific and Cultural Organization, 2010; 
Wahlqvist, Kouris-Blazos, Trichopoulou, & Polychronopoulos, 1991). The 
Mediterranean diet terminology came into existence after the famous Seven Countries 
Study (SCS) (Hatzis, Sifaki-Pistolla, & Kafatos, 2015). Therefore, it is generally agreed 
that the archetypal ‘traditional’ diet relates to dietary intakes, as well as cooking and 
related lifestyle habits, from rural villages in Southern Italy and Crete, Greece, during the 
late 1950s and early 1960s. These cohorts from the SCS were found to have the lowest 
chronic disease risks. Their ‘traditional’ diet differed considerably from that of some other 
Mediterranean countries and time periods. For example, it included a higher intake of 
extra virgin olive oil and fish, and a relatively low meat intake facilitated by regular 
religious fasting from animal products (Hatzis et al., 2015).  
 
Chapter Two reviewed the evidence base and described the evolution of Mediterranean 
diets from ancient to ‘traditional’ and modern times. This was required as a broad range 
of definitions exist for the diet, impeding synthesis across trials. Confusion about the 
Mediterranean diet is also evident in the public domain. For example, a recently published 
consumer book, The Pioppi Diet (Malhotra & O'Neill, 2017), forbids eating bread and 
grain foods yet extols the virtues of coconut fat and recommends dark chocolate daily. 
This is a significant deviation from the ‘traditional’ Mediterranean diet of Pioppi, 
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Southern Italy, where Ancel Keys, who initiated the SCS from the University of 
Minnesota, eventually chose to reside. The ‘traditional’ Mediterranean diet has a solid 
biological foundation and does not represent a transient fashion (Trichopoulou & 
Vasilopoulou, 2000). 
 
Chapter Two confirmed the unprocessed, plant-based and frugal nature of the ‘traditional’ 
Mediterranean diet. It also identified some unique elements relating to ‘traditional’ 
cooking and eating habits. These elements have not been collectively studied or well 
characterised by previous diet index tools, but may provide synergies with the foods 
consumed. They include home cooked meals; use of moist, lower temperature, cooking 
methods; eating main meals in company; reduced snacking occasions; fasting practice; 
cultivation of a vegetable garden; use of traditional foods and food combinations; and 
napping after the midday meal.  
 
Therefore, this thesis has contributed to an improved understanding of the ‘traditional’ 
Mediterranean cuisine. Greater understanding of this cuisine may assist with future trial 
design, as it is often erroneously believed that any Mediterranean diet intervention 
represents the ‘traditional’ diet, which may have different health effects. It is also 
important for new tool development, or adaptation of existing tools, so that greater 
discernment is possible with other healthy plant-based dietary patterns.  
 
7.1.2 Evidence for cognitive benefits warranting additional trials 
Chapter Three described the results of the first systematic review on the effect of the 
Mediterranean diet on cognition and brain morphology and function, exclusively within 
randomised controlled trials. This review included a particular focus on the quality of 
interventions, and how the prescribed diets related to minimum food criteria for the 
‘traditional’ dietary pattern, which has not been done previously.  
 
The review found that the Mediterranean diets used in the included clinical trials varied 
considerably and did not necessarily represent the ‘traditional’ diet. It showed mostly 
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non-significant and small effect sizes of a Mediterranean diet on cognitive function, and 
no evidence for brain morphology or connectivity outcomes across the limited 
experimental evidence. However, the largest and most robustly-designed trial included in 
the review provided evidence for attenuation of cognitive decline over four years of 
ageing, compared to a healthy lower fat diet. This finding persisted, even with the recently 
published corrections within the original paper for a sub-cohort of this study (Valls-Pedret 
et al., 2015). Therefore, taken in conjunction with the considerable evidence from 
observational studies, this systematic review indicated great scope for additional clinical 
trials in this area. It has also contributed to the body of knowledge by providing detailed 
recommendations for methodological improvements in future trials.  
 
7.1.3 Development of a new empirically-based adherence tool  
Chapter Four reviewed the limitations of existing Mediterranean diet index tools. It also 
described the method for development of a new tool to address these limitations and 
assess adherence to the ‘traditional’ dietary pattern, Mediterranean foods and aspects of 
cuisine (e.g., limited snacking, fasting) within Western populations. While no currently 
available dietary assessment method is perfect or ideal for all circumstances, and 
difficulties remain in accurately assessing specific food intakes (e.g., vegetables), a diet 
index tool was selected as the best fit for purpose to assess the unique pattern and cuisine 
aspects previously missed by other tools. This novel tool was named Mediterranean Diet 
and Culinary Index (MediCul) to signify the inclusion of cuisine elements, some of which 
are novel.  
 
MediCul is a 50-item survey tool spanning 17 main dietary elements, within which foods 
and cuisine aspects have been categorised using professional judgement. These include 
nine desirable elements of the ‘traditional’ Mediterranean diet and four undesirable 
elements of a Western diet. A measure of exposure to non-traditional foods is important 
for a tool to be used within Westernised countries. MediCul is scored between 0 and 100 
with higher scores representing greater adherence to the dietary pattern.
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Importantly, the elements and cut-off points used in MediCul were informed by empirical 
data on the ‘traditional’ Mediterranean diet and cuisine (Chapter Two). Therefore, 
MediCul enables assessment of adherence to a ‘traditional’ Mediterranean dietary pattern, 
to provide greater discernment in future with other plant-based dietary patterns. A 
practical feature of MediCul is that a score for the popular Spanish Mediterranean Diet 
Adherence Screener (MEDAS) can also be derived. This may be useful for comparison 
with previous or future studies using this screener.  
 
A major contribution of this thesis is to make MediCul freely available online as 
Supplementary Material published in the British Journal of Nutrition, for use in research 
and education initiatives to help progress the field (Chapter Four). 
 
7.1.4 Tool validation in two cohorts for online and in-person use 
While most Mediterranean diet index scores are derived indirectly from a food frequency 
questionnaire (FFQ), scoring for MediCul is derived directly from the MediCul tool. This 
new tool has also been validated for online (Chapter Five) and in-person (Chapter Six) 
use and found to have very good reliability and moderate validity. This was done with 
two cohorts representing: a) middle-aged and older Australians having risk factors for 
cognitive decline, but no current diagnosis of dementia or neurodegenerative disease and, 
b) older Australians diagnosed with mild cognitive impairment (MCI). Therefore, 
MediCul has been tested and is suitable for use among middle-aged and older individuals 
within a Western country, including those at elevated risk of dementia. Although 
dementia has been identified as a global health priority (Shah et al., 2016) and mounting 
evidence suggests adoption of a Mediterranean diet may benefit cognition, to the author’s 
knowledge, no other published Mediterranean diet index tool, needed to assess adherence 
to the diet, has been validated for use within cognitively at-risk populations.  
 
In a systematic review of 28 Mediterranean diet indexes up until December 2015, the 
most deficient quality identified related to their test-retest reliability (Zaragoza-Martí, 
Cabañero-Martínez, Hurtado-Sánchez, Laguna-Pérez, & Ferrer-Cascales, 2018). 
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Chapters Five and Six of this thesis confirmed that MediCul has very good test-retest 
reliability in both cohorts studied as assessed by using intra-class correlation coefficients 
(ICC), Bland-Altman plots and Kappa agreement within the 17 main MediCul elements. 
While studies often report a Pearson’s correlation coefficient, a high correlation does not 
necessarily mean good agreement (Bland & Altman, 1986). The ICC is a more acceptable 
correlation coefficient because a pooled mean and standard deviation of the data is 
derived and used (Bountziouka & Panagiotakos, 2010). The ICC results obtained were 
similar for the two cohorts as can be seen in Table 7.1. Using Bland-Altman plots, which 
assess actual agreement, only a minor mean difference was identified between the scores 
at two time points. Across both studies, 95-97% of participants fell within or on the limits 
of agreement (LOA) representing ±2 standard deviations from the mean difference in 
scores. Also, there was no systematic bias detected across the two time points. Percent 
agreement within the same dietary element category ranged from almost perfect to fair, 
depending on the element, with no elements having poor agreement in either study.  
 
Table 7.1. Comparison of intra-class correlation coefficients (ICC) from two cohorts for 
test-retest reliability of the Mediterranean Diet and Culinary Index (MediCul) 
 ICC 
MYB cohort of healthy participants ICC=0.86, 95% CI: 0.789, 0.910, p<0.0001 
SMART cohort of MCI participants ICC=0·93, 95% CI: 0·884, 0·954, p<0·0001 
MYB, Maintain Your Brain study; SMART, Study of Mental and Resistance Training; 
MCI, mild cognitive impairment. 
 
Concurrent validity of MediCul was found to be moderate in both studies (Chapters Five 
and Six). The mean difference from the paired samples t-tests for MediCul scores from 
the new tool versus a 3-day food record (FR) was similar for the two cohorts as shown in 
Table 7.2. Both studies found the new tool overestimates the mean total MediCul score 
relative to a FR by 6% with similar LOA, ranging from under- and overestimates of 11 
to 25%, respectively. It is unknown whether the approximately 20 point maximum 
difference between the new tool and the FR derived MediCul score may be clinically 
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meaningful. However, a certain degree of disagreement can be expected when validating 
a tool reflecting usual intake against a reference tool of actual intake over a limited 
number of days (Cade, Thompson, Burley, & Warm, 2002). Despite being considered a 
‘gold standard’ method, food records may also under-report intake or include atypical 
days (Thompson & Subar, 2017). 
 
Table 7.2. Comparison of the mean difference from paired samples t-tests for 
Mediterranean Diet and Culinary Index (MediCul)* scores from the tool versus a 3-day 
food record (FR) in two cohorts  
(Mean differences and 95% confidence intervals (CI)) 
  Mean difference 
95% CI of the 
difference P value 
MYB cohort 
 
MediCul tool versus FR† 5.32 3.03, 7.62 <0.0001 
SMART cohort MediCul tool versus FR‡ 5.95 3.85, 8.05 <0.0001 
MYB, Maintain Your Brain study; SMART, Study of Mental and Resistance Training. 
*Represents first administration of MediCul to the study participants; †n=68; ‡n=65. 
 
Nevertheless, scores derived from the MediCul tool were closer to the reference method 
used in validity testing than what has been reported for MEDAS, a popular short screener 
(Schroder et al., 2011). When validated against a FFQ within a Spanish population, 
MEDAS was found to under- and overestimate scores by 43% and 53%, respectively. 
When validated against a FR within a UK cohort, the MEDAS tool under- and 
overestimated scores by 16% and 36%, respectively (Papadaki et al., 2018). By 
comparison, the MediCul index tool score deviations from the FR were only 11 to 25%.  
 
Validity of the MediCul tool was further tested indirectly by linear nutrient trends, which 
were observed in the expected direction for nutrients from the FR and tertiles of the 
MediCul score from the tool or FR (Chapters Five and Six). For example, in both studies, 
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saturated fatty acids as % fat and the unsaturated to saturated fat ratio from the FR, 
increased with increasing tertiles of MediCul score derived from both the tool and the FR. 
There was also good discrimination between the first and third tertiles of the MediCul 
score for the unsaturated to saturated fat ratio in both studies. Hence, a higher MediCul 
score reflects the more unsaturated nature of the fat in the Mediterranean diet, as 
compared to a Western diet. Finally, a higher MediCul score was associated with a higher 
quality diet, based on various nutrient trends and intakes of healthy and unhealthy foods. 
 
7.2 Limitations and strengths 
Certain limitations of this thesis deserve consideration. Dietary, brain, and 
cardiometabolic outcomes in relation to the MediCul tool are lacking to support predictive 
validity. However, these data were either unavailable or beyond the scope of the work 
possible for this thesis. Examination of some outcomes is already planned in other 
research. For example, the main Maintain Your Brain (MYB) study (Heffernan et al., 
2018), a 3-year randomised controlled trial with 6236 participants, will be utilising 
MediCul at baseline and annual follow up. This study will generate data for multiple 
outcomes, including chronic disease risk factors, which will be analysed in relation to 
MediCul scoring. 
 
Different modes of administration were used for the MediCul index tool in the two 
cohorts. The MediCul tool was administered in-person to participants from the Study of 
Mental and Resistance Training (SMART), allowing for greater engagement and the 
ability to ask questions of the dietitian and clarify meaning, whereas it was administered 
online to MYB participants, without a researcher present. Online use of MediCul may 
reduce accountability and the effort taken to carefully respond to questions. Further, for 
the MYB cohort, MediCul was administered as part of a suite of online surveys used in 
the MYB validation study. This may have caused fatigue and influenced the results. While 
dietitian administration of MediCul may be best for certain sub-groups, future research 
may be needed to directly compare in-person and online administration within the same 
individuals in order to investigate potential differences in scoring due to the mode of 
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administration. Therefore, until more information is available, only one mode of 
administration should be recommended within a single study or practice setting. 
It is unknown how well MediCul may perform across various MCI cohorts, as well as 
poorly educated or ethnically diverse groups. Individuals with MCI are a clinically and 
neuropathologically heterogeneous group (DeCarli, 2003). Hence, the SMART cohort 
investigated within this thesis may have responded better than some other MCI cohorts. 
While poorly educated individuals were not intentionally excluded, the included 
participants in both studies had more than primary school education, which may be the 
maximum education level in some other cohorts. The effect of ethnicity on response 
outcomes was also not studied. Although Australia is a multi-cultural society, the majority 
of volunteers for the validation studies were Caucasian, precluding any analysis of 
responses stratified by ethnicity. Future studies targeting multiple ethnic groups and 
geographical locations are necessary to determine the performance characteristics of 
MediCul within various populations. 
The participants involved in both validation studies consumed predominantly Western 
diets, as indicated by their moderately low MediCul scores (MYB=56.1/100.0; 
SMART=54.6/100.0) and poor compliance with thresholds for healthy Mediterranean 
foods. Hence, there was a relative lack of scoring for MediCul at the higher end. Although 
it was inevitable that some participants would score poorly for questions relating to foods 
atypical in the Australian diet, e.g., extra virgin olive oil, it may be expected that such 
scoring would increase during an intervention as participants learned to adopt the 
Mediterranean diet. Either way, it would be useful in future to test the performance of 
MediCul within a Mediterranean population as some participants would presumably 
achieve scores at the higher end. However, adherence to the Mediterranean diet has been 
declining in Mediterranean countries (León-Muñoz et al., 2012), although this trend may 
have stabilised in some regions (Bibiloni et al., 2017). A wider range of responses to 
MediCul may also be provided by Mediterranean migrants who have settled more 
recently in Australia. 
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The validity of a derived MEDAS score from the MediCul tool, which is not based on 
the ‘traditional’ Mediterranean diet discussed in this thesis but widely used in 
various geographical locations as it is a simple 14-item screener for a Mediterranean diet, 
was not tested as this was not an aim of the thesis. Interestingly, MEDAS scores 
derived from validated FFQs have previously been reported in relation to health 
outcomes without further validity testing (Alvarez-Alvarez et al., 2018; Livingstone et 
al., 2016).  
Finally, MediCul is not designed to assess nutrient intakes or broader lifestyle factors, 
such as the Mediterranean Lifestyle (MEDLIFE) index (Sotos-Prieto et al., 2014) or the 
Total Lifestyle Index (TLI) (Anastasiou et al., 2018), although it includes some cultural 
and lifestyle elements related to diet and eating behaviour. The total Mediterranean 
lifestyle may be even more important for health and wellbeing than the diet alone. 
Strengths of this thesis include a review of historical data sources to describe the 
‘traditional’ Mediterranean cuisine. Also, the use of a robust and pre-registered protocol 
to conduct the systematic review on the effect of the Mediterranean diet on cognition and 
brain morphology and function within clinical trials. This review has been published in 
a leading nutrition journal for wide knowledge dissemination (Radd-Vagenas et al., 
2018). 
It has been suggested that a more precise definition of the Mediterranean diet is needed 
to be able to find consistent health effects across studies (Struijk, Guallar-Castillón, 
Rodríguez-Artalejo, & López-García, 2018). Also, since all the features of the 
‘traditional’ cuisine may contribute to maintenance of cognitive function 
(Barberger-Gateau, Samieri, & Féart, 2015), that an attempt should be made to assess 
these. The new MediCul tool was developed using elements and cut-off points based 
on ‘traditional’ intakes, eating habits and cooking methods using professional 
judgement based on historical data rather than a posteriori statistical derivations, 
which may be population-specific and not reflect the ‘traditional’ diet. MediCul can 
therefore provide a more detailed and precise assessment of adherence to the 
‘traditional’ diet and aspects of cuisine, including elements not previously studied, 
compared to existing tools.
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MediCul is quicker to use as a tool than a typical FFQ but more comprehensive than a 
short screener. While short screeners may be useful to elicit behaviour change within 
interventions, they may not capture extreme levels of intake, leading to overestimation of 
associations with health outcomes (Panagiotakos, Pitsavos, & Stefanadis, 2006). When 
validated in an UK cohort, MEDAS was found to be limited in elements assessing 
exposures to common and harmful Western foods (Papadaki et al., 2018). Larger scale 
diet index tools may therefore provide increased diagnostic accuracy compared to smaller 
scale tools (Kourlaba & Panagiotakos, 2009). 
 
Compared to the Mediterranean Diet Score (MedDietScore) (Panagiotakos et al., 2006), 
which has mostly been calculated by extracting data from independent FFQs, use of the 
MediCul tool enables scores to be directly derived. Direct score derivation may avoid the 
introduction of errors with various assumptions needing to be made when converting data 
captured in a FFQ. Calculating a Mediterranean score directly from a tool that supplies 
the questions of interest has been associated with improved repeatability, whereas an 
indirectly calculated score could result in overestimation of adherence (Bountziouka et 
al., 2012). However, the use of FFQs to derive a Mediterranean diet adherence score is 
widespread. It is also unlikely to diminish in the near future given the availability of data 
sets from existing FFQs for secondary analysis and the popularity of certain FFQs for use 
in observational studies. Thus, indirectly derived Mediterranean diet adherence scores 
will continue to play a role but their limitations should be acknowledged.  
 
Finally, the use of two cohorts and two different modes of administration to test the 
reliability and validity of MediCul enhances the importance of the results and enables the 
tool to be used in future studies with people who have risk factors for dementia or a 
clinical diagnosis of MCI. 
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7.3 Implications 
Various plant-based dietary patterns (Hillesund, Bere, Haugen, & Øverby, 2014; Kwan 
et al., 2013; Martinez-Gonzalez et al., 2014; Morris et al., 2015; Willett et al., 2019) and 
those based on dietary guidelines (Croll et al., 2018; McCullough et al., 2002; Zang et al., 
2018) may be beneficial for healthier ageing, with less chronic disease, including for the 
brain. However, to date, most evidence exists to support a Mediterranean dietary pattern 
(Chen, Maguire, Brodaty, & O'Leary, 2019; Scarmeas, Anastasiou, & Yannakoulia, 
2018), although the ‘traditional’ Mediterranean diet has not been adequately studied. 
Therefore, a validated Mediterranean diet index tool, that has overcome common 
limitations of existing tools and assesses adherence to a ‘traditional’ dietary pattern and 
aspects of cuisine, could be useful and a timely contribution for future research, especially 
within Western countries.  
 
7.3.1 Future research 
Further trials are warranted on the effect of the Mediterranean diet in preventing cognitive 
decline as well as metabolic and morphological changes in the brain associated with 
dementia. These trials should include testing of the ‘traditional’ Mediterranean diet 
(Trichopoulou et al., 2014) as an intervention. Until more objective biomarkers of 
adherence to this diet and cuisine are available (Playdon et al., 2017), such as a 
Mediterranean food metabolome mentioned in Chapter Three, various outcomes could be 
examined in relation to changes in MediCul scoring, as has been done for the MEDAS 
screener (Valls-Pedret et al., 2015). Future studies should also further investigate the 
mechanisms of action for the Mediterranean diet as discussed in Chapter Three, 
particularly in relation to the microbiome (Jin et al., 2019). 
 
The MediCul tool may be attractive for multi-domain interventions incorporating the 
Mediterranean diet, in order to reduce participant and researcher burden since multiple 
assessments are required in such studies. In addition, while many Mediterranean diet 
index tools have been developed specifically for epidemiological purposes (Vitale et al., 
2019), MediCul may be utilised in both clinical and observational settings.
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7.3.2 Public health and clinical significance 
While more research on the Mediterranean diet is required before conclusive statements 
can be made in relation to brain health, this diet is already relevant within public health 
and clinical settings. It is promoted by the Australian and other dietary guidelines 
(National Health and Medical Research Council, 2013; US Department of Health and 
Human Services and US Department of Agriculture, 2015) as a healthy eating pattern to 
reduce chronic disease risk, which increases with age, based on high level evidence for 
cardiovascular disease (National Health and Medical Research Council, 2013). It is 
therefore reasonable for clinicians to recommend it to improve vascular risk factors for 
dementia (Zhao et al., 2018). Indeed, the World Health Organization has most recently 
started promoting a Mediterranean-like diet for risk reduction of cognitive decline and 
dementia (World Health Organization, 2019). 
 
The Mediterranean diet has also been identified as being of particular significance for 
older people and an ageing population, such as in Australia, since the confirmed benefits 
are relevant to key areas of morbidity (Nowson, Service, Appleton, & Grieger, 2018) and 
survival (Bonaccio et al., 2018). In a meta-analysis of seven prospective studies of older 
people, a one-point increase in the Mediterranean diet score used was associated with a 
5% (range: 4-19%) lower risk of overall mortality (Bonaccio et al., 2018). According to 
the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Ageing, higher 
adherence to a Mediterranean diet may also help maintain brain health in cognitively 
normal older people by slowing down the rate of amyloid pathology accumulation 
(Rainey-Smith et al., 2018).  
 
Notably, the middle-aged and older participants included in both validity studies within 
this thesis did not have high adherence to this dietary pattern, based on their MediCul and 
derived MEDAS scores. Also, few reached ‘traditional’ Mediterranean intake thresholds 
for protective foods and food combinations, such as extra virgin olive oil, legumes, fruit 
and sofrito. It is well-known that Australians eat an unhealthy Western diet, confirmed 
recently by another government report (Australian Institute of Health and Welfare, 2018). 
Yet Western diets are associated with increased risk of cognitive decline and dementia. 
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In one study of people aged 65 years and older, a Western dietary pattern was associated 
with an 8-fold increase in cognitive decline over eight years (Tsai, 2015). In another 
longitudinal community study of older people from Australia, a Western dietary pattern 
was associated with a smaller left hippocampal volume (Jacka, Cherbuin, Anstey, 
Sachdev, & Butterworth, 2015). This finding is concerning since the hippocampus is 
important for memory and learning and one of only two areas within the brain where adult 
neurogenesis occurs, with the left hippocampus being particularly prone to 
neurodegeneration. Such findings present an opportunity for nutrition education utilising 
the Mediterranean diet to reduce chronic disease risk generally, and possibly preserve 
brain structure and slow the rate of cognitive decline among middle-aged and older adults 
with ageing. 
 
Therefore, development of Mediterranean food guidelines for brain health (Scarmeas et 
al., 2018) and practical instructions such as cooking lessons (Martinez-Gonzalez, 
Hershey, Zazpe, & Trichopoulou, 2017) may be beneficial for the increasingly ageing 
Australian and world population. Preserving cognition for as long as possible is crucial 
because age-related cognitive decline, even without clinical symptoms or progression to 
dementia, is associated with increased mortality risk, falls with serious injury (Muir, 
Gopaul, & Montero Odasso, 2012) and decreased quality of life (Pusswald et al., 2015).  
 
Importantly, evidence exists that the Mediterranean diet is transferable to Australians 
(Murphy & Parletta, 2018). This includes men with coronary heart disease representing 
multiple ethnicities (Mayr, Tierney, Kucianski, Thomas, & Itsiopoulos, 2019). A 
Mediterranean eating pattern is also feasible for adoption by older people (Martinez-
Gonzalez et al., 2017; Yannakoulia et al., 2018), and those with MCI and dementia 
(Hassan et al., 2018). The provision of Mediterranean meals could be of interest in the 
care of individuals with Alzheimer’s disease (AD) as higher adherence to the 
Mediterranean diet has been associated with better survival in AD (Opie, Ralston, & 
Walker, 2013). In one study from Spain, participants with AD were found to have poor 
adherence to the diet, despite residing in a Mediterranean country (Rocaspana-García, 
Blanco-Blanco, Arias-Pastor, Gea-Sánchez, & Piñol-Ripoll, 2018). While cost may be a 
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perceived barrier, the data suggest a Mediterranean diet is no more expensive (Lara et al., 
2015), or even cheaper than a typical Australian diet (Chatterton et al., 2018; Opie et al., 
2015). It could also offer a good return on investment to manage chronic disease using 
group sessions, such as Mediterranean cooking workshops (Segal et al., 2018). 
 
Finally, the MediCul tool may be useful to help train individuals to increasingly adopt 
Mediterranean eating habits by providing feedback on current choices. It could be 
integrated into electronic medical records (Rasmussen et al., 2018), or practice software, 
to screen patients who should be routinely referred to a dietitian if they have a low 
MediCul score. This could save on assessment time by clinicians so that 
consultations/group sessions can focus more on dietary education.  Tools that evaluate 
adherence in patients may also indirectly benefit health professionals through a learning 
effect. In another study from Spain, primary care physicians were found to have poor 
adherence to the Mediterranean diet (Sentenach-Carbo et al., 2018), which is also likely 
to be the case for health professionals in Western countries. Additionally, MediCul could 
be transformed into a web-based or mobile application to provide personalised feedback 
in real time with dietary tips, recipes and menus. Such an application of the MediCul tool 
could likewise be utilised in clinical trials (Cattaneo et al., 2018). 
 
7.4 Conclusions 
Promotion of lifestyle interventions for healthy brain ageing is critical since there is no 
pharmacologic treatment to prevent, delay or reverse the course of dementia. This thesis 
has identified promising scope for the Mediterranean diet as a treatment modality based 
on a systematic literature review, warranting additional, well-designed trials to examine 
the relationship between the Mediterranean diet and brain health. In particular, the 
‘traditional’ diet should be further studied as this was originally associated with the lowest 
rates of chronic disease. The thesis has improved understanding of ‘traditional’ 
Mediterranean cuisine, underpinning the development of a novel diet index tool called 
MediCul that has overcome common limitations of existing tools. MediCul provides 
comprehensive assessment of adherence to the ‘traditional’ dietary pattern, including 
important and unique Mediterranean foods and cultural/lifestyle aspects related to eating 
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that have previously been missed, to enable greater discernment also with other types of 
plant-based dietary patterns. MediCul has been tested in two Western cohorts at increased 
risk of dementia, for online and in-person administration, and shown to be suitable for 
use among such populations that have previously been poorly studied within clinical 
settings, with respect to a Mediterranean diet and cognition. This new tool is now freely 
available for future research and education purposes. It is already being used in the large 
Maintain Your Brain (MYB) study for examination of the role of implementing this 
dietary pattern to attenuate cognitive decline over time. Availability of validated tools 
such as MediCul may advance understanding of the role of diet in healthy brain ageing, 
which is urgently required.  
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Background:
The Mediterranean diet is beneficial for 
health and used in research and clinical 
practice.  It is associated with a reduced 
risk of chronic disease, including CVD, 
cancer and neurodegenerative disease and 
increased survival.1
However, this dietary pattern has proven 
difficult to define as it is surprisingly 
complex and varies between countries and 
time periods.  Variations exist in 
definitions provided by educational tools 
such as Mediterranean diet pyramids and 
index tools used to measure adherence to 
this diet.
Aim:
The aim of this study is to describe the ‘traditional’ 
Mediterranean diet and identify additional elements 
relating to cuisine and eating habits not covered by 
existing educational and index tools.
Method:
• We conducted a literature review of Mediterranean 
diet definitions, including seminal research studies 
such as the Seven Countries Study and educational 
and index tools.2
• Papers were sourced from nine databases searched 
for a systematic review on a related topic from 
inception to July 2015.
• The definition of the Mediterranean diet in the 
Candidature Dossier submitted to United Nations 
Educational, Scientific and Cultural Organization 
(UNESCO) was also reviewed.3
Results:
• Mediterranean diet definitions vary in the literature 
and focus mostly on the relative proportion of 
characterising foods.  Disparities exist in the 
criteria, cut offs and scoring system used by 
common Mediterranean diet pattern index tools.
• Most researchers agree the ‘traditional’ 
Mediterranean diet is a plant-based dietary pattern
common to the olive growing regions of the 
Mediterranean documented in the late 1950s and 
early 1960s on the island of Crete, Greece and 
rural villages in Southern Italy such as Nicotera, 
which were part of the Seven Countries Study.2
• This pattern is high in fruits, vegetables, cereals, 
legumes, nuts/seeds and extra virgin olive oil; 
moderate in fish/shellfish and red wine; and low in 
meat, dairy, eggs and animal fats.
• UNESCO supports a broader definition of the 
Mediterranean diet incorporating culinary practices 
and consumption habits since ‘diet’ (diaita) in the 
Greek language means a ‘way of life’. 
• We identified additional elements of the traditional 
Mediterranean diet, which have not been
consistently or collectively documented in previous 
tools.  See Table 1.
Table 1: Elements of the traditional Mediterranean diet 
absent in existing tools
• The recently updated Mediterranean diet pyramid 
considers a wide range of lifestyle elements but 
this educational tool does not emphasise the 
potentially important role of type of cooking 
methods, fasting habits and ownership of a home 
garden.  See Figure 1.
• Existing Mediterranean diet pattern index tools have 
been used in observational studies and clinical trials 
to assess the effect of dietary patterns on disease 
outcomes but most only include criteria relating to 
specific foods and, in some cases, nutrients. 
• Mediterranean Diet Adherence Screener (MEDAS) 
used in the landmark PREDIMED trial is an 
advanced version of earlier tools incorporating 
elements of cuisine.  However, it measures a limited 
number of traditional foods and does not assess 
frequency of home cooked meals, cooking methods, 
eating in company, snacking occasions, fasting, 
home garden use and napping.5 See Table 2.
Table 2: Components assessed in the 14-point MEDAS tool
• MEDLIFE is the most holistic index tool identified, 
based on the updated Mediterranean diet pyramid. 
However, it lacks the same elements as the 
educational tool which it is based on.6
Conclusions:
The traditional Mediterranean diet is much broader 
than just a collection of foods.  It includes a cuisine 
with unique recipes and cooking methods and other 
psycho-social factors that may additionally impact on 
food and nutrient intake.  Scope exists for improved 
educational and index tools for use by researchers and 
clinicians.  Existing tools should be reviewed to 
incorporate broader elements of the Mediterranean 
‘way of life’ that may influence dietary adherence 
and/or provide independent health effects.
References:
1. Sofi F et al. (2014) Mediterranean diet and health status: an updated meta-analysis and a 
proposal for a literature-based adherence score. Public Health Nutr, 17:2769-2782. 
2. Kromhout D et al. (1989) Food consumption patterns in the 1960s in seven countries. Am J
Clin Nutr, 49:889-894. 
3. UNESCO (2010) Convention for the safeguarding of the intangible cultural heritage.
www.unisob.na.it/ateneo/c002/unesco_nomination_file_rl2010.pdf
4. Bach-Faig A et al. (2011) Mediterranean diet pyramid today. Science and cultural updates.
Public Health Nutr, 14:2274-2284. 
5. Schroder H et al. (2011) A short screener is valid for assessing Mediterranean diet
adherence among older Spanish men and women. J Nutr, 141:1140-1145. 
6. Sotos-Prieto M et al. (2014) Design and development of an instrument to measure overall 
lifestyle habits for epidemiological research: the Mediterranean Lifestyle (MEDLIFE) index.
Public Health Nutr, 18:959-967.
Practices relating to cuisine and eating
1. Frequent intake of home cooked meals
2. Moist, lower temperature, cooking
methods
3. Eating main meals in company
4. Reduced snacking occasions
5. Regular fasting
6. Home garden to grow vegetables
7. Use of unique traditional foods
8. Napping after the midday meal
Figure 1: Updated Mediterranean diet pyramid, Mediterranean 
Diet Foundation, Barcelona, Spain4
Did you know?
The Mediterranean diet is the only 
dietary pattern protected by UNESCO. 
In 2010, UNESCO recognised the 
Mediterranean diet as an Intangible 
Cultural Heritage.
1. Olive oil asmainfat
2. Oliveoilquantity
3. Vegetables
4. Fruit
5. Red&processedmeat
6. Butter,margarine&cream
7. Sugarydrinks
8. Wine
9. Legumes
10. Fish/seafood
11. Sweets
12. Nuts
13. Whitemeatpreference
14. Sofrito
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Background
Every 3 seconds somebody in the world 
dies from dementia.  Dementia is a leading 
cause of death and disability without 
treatment to prevent, slow or reverse its 
course.  Observational studies suggest 
plant-based diets may benefit cognition.  In 
particular, a Mediterranean (Med) style diet 
has been associated with a reduced risk of 
cognitive decline, dementia, mild cognitive 
impairment (MCI), conversion of MCI to 
dementia and a reduced risk of mortality 
among those with Alzheimer’s disease.  
Aim
To perform the first published systematic review, 
to our knowledge, of randomized controlled trials 
(RCTs) investigating the effects of a Med diet on 
cognition or brain morphology/function, with 
additional focus on how interventions relate to the 
‘traditional’ Med dietary pattern, which was 
predominantly plant-based.
Method
• Search: 9 databases (inception to Dec 2017), using 
pre-defined protocol registered with PROSPERO.
• Inclusion: RCT design or post-test comparisons 
within an RCT; Med diet compared to alternate diet; 
10 days duration; any aspect of cognition or brain 
morphology/function.
• Exclusion: acute exposures; single foods; partial 
Med diet.
• Quality: modified PEDro scale + 7 additional 
indicators, including 19 elements describing the 
‘traditional’ Med diet.
• Statistics: between group Effect Sizes (ESs).
Results – study characteristics
Table 1. Study characteristics at baseline
Conclusions
1. Inconsistent empirical evidence exists for
significant benefits of a Med diet for
cognitive function across trials.
2. No empirical data has been reported for
brain morphology.
3. But significant and clinically meaningful
ESs have been found for cognitive domain
composites in the most robustly designed
trial (PREDIMED).
4. Further well designed RCTs are required to
test the effect of a ‘traditional’ Med diet
(high plant to animal ratio) using
standardized neuropsychological tests,
biomarkers and neuroimaging.
5. In the absence of treatment/cure for
dementia, reducing lifestyle and metabolic
risk factors takes on added importance.
6. The Med diet is already proven to reduce
vascular risk factors and primary CVD, and
recommended by various dietary guidelines
as a healthy eating pattern to prevent and
better manage chronic disease.Figure 1: PRISMA flow diagram of study selection procedure
Results – brain morphology/function
• No studies reported brain morphology
outcomes.
• Post-test comparison at 3 years in
PREDIMED found a 78% reduced risk of
low plasma BDNF – a neuroplasticity
biomarker – in the Med diet group.
Study Study design & 
duration 
n (% F) Mean 
age (y) 
(SD)
Cognitive 
status at
baseline
Health status Comparative 
condition/s
1. Wardle (2000), 
Britain
Parallel, 12 wk 176 
(52)
53.01 
(10.1)
Not specified CV risk: total 
ĐŚŽůĞƐƚĞƌŽůшϱ͘ϮŵD
Waiting list & 
ǆƉĞƌŝŵĞŶƚĂů
low fat diet 
2. McMillan 
(2011), Australia
Parallel, 10 d 25 
(100)
21.10 
(3.3)
Not specified Healthy Usual diet
3. PREDIMED sub-studies (2011-2015)
- Sanchez-
Villegas (2011), 
Spain 
Post-test
ĐŽŵƉĂƌŝƐŽŶ at 3 y
243 
(51)
67.85 
(6.0) 
Not specified CV ƌŝƐŬ͗ƚǇƉĞϮDŽƌ
шϯŵĂũŽƌsƌŝƐŬ
factors
Low fat diet 
- Martinez-
Lapiscina 
(2013a), Spain 
Post-test
ĐŽŵƉĂƌŝƐŽŶ at 6.5 y
285 
(55)
67.34 
(5.7) 
Not specified CV ƌŝƐŬ͗ƚǇƉĞϮDŽƌ
шϯŵĂũŽƌsƌŝƐŬ
factors
Low fat diet
- Martinez-
Lapiscina 
(2013b), Spain 
Post-test
ĐŽŵƉĂƌŝƐŽŶ at 6.5 y
522 
(55)
67.38 
(5.7)
Not specified CV ƌŝƐŬ͗ƚǇƉĞϮDŽƌ
шϯŵĂũŽƌsƌŝƐŬ
factors
Low fat diet
- Martinez-
Lapiscina (2014), 
Spain 
Post-test
ĐŽŵƉĂƌŝƐŽŶ at 6.5 y
522 
(56)
67.00 
(6.0)
Not specified CV ƌŝƐŬ͗ƚǇƉĞϮDŽƌ
шϯŵĂũŽƌsƌŝƐŬ
factors
Low fat diet
- Valls-Pedret 
(2015), Spain 
Parallel, 4.1 y 447 
(51)
66.73 
(5.5)
EŽƌŵĂů CV ƌŝƐŬ͗ƚǇƉĞϮDŽƌ
шϯŵĂũŽƌsƌŝƐŬ
factors
Low fat diet
4. Lee (2015), 
Australia
Cross-over, 10 d 24 
(100)
25.60 
(5.1)
EŽƌŵĂů Healthy Usual diet
5. Knight (2016), 
Australia
2-cohort parallel, 
24 wk
166 
(53)
72.10 
(5.0)
EŽƌŵĂů Healthy Usual diet
Results - cognition
• Analyses based on 66 cognitive tests
(n=1888) from 5 included studies.
• Only 8/66 (12.1%) of individual outcomes at
trial level were significant in favour of Med
diet [ESs ranged from small (0.32) to large
(1.66)]; 2/66 favoured control.
• Data limitations precluded a meta-analysis.
• Two studies reported composite z scores for
8 domains with all 3/8 from PREDIMED
being significant:
• Memory (ES=0.39 for Med Nuts),
• Frontal cognition (ES=1.02 for Med EVOO
& 0.72 for Med Nuts),
• Global cognition (ES=1.29 for Med EVOO
& 1.12 for Med Nuts).
• Post-test comparison at second PREDIMED
site showed mixed results for diet-gene
interactions and cognition at 6.5 years.
Results – study quality
• 0RGHUDWHRYHUDOOZLWKVWXGLHVVFRULQJ
on modified PEDro scale (range: 4-8/10).
• The Mediterranean diets varied considerably
between studies, and in important ways,
including a) mentioning b) advising a quantity
and c) meeting minimum criteria for key
elements that describe the ‘traditional’ dietary
pattern (Table 1). Y=yes; N=no.
Table 2.  Examples of variable intervention elements
Element Wardle (2000) McMillan (2011) PREDIMED Study Lee (2015) Knight (2016)
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Olive oil N N N N N N Y Y Y N N N Y Y Y
Nuts N N N Y N N Y Y Y Y N N Y Y Y
Legumes N N N N N N Y Y Y N N N Y Y N
Veges Y N N Y N N Y Y Y Y N N Y Y Y
Fruit Y N N Y N N Y Y Y Y N N Y Y Y
Grains N N N Y N N N N N N N N Y Y Y
Fish Y N N Y N N Y Y Y Y N N Y Y Y
Water N N N N N N N N N N N N N N N
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title or abstract
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Reliability and validity of MediCul (Mediterranean Diet & Culinary Index) in older Australian 
adults
Radd-Vagenas, S1, Fiatarone Singh, MA1,2, Daniel, K1, Noble, Y1, O’Leary, F3, Mavros, Y1,
Brodaty, H4 and Flood, VM1,5
1 The University of Sydney, Physical Activity, Lifestyle, Ageing and Wellbeing Research Group, 
Faculty of Health Sciences, Lidcombe, NSW, Australia
2 Hebrew SeniorLife and Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts 
University, Boston, MA, USA
3 The University of Sydney, Nutrition and Dietetics Group, School of Life and Environmental 
Science, Faculty of Science & The Charles Perkins Centre, Camperdown, NSW, Australia
4 Centre for Healthy Brain Ageing, University of New South Wales, Sydney, NSW, Australia
5 Western Sydney Local Health District, Westmead Hospital, Westmead, NSW, Australia
A Mediterranean diet has been associated with multiple health benefits for chronic 
disease. Yet no index tool has been developed for, and/or validated in, a Western 
population to assess adherence to the ‘traditional’ dietary pattern and aspects of cuisine. 
We aimed to test the reliability and validity of the 50-item MediCul among older 
Australian adults. Participants were recruited January to March 2017 from the 45 and Up 
Study, as part of the Maintain Your Brain validation study, completing MediCul online 
on two occasions. Reliability was assessed using the intraclass coefficient (ICC) and 
Bland-Altman plots. Validity was tested against a 3-day food record (FR) using the 
Research Food Diary app. Participants (n=84; 59.5% female) were aged 65.4 years 
(SD=5.9) and overweight (BMI 26.1; SD=4.0). Mean MediCul scores at two time points 
(n=74) were 55.9/100.0 and 56.5/100.0, respectively. MediCul had very good reliability 
according to the ICC (ICC=0.87, 95% CI: 0.796, 0.914, p<0.0001) and Bland-Altman 
plots. For validity, the Bland-Altman indicated MediCul over-reported the score by 5.4 
points versus FR, but with no indication of systematic bias (y=8.46-0.06*x) (95% CI: -
0.275, 0.155, p=0.582). MediCul has very good reliability and moderate validity for 
assessing adherence to a ‘traditional’ Mediterranean pattern among older adults.
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Abstract:33
Background: Maintain Your Brain (MYB) is a randomized controlled trial of an online multi-modal lifestyle intervention
targeting modiﬁable dementia risk factors with its primary aim being to reduce cognitive decline in an older age cohort.
34
35
Methods: MYB aims to recruit 8,500 non-demented community dwelling 55 to 77 year olds from the Sax Institute’s 45 and
Up Study in New South Wales, Australia. Participants will be screened for risk factors related to four modules that comprise
the MYB intervention: physical activity, nutrition, mental health, and cognitive training. Targeting risk factors will enable
interventions to be personalized so that participants receive the most appropriate modules. MYB will run for three years and
up to four modules will be delivered sequentially each quarter during year one. Upon completing a module, participants will
continue to receive less frequent booster activities for their eligible modules (except for the mental health module) until the
end of the trial.
36
37
38
39
40
41
42
Discussion: MYB will be the largest trial to attempt to prevent cognitive decline and potentially dementia. If successful,
MYBwill provide a model for not just effective intervention among older adults, but an intervention that is scalable for broad
use.
43
44
45
Keywords: Alzheimer’s disease, clinical trial, cognitive decline, cognitive training, dementia, depression, non-
pharmacological, physical activity, nutrition, randomized controlled trial
46
47
Trial registration: ACTRN 12618000851268. Registered on the Australian New Zealand Clinical Trials Registry (http://
www.anzctr.org.au).
48
49
INTRODUCTION33
Dementia affects approximately 44 million peo-34
ple worldwide [1] and assuming the status quo is35
projected to expand to over 136 million by 205036
[1, 2]. Globally, it is a leading cause of disability37
with costs estimated to exceed 800 billion dollars38
[1]. In the next 40 years, these costs are projected39
to exceed those of all other chronic diseases [3]. In40
light of the modest efﬁcacy of symptomatic drugs for41
Alzheimer’s disease and the lack of success in tri-42
als of disease-modifying medications, interventions43
to delay onset and possibly prevent dementia have44
gained momentum [4]. Given that dementia has a45
multifactorial etiology, multi-domain interventions46
are arguably more likely to be effective in delay-47
ing onset [5, 6]. However, evidence for the beneﬁts48
of multiple combined interventions such as physical49
activity and cognitive training is limited [7, 8].50
In the FINGER (Finnish Geriatric Intervention51
Study to Prevent Cognitive Impairment and Dis-52
ability) trial a multi-modal intervention (physical53
activity, diet, and cognitive training) was effective54
at reducing cognitive decline in a group of 60 to55
77 year olds at risk of dementia and with average56
or below cognitive scores [9]. Two other trials, the57
Multidomain Alzheimer Preventive Trial (MAPT)58
and the Prevention of Dementia by Intensive Vas-59
cular care (PreDIVA), reported encouraging results60
in post-hoc or subgroup analyses [10, 11]. Impor-61
tantly, a limitation of both FINGER and PreDIVA62
was their requirement for clinic attendance that63
would restrict large scale deployment should positive64
results on clinically meaningful outcomes be found. 65
Internet delivered interventions have the potential 66
to overcome some of the limitations of traditional 67
face-to-face interventions, in that the former are scal- 68
able, can reach geographically isolated individuals, 69
are convenient (e.g., can be undertaken at home), and 70
are cost effective. 71
We therefore designed an internet-delivered multi- 72
domain preventative intervention—Maintain Your 73
Brain (MYB)—to target multiple risk factors for 74
dementia in general and AD in particular. Tar- 75
geted risk factors are physical inactivity, sub-optimal 76
dietary patterns, cognitive inactivity, depression, anx- 77
iety, and health-related issues implicated in dementia 78
risk such as overweight, obesity, excess alcohol con- 79
sumption, smoking, and chronic health conditions. 80
The MYB program is organized into four differ- 81
ent modules—Physical Activity, Nutrition, Peace of 82
Mind. and Brain Training—each of which is cus- 83
tomized to a person’s individual risks. MYB builds 84
upon previous trials but introduces novel elements 85
and state-of-the-art concepts in mode of delivery and 86
behavioral change theory to make it unique. Other 87
advantages of MYB are that it is comprehensive 88
in addressing risk factors and it will be one of the 89
ﬁrst prevention trials to address depression. Modules 90
are also responsive to individual participant progress 91
rather than a one-size-ﬁts-all approach. The program 92
will initially deploy interventions sequentially and 93
then build up booster sessions over time, minimiz- 94
ing the possibility of interference or over-dose effects 95
[12, 13]; it introduces innovations in computer-based 96
cognitive training including insights from gaming, 97
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remote supervision, social support, and coaching98
when required. Finally, the randomized controlled99
trial (RCT) will be larger than previous studies allow-100
ing for sub-analyses of subsidiary questions101
MYB aims to: 1) in the short term, develop102
a new MYB digital platform that delivers multi-103
modal, personalized, and sequential modules that104
target dementia risk factors via the Internet; 2) in the105
medium term, evaluate the efﬁcacy of the MYB dig-106
ital platform to reduce the rate of cognitive decline107
in non-demented community dwelling persons aged108
55 to 77 years; 3) to examine the impact on reduc-109
tion in risk factors, improvement in speciﬁc module110
targets (physical activity, nutrition, depression, indi-111
vidual cognitive domains); and4) evaluate the relative112
cost effectiveness of the platform.113
The primary hypothesis of MYB is that over114
three years of intervention participants engagingwith115
coaching (intervention) modules on the MYB digi-116
tal health platform will have less cognitive decline117
than the information only control group. Secondary118
hypotheses are that there will be less incident all-119
cause dementia than the control group; a relationship120
between intervention ﬁdelity (compliance and adher-121
ence) and cognitive outcomes; there will be less122
categorical cognitive impairment in the intervention123
group compared to the control; dementia risk proﬁle124
will improve signiﬁcantly more in the intervention125
group; and such a risk proﬁle improvement will cor-126
relate with better cognitive outcomes.127
METHODS128
Design129
MYB is an online single-blind randomized con-130
trolled trial (Australian New Zealand Clinical Trials131
Registry ACTRN 12618000851268) of a person-132
alized, multi-modal intervention designed to target133
modiﬁable risk factors for Alzheimer’s disease and134
dementia. Risk factors to be addressed include135
physical inactivity, poor diet, cognitive inactivity,136
depression/anxiety, and chronic diseases and habits137
(alcohol, smoking) linked to dementia risk. Up to138
four intervention modules (physical activity, nutri-139
tion, peace of mind, and brain training) will be140
administered based on individual risk proﬁles. Each141
module will be initially delivered using the MYB142
digital platform over 10 weeks. In the ﬁrst year of143
the RCT, participants will complete their assigned144
modules sequentially, noting that the total number145
of modules varies depending on the respective indi-146
vidual’s risk factors. In practice, this will translate 147
to a minimum of two modules and a maximum of 148
four modules. Upon completing a module, booster 149
sessions (speciﬁc to each module) and ongoing mon- 150
itoring will then continue for up to three years. 151
Follow-up assessments measuring these risk factors 152
and cognition will be completed annually for three 153
years. The control group (“information” group) will 154
receive basic psychoeducation about dementia risk 155
factors accessed through the MYB digital platform. 156
Set activities will be organized by corresponding 157
module eligibility and also themed into the same 158
modules of physical activity, nutrition, peace ofmind, 159
and brain training. Control participants will not be 160
receiving anymodule-related tailored advice (i.e., the 161
“coaching” component in intervention). They will 162
otherwise undertake the same enrolment, baseline 163
and annual follow-up assessments. An overview of 164
participant ﬂow through the trial is provided in Fig. 1. 165
Owing to the nature of the intervention, par- 166
ticipants and research staff involved in delivering 167
modules will not be blind to allocation. However, 168
the MYB digital platform is an automated system 169
with all activities and assessments delivered elec- 170
tronically without researcher intervention (unless a 171
participant has requested to be withdrawn or for 172
safety). Researchers responsible for analyses will be 173
blinded to group allocation and analyses will be com- 174
pleted (as much as possible) without the use of data 175
that may incidentally unblind the analysis (e.g., mod- 176
ule allocation, types of completed activities). 177
Setting 178
MYB is online and all study procedures will be 179
delivered andmanaged via theMYBdigital platform. 180
Participants will access all trial materials and associ- 181
ated help by logging into the MYB digital platform. 182
Personalized activities, with due dates, reminders, 183
andprogresswill be available through this online plat- 184
form.MYBwill be supportedby a teamof researchers 185
who will provide technical assistance to participants. 186
Each module is led and supported by experienced 187
researchers with relevant expertise in delivering their 188
respective interventions. 189
Recruitment and selection of participants 190
Participants will be recruited from the Sax Insti- 191
tute’s 45 and Up Study [14]. From January 2006 to 192
December 2009, men and women from the general 193
population of New South Wales (NSW), Australia 194
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Fig. 1. MYB trial ﬂowchart.
were sampled through the Department of Human195
Services (formerly Medicare Australia) database196
and joined the study by completing a postal ques-197
tionnaire. Participants provided written informed198
consent for follow-up through repeated contact and199
linkage to population health databases. A total of 200
267,153 people, about 1 in every 10 NSW men and 201
women aged over 45, are participating in the 45 202
and Up Study, making it the largest ongoing study 203
of healthy aging in the Southern Hemisphere. Now 204
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8–11 years after recruitment, participants are aged205
53 years and up. The 45 and Up Study is among206
the most heterogeneous large-scale cohort studies207
internationally, with participants from diverse socio-208
demographic, geographic, and cultural backgrounds,209
which will increase the likelihood that any cogni-210
tive effects or risk reduction observed in the trial are211
generalizable to other populations.212
Invitations will be sent by the 45 and Up Study213
electronically and by mail to potential MYB par-214
ticipants. Participants will not receive both types of215
invitations. AsMYB, being fully online, requires par-216
ticipants to have an email address to be able to login217
and receive notiﬁcations; electronic invitations will218
be prioritized over physical mail. Invitations sent by219
email or mail will be identical, except that a unique220
registration link cannot be sentwith the physicalmail.221
Participants receiving mailed invitations will need222
to enter an email address to be able to receive the223
unique registration link. All subsequent registration224
procedures will be identical.225
Participants will be eligible to receive invitations if226
they are enrolled in the 45 and Up Study, have agreed227
to be contacted about further studies, are aged 55 to228
77 years on the ﬁrst day of the year recruitment com-229
mences, do not have dementia, Parkinson’s disease,230
or multiple sclerosis (based on available 45 and Up231
records) and did not participate in any previousMYB232
validation or pilot studies.233
Participants who provide consent and register on234
the MYB digital platform will complete a brief235
screening tool developed for the MYB trial. Par-236
ticipants will be excluded if they: do not respond237
to the invitation (one reminder may be sent); are238
unwilling or unable to access trial tasks on the239
MYB digital platform; are involved in another inter-240
vention trial involving exercise, brain training, diet,241
depression/anxiety treatment, or any drug/nutritional242
supplement trial; do not have home internet or243
computer access (desktop or laptop); have vision244
problems which prevent them from reading a com-245
puter screen or are otherwise unable to use a246
mouse/keyboard without assistance; have a life247
threatening condition; have any dementia, Parkin-248
son’s disease, or multiple sclerosis; have ever been249
prescribed amedication used to treatAlzheimer’s dis-250
ease; have been hospitalized overnight (≥24 h) more251
than 6 times in the past 12 months; report having had252
a stroke or heart attack in the previous 3months; have253
been diagnosed with brain cancer; have any form of254
current malignancy other than cancer that has been in255
remission for at least 5 years (and does not currently256
require continuing chemotherapy), or non-metastatic 257
prostate or skin cancer; have ever been diagnosed 258
with bipolar disorder or schizophrenia; have severe 259
depression (Patient HealthQuestionnaire [15], PHQ9 260
total score >19); report having suicidal intent (PHQ-9 261
item 9 >1 and Beck Depression Inventory [16] item 262
9 >1); are unable to write/converse in English; do not 263
have at least two unique risk factors and are not eligi- 264
ble for at least two modules (risk factors determined 265
after baseline assessment). 266
Participants who are eligible for the trial will then 267
complete baseline assessments used to assess their 268
risk factors and module eligibility. Participants will 269
be enrolled if they complete all baseline assessments 270
(by the MYB start date) and have at least two unique 271
risk factors and are eligible for at least two modules. 272
Randomization 273
Participants who provide informed consent, meet 274
trial inclusion criteria and none of the exclusion cri- 275
teria, and complete all baseline assessments will be 276
enrolled in the trial. Participants agreeing to be in 277
MYB will be randomized (1:1 allocation ratio) using 278
the minimization technique [17] based on the follow- 279
ing stratiﬁcation variables: 280
• Age (55–65 years; 66–77 years) as of 281
01/01/2018 282
• Gender (male, female) 283
• Dementia risk as measured by Australian 284
National University Alzheimer’s Disease Risk 285
Index Short Form [18] (tertiles total risk score) 286
• Module eligibility (1module; 2modules; 3mod- 287
ules; 4 modules) 288
Per the minimization technique, a weighted- 289
coefﬁcient variable is used to assign the participants 290
within each proﬁle into intervention and control 291
groups (1:1 allocation ratio). Randomization will 292
occur after baseline assessments have been com- 293
pleted and therefore after module eligibility has 294
been determined. We will conceal allocation with 295
randomization performed centrally by a computer- 296
ized process and activities are then automatically 297
delivered to participants through the MYB digital 298
platform. 299
Module eligibility 300
Participants who are otherwise eligible for the trial 301
will be assessed for module eligibility using baseline 302
assessments (i.e., prior to randomization). Eachmod- 303
419
Un
co
rre
cte
d A
uth
or
 P
ro
of
6 M. Heffernan et al. / Maintain Your Brain protocol
ule is designed to address a known dementia risk and304
therefore criteria are unique to each of the modules305
(see below). Module rules are built into the MYB306
platform and applied automatically. Researchers can-307
not override this pre-set decision algorithm except in308
cases of safety where participants may be removed309
from a module should they reveal, as the trial pro-310
gresses, a new health issue not disclosed or present311
at baseline, or they withdraw consent.312
Participants with only one unique risk factor and313
hence eligible for less than two modules will be314
allowed to enter in MYB, however, only participants315
with at least two unique risk factors and eligible for316
at least two modules will be included in the planned317
primary MYB analyses. This means if a participant318
has only one risk factor, such as high blood pressure,319
which makes them eligible for two modules (such320
as physical activity and nutrition) they will not be321
included in the primary analysis.322
Individual module eligibility323
Physical activity (PA)324
Participants will be eligible for the PA module325
based on health conditions identiﬁed in the Aus-326
tralian National University Alzheimer’s Disease Risk327
Index Short Form (ANU-ADRI-SF [18, 19], medical328
history (MYB Medical History), and MYB Physi-329
cal Assessment battery (includes measures of body330
composition, Harvard Alumni Questionnaire [20],331
International Physical Activity Questionnaire [21]332
sitting, and Virtual Short Physical Performance Bat-333
teryProtocol [22]).Risks identiﬁed include low levels334
of physical activity (aerobic and/or resistance train-335
ing), high levels of sitting, high blood pressure,336
dyslipidemia, diabetes, heart related issues, stroke,337
transient ischemic attack (TIA), high body mass338
index (BMI), high waist circumference, and active339
smoking status. Participants will be excluded from340
the PA module (but not the trial) if they report341
any health concerns that would make continuing342
in this module unsafe. This includes being advised343
not to exercise by a health professional, worsening344
angina in the previous three months, angina at times345
other than moderate to vigorous activity, unrepaired346
aneurysms and 12 or more seizures in the previous347
12 months.348
Nutrition349
Participants will be eligible for the Nutrition mod-350
ule based on health conditions identiﬁed in the MYB351
Medical History or a dietary assessment using the352
Mediterranean Diet and Culinary Index (MediCul). 353
Medicul is a newly created diet assessment for the 354
Mediterranean diet [23] from which a score for the 355
Mediterranean Diet Adherence Screener (MEDAS) 356
[24] is also derived.MEDASwas selected as it is used 357
inPREDIMED(Prevencio´n conDietaMediterra´nea), 358
the largest clinical trial on the Mediterranean diet, 359
and has been associated with cognitive outcomes 360
[25, 26]. A MEDAS score of nine or less indi- 361
cates low adherence with a Mediterranean dietary 362
pattern. Other risks identiﬁed include high blood 363
pressure, high cholesterol, diabetes, heart related 364
issues, stroke, TIAs, peripheral vascular disease, 365
BMI, waist circumference, and excessive alcohol 366
consumption. 367
Peace of mind 368
Participants who currently meet probable criteria 369
for unipolar depression and/or an anxiety disorder as 370
assessed by their total Patient Health Questionnaire 371
(PHQ-9) [15] and/or Generalized Anxiety Disorder- 372
7 (GAD-7) [27] scores; and/or report having been 373
diagnosed and/or treated for unipolar depression 374
or their anxiety during their lives (MYB Medi- 375
cal History) will be eligible for the “ThisWayUp 376
Mixed Depression and Anxiety” course (e.g., see 377
https://thiswayup.org.au). 378
Brain training 379
Participants will be eligible for Brain Training 380
based on years of education (ANU-ADRI-SF), or 381
lower than average late life mental activity (Life 382
Experiences Questionnaire, LEQ late life subscale 383
subthreshold [28]) or mental activity during mid-life 384
(LEQ midlife sub scores subthreshold). 385
Sequencing of modules 386
The order that participants will receive modules 387
is determined by a pseudo-random process (Sup- 388
plementary Material 1). This process is carried out 389
automatically by the MYB digital platform once a 390
participant has completed all baseline assessments, 391
module eligibility has been determined and prior to 392
randomization. 393
Interventions 394
Coaching (intervention) 395
The MYB intervention comprises up to four 396
10-week modules delivered quarterly in the ﬁrst 397
12 months of the trial, with monthly boosters 398
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for modules where appropriate thereafter. These399
modules are Physical Activity, Nutrition, Peace of400
Mind, and Brain Training. All procedures described401
will be accessed through the MYB digital plat-402
form. All modules will begin with a brief module403
expectations questionnaire and end with a brief ques-404
tionnaire measuring participants’ appraisal of the405
module.406
Physical activity (PA)407
The basic PA prescription is designed to increase408
aerobic and resistance training to levelswith a demon-409
strated positive impact on cognition and other health410
outcomes [29, 30]. Where feasible, the module will411
support progression to higher exercise intensities412
as this is linked to improved risk reduction, ﬁtness413
outcomes and cognition in observational and exper-414
imental studies [31, 32]. In addition, daily balance415
training exercises and information on smoking ces-416
sationwill be included. A behavioral change program417
[33] is integrated within the PA module by providing418
personalized goals and feedback, and by encouraging419
activity logging.420
The PA module is fully online and provided421
through the PA portal on the MYB digital platform.422
All goals, feedback, and materials (e.g., videos, fact-423
sheets) are arranged around three exercisemodalities:424
aerobic exercise, resistance training, and balance425
training. Information is provided to support achieve-426
ment of the long-term goal of 300min/week of427
moderate to vigorous intensity aerobic activity, three428
days/week of vigorous intensity progressive resis-429
tance training, and challenging balance training every430
day. Behavioral change is integrated within the mod-431
ule through updating feedback and goals. These are432
personalized based on activity logged by the partici-433
pant (weekly self-report via Short Physical Activity434
Assessment). Feedback is responsive to both partic-435
ipants who are improving (for example, providing436
updated goals) and participants who are not pro-437
gressing or are regressing. If a lack of progression is438
detected, the module will direct participants to infor-439
mation on barriers and how to overcome them, as440
well as how exercise can be modiﬁed for pain or441
injury. Participants are also encouraged to use the442
online Action Plan to write how their goals will be443
achieved. Feedback on progress is displayed to par-444
ticipants visually (via a virtual “staircase”) for each445
of the three exercise modalities. Short term goals446
and feedback will follow the general approach of447
starting exercise at low frequencies and intensities448
for those not currently exercising and then reaching449
the target volume within the ﬁrst month. Once the 450
desired volume is reached, intensity goals will be 451
addressed aiming to reach these by the end of the 452
10-week module. Progression from moderate to vig- 453
orous aerobic and resistance training activities will be 454
encouraged as feasible based on their logged behav- 455
ior which includes modality, volume, frequency, and 456
perceived intensity (Borg Scale of Perceived Exer- 457
tion). Participants will be encouraged to add dual 458
tasking to their balance exercises once they have 459
achieved daily balance practice and reached the most 460
challenging level of each exercise. Balance intensity 461
is advanced by gradual reduction of hand support 462
and visual input during static and dynamic exercises. 463
After the initial 10 weeks of the intervention, booster 464
or “refresher” sessions will be added. Booster ses- 465
sions are identical to module activities but occur less 466
frequently (every four weeks for up to three years 467
follow-up) to allow internalization of monitoring and 468
progression. 469
All materials are developed by qualiﬁed exercise 470
physiologists and/or physiotherapists and provided 471
on theMYBdigital platform.Content can be accessed 472
as many times as the participant wishes and will also 473
cover topics related to behavioral change, chronic dis- 474
eases, relapse prevention, progression, variety, and 475
long-term adherence. All materials can be updated, 476
removed, and new materials added. The PA module 477
is designed to be self-administered, with participants 478
able to engage with materials in their own time. 479
During the module and follow-up, participants will 480
also be able to contact “module trainers” (qualiﬁed 481
exercise physiologists or physiotherapist) with ques- 482
tions or issues related to the module. This contact 483
will initially be via the online interface, with follow- 484
up contact as appropriate (e.g., email and phone). 485
Module trainers will also update “Frequently asked 486
questions” factsheets for triaging common problems 487
and questions arising during exercise adoption, refer 488
participants to their GP for suspected exercise-related 489
or other injury, recurrent falls, potential medication- 490
related side effects, or instability /progression of 491
underlying chronic diseases such as osteoarthritis, 492
angina, etc. 493
The PA module will be adjusted if a participant 494
reports being diagnosed with osteoporosis, or a high 495
number of falls in the past 12months, or scores poorly 496
in the virtual Short Physical Performance Battery 497
(vSPPB) [22] by removing any goals and feedback 498
related to aerobic exercise as walking may increase 499
risk of falls until strength and balance are improved 500
[34, 35]. During annual assessments, participants 501
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could be reallocated to the main PA module if appro-502
priate. Initially, baseline assessments will be used503
to exclude any participant from PA owing to safety504
concerns (for example, being advised by a medical505
professional not to exercise). Participants who are506
eligible for PA at baseline may subsequently report507
a health concern that requires adjustment to their PA508
module. The aerobic component of the module can509
be removed based on pre-set rules applied automati-510
cally by the MYB digital platform (for example too511
many reported falls). Their PA module can also be512
temporarily blocked (or ‘unblocked’ if recovered) on513
a case-by-case basis by qualiﬁed PA module staff514
(e.g., clinicians and exercise physiologists). For any515
health-related concern that is not planned or reported516
via the MYB platform, researchers may inform the517
MYB administrator to remove participants from the518
module entirely.519
Physical activity logged via the Short Physical520
Activity Assessment (weekly in the ﬁrst 10 weeks,521
then monthly) will be used to measure PA/sedentary522
behavior levels during themodule. Theseweekly log-523
ging tasks, email notiﬁcations about new tasks aswell524
as intermittent newsletters will be used to support525
adherence to the module. Whether a participant com-526
pletes activity logs and action plans, and how many527
times they visit the PA module can be used to assess528
engagement with the module.529
Nutrition530
The Nutrition module is designed to encourage531
adoption of a Mediterranean diet acknowledged in532
dietary guidelines as a healthy eating pattern for533
chronic disease [36, 37]. The rationale for this diet534
is based on its relevance to risk factors for cognitive535
decline and RCT and prospective cohort data for a536
Mediterraneandiet [38–41].At this time, theMediter-537
ranean diet appears to be the most strongly supported538
dietary pattern for cognitive beneﬁts in clinical trials539
[41].540
The Nutrition module is fully online and pro-541
vided through the Nutrition portal on the MYB542
digital platform. All dietary messages, feedback,543
and materials (such as cooking videos, meal plans,544
recipes, shopping lists, health tips, factsheets, and545
behavioral change resources) are arranged around546
10 food groups (discretionary foods, animal pro-547
tein, extra virgin olive oil, nuts, vegetables, fruit,548
legumes, wholegrains, ﬁsh and seafood, and water)549
within the Mediterranean diet to provide smaller550
manageable targets for change. The Nutrition portal551
provides a visual display of the Mediterranean diet552
that participants are aiming to achieve (via an ideal 553
“Mediterranean diet food pyramid”) based on their 554
self-reported food intake. Food intake will be via the 555
MiniCul, a screener form of the MediCul [23] that is 556
used to prompt behavior change within the module. 557
The components of theMediterranean diet food pyra- 558
mid will be completed in sections, with personalized 559
messages and feedback provided for food groups 560
that require improvement.Althoughpersonalized, the 561
overall approach of dietary messages and feedback is 562
to target the most poorly scored and crucial changes 563
ﬁrst. Additionally, participants will only receive a 564
manageable number of changes each week (maxi- 565
mum four messages). If a participant does not make 566
any changes for two weeks (as measured by weekly 567
online food intake logging), messages will move onto 568
other poorly scored food groups and cycle back to 569
the unchanged groups if time is available. There- 570
fore, even a participant who needs to make changes 571
across all 10 food groups but shows no change in 572
their weekly log, will receive advice and recommen- 573
dations for all food groups. If a participant reaches 574
the ‘ideal’ Mediterranean diet food pyramid they 575
will be encouraged to maintain their Mediterranean 576
diet. 577
The initial Nutrition module is delivered over 10 578
weeks during the ﬁrst 12months ofMYB. During the 579
ﬁrst 10 weeks participants are encouraged to log their 580
adherence to the Mediterranean diet weekly (self- 581
report via MiniCul). Participants are also encouraged 582
to ﬁll out a weekly action plan for how they will 583
improve theirMediterranean diet score for each of the 584
suggested food changes. After the initial 10 weeks of 585
intervention, booster sessions will be added. Proce- 586
dures and materials for booster sessions are identical 587
to the initial Nutrition module. However, booster 588
sessions and therefore diet logging will occur less 589
frequently (every 4 weeks). 590
All materials are designed by qualiﬁed dietitians 591
and can be accessed as many times as the par- 592
ticipant wishes. Materials include recipes, videos, 593
shopping lists, and factsheets. Topics covered by 594
these materials will be related to the recommended 595
diet as well as areas such as behavioral change, sci- 596
entiﬁc literature, special dietary considerations and 597
food allergies, intolerances and drug interactions. All 598
materials can be updated, removed,and newmaterials 599
can be uploaded by the Nutrition module staff (i.e., 600
qualiﬁed dietitians). 601
The Nutrition module is designed to be self- 602
administered with participants able to engage with 603
the materials in their own time. During the module 604
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and follow-up, participants will also be able to605
contact “module trainers” (qualiﬁed dietitians) with606
questions or issues related to the module. This607
contact will initially be via the online interface, with608
follow-up contact as appropriate (e.g., email and609
phone). Module trainers will also provide updates to610
“Frequently asked questions” and refer participants611
to a GP if necessary.612
There are two planned modiﬁcations to the Nutri-613
tion module based on alcohol consumption and being614
underweight. If participants report a high rate of615
alcohol consumption, diet messages related to alco-616
hol will be prioritized and remain until participants617
report a reduced alcohol intake. Participants report-618
ing low body weight will receive modiﬁed advice619
that encourages adapted serving sizes compared to620
the main Nutrition module. After the 10-week inter-621
vention, such participants could be reallocated to622
the main Nutrition module if goals are achieved.623
Likewise, participants receiving the main Nutrition624
module could be reallocated to the modiﬁed alcohol625
or underweight Nutrition module after the 10-week626
intervention if appropriate. These modiﬁcations are627
pre-set and the rules are applied automatically by628
the MYB digital platform. For any other diet-related629
concerns, such as medical advice not to alter their630
diet, researchers may remove participants from the631
module entirely if it becomes unsafe for them to con-632
tinue. However, there is ﬂexibility to allow for food633
preferences, ﬁnancial circumstances, special dietary634
requirements, food allergies, intolerances, and ethnic635
backgrounds.636
The MiniCul is used weekly in the ﬁrst 10637
weeks, then monthly, to track progress with adopt-638
ing a Mediterranean diet during the intervention.639
In addition, self-reported body measurements (waist640
circumference, weight) are also checked during641
this module. Weekly email reminders to complete642
MiniCul and intermittent newsletters to support643
adherence to the module are also provided. Engage-644
ment with the Nutrition module is tracked by the645
number of completed MiniCuls, action plans to646
achieveMediterranean goals and the number of times647
participants login.648
Peace of mind649
Participants who are currently depressed and/or650
anxious; and/or have ever been diagnosed/treated651
for depression and/or anxiety will have access to652
the “ThisWayUp Mixed Depression and Anxiety”653
course. This course has been developed by the654
Clinical Research Unit for Anxiety and Depression655
(CRUfAD) at UNSW/St Vincent’s Hospital and the 656
efﬁcacy and effectiveness of the program reported 657
previously [42–44]. During the module, participants 658
will be able to contact CRUfAD staff with clinical 659
and technical questions. 660
The Mixed Depression and Anxiety course 661
includes six lessons delivered over 10 weeks. These 662
lessons include: 1) Psychoeducation about anxiety 663
and depression, identifying symptoms, the ﬁght or 664
ﬂight response, controlled breathing and physical 665
activity/exercise; 2) Cognitive therapy components: 666
education about the cognitive model, cognitive dis- 667
tortions, and introduction to thought monitoring; 668
activity planning; 3) Thought challenging/cognitive 669
restructuring; challenging positive & negative meta- 670
cognitive beliefs about repetitive thinking; shifting 671
attention, hunt for positives; 4) Education about 672
avoidance and safety behaviors; graded expo- 673
sure and structured problem solving; 5) Advanced 674
graded exposure (imaginal exposure, interoceptive 675
exposure); troubleshooting difﬁculties with graded 676
exposure; and 6) Relapse prevention. There are 677
no boosters associated with the Peace of Mind 678
module. 679
Participants’ completion of each lesson will be 680
used to assess adherence to the module. During 681
the module, participants will complete measures of: 682
psychological distress at the start of each lesson 683
(Kessler Psychological Distress Scale, K10) [45]; 684
and depression (PHQ-9) [15] and anxiety symp- 685
tom severity (GAD-7) [27] prior to lessons 1, 4, 686
and 6. 687
Brain training 688
Participants with an at-risk cognitive proﬁle will 689
be eligible for the Brain Training module. Partici- 690
pants will complete a personalized cognitive training 691
program that is vertically and horizontally adap- 692
tive called the “Brain Training System” (BTS). That 693
is, the training regimen is deﬁned on participant’s 694
baseline cognitive proﬁle and continues to evolve in 695
response to within-training task performance. Indi- 696
vidual cognitive exercises are run as Flash ﬁles as 697
provided by our commercial partner (Synaptikon, 698
trading as NeuroNation, Germany); more than 30 699
are available at the outset and will be supplemented 700
throughout the trial. BTS has otherwise been orig- 701
inally designed, including the approach to exercise 702
selection, streaming, feedback, coaching, and social 703
support. 704
A participant’s cognitive proﬁle is generated 705
based on cognitive tests completed at baseline. 706
423
Un
co
rre
cte
d A
uth
or
 P
ro
of
10 M. Heffernan et al. / Maintain Your Brain protocol
These proﬁles will rank performance across cogni-707
tive domains (i.e., verbal executive, speed, verbal708
memory, visual executive, visual memory, visual709
attention) in descending order. The initial exercise710
selection and streaming order will reﬂect this proﬁle,711
preferentially targeting areas of weakness in the mid-712
dle of the session. Exercise selection and streaming713
will be recalibrated during training several times, in714
this case based on degree of improvement on exer-715
cises at the domain-level.716
Exercises will be presented as three sessions per717
week, translating to 30 sessions over 10 weeks.718
Each session will last 45 minutes and comprise 17719
exercises. If participants miss sessions, they will720
remain available until completed. During follow-up,721
booster exercises will be offered once a month (up722
to three years follow-up). Cognitive training mate-723
rials (e.g., factsheets) will also be provided and724
can be accessed as many times as the participant725
wishes.726
After completing the ﬁrst ﬁve sessions, partic-727
ipants will receive a feedback performance graph728
that summarizes their cognitive performance on729
each cognitive domain trained thus far. This perfor-730
mance graph will also indicate the range of scores731
for the top 25% performers in the module based732
on previous sessions. Participants’ individual per-733
formance will be updated after completing each734
session and the top 25% range will be updated735
weekly.736
In order to maximize adherence and motivation,737
BTS will deploy several socialization and gaming738
strategies. This includes access to an online Trainer,739
prioritized for participants ‘red-ﬂagged’ as strug-740
gling with engagement or performance. Video chat741
will be preferred for these interactions, but partici-742
pants will also be able to contact module trainers via743
MYB’s online interface. Participants can also nomi-744
nate friends or family members who will be advised745
via email when the participant reaches certain adher-746
ence milestones, with the aim of providing social747
support and encouragement and establishing a com-748
munity of practice.749
TheBrain Trainingmodule is therefore designed to750
be automatically adaptive to a participant’s baseline751
score and progress during training. Safety issues are752
not foreseen for this module.753
Participants will receive email notiﬁcations when754
a new activity is available as well as when perfor-755
mance problems are noted to support adherence. The756
Brain Training module will measure within-exercise757
improvement, domain-level performance changes,758
program adherence (completed sessions) and social 759
platform engagement. 760
Information (Control) 761
Participants in the control group will receive basic 762
health information organized in the same module 763
topics as the intervention (Physical Activity, Nutri- 764
tion, Peace ofMind, andBrain Training). Participants 765
will have access to these information-based modules 766
based on their module eligibility and in a pseudo- 767
random order as described in the previous section. 768
Although control participants receive modules based 769
on their individual risk proﬁle they will not be pro- 770
vided with any tailored advice (i.e., the ‘coaching’ 771
intervention component) about how to improve their 772
risk factors. The control group will receive infor- 773
mation monthly for up to four 10-week modules in 774
the ﬁrst 12 months. All procedures described will be 775
delivered online and accessed through the MYB dig- 776
ital platform. All modules will begin with a brief 777
module expectations questionnaire and end with a 778
brief questionnaire measuring participants’ appraisal 779
of the module. 780
For the Physical Activity, Nutrition, and Peace of 781
Mind control modules, the information provided will 782
be focused on existing health guidelines and gen- 783
eral advice for achieving these targets. For example, 784
providing the Australian Dietary Guidelines from 785
the Australian Government Department of Health 786
and Ageing without specifying how participants can 787
achieve these guidelines. The Brain Training control 788
module will involve a brief task (such as showing 789
videos with a brief quiz). These tasks have been used 790
in previous trials and have been shown to be enjoyable 791
with minimal impact on cognition [46]. Participants 792
will access the 10-week modules via the MYB dig- 793
ital platform with new module information or tasks 794
provided once a month. Upon completing the Physi- 795
cal Activity, Nutrition, and Brain Training modules, 796
these activities are then reduced to quarterly (i.e., 797
boosters) for up to three years follow-up. As with 798
intervention, there will be no boosters for the Peace 799
of Mind module. 800
The control group will receive periodic emails 801
reminding them to login to the MYB digital 802
platform to access module information. All partic- 803
ipants in a control module will receive the same 804
basic health information or task (with no tailored 805
advice). However, they may be removed from a 806
module for safety reasons (e.g., a previously undis- 807
closed/undiagnosed health issue that might prevent 808
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safe exercise). Engagement with the module can809
be measured by the amount of times a partici-810
pant logs into the MYB eHealth platform and the811
amount of times they visit the module information812
webpage.813
Outcome measures814
Primary outcome815
The primary outcome is change in cognition from816
baseline to three years. We will test whether the817
groups show differential change over the trial as818
indicated by the group by time interaction. In addi-819
tion, we will test the group difference at three years820
as a planned comparison. The outcome variables821
are the global cognition composite domain scores,822
at baseline and three years, as measured by the823
MYB online cognitive test battery (“MYB Battery”).824
Domains and tests inMYBaredeﬁned as: 1)Complex825
attention (Cogstate Detection and Cogstate Identiﬁ-826
cation); 2) Executive Function (Cogstate One Back,827
Cambridge Brain Sciences Spatial (Tokens) Search828
andCambridgeBrain SciencesGrammatical Reason-829
ing); and 3) Learning and Memory (Cogstate One830
Card Learning and Cambridge Brain Sciences Paired831
Associates). Two valid test scores per domain are832
required to generate a participant’s domain score at833
each time point. Individual test scores will be con-834
verted to standard scores (z-scores) using the means835
and standard deviations (SD) of the MYB baseline836
sample. Domain scores will be calculated by ﬁrst837
averaging the z-scores of the component tests, and838
then transforming the composite scores using the839
means and SDs of the MYB baseline sample. A840
global cognition score will be calculated by aver-841
aging across the three standardized domain scores,842
and then the score will be similarly transformed to z-843
scores using the means and SDs of theMYB baseline844
sample.845
Secondary outcomes846
Secondary outcomes related to cognitive impair-847
ment and dementia are: 1) incident deme tia at three848
years; 2) change in dementia risk (ANU-ADRI-SF849
total score); and 3) using the method described for850
the primary outcome, change in cognitive domain851
scores and individual cognitive tests that form the852
MYB Battery as well as LOGOS.853
Dementia in MYB will be determined according854
to the following:855
• Participants are screened for dementia at base- 856
line via self-report questions. However, if 857
baseline dementia is subsequently identiﬁed dur- 858
ing baseline assessment via any of the processes 859
below, participants will be retrospectively cen- 860
sored as they cannot meet the deﬁnition of 861
incident dementia. 862
• Dementia is assumed if there is any self-reported 863
dementia to MYB via the medical history 864
questionnaire (diagnosis or dementia medica- 865
tions), stated as a reason to withdraw from 866
the trial, or it is otherwise reported to MYB 867
that dementia has been conﬁrmed by a medical 868
professional. 869
• If there is no self-report, dementia will be 870
assumed if linked data contain any of the fol- 871
lowing: 872
◦ Pharmaceutical Beneﬁts Scheme (PBS) 873
claims for dispensing of Alzheimer’s dis- 874
ease medications (donepezil, galantamine, 875
or rivastigmine or memantine). 876
◦ Dementia listed as a diagnosis in hospital 877
records. 878
◦ Dementia listed as a cause of death in mor- 879
tality records. 880
• If none of the above indicates dementia, DSM-5 881
criteria [47] requiring cognitive impairment and 882
functional impairment will be applied. 883
◦ Cognitive impairment is measured by the 884
MYB Battery and an additional auto- 885
mated telephone-based verbal memory test 886
(LOGOS), developed and validated for 887
MYB. 888
◦ Cognitive impairment is deﬁned as≥2 SD 889
below the mean of the baseline sample on 890
any individual test (stratiﬁed for age, sex, 891
education) OR≥1.5 SD below the mean of 892
the baseline sample in≥1 domain. (strati- 893
ﬁed for age, sex, education). 894
◦ Functional impairment is deﬁned by the 895
Amsterdam-Instrumental Activity of Daily 896
Living-Short Form (A-IADL-SF; cut-off is 897
less than 51.4 [48]). 898
• If there are no cognitive data, dementia will be 899
“undetermined”. 900
• If there is evidence for cognitive impairment 901
(deﬁned above) but no data on function, partic- 902
ipants will be classiﬁed as “impaired cognition, 903
function undetermined”. 904
Secondary outcomes related to the overall impact 905
of the intervention and participant experience are: 1) 906
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service utilization identiﬁed through routinely col-907
lected linked data: hospital admissions, emergency908
department presentations, medical and social care909
services, and prescribed medications; 2) costs of pro-910
gram as determined by quality adjusted life years911
(QALYs) based on MYB used resources (e.g., staff912
time) and intervention effect; 3) change in module913
expectations as measured by the Module Expecta-914
tions questionnaire (total; adapted from Rabipour &915
Davidson [49]); 4) compliance with the intervention916
and for each module undertaken (percentage activi-917
ties complete and accessed per module; MYB digital918
platform login data); and 5) number of adverse events919
reported toMYB via the medical history and medical920
events forms. Events include hospitalizations,muscle921
soreness and food allergies.922
Secondary outcomes related to risk factors targeted923
by the four module interventions are: 1) change in924
waist circumference and BMI if overweight/obese925
(self-report inMYBPhysicalActivity questionnaire);926
2) change in level of physical activity (HAQ energy927
expenditure, stair climbing, walking. IPAQ sitting928
time and volume and intensity of aerobic exercise,929
resistance training, and balance exercise/week); 3)930
new chronic conditions (count based on medical his-931
tory andmedical events forms); 4) change in physical932
functional performance during the PA module as933
measured by the virtual Short Physical Performance934
Battery Score; 5) change in adherence to theMediter-935
ranean diet (MediCul score and derived MEDAS936
score); 6) change in exposure to foods/culinary prac-937
tices assessed via MediCul; 7) change in alcohol938
(self-report in ADRI-SF and MediCul) and smoking939
status (self-report in ADRI-SF); 8) change in within940
task cognitive training performance in the Brain941
Training module (percentage correct per session);942
9) change in mental activity levels (LEQ late-life943
subscale); 10) engagement during Brain Training944
module (count use of social platform); and 11) change945
from baseline to three years in psychological distress946
(K10).947
Data management948
Electronic ﬁles collected by MYB that are not949
linked data will be stored on a secure server. The des-950
ignated MYB data custodian (MYB Data Manager)951
will be responsible for maintaining data security and952
assigning access controls. MYB has implemented953
a role-based access mechanism that controls the954
access to research data. TheMYB platform can allow955
authorized researchers, responsible for the day-to-956
day running of the trial, to access information needed957
for tasks such as responding to participant enquiries, 958
while ensuring trial-wide clinical data are not acces- 959
sible through the same pathway. 960
Assessments and linked data 961
MYB assessments to be completed by all partici- 962
pants (self-report), module speciﬁc assessments and 963
data sources for linked health data are summarized 964
in Table 1. Medicare Beneﬁts Schedule (MBS) and 965
Pharmaceutical Beneﬁts Scheme (PBS) data will be 966
accessed from the Department of Human Services 967
(DHS) and linkage completed by the Sax Institute 968
using a unique identiﬁer that was p ovided by DHS. 969
Other linkage data (Table 1) will be performed by 970
the Centre for Health Record Linkage (CHeReL, 971
www.cherel.org.au) using probabilistic record link- 972
age techniques and ChoiceMaker software. 973
Statistics 974
Sample size 975
Wewill have 80%power to detect signiﬁcant group 976
by time interaction in the MYB Battery primary out- 977
come, assuming linear change and a ﬁnal difference 978
of 0.1 SD if we have 1,714 people in each group 979
(total N = 3,428) with type 1 error rate of 0.05. This 980
assumes a within-subjects correlation of 0.6 and a 981
Lear deterioration rate of 0.1. If we assume a 20% 982
drop out rate over the trial, we will need to recruit 983
at least 2,143 people in each arm. With 2,143 par- 984
ticipants per arm (4,285 in total), we will also have 985
80% power to detect differences of at least 0.1 SD for 986
continuous secondary outcomes. 987
Sample size estimates were obtained using 988
GLIMMPSE 2.0.0 [50] and G*Power 3.1 [51]. MYB 989
has the capacity to enroll up to 16,000 persons if it is 990
oversubscribed. 991
Analysis 992
Participants with at least two unique risk fac- 993
tors and eligibility for two modules or more will 994
be included in the MYB analysis. The trial will be 995
reported in accordance with the CONSORT guide- 996
lines. We will analyze all outcomes by the arm to 997
which participants were allocated (i.e., intention to 998
treat analyses).Wewill analyze the primary outcome, 999
change in cognition, using linear mixed models to 1000
examine the treatment group by time interaction and 1001
will obtain a test of the difference between the groups 1002
at the end of the trial. We will also conduct anal- 1003
yses adjusting for baseline demographic variables; 1004
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Table 1
MYB assessments and timing of administration
Assessment/data source Measures Timing
MYB Eligibility 1a Trial eligibility Screening only
ANU-ADRI SF Dementia risk Baseline and annual follow-up
MYB Batteryb Cognitive ability Baseline, every 3 months in the ﬁrst 12
months and then annually
LOGOSc Verbal memory Baseline, every 3 months in the ﬁrst 12
months and then annually
Medical History Baseline Medical history Baseline only
Medical History Follow-up Medical history Annual follow-up
Physical Assessment batteryd Body composition, physical
activity, sitting time and
functional mobility performance
Baseline and annual follow-up
MediCul and derived MEDASe Dietary pattern Baseline and annual follow-up
Wellbeingf Psychological distress,
depression and anxiety
Baseline and annual follow-up
LEQ Cognitive lifestyle Baseline only
LEQ– Late life Late life subscale of LEQ Annual follow-up
A-IADL SF g Daily function Baseline and annual follow-up
Module Expectations Module expectations Pre/post modules only
Medical Events form Adverse events Every 3 months
Short Physical Activity measure (HAQ) Weekly physical activity Intervention Physical Activity module only -
module baseline and weekly during the
module; monthly during follow-up
MiniCul, weight and waist circumference Weekly nutrition Intervention Nutrition module only - module
baseline and weekly during the module;
monthly during follow-up
K10 Psychological distress Intervention Peace of Mind module only -
start of each lesson (6 over 10 weeks)
PHQ-9 Depression Intervention Peace of Mind module only -
start of lessons 1, 4 and 6
GAD-7 Anxiety Intervention Peace of Mind module only -
start of lessons 1, 4 and 6
Medicare Beneﬁts Schedule (MBS)h Primary health care service use Available data at baseline to follow-up
Pharmaceutical Beneﬁts Scheme (PBS)h Prescribed medicines Available data at baseline to follow-up
NSW Admitted Patient Data Collection (APDC)h Hospital use Available data at baseline to follow-up
NSW Emergency Department Data Collection
(EDDC)h
Emergency department
admissions
Available data at baseline to follow-up
NSW RBDM Death Registrationsh Deaths Available data at baseline to follow-up
Cause of Death Unit Record File (COD URF)h Deaths Available data at baseline to follow-up
NSW Mental Health Ambulatory Data Collectionh Service utilization Available data at baseline to follow-up
ANU-ADRI SF, ANU Alzheimer’s Disease Risk Index Short Form [18]; A-IADl-SF, Amsterdam IADL Questionnaire Short Form [48];
LEQ, Lifetime of Experiences Questionnaire [28]; K10, Kessler Psychological Distress Scale [45]; GAD-7, Generalized Anxiety Disorder
7-item [27]; PHQ9, Patient Health Questionnaire [15]. aMYB Eligibility 1 includes baseline Patient Health Questionnaire (PHQ-9). bThe
MYB Battery comprises tasks from the Cogstate Brief Battery (Detection, Identiﬁcation, One Card and One Back) and Cambridge Brain
Sciences (Spatial (Tokens) Search, Grammatical Reasoning and Paired Associates). cLOGOS: an automated telephone-based test of episodic
verbal memory developed and validated for MYB. dThe Physical Assessment battery includes measures of body composition (self-reported
standing height, body mass, waist circumference); physical activity (the Harvard Alumni Questionnaire, HAQ [20]); sitting time (item from
the International Physical Activity Questionnaire, IPAQ [21]); and a measure of functional mobility and performance (the Virtual Short
Physical Performance Battery Protocol, vSPPB [22]). eAdherence to the Mediterranean dietary patterns include MediCul (Mediterranean
Diet & Culinary Index [23]) and MEDAS (Mediterranean Diet Adherence Screener [24]). fWellbeing assessment includes the Generalized
Anxiety Disorder 7-item (GAD-7), PHQ-9a, and Kessler Psychological Distress Scale (K10). gA-IADL-SF to be completed by an informant
for all participants (non-compulsory assessment). hLinked data.
additional adjustment for differential expectations1005
between arms or modules will be applied as neces-1006
sary. In addition, we will conduct subgroup analyses1007
on the primary outcome to determine if there is1008
effect modiﬁcation by the number of risk factors1009
at baseline (3 or 4 risk factors versus 2 risk fac-1010
tors). We expect change in cognition to show a 1011
normal distribution. However, if there are viola- 1012
tions of the assumptions of linear mixed models, 1013
appropriate transformations or a generalized linear 1014
mixed model with an appropriate distribution will be 1015
used. 1016
427
Un
co
rre
cte
d A
uth
or
 P
ro
of
14 M. Heffernan et al. / Maintain Your Brain protocol
Secondary outcomes will be analyzed using linear1017
mixed models for continuous normally distributed1018
outcomes or chi-squared tests for categorical out-1019
comes.Wewill use nonparametric tests for analyzing1020
continuous outcomes if the assumption of normality1021
is violated.1022
Safety1023
Data safety and monitoring board (DSMB)1024
A DSMB will be convened for this trial. It is1025
an independent group of experts that advises MYB1026
investigators. No member of the DSMB will have1027
direct involvement in the conduct of the study;1028
ﬁnancial, proprietary, professional, or other interests1029
that may affect independent decision-making by the1030
DSMB.1031
Adverse event and serious adverse events1032
All MYB participants will be routinely logging1033
into theMYBplatform (both control and intervention1034
group) for trial procedures. During these, they will1035
be prompted every 3 months by an on-screen ‘pop-1036
up’ to report any adverse event(s) in both a check1037
box and text box format, which will be followed by1038
speciﬁc advice to continue/start exercises or dietary1039
changes or not, or to see their health care provider1040
if indicated. All participants can also report adverse1041
events at any time of the trial (ad hoc reporting).1042
Adverse events during the Physical Activity and/or1043
Nutrition modules that are potentially related to the1044
interventions (e.g., muscles soreness, bloating) will1045
be proactively deﬁned via factsheets and instructions1046
within each module, and recorded by the participants1047
on the web interface as they occur. These logged1048
events will be triaged by the Physical Activity and/or1049
Nutrition module leader and trainers as appropriate1050
for follow-up, referral to GP or study physicians, or1051
reporting to ethics.1052
A serious adverse event (SAE) is death, a life-1053
threatening adverse event, inpatient hospitalization or1054
prolongation of existing hospitalization, a persistent1055
or signiﬁcant incapacity or substantial disruption of1056
the ability to conduct normal life functions. All SAEs1057
will be reported to the relevant ethics committees for1058
this trial.1059
Ethics1060
All trial procedures have been approved by the1061
University of New South Wales Human Research1062
EthicsCommittee (#16252) andNSWPopulation and1063
Health Services Ethics Committee (#2016/03/636). 1064
The conduct of the 45 and Up Study was approved by 1065
the University of New SouthWales Human Research 1066
Ethics Committee (HREC). 1067
DISCUSSION 1068
Maintain Your Brain targets known modiﬁable 1069
cognitive decline and dementia risk factors through 1070
a personalized, multimodal online intervention. The 1071
expected beneﬁts of this approach are that MYB 1072
has the capacity to target a number of risks in a 1073
large number of participants. A range of modiﬁ- 1074
able risk factors for Alzheimer’s disease and vascular 1075
dementia including vascular, cognitive, lifestyle, and 1076
psychosocial factors, account for up to one third of 1077
the population attributable risk for Alzheimer’s dis- 1078
ease [52] and are major risk factors for vascular 1079
dementia. In Australia, there is an even higher esti- 1080
mated population attributable risk for dementia of 1081
48% owing to the distribution of these risk factors in 1082
theAustralian population [53]. ShouldMaintainYour 1083
Brain be successful in addressing cognitive decline 1084
by targeting multiple risk factors, it could provide a 1085
model for interventions suitable for use in the broader 1086
community. 1087
TRIAL STATUS 1088
The MYB trial (Protocol v1.29, 03/05/18) plans to 1089
recruit from June to October 2018. 1090
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Trends in Legume Consumption Among Ethnically Diverse Adults in a 
Longitudinal Cohort Study in Australia
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The aim of this study was to investigate changes in legume consumption among a 
population of ethnically diverse middle- aged adults in an urban area of Australia. The 
Melbourne Collaborative Cohort Study is a prospective cohort study of people aged 40-
69 years at baseline (1990-1994) (n=41,514 at baseline), with follow up 13 years later 
(2003-2007). One quarter of the participants were migrants from Southern Europe, in 
particular Greece and Italy. Diet was assessed using a 121 item Food Frequency 
Questionnaire (FFQ), including 2 questions about legume consumption. The FFQ was 
previously validated in a population of ethnically diverse participants. At baseline 34% 
of all participants reported never consuming legumes and this reduced to 12.4% at follow 
up. Greek and Italian born participants had the highest baseline intake of legume 
consumption (2.56 and 1.87serves per week, respectively) and these groups also reported 
the highest negative change in weekly legume consumption over 13 years of follow-up (-
1.29 and -0.65 times per week respectively, p < 0.05). These findings suggest that as 
people from Southern Europe reside longer in Australia, there is a tendency towards 
acculturation, with people reporting less adherence to the traditional high legume 
consumption observed in Mediterranean countries.
Flood, V., Russell, J., & Radd, S. (2015). Trends in legume consumption among 
ethnically diverse adults in a longitudinal cohort study in Australia. The FASEB Journal,
29(1) (abstract 381.4).
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Review question
The objective of this review is to assess the effect of the Mediterranean diet on cognitive functioning or any
measure of brain morphology or function in humans by reviewing randomised controlled trials.
Searches
The search strategy included a combination of 'Intervention' AND 'Outcome' terms but did not include
'Population', 'Comparator' or 'Study design' terms in order to maximise the search sensitivity. We searched
for ‘search terms’ in all fields. The Intervention terms included “cretan diet” OR “Mediterranean diet” OR
“Mediterranean dietary pattern*” OR “Mediterranean type diet” OR MedDiet OR MeDi OR MeDiet. The
Outcomes terms included “brain-derived neurotrophic factor” OR “CT scan*” OR “executive function” OR
“gray matter” OR “grey matter” OR “lumbar puncture” OR “magnetic resonance imaging” OR “mild
cognitive impairment” OR “neurological test*” OR “neuropsychological test*” OR “post-mortem brain
examination” OR “problem solving” OR “reaction time” OR “spinal puncture” OR “spinal tap” OR “white
matter” OR Alzheimer OR BDNF OR brain OR cerebral OR cerebrovascular OR cognition OR cognitive OR
cortical OR dement* OR fMRS OR intellect* OR intelligen* OR IQ OR memory OR mental OR MRI OR
neural OR neuro* OR neurologic OR neurotransmitter* OR thinking OR tomography OR visuo-spatial. Each
search strategy was customised for the coding of each database used in order to encompass all fields and
maximise sensitivity. The two search terms were combined with 'AND' to produce the final results pool. The
systematic search was conducted across a wide range of databases from the earliest record available to the
time of the search. Databases searched included: Ovid interface - MEDLINE (1946-Current), Premedline (not
yet indexed in medline), AMED (1985-current), All EBM review databases including Cochrane Database of
Systematic Reviews (DSR) (2005-current), ACP Journal Club (1991-current), Database of Abstracts of
Reviews of Effects (DARE) (2nd quarter of 2015), Cochrane Central Register of Controlled Trials (CCTR)
(June 2015), NHS Economic Evaluation Database (CLEED) (2nd quarter of 2015), Cochrane Methodology
Register (CLMCR) (3rd quarter 2012-current), Health Technology Assessment (CLHTA) (2nd quarter 2015).
EBSCO interface - CINAHL (1981-current), EMBASE (1947-current), PubMed (inception-current),
PsychINFO (1806-July week 2, 2015), Web of Science (excluding entries indexed in MEDLINE)
(1900-current). We also hand searched grey literature including CHEBA (http://cheba.unsw.edu.au/),
Alzheimer’s Australia (https://fightdementia.org.au/), Alzheimer’s Association (http://www.alz.org/research/),
Neuroscience Research Australia (http://www.neura.edu.au/research/themes/ageing-neurodegeneration),
McCusker Alzheimer’s Research Foundation (http://alzheimers.com.au/research/), NIH Alzheimer’s
Disease Research Centers (https://www.nia.nih.gov/alzheimers/alzheimers-disease-research-centers),
BrightFocus Foundation (http://www.brightfocus.org/alzheimers/), Alzheimer’s Research UK
(http://www.alzheimersresearchuk.org/). The section of each website labeled ‘research’ or the research
related tab was screened in detail on July-Aug 2015. In addition, we queried known experts in dementia and
MCI and reviewed reference lists of retrieved papers for potentially eligible articles in order to identify all
possible studies. For references with missing data, we contacted corresponding authors for additional
information.
Types of study to be included
Randomised controlled trials (RCTs) published as peer reviewed, full-length articles. All other study designs
and publication formats and unpublished data were excluded.
Condition or domain being studied
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Over 322,000 individuals were affected by dementia in Australia in 2013, with many more individuals at risk
by virtue of their borderline cognitive impairment. Current estimates suggest approximately one million
Australians will be affected by 2050. This disorder presents a major challenge to sufferers, carers and the
healthcare system. Urgent interventions are required to delay the onset of dementia and slow the
progression of cognitive decline. Current research suggests it may be too late to intervene or expect
significant health outcomes once dementia has been diagnosed. A window of opportunity may exist during a
pre-clinical stage known as mild cognitive impairment (MCI) to alter the course and speed of the cognitive
decline. Testing various interventions among individuals with MCI is also important since the majority of such
people progress to more severe forms of neurodegenerative disease within five years, at a rate of between
10-15 % per year. While no pharmacological agents have yet been identified to target the underlying
pathology, recent studies suggest simple lifestyle improvements may influence memory and cognition to slow
progression towards dementia and the rate of cognitive decline among those with MCI. In particular, the
Mediterranean diet has been identified in epidemiological studies as a potentially beneficial modality.
However, relatively few clinical trials exist testing the effect of the Mediterranean diet on cognitive functioning
or brain morphology. Research into the effects of the Mediterranean diet is imperative in establishing its
potential as a therapeutic tool.
Participants/population
No restrictions were placed on the participants in the clinical trials as long as they were human.
Participants already consuming the Mediterranean diet as defined in this review were excluded if they had
habitually consumed this diet within three months of enrolment on the trial.
Intervention(s), exposure(s)
For the purposes of this review the intervention used must have been described as a Mediterranean diet or
Mediterranean-style dietary pattern. The intervention diet may have been provided within a Mediterranean
country or other country. Supervision of cooking or food intake was not required. Interventions testing the
short term or immediate effect of exposure to single foods or nutrients were excluded. Trials of less than 10
days of dietary intervention were excluded. Unpublished data, reviews, editorials, letters, commentaries,
abstracts, news pieces, lectures, articles in lay literature were excluded. Definitions for the ‘Mediterranean
diet’ for the purposes of quality review can be found in the accompanying PDF document. (See link below
under "Reference and/or URL for published protocol"). The criterion are based primarily on the lowest
denominator used in the PREDIMED 14-point Mediterranean Diet Adherence Screener (MEDAS) [Schroder,
Fito et al. (2011)] or the new Mediterranean diet pyramid from the Mediterranean Diet Foundation,
Barcelona, Spain [Bach-Faig, Berry et al. (2011)]. Serves are defined as per Australian standard serve sizes
in the Australian Guide to Healthy Eating as appropriate.
Comparator(s)/control
The control group must have been provided or advised to consume an alternative diet to the Mediterranean
diet for comparison. This may be a healthy dietary pattern as described in the literature (e.g. DASH diet, low-
GI diet) or it may be the usual diet of the participant. A comparator group may also be one where additional
non-dietary interventions were included, as long as these same modalities were also given to the intervention
group.
Context
The clinical trials may have been conducted anywhere in the world and could have included either free living
subjects or those in nursing homes or hospital metabolic wards or other residential or healthcare facilities.
The intervention may also have been administered in various ways, including provision of printed educational
materials, verbal instruction, internet- or mobile-assisted technology assisted implementation and/or
provision of prepared foods or dietary constituents (such as olive oil or nuts). It may have been provided
individually or within a group setting. Participants may or may not have been asked to keep records or
provide biomarker evidence of their adherence to the prescribed diet.
Main outcome(s)
Cognitive functioning as assessed by any of the following or other validated tests in the literature: 1. Any
validated test of intelligence or cognitive performance in any domain or globally (e.g. Mini-Mental State
Examination (MMSE) - Folstein, Folstein et al. (1975); Alzheimer’s Disease Assessment Scale (ADAS-Cog)
- Graham, Cully et al. (2004); Matrices - Kaufman and Lichtenberger (1999); Similarities - Kaufman and
Lichtenberger (1999); Trail Making Test (TMT) - Bowie and Harvey (2006); Logical Memory, Benton Visual
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Retention Test (BVRT) - Sivan (1992); Symbol Digit Modalities Test (SDMT) - Strauss, Sherman et al.
(2006); Category Fluency - Strauss, Sherman et al. (2006); Controlled Oral Word Association Test (COWAT)
- Strauss, Sherman et al. (2006). 2. Subjective reporting of memory or cognitive concern, reported on
validated scales such as the Memory Awareness Scale or obtained during semi-structured interview (e.g.
GPCog - Brodaty, Pond et al. (2002); Subjective Memory Complaint (SMC) - Abdulrab and Heun (2008); Life
Experience Questionnaire (LEQ) - Valenzuela and Sachdev (2007); Memory Awareness Rating Scale-
Memory Functioning (MARS-MF) - Carter, Clare et al. (2002)). 3. Global assessment of cognitive function by
semi-structured interview by a clinician (e.g. Clinical Dementia Rating (CDR) - Hughes, Berg et al. (1982);
DSM-5R criteria for cognitive impairment or dementia – American Psychiatric Association (2013) etc.). 4.
Self- or informant report of functional deficits related to cognition (e.g. Bayer Informant Instrumental Activities
of Daily Living (B-IADLs) - Hindmarch, Lehfeld et al. (1998). AND/OR Brain morphology and/or function as
assessed by any of the following or other validated tests in the literature: 1. MRI scans. 2. fMRS scans. 3. CT
scans. 4. Lumbar puncture. 5. Measurement of neurotransmitters or biomarkers such as Brain-derived
neurotrophic factor (BDNF) or others. 6. Post-mortem examination of brain.
Timing and effect measures
Measures must have been taken at baseline before randomisation to the experimental or control condition,
and at least one time point after the intervention or control period began. The minimum time period between
baseline and follow-up cognitive/brain assessments had to have been 10 days. Alternatively, measures could
have been taken post intervention only, so long as such measures were provided for both experimental and
control conditions.
Additional outcome(s)
The following secondary outcomes will be extracted but may not be reported in the primary systematic
review, especially if unrelated to cognitive outcomes. 
1. Body composition (weight, BMI, fat mass and distribution, FFM, LBM or muscle mass, bone density or
mass, anthropometric measurements such as WC, WHR, skinfolds, etc.).
2. Cardiometabolic profile (FBS, insulin, insulin resistance, inflammatory markers, BP, lipid profile,
coagulation factors, homocysteine, arterial stiffness etc.).
3. Functional status (ADL and IADL status, need for assistive devices or persons, need for residential care or
home care support services, etc.).
4. Psychological status (depressive symptoms, anxiety, sleep disturbance, self-efficacy, wellbeing, quality of
life, etc.) reported by such measures as Geriatric Depression Scale (GDS) - Brink, Yesavage et al. (1982);
Depression Anxiety and Stress Scale (DASS) - Ng, Trauer et al. (2007); Scale of Psychological Wellbeing
(SPWB) - Ryff and Keyes (1995); Duke Social Support (DSS) - Koenig, Westlund et al. (1993); Life
Satisfaction Scale (LSS) - Andrews and Withey (1976); Physical and Mental Health Summary Scales (SF36)
- Ware and Sherbourne (1992); Quality of Life Scales (QoLS) - Burckhardt and Anderson (2003), or any
other validated tools in the literature.
*Covariates: Age, sex, ethnicity, geographical setting, residential setting, health status (all diseases and
medications, health care utilisation or costs), habitual physical activity level, sedentary time, socio-economic
status, educational level, financial status.
*Process measures: Adherence to the Mediterranean diet, adverse events, perceptions of burden and
benefits of diet.
Timing and effect measures
Covariates measured at baseline, and at follow up for those that could change (e.g. health status).
Secondary outcomes measured at baseline and 10 or more days after intervention has commenced. Process
measures captured throughout the trial or retrospectively at trial conclusion.
Data extraction (selection and coding)
Screening procedure: Studies were selected for inclusion using a screening process, which progressively
eliminated irrelevant articles. The following steps were followed: 1. Duplicates were removed from the
reference management software (EndNote X7) by the primary author (SR-V). 2. The titles and abstracts
were then screened by SR-V and those which did not satisfy the inclusion/exclusion criteria were removed,
with the reason for removal being recorded. Any queries were discussed and agreed upon with the co-
authors of this review by consensus. 3. The full text of potentially relevant articles was then retrieved and
comprehensively reviewed by SR-V and SD any queries discussed with VF and/or MFS, if required to reach
consensus. Those which did not meet inclusion/exclusion criteria were removed with the reason for removal
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being recorded. 4. The remaining eligible articles were included in the systematic review. 
Data extraction procedure: Two authors (SR-V) and (SD) then independently extracted data from the
included studies using a standardised, pre-designed form, which was pilot tested. Any discrepancies in the
chosen data or analysis were discussed and resolved by mutual consent, or involvement of a third and/or
fourth reviewer (VF and/or MFS) prior to tabulation. The data extracted were based on the following
categories: 1. Study design/setting: author, study name, publication year, study year, study design, city &
country, setting, study duration. 2. Study quality/risk of bias: eligibility criteria specified, random allocation of
subjects, concealed allocation of subjects, similar prognostic indicators at baseline, blinding of subjects,
blinding of clinicians, blinding of assessors, key outcome obtained for >85 % subjects initially allocated to
groups, intention to treat analysis, between group analysis for key outcome/s, point measures provided,
variability measures provided, diet designed by dietitian, minimum amounts specified for required foods, diet
assessment method described, dietary compliance monitored, Mediterranean diet adherence tool validated,
quality of validation study, social setting for meals reported. 3. Intervention/Control condition: Mediterranean
diet definition, how diet administered/who provided education, educational tools provided, frequency of
dietary intervention, individual or group intervention, provision of free food samples, diet tolerance,
perception of burden or benefit of diet, comparator diet/s, method used to assess dietary intake, method
used to assess adherence to Mediterranean diet, method adherence tool administered. 4. Cohort: subject
number, % female, age range, mean age, ethnicity, geographical location, residential setting, health status,
years since diagnosis if cognitively impaired, composite estimate of cognitive functioning at baseline,
weight/BMI/other body composition, habitual physical activity level, sedentary time, size of family/residential
unit, whether participant was cook for family/residential unit, SES or financial level, educational level. 5.
Outcome: blinding of assessors, cognitive measurement tools/tests used, cognitive outcomes number,
diagnosis criteria used for cognitive outcomes, brain morphology/function tests used, body composition tests
used, cardiometabolic profile tests used, functional status tests used, psychological status tests used. 6.
Statistical results: mean and standard deviation (SD), effect sizes (ES's), confidence intervals, mean
differences between groups, statistical tests between and within groups, drop out rate, adjustments, missing
data. Where possible, ES's not provided were calculated from extracted data for each outcome within each
study or via contact with corresponding authors. 7. Other: funding source.
Risk of bias (quality) assessment
Two reviewers (SR-V and SD) independently assessed the quality of the design and reporting of the included
studies using the PEDro scale [validated by Maher, Sherrington et al. (2003); Foley, Bhogal et al. (2006)].
Additional criterion used to further evaluate the quality of the interventions included: whether the intervention
diet was designed and administered by a dietitian; whether minimum amounts for consumption of
Mediterranean foods were specified to participants; whether the prescribed diet meets the defined minimum
criterion (see uploaded table with Minimum Criterion for Traditional Mediterranean Diet); whether diet
tolerance was reported; whether the frequency and setting for diet instruction was reported; whether diet
compliance was assessed; and whether perception of diet burden or benefit was reported.
However, these did not form part of the overall PEDro score. Any discrepancies were resolved by discussion
with a third and/or fourth reviewer (VF and/or MFS).
Strategy for data synthesis
The data extracted from the included trials will be aggregated (at the level of the study, not the individual)
unless individual data are available for participants in all included studies, which is not anticipated. At this
time, a meta-analysis is not planned and a narrative summary is planned, due to anticipated heterogeneity in
interventions and outcomes. Individual trial ESs will be calculated for all outcomes possible, as noted above.
However, if sufficient homogenous data is available when the search is completed to allow a quantitative
synthesis across studies for some outcomes, a meta-analysis will be added.
Analysis of subgroups or subsets
None planned. However, if sufficient data are available, subgroup analysis based on residential status
(community dwelling vs. residential care), sex, age (young, middle-aged, old) and baseline cognitive status
(intact, mild cognitive impairment, dementia), or other potentially relevant sub-groups will be conducted.
Contact details for further information
Sue Radd-Vagenas
srad3618@uni.sydney.edu.au
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APPENDIX FOUR
Corrections within PREDIMED for cognitive outcomes
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Table 4.1. Comparison of baseline cognitive test scores and changes by study group - original values* 
 Variable 
Mean (95% CI) 
 P Valuea 
 Mediterranean Diet Plus
Extra Virgin Olive Oil 
 (n = 127) 
 Mediterranean Diet Plus Nuts  
 (n = 112) 
 Control Diet 
 (n = 95) 
 MMSEb 
 Baseline  28.01 (27.79 to 28.24)  28.11 (27.87 to 28.35)  28.38 (28.12 to 28.65)  0.10 
 Change  0.16 (−0.12 to 0.44) −0.07 (−0.36 to 0.23) −0.26 (−0.57 to 0.06)  0.15 
 RAVLT, total learningb 
 Baseline 39.31 (37.92 to 40.70)  39.46 (37.98 to 40.94)  39.24 (37.63 to 40.85)  0.98 
 Change  4.50 (3.24 to 5.77)c  4.26 (2.91 to 5.60)  2.10 (0.64 to 3.57)  0.04 
 RAVLT, delayed recallb 
 Baseline  6.61 (6.09 to 7.13)  6.48 (5.93 to 7.03)  6.37 (5.77 to 6.96)  0.83 
 Change  1.47 (1.02 to 1.92)  1.80 (1.32 to 2.28)  0.95 (0.43 to 1.47)  0.06 
441
 Variable 
Mean (95% CI) 
 P Valuea 
Mediterranean Diet Plus
Extra Virgin Olive Oil 
(n = 127) 
 Mediterranean Diet Plus Nuts  
 (n = 112) 
 Control Diet 
 (n = 95) 
 Paired associatesb 
 Baseline 15.25 (14.69 to 15.82)  15.25 (14.65 to 15.85)  14.89 (14.24 to 15.54)  0.66 
 Change 0.25 (−0.33 to 0.83)  0.41 (−0.21 to 1.03) −0.09 (−0.76 to 0.58)  0.56 
 Verbal fluencyd 
 Baseline 18.44 (17.18 to 19.70)  20.33 (18.86 to 21.79)  19.02 (17.53 to 20.51)  0.16 
 Change  0.53 (−0.78 to 1.84) −1.51 (−3.08 to 0.06)  0.30 (−1.27 to 1.87)  0.13 
 Digit Span Forwardd 
 Baseline  5.33 (5.03 to 5.63)  5.20 (4.85 to 5.56)  5.23 (4.89 to 5.57)  0.85 
 Change  0.11 (−0.16 to 0.38)  0.36 (−0.01 to 0.73) −0.08 (−0.40 to 0.25)  0.28 
 Digit Span Backwardd 
 Baseline  3.76 (3.49 to 4.02)  3.83 (3.52 to 4.14)  3.95 (3.66 to 4.25)  0.63 
 Change 0.25 (−0.10 to 0.59)  0.34 (−0.12 to 0.81) −0.24 (−0.64 to 0.17)  0.14 
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 Variable 
Mean (95% CI) 
 P Valuea 
Mediterranean Diet Plus
Extra Virgin Olive Oil 
(n = 127) 
 Mediterranean Diet Plus Nuts  
 (n = 112) 
 Control Diet 
 (n = 95) 
 Color Trail Test part1d,e 
 Baseline 62.60 (56.29 to 68.91)  61.15 (53.56 to 68.74)  57.00 (49.61 to 64.38)  0.53 
 Change −5.77 (−11.25 to −0.28)  2.48 (−5.29 to 10.26)  4.53 (−2.11 to 11.17)  0.045 
 Color Trail Test part2d,e 
 Baseline 136.55 (123.19 to 149.90)  131.59 (115.13 to 148.05)  129.99 (114.39 to 145.60)  0.81 
 Change  5.66 (−10.23 to 21.55)c  24.23 (1.36 to 47.10)  37.56 (18.14 to 56.97)  0.045 
MMSE, Mini-Mental State Examination; RAVLT, Rey Auditory Verbal Learning Test. 
* Data extracted from Table 3 in original publication (May 11, 2015) from Valls-Pedret, C., Sala-Vila, A., Serra-Mir, M., Corella, D., de la
Torre, R., Martínez-González, M. Á., . . . Salas-Salvadó, J. (2015). Mediterranean diet and age-related cognitive decline: A randomized
clinical trial. JAMA Internal Medicine, 175(7), 1094-1103. doi:10.1001/jamainternmed.2015.1668
a P value by analysis of covariance adjusted for sex, baseline age, years of education, marital status, APOE ε4 genotype, ever smoking,
baseline body mass index, energy intake, physical activity, type 2 diabetes mellitus, hyperlipidaemia, ratio of total cholesterol to HDL-C,
statin treatment, hypertension, use of anticholinergic drugs, and time of follow-up (not in baseline, only in change).
b Measured in 334 participants (127, 112, and 95 participants, respectively).
c Significantly different from control group (Bonferroni post hoc test).
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d Measured in 96 participants (41, 25, and 30 participants, respectively). 
e Lower scores indicate improvement. 
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Table 4.2. Comparison of baseline cognitive test scores and changes by study group - corrected values* 
 Variable 
Mean (95% CI) 
 P Valuea 
Mediterranean Diet Plus 
Extra Virgin Olive Oil 
(n = 127) 
Mediterranean Diet Plus Nuts 
 (n = 112) 
 Control Diet 
 (n = 95) 
 MMSEb 
 Baseline 28.03 (27.80 to 28.25)  28.10 (27.63 to 28.35)  28.37 (28.11 to 28.63)  0.15 
 Change 0.15 (−0.13 to 0.42) −0.06 (−0.36 to 0.23) −0.24 (−0.56 to 0.08)  0.20 
 RAVLT, total learningb 
 Baseline  39.40 (38.01 to 40.79)  39.41 (37.94 to 40.89)  39.18 (37.57 to 40.79)  0.97 
 Change  4.38 (3.11 to 5.64)  4.33 (2.99 to 5.64)  2.19 (0.73 to 3.65)  0.052 
 RAVLT, delayed recallb 
 Baseline  6.62 (6.11 to 7.14)  6.46 (5.91 to 7.01)  6.37 (5.77 to 6.96)  0.81 
 Change  1.46 (1.01 to 1.91)  1.82 (1.34 to 2.29)  0.94 (0.42 to 1.46)  0.054 
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 Variable 
Mean (95% CI) 
 P Valuea 
Mediterranean Diet Plus 
Extra Virgin Olive Oil 
(n = 127) 
Mediterranean Diet Plus Nuts 
 (n = 112) 
 Control Diet 
 (n = 95) 
 Paired associatesb 
 Baseline  15.27 (14.71 to 15.84)  15.24 (14.64 to 15.84)  14.87 (14.22 to 15.23)  0.62 
 Change  0.24 (−0.34 to 0.82)  0.42 (−0.21 to 1.04) −0.08 (−0.76 to 0.59)  0.56 
 Verbal fluencyc 
 Baseline  18.42 (17.14 to 19.70)  20.38 (18.90 to 21.86)  19.00 (17.48 to 21.86)  0.16 
 Change  0.53 (−0.78 to 1.84) −1.51 (−3.08 to 0.06)  0.30 (−1.27 to 1.87)  0.14 
 Digit Span Forwardc 
 Baseline  5.37 (5.08 to 5.67)  5.23 (4.88 to 5.57)  5.16 (4.83 to 5.49)  0.65 
 Change  0.07 (−0.20 to 0.35)  0.37 (−0.00 to 0.74) −0.04 (−0.36 to 0.28)  0.30 
 Digit Span Backwardc 
 Baseline 3.78 (3.52 to 4.05)  3.83 (3.52 to 4.14)  3.92 (3.62 to 4.22)  0.80 
 Change 0.23 (−0.12 to 0.58)  0.36 (−0.11 to 0.83) −0.23 (−0.64 to 0.18)  0.16 
446
 Variable 
Mean (95% CI) 
 P Valuea 
Mediterranean Diet Plus 
Extra Virgin Olive Oil 
(n = 127) 
Mediterranean Diet Plus Nuts 
 (n = 112) 
 Control Diet 
 (n = 95) 
 Color Trail Test part 1c,d 
 Baseline  62.62 (56.24 to 69.01)  60.80 (53.20 to 68.40)  57.28 (49.76 to 64.80)  0.58 
 Change −6.03 (−11.66 to −0.40)  2.84 (−5.07 to 10.74)  4.58 (−2.14 to 11.31)  0.043 
 Color Trail Test part 2c,d 
 Baseline  134.18 (120.79 to 147.58)  131.74 (115.44 to 148.04)  132.99 (117.29 to 148.68)  0.97 
 Change  5.55 (−10.94 to 21.94)  24.71 (1.29 to 48.14)  37.30 (17.63 to 56.98)  0.055 
MMSE, Mini-Mental State Examination; RAVLT, Rey Auditory Verbal Learning Test. 
* Data extracted from Table 3 in corrected publication (November 5, 2018; corrected values bolded) from Valls-Pedret, C., Sala-Vila, A.,
Serra-Mir, M., Corella, D., de la Torre, R., Martínez-González, M. Á., . . . Salas-Salvadó, J. (2015). Mediterranean diet and age-related
cognitive decline: A randomized clinical trial. JAMA Internal Medicine, 175(7), 1094-1103. doi:10.1001/jamainternmed.2015.1668
a P value by analysis of covariance adjusted for sex, baseline age, years of education, marital status, APOE ε4 genotype, ever smoking,
baseline body mass index, energy intake, physical activity, type 2 diabetes mellitus, hyperlipidaemia, ratio of total cholesterol to HDL-C,
statin treatment, hypertension, use of anticholinergic drugs, time of follow-up (not in baseline,
only in change), and propensity score for group allocation (30 variables as predictors of allocation).
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b Measured in 334 participants (127, 112, and 95 participants, respectively). 
c Measured in 96 participants (41, 25, and 30 participants, respectively). 
d Lower scores indicate improvement.  
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Table 4.3. Comparison of composite cognitive domains – original and corrected values* 
Original Corrected 
Composite 
domain 
Group Change score fully 
adjusted model 
P value# Group Change score fully 
adjusted model 
P value# 
Memory Med + EVOO 0.04 (−0.09 to 0.18) Med + EVOO 0.04 (−0.10 to 0.17) 
Med + Nuts 0.09 (−0.05 to 0.23) 0.04 Med + Nuts 0.10 (−0.04 to 0.24) 0.04 
Control −0.17 (−0.32 to −0.01) Control −0.16 (−0.32 to −0.01)
Frontal Med + EVOO 0.23 (0.03 to 0.43) 0.003 Med + EVOO 0.23 (0.02 to 0.43) 0.004 
Med + Nuts 0.03 (−0.25 to 0.31) Med + Nuts 0.03 (−0.26 to 0.32) 
Control −0.33 (−0.57 to −0.09) Control −0.33 (−0.57 to −0.09)
Global Med + EVOO 0.05 (−0.11 to 0.21) 0.005 Med + EVOO 0.04 (−0.12 to 0.20) 0.008 
Med + Nuts −0.05 (−0.27 to 0.18) Med + Nuts −0.04 (−0.27 to 0.19)
Control −0.38 (−0.57 to −0.18) Control −0.37 (−0.56 to −0.17)
Med, Mediterranean diet; EVOO, extra virgin olive oil. 
* Data extracted from Table 4 in original and corrected publications including abstract (May 11, 2015 and November 5, 2018; corrected
values bolded) by Valls-Pedret, C., Sala-Vila, A., Serra-Mir, M., Corella, D., de la Torre, R., Martínez-González, M. Á., . . . Salas-Salvadó,
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J. (2015). Mediterranean diet and age-related cognitive decline: A randomized clinical trial. JAMA Internal Medicine, 175(7), 1094-1103.
doi:10.1001/jamainternmed.2015.1668
#significantly different from control group (Bonferroni post hoc test).
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APPENDIX FIVE
Comparison of selected Mediterranean diet index tools
451
Original Greek index and variants
Author, year, country (Trichopoulou et al., 1995), Greece
Index tool name MDS-1 original (Mediterranean Diet Score)
a priori or posteriori a priori - elements only
Score range 0-8
Adherence categorised as:
KLJK
Elements assessed 8 elements:
1. Vegetables
2. Legumes
3. Fruit & nuts
4. Cereals (includes potatoes)
5. MUFA:SFA
6. Meat & meat products
7. Dairy products
8. Ethanol
Cut-off points used & 
scoring
Median 
1 point for each positive element above & each negative 
element below median for sex
Score derivation source 
for index
190-item semi-quantitative FFQ (validated)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Survival in older Greeks (aged >70 years) from a
prospective  study
Comments 1. First Mediterranean dietary pattern score (also called
MDPS, Mediterranean Diet Pattern Score)
2. Food groups based on Davidson, Passmore, Brock,
and Truswell (1979), except for alcohol which was
added
3. Cut-off points for scoring based on Mediterranean
intakes of elderly Greeks from three rural villages &
adjusted for energy intake for sex
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Author, year, country (Trichopoulou, Costacou, Bamia, & Trichopoulos, 
2003), Greece
Index tool name MDS-2 (MDS-1 score updated by original authors)
a priori or posteriori a priori - elements only
Score range 0-9
Elements assessed 9 elements: 
1. Vegetables
2. Legumes
3. Fruit & nuts
4. Cereals (includes potatoes)
5. MUFA:SFA
6. Meat & meat products
7. Dairy products
8. Ethanol
9. Fish
Cut-off points used & 
scoring
Median 
1 point for each positive element above & each negative 
element below median for sex
Score derivation source 
for index
150-item semi-quantitative FFQ (validated)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Mortality in Greek adults (aged 20-86 years) from the 
prospective EPIC-Greece study
Comments 1. Original score updated to include fish, based on
benefits described by Hu et al. (2002) from NHS
2. Cut-off points for scoring based on sex specific
median intakes of the Greek population studied
453
Author, year, country (Trichopoulou et al., 2005), 9 European countries
Index tool name MDS-2 variant: MMD (Modified Mediterranean Diet)
a priori or posteriori a priori - elements only
Score range 0-9
Elements assessed 9 elements: 
1. Vegetables
2. Legumes
3. Fruit & nuts
4. Cereals
5. MUFA + PUFA:SFA
6. Meat & meat products
7. Dairy products
8. Ethanol
9. Fish
Cut-off points used & 
scoring
Median
1 point for each positive element above & each negative 
element below median for sex
Score derivation source 
for index
FFQ (validated)
7-d or 14-d FR (in subset)
24 hr recall (in subset)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Mortality in European DGXOWVDJHG\HDUVfrom the 
prospective EPIC-elderly study
Comments 1. MMD was developed for EPIC-elderly study (n=74
607)
2. Swapped MUFA g/d used in original index with sum
of MUFA +  PUFA so could apply to non-
Mediterranean populations
454
Author, year, country (Fung, Hu, McCullough, & Newby, 2006), USA
Index tool name MDS-2 variant: aMED (Alternate Mediterranean Diet 
Score)
a priori or posteriori a priori - elements only
Score range 0-9
Elements assessed 9 elements:
1. Vegetables (no potatoes)
2. Legumes
3. Fruit
4. Wholegrains
5. MUFA:SFA
6. Red/processed meat
7. Nuts
8. Alcohol
9. Fish
Cut-off points used & 
scoring
Median
1 point for each positive element above & each negative 
element below median for sex
Score derivation source 
for index
FFQ (validated)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Estrogen receptor-negative breast cancer risk in US 
postmenopausal women from the NHS
Comments 1. MDS-2 modified by excluding potato from
vegetables, separating fruit & nuts, eliminating dairy
products, including only wholegrains in cereals group,
including only red/processed meats in meat group &
awarding 1 point for ‘moderate’ alcohol intake defined
as 5-15g/d
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Author, year, country (Agnoli et al., 2011), Italy
Index tool name MDS-2 variant: IMI (Italian Mediterranean Index)
a priori or posteriori a priori - elements only
Score range 0-11
Elements assessed 11 elements:
• 6 typical Mediterranean foods:
1. Pasta
2. Mediterranean vegetables
3. Fruit excluding FJ
4. Legumes
5. Olive oil
6. Fish
• 4 non-Mediterranean foods:
7. Soft drinks
8. Butter
9. Red/processed meat
10. Potatoes
• Plus
11. Alcohol
Cut-off points used & 
scoring
Tertiles
1 point if in 3rd tertile for Mediterranean foods or 1st 
tertile for non-Mediterranean foods; otherwise 0, except 
for alcohol where 1 point for 0.01-12 g/d otherwise 0 for 
abstainers & those consuming >12 g/d
See Table 1 in paper for scoring
Score derivation source 
for index
154-, 248-, & 438-item semi-quantitative FFQ (for 3 
Italian regions) (validated)
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
1. Six plasma carotenoids (lutein, zeaxanthin,
canthanxanthiQȕ-FU\SWR[DQWKLQĮ-carotene, & ȕ-
carotene)
2. Three other index scores: Healthy Eating Index 2005
(HEI-2005), DASH & MDS-2
Statistics for dietary 
reference method
Spearman's correlation coefficient 
Validity results against 
dietary reference 
method*
1. Increased IMI score correlated with higher plasma
FDURWHQRLGVĮ-FDURWHQHȡ Sȕ-carotene
ȡ SOXWHLQȡ S]HD[DQWKLQ
ȡ S
2. IMI also correlated with three other index scores
ȡ -0.58, depending on index, p<0.001)
Outcome associated with 
tool use
1. Stroke risk in Italian adults from the EPICOR cohort,
recruited to the prospective EPIC-Italy study
2. Validity within the same population
Comments 1. Validated against dietary biomarkers but only using
correlation coefficients
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Author, year, country (Tognon et al., 2012), Sweden
Index tool name MDS-2 variant: rMDS (Refined Modified 
Mediterranean Diet Index)
a priori or posteriori a priori - elements only
Score range 0-8
Adherence categorised as:
high: >4
Elements assessed 8 elements:
1. Vegetables & potatoes
2. Fruit & juices
3. Wholegrain cereals
4. MUFA+PUFA:SFA
5. Meat, meat products & eggs
6. Dairy products
7. Alcohol
8. Fish & fish products
Cut-off points used & 
scoring
Median
1 point for each positive element above & each negative 
element below median for sex
Score derivation source 
for index
FFQ (validated)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Mortality in Northern Swedish (subarctic region) adults 
from the prospective Vasterbotten Intervention Program 
study
Comments 1. MDS-2 modified by swapping MUFA g/d with sum
of MUFA + PUFA, including only wholegrains in
cereals group & removing legumes & nuts
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Author, year, country (Vitale et al., 2019), Italy
Index tool name MDS-2 variant: MEDI-Quest
a priori or posteriori a priori 
Score range 0-9
Adherence categorised as:
low: 0-3
unsatisfactory: 4-5
high: 6-7
very high: 8-9
Elements assessed 9 elements:
1. Vegetables
2. Legumes & nuts
3. Fruit
4. Wholegrain cereals
5. Olive oil
6. Meat/meat products
7. Foods rich in animal fat, e.g., butter, cake, dairy
(excluding milk & yoghurt)
8. Alcohol
9. Fish/fish products
Cut-off points used & 
scoring
Absolute
1-2 points awarded for each element if met criteria
Values summed & total score divided by 2
Score derivation source 
for index
MEDI-Quest tool
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
MDS-2 by Trichopoulou 2003 (derived from FFQ using 
sex specific median cut-off points)
Statistics for dietary 
reference method
1. Spearman's correlation coefficient
2. ICC
3. Percent of participants correctly categorised within
same score
Validity results against 
dietary reference 
method*
1. Good correlation between total score for MEDI-Quest
& MDS-ȡ S,&& S
2. Percent of participants awarded same score by the
two tools ranged from 55.8%-91.3%, depending on
element; for total score 74.7% received the same score
Outcome associated with 
tool use
Validity in healthy Southern Italian adults (aged 18-85
years) from a cross-sectional study
Comments 1. Quick self-evaluation possible; however, MEDI-
Quest tool with cut-off points for scoring not provided
within paper
2. Dietary reference method limited by similar recall
bias
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Spanish PREDIMED index and variants
Author, year, country (Schroder et al., 2011), Spain
Index tool name MEDAS (Mediterranean Diet Adherence Screener) -
Spanish
a priori or posteriori a priori
Score range 0-14
Elements assessed 14 elements: 
• 12 assess food consumption:
1. Olive oil
2. Vegetables
3. Fruit
4. Red/processed meat
5. Butter, margarine or cream
6. Sugary drinks
7. Wine
8. Legumes
9. Fish/seafood
10. Commercial pastries
11. Nuts
12. Sofrito
• 2 assess food intake habits:
13. Olive oil as primary fat
14. Preference for poultry
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
See Table 2 in paper for scoring
Score derivation source 
for index
MEDAS tool
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
137-item semi-quantitative FFQ (validated)
Statistics for dietary 
reference method
1. Pearson's correlation coefficient
2. ICC
3. General linear modelling for food & nutrient trends
4. Cohen's Kappa
5. Bland-Altman plot
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Validity results against 
dietary reference 
method*
1. Total MEDAS score from tool correlated with score
from FFQ (r=0.52, p<0.001; ICC=0.51, CI N/A,
p<0.001)
2. MEDAS tool score was positively associated with
healthy nutrients & foods from FFQ including vitamin
&ȕ-carotene, folic acid, fibre, unsaturated fatty acids,
vegetables, fruits, wholegrains, nuts & fish & negatively
associated with sodium, saturated fat, sugary drinks &
refined cereals
3. Absolute agreement between tool & reference method
varied for individual elements (mean N=0.43)
4. MEDAS tool over-estimated score by 5% compared
to FFQ in Bland-Altman analysis with upper & lower
LOA of 53% & 43%, respectively
Outcome associated with 
tool use
Validity in older Spanish adults (aged 55-80 years) from 
the PREDIMED RCT
Comments 1. Allows for quick scoring
2. Provides absolute cut-off points
3. Assesses exposure to some non-Mediterranean foods,
i.e., sugary drinks, pastries
4. Dietary reference method limited by similar recall
bias
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Author, year, country (Hebestreit et al., 2017), Germany
Index tool name MEDAS (Mediterranean Diet Adherence Screener) -
German
a priori or posteriori a priori
Score range 0-14
Elements assessed 14 elements: 
• 12 assess food consumption:
1. Olive oil
2. Vegetables
3. Fruit
4. Red/processed meat
5. Butter, margarine or cream
6. Sugary drinks
7. Wine
8. Legumes
9. Fish/seafood
10. Commercial pastries
11. Nuts
12. Sofrito
• 2 assess food intake habits:
13. Olive oil as primary fat
14. Preference for poultry
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
See Table 1 in paper for scoring
Score derivation source 
for index
MEDAS tool
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
1. 148-item semi-quantitative FFQ (validated)
2. Plasma omega-6, omega-3 & omega-IDWW\DFLGVȕ-
carotene; hsCRP
Statistics for dietary 
reference method
1. Pearson's correlation coefficient
2. Cohen's Kappa
3. ICC
4. Bland-Altman plot
5. t-test for independent groups
461
Validity results against 
dietary reference
method*
1. Highest concordance for elements from tool vs. FFQ
at BL was found for Q1 re olive oil (r=0.70; N=0.70,
95% CI 0.51, 0.89; ICC=0.68, 95% CI 0.07, 1.3) & Q12
re nuts (r=0.72; N=0.70, 95% CI 0.52, 0.87; ICC=0.68,
95% CI 0.05, 1.30)
2. Highest concordance for elements from tool vs. FFQ
at 3 months was found for Q9 re fish/seafood (r=0.86;
N=0.85, 95% CI 0.66, 1.1; ICC=0.91, 95% CI 0.68,
1.14) & Q12 re nuts (r=0.78; N=0.77, 95% CI 0.61,
0.94; ICC=0.76, 95% CI 0.23, 1.28)
3. Total MEDAS score was over-estimated from tool
compared to FFQ by 15% at BL & 23% at 3 months
4. At 3 months, intake of fish (using Q9 cut-off) was
associated with lower plasma omega-6 (p=0.035); fruit
(using Q3 cut-RIIZLWKKLJKHUȕ-carotene (p=0.056), at
least 2 serves vegetaEOHVZLWKKLJKHUȕ-carotene
(p=0.004); in multi-variate model fish (using Q9 cut-
off) was associated with higher plasma omega-3
(p=0.037) & lower omega-6 levels (p=0.026)
Outcome associated with 
tool use
Validity in German women (aged 24-72 years) from the
LIBRE RCT of breast cancer incidence among carriers 
of BRCA 1 & BRCA 2 genetic mutations
Comments 1. MEDAS translated into German & validated for use
in that language
2. Validation against dietary biomarkers included
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Author, year, country (Papadaki et al., 2018), UK
Index tool name MEDAS (Mediterranean Diet Adherence Screener) -
English
a priori or posteriori a priori
Score range 0-14
Elements assessed 14 elements: 
• 12 assess food consumption:
1. Olive oil
2. Vegetables
3. Fruit
4. Red/processed meat
5. Butter, margarine or cream
6. Sugary drinks
7. Wine
8. Legumes
9. Fish/seafood
10. Commercial pastries
11. Nuts
12. Sofrito
• 2 assess food intake habits:
13. Olive oil as primary fat
14. Preference for poultry
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
See Table 1 in paper for scoring
Score derivation source 
for index
MEDAS tool
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
3-day estimated FR
Statistics for dietary 
reference method
1. Pearson's correlation coefficient
2. ICC
3. Cohen's Kappa
4. Bland-Altman plot
5. General linear modelling
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Validity results against 
dietary reference 
method*
1. Total MEDAS score from tool correlated moderately
with FR derived score (r=0.50, p<0.001; ICC=0.53,
95% CI 0.07, 0.74, p<0.001)
2. Proportion of participants classified in same category
for total score by tool & FR was 45.8% with borderline
fair agreement between the methods (N=0.19, 95% CI
0.07, 0.31, p=0.002)
3. Total MEDAS score from tool was over-estimated by
1.47 points compared to score derived from FR
(p<0.001)
4. Linear trends were found for key foods & nutrients
from the FR and MEDAS tool score tertiles in the
expected direction: olive oil, vegetables, red meat &
sugary drinks (p=0.001); as well as carbohydrate
(p=0.007), total fat (p=0.021), MUFA (p=0.002), PUFA
(p=0.022) & vitamin E (p=0.001)
5. Test-retest reliability for MEDAS was good (r=0.69,
p<0.001; ICC=0.69, 95% CI 0.571, 0.783, p<0.001)
(N=0.38, 95% CI 0.24, 0.52, p<0.001)
Outcome associated with 
tool use
Validity in UK adults (mean age 68.3 years) at high CV 
risk from a cross-sectional study
Comments 1. MEDAS translated into English & validated for use
in that language
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Author, year, country (Galilea-Zabalza et al., 2018), Spain
Index tool name MEDAS (Mediterranean Diet Adherence Screener) 
variant: energy reduced
a priori or posteriori a priori
Score range 0-17
Adherence categorised as:
low: 0-6
low to moderate: 7-8
moderate to high: 9-10
high: 11-17
Elements assessed 17 elements: 
1. EVOO
2. Fruit
3. Vegetables
4. White bread
5. Wholegrain cereals & pasta
6. Red/processed meat
7. Butter, margarine, cream
8. Sugary drinks
9. Legumes
10. Fish/shellfish
11. Commercial sweets/pastries
12. Nuts
13. Preference for poultry
14. Sofrito
15. Preference for non-caloric sweetener
16. White pasta or rice
17. Wine
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
See Table 1 in paper for scoring
Score derivation source 
for index
MEDAS variant tool
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Quality of life in older Spanish adults (aged 55-75 
years) with overweight or obesity & harbouring the 
metabolic syndrome from the PREDIMED-Plus RCT
465
Comments 1. Designed for PREDIMED-Plus to take into
consideration need for weight loss
2. Includes 4 new Qs re white bread, wholegrains, non-
caloric sweeteners & white pasta or rice compared to
original MEDAS
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Author, year, country (Abu-Saad et al., 2019), Israel
Index tool name MEDAS (Mediterranean Diet Adherence Screener)
variant: I-MEDAS (Israeli Mediterranean diet screener)
a priori or posteriori a priori
Score range 0-17
Elements assessed 17 elements: 
1. Preference for olive oil
2. Non-starchy vegetables including sofrito
3. Fruit (excludes FJ)
4. Red/processed meat
5. Poultry more than red meat
6. Butter/margarine
7. Sweet soft drinks
8. Alcohol
9. Legumes
10. Fish (fresh & preserved)
11. Desserts (cakes & cookies)
12. Nuts
13. Salty snacks
14. Savoury pastries
15. Wholegrains
16. Non-sweetened dairy
17. Hummus/tahini salad
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
See Table 3 in paper for scoring
Score derivation source 
for index
240-item FFQ
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Mortality in Israeli adults representing multi-ethnic 
population (aged 25-74 years) from a prospective study
Comments 1. Adapted to reflect Israeli Mediterranean diet &
national dietary recommendations
2. Assessment of following MEDAS elements was
modified: deleted 4 TBSP EVOO/d; added savoury
pastries, wholegrains & dairy; sofrito combined with
non-starchy vegetables; both commercial & home-made
cake types included; FJ excluded from fruit
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Other indexes
Author, year, country (Alberti, Fruttini, & Fidanza, 2009), Italy
Index tool name MAI (Mediterranean Adequacy Index)
a priori or posteriori a priori - elements only
Score range 0-100+, depending on food intake patterns
Elements assessed 17 elements:
• Carbohydrate foods:
1. Bread
2. Cereals
• Protective food group:
3. Fish
4. Legumes
5. Potatoes
6. Vegetables
7. Fruit & nuts
8. Olive oil
9. Wine
• Food of animal origin:
10. Milk
11. Cheese
12. Meat
13. Eggs
14. Fats & margarines
• Sweets food group:
15. Sweet beverages
16. Cakes/pies/cookies
17. Sugar
Cut-off points used & 
scoring
Score calculated either by a) dividing sum of percent 
energy intake from Mediterranean foods (carbohydrate 
foods + protective food group) by sum of percent energy 
intake from non-Mediterranean foods (food of animal 
origin + sweets food group), or b) by ratio of 
Mediterranean foods (g/d) vs. non-Mediterranean foods, 
depending on data availability
Score derivation source 
for index
24-hr recall
Estimated FR
Weighed FR
FFQ
(depending on cohort)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
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Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
1. Adherence to Healthy Reference National
Mediterranean Diet (HRNMD) in adults from 23
cohorts in Italy, Greece, USA, Costa Rica, Chile, Spain
& Germany
2. Coronary heart disease & total mortality for 16
cohorts from the SCS
Comments 1. Based on Nicotera diet in the 1960s at time of SCS,
as this was related to low chronic disease outcomes
2. Heavy drinkers can obtain very high MAI scores
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Author, year, country (Ciccarone et al., 2003), Italy
Index tool name Unnamed 
a priori or posteriori a priori
Score range 0-18
Elements assessed 18 elements: 
1. Cooked vegetables
2. Raw vegetables
3. Carrots
4. Fruit
5. Fish
6. Cheese
7. Eggs
8. Meat
9. Processed meat
10. Olive oil
11. Vegetable oils
12. Butter
13. Cream
14. Margarine
15. Wine
16. Beer
17. Spirits
18. Ethanol
Cut-off points used & 
scoring
Absolute
1 point for each element if met criteria
See Table 2 in paper for scoring
Score derivation source 
for index
24-item semi-quantitative FFQ
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
7-day FR
Statistics for dietary 
reference method
Correlation coefficient (assumed Pearson's)
Validity results against 
dietary reference 
method*
1. Good correlation between total score derived from
FFQ & 7-day FR (r=0.71, p=0.001)
2. Total energy underestimated by FFQ, although
significant correlation coefficient observed between
FFQ & 7-day FR (r=0.457, p=0.007); energy-adjusted
correlation coefficients for nutrients ranged from 0.118
(protein) to 0.919 (alcohol)
Outcome associated with 
tool use
1. PAD in Italian adult patients with type 2 diabetes
from a case control study
2. Validity within the same population
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Comments 1. Scoring based on average intake of population within
Abruzzo region, Italy
2. Cereals, e.g., pasta, bread, as well as dairy, not scored
as considered neutral
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Author, year, country (Goulet, Nadeau, & Lemieux, 2003), Canada
Index tool name MedScore (Mediterranean Score)
a priori or posteriori a priori
Score range 0-44
Adherence categorised as:
low: 0-27
Elements assessed 11 elements: 
1. Vegetables
2. Legumes/nuts/seeds
3. Fruit
4. Wholegrains
5. Olive oil
6. Fish/seafood
7. Poultry
8. Dairy products
9. Eggs
10. Sweets
11. Red/processed meat
Cut-off points used & 
scoring
Absolute
1-4 points for each element if met criteria
See Appendix A in paper for scoring
Score derivation source 
for index
FFQ
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Lipids & body weight in free-living French Canadian 
women (aged 30-65 years) from an uncontrolled
Mediterranean diet intervention
Comments 1. Scoring based on Oldways Mediterranean pyramid
2. Max. 1 point awarded for refined grain products
within scoring for wholegrains
3. Olive oil, margarine from olive oil & olives grouped
together; max. 1 point awarded for use of canola oil or
margarine made with canola within scoring for olive oil
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Author, year, country (Panagiotakos, Pitsavos, & Stefanadis, 2006), Greece
Index tool name MedDietScore (Mediterranean Diet Score) 
a priori or posteriori a priori
Score range 0-55
Adherence categorised as:
KLJK
Elements assessed 11 elements:
1. Non-refined cereals
2. Potatoes
3. Fruits
4. Vegetables
5. Legumes
6. Fish
7. Red meat & products
8. Poultry
9. Full fat dairy products
10. Olive oil in cooking
11. Alcohol
Cut-off points used & 
scoring
Absolute
1-5 points awarded for each element if met criteria
Score derivation source 
for index
190-item semi-quantitative FFQ for EPIC-Greece
(validated)
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
Food groups & nutrients derived from same FFQ
Statistics for dietary 
reference method
One-way ANOVA
Validity results against 
dietary reference 
method*
1. Highest tertile of MedDietScore associated with
increased intakes of fruits (p=0.03), vegetables
(p=0.01), potatoes (p=0.04), non-refined cereals
(p=0.02), fish (p=0.01), legumes (p=0.001) & olive oil
(p=0.01); lowest tertile associated with higher intakes of
red meat & products (p=0.03), poultry (p=0.03) & full
fat dairy (p=0.04)
2. Significant positive association of MedDietScore with
MUFA (p=0.001) & MUFA:SFA (p=0.02)
Outcome associated with 
tool use
1. CV risk factors in Greek adults (>18 years old) from
the prospective ATTICA study & CHD incidence from
the CARDIO2000 case-control study
2. Validity within the same population
Comments 1. Tool based on rationale of Mediterranean dietary
pattern by Supreme Scientific Health Council, Greece
2. Dietary reference method limited by similar recall
bias
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Author, year, country (Panagiotakos et al., 2009), Greece
Index tool name MedDietScore variant (by original authors)
a priori or posteriori a priori
Score range 0-130
Elements assessed 11 elements:
1. Non-refined cereals
2. Potatoes
3. Fruits
4. Vegetables
5. Legumes
6. Fish
7. Red meat & products
8. Poultry
9. Full fat dairy products
10. Olive oil in cooking
11. Alcohol
Cut-off points used & 
scoring
Absolute
1-5 points awarded for each element if met criteria
Weighting then applied by multiplying scores for daily
intake by 3, weekly intake by 2 & monthly intake by 1
See Table 1 in paper for scoring
Score derivation source 
for index
190-item semi-quantitative FFQ for EPIC-Greece
(validated)
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
Plasma fatty acids
Statistics for dietary 
reference method
1. Spearman's correlation coefficient
2. Linear regression models
Validity results against 
dietary reference 
method*
1. Correlation coefficients between MedDietScore
YDULDQW	SODVPDELRPDUNHUV08)$ȡ 
S08)$6)$ȡ S'+$
ȡ S	Q-IDWW\DFLGVȡ S
PUFA (n-3 + n-IDWW\DFLGVȡ íS6)$
ȡ íS	WRWDOQ-IDWW\DFLGVȡ í
p<0.001)
2. MedDietScore variant was in full agreement with
SUHYLRXV0HG'LHW6FRUHȡ S
3. Age-adjusted & sex-adjusted regression models
confirmed previous unadjusted results
Outcome associated with 
tool use
Validity in healthy Greek adults (mean age: 44 years in 
men & 40 years in women) from the prospective 
ATTICA study
Comments 1. Updated MedDietScore with weighting applied
2. First study to evaluate validity of diet index against
plasma fatty acids as dietary biomarkers
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Author, year, country (Rumawas et al., 2009), USA
Index tool name MSDPS (Mediterranean-style Dietary Pattern Score) 
a priori or posteriori a priori
Score range 0-100
Elements assessed 13 elements:
1. Wholegrains
2. Fruits
3. Vegetables
4. Dairy
5. Wine
6. Fish/seafood
7. Poultry
8. Olives, legumes & nuts
9. Potatoes & other starchy foods
10. Eggs
11. Sweets
12. Meat
13. Olive oil
Cut-off points used & 
scoring
Absolute
1-10 points awarded for each element if met criteria
Sum of scores then standardised to a 0–100 score by
dividing by 130 & multiplying by 100
Standardised score then weighted by proportion of total
energy intake from Mediterranean diet pyramid foods
See Table 1 in paper for scoring
Score derivation source 
for index
126-item semi-quantitative FFQ (validated)
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
24 selected nutrients derived from same FFQ
Statistics for dietary 
reference method
1. Spearman's correlation coefficient
2. Linear & logistic regression
Validity results against 
dietary reference 
method*
1. Correlation coefficients for total MSDPS score &
individual element scores were all positive & significant
ranging IURPȡ PHDWWRȡ YHJHWDEOHV
2. MSDPS score tertiles were significantly & positively
associated with fibre, n-IDWW\DFLGVȕ-carotene,
lycopene, folate, vitamins C & E, Ca, Mg & K (p<0.001
for all) & inversely associated with added sugar
(p=0.001), GI, saturated fat, trans fat & n-6:n-3 ratio
(p<0.001 for all); a significant inverse association found
PUFA & positive association found for linolenic acid
3. MSDPS score was unexpectedly positively associated
with total energy & inversely associated with MUFA &
oleic acid (p<0.001 for all)
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Outcome associated with 
tool use
Validity in US adults from the Framingham Heart Study 
Offspring Cohort
Comments 1. Scoring based on the Greek Mediterranean diet
pyramid from Ministry of Health and Welfare: Supreme
Scientific Health Council (1999)
2. Complicated computation for scoring
3. Scoring for olive oil is categorical based on:
exclusive use of olive oil (score 10), use of olive oil
along with other vegetable oils (score 5), or no olive oil
(score 0)
4. Dietary reference method limited by similar recall
bias
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Author, year, country (Naja et al., 2015), Lebanon
Index tool name LMD (Traditional Lebanese Mediterranean Diet)
a priori or posteriori a priori - elements only
Score range 9-27
Elements assessed 9 elements:
1. Fruits
2. Dried fruits
3. Vegetables
4. Legumes
5. Dairy products
6. Burghol
7. Olive oil
8. Eggs
9. Potatoes
Cut-off points used & 
scoring
Tertiles
1-3 points awarded for each element if met criteria
Score derivation source 
for index
61-item FFQ (not validated)
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
5 selected European Mediterranean diet indexes derived 
from same FFQ
Statistics for dietary 
reference method
1. Spearman's correlation coefficient
2. Cohen's Kappa
Validity results against 
dietary reference 
method*
1. Significant correlation coefficients (p<0.01) for total
LMD score & scores for other indexes: Greek
0HG'LHW6FRUHȡ 6SDQLVKU0('ȡ 
,WDOLDQ,0,ȡ )UHQFK0HG-'4,ȡ (3,&
MDS-2 vDULDQWȡ 
2. Only ,0,KDGFRUUHODWLRQZLWK/0'
3. Highest agreement found between LMD & IMI
scores with 53.17% of participants classified in same
tertile & 92.38% classified in same or adjoining tertiles
(N=0.49, 95% CI: 0.45, 0.52)
Outcome associated with 
tool use
Validity in Lebanese adults (aged 20-55 years) from the 
nation-wide nutrition & non-communicable diseases 
risk factors cross-sectional survey in Lebanon
Comments 1. First Mediterranean diet index developed for Middle
Eastern Mediterranean region with unique Lebanese
foods, e.g., burghol, dried fruits
2. Alcohol not included for scoring as large Muslim
population
3. Choice of elements based on previous factor analyses
using same dataset
4. Dietary reference method limited by similar recall
bias
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Author, year, country (Tong, Wareham, Khaw, Imamura, & Forouhi, 2016),
UK
Index tool name PyrMDS (Pyramid-based Mediterranean Diet Score) 
a priori or posteriori a priori
Score range 0-15
Elements assessed 15 elements:
1. Vegetables
2. Legumes
3. Fruits
4. Nuts
5. Cereals
6. Dairy
7. Fish
8. Red meat
9. Processed meat
10. White meat
11. Eggs
12. Potatoes
13. Sweets
14. Alcohol
15. Olive oil
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
Adjusted to 2000 Cal/d for scoring
See Table S2 in paper for scoring
Score derivation source 
for index
130-item semi-quantitative FFQ (validated)
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
3 selected Mediterranean diet indexes derived from 
same FFQ:
LitMDS (Literature based MDS)
mMDS (median based MDS)
tMDS (tertile based MDS)
Statistics for dietary 
reference method
Spearman's correlation coefficient
Validity results against 
dietary reference 
method*
1. Total score for PyrMDS correlated with total scores
IRURWKHULQGH[HVDW%/P0'6ȡ W0'6
ȡ /LW0'6ȡ SYDOXH1$
2. Correlation coefficient for PyrMDS total score at BL
(recruited 1993-19	)8WRZDVȡ 
(p value N/A)
Outcome associated with 
tool use
1. CVD incidence & mortality in UK adults (aged 40-79
years) from the EPIC-Norfolk study
2. Validity within the same population
Comments 1. Based on Mediterranean Food Guide Pyramid
developed by Mediterranean Diet Foundation
478
2. Dietary reference method limited by similar recall
bias
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Author, year, country (Cerwinske, Rasmussen, Lipson, Volgman, & Tangney, 
2017), USA
Index tool name MEPA (Mediterranean Eating Pattern for Americans)
a priori or posteriori a priori
Score range 0-16
Elements assessed 16 elements:
1. Olive oil
2. Green leafy vegetables
3. Other vegetables
4. Berries
5. Other fruit
6. Meat
7. Fish
8. Chicken
9. Cheese
10. Butter/cream
11. Beans
12. Wholegrains
13. Pastries
14. Nuts
15. Fast food
16. Alcohol
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
See Appendix A in paper for scoring
Score derivation source 
for index
MEPA tool
Validated against dietary
reference method Y/N
Y
Dietary reference 
method used
156-item VioScreen FFQ (validated)
Statistics for dietary 
reference method
1. Spearman's correlation
2. Cohen's Kappa
3. Bland-Altman plot
4. Kruskal-Wallis & Bonferroni-adjusted Mann-
Whitney post-hoc comparisons
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Validity results against 
dietary reference 
method*
1. Total MEPA score from tool correlated moderately
ZLWKVFRUHIURP))4ȡ S 
2. Percent agreement ranged from fair to moderate-to-
good, depending on element; highest was for alcohol
(85.7%, p<0.001), fish (84.3%, p<0.001), olive oil
(82.9%, p=0.006) & wholegrains (81.4%, p=1.00) &
lowest for fast food (45.7%, p=1.00)
3. Agreement for total MEPA score from tool with score
from FFQ was fair (mean N=0.27); agreement was poor
for other vegetables (N=0.19), meat (N=0.12), chicken
(N=0.13), wholegrains (N íSDVWULHVN=0.19) &
fast food (N íDJUeement was fair for olive oil
(N=0.33), green leafy vegetables (N=0.36), other fruit
(N=0.25), cheese (N=0.21), butter (N=0.21), & beans
(N=0.29); agreement was moderate to good for berries
(N=0.47), nuts (N=0.42), fish (N=0.62) & alcohol
(N=0.64)
4. MEPA tool over-estimated score relative to FFQ
5. Nutrients derived from FFQ were in expected
direction with MEPA tool score: K (p=0.001), Mg
(p<0.0001), vitamin C (p=0.002), saturated fat
(p=0.005), selected carotenoids (p=0.007 to <0.0001),
folate (p=0.009) & fibre (p<0.0001)
Outcome associated with 
tool use
Validity in US women (aged 24-79 years) from a cross-
sectional study
Comments 1. Modified version of MEDAS screener for use within
US population
2. MEPA incorporates selected elements protective for
brain health
3. Dietary reference method limited by similar recall
bias
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Author, year, country (Sofi, Dinu, Pagliai, Marcucci, & Casini, 2017), Italy
Index tool name MEDI-LITE (Mediterranean Diet Based on the 
Literature)
a priori or posteriori a priori - elements only
Score range 0-18
Elements assessed 9 elements:
1. Fruit
2. Vegetables
3. Cereal grains
4. Legumes
5. Fish & fish products
6. Meat & meat products
7. Dairy products
8. Alcohol
9. Olive oil
Cut-off points used & 
scoring
Tertiles
For typical Mediterranean foods: 2 points awarded for 
highest tertile of intake, 1 for middle & 0 for lowest;
vice versa for non-Mediterranean foods
For alcohol: 2 points awarded for 1-2 std units/d, 1 point 
for 1 unit/d & 0 for highest category of intake
For olive oil: 2 points awarded for regular use, 1 point 
for frequent use & 0 for occasional use
Score derivation source 
for index
MEDI-LITE tool
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
MedDietScore
Statistics for dietary 
reference method
1. Pearson’s correlation coefficient
2. Receiver operating characteristic (ROC) curve
methodology for correct classification of adherence to
Mediterranean diet
Validity results against 
dietary reference 
method*
1. Good correlation of MEDI-LITE with MedDietScore
for total score (r=0.70, p<0.0001) & most of 9 elements
(r=0.56-0.90, p<0.05, except for alcohol where r=0.27)
2. MEDI-LITE had significant discriminative capacity
of 85% for adherents vs. non-adherents to
Mediterranean diet (AUC: 0.851, 95% CI 0.799, 0.904,
p<0.0001)
Outcome associated with 
tool use
Validity in healthy Italian adults (aged 18-80 years) 
from a cross-sectional study
Comments 1. Elements for tool originally obtained by posteriori
analyses but scoring adapted according to method used
by MedDietScore
2. Dietary reference method limited by similar recall
bias
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Lifestyle index
Author, year, country (Sotos-Prieto et al., 2015), Spain
Index tool name MEDLIFE (MEDiterranean LIFEstyle)
a priori or posteriori a priori
Score range 0-28
Elements assessed 28 elements:
• 15 food frequencies:
1. Pastries
2. Red meat
3. Processed meat
4. Eggs
5. Legumes
6. White meat
7. Fish/seafood
8. Potatoes
9. Low fat dairy products
10. Nuts & olives
11. Herbs & spices
12. Fruit
13. Vegetables
14. Olive oil
15. Grain products
• 7 traditional dietary habits:
16. Water or tea
17. Wine
18. Added salt
19. Wholegrain preference
20. Snacking frequency
21. Snacking between meals
22. Sugary drinks
• 6 lifestyle habits:
23. Physical activity
24. Siesta/nap
25. Sleep
26. TV
27. Social interaction
28. Team sports
Cut-off points used & 
scoring
Absolute
1 point for each element if met criteria
See Table 1 in paper for scoring
Score derivation source 
for index
MEDLIFE tool
Validated against dietary 
reference method Y/N
Y
Dietary reference 
method used
142-item FFQ (validated)
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Statistics for dietary 
reference method
1. Pearson's correlation coefficient
2. ICC
3. Cohen's Kappa
4. Bland-Altman plot
Validity results against 
dietary reference 
method*
1. Moderate to good correlation for total MEDLIFE
score from tool & FFQ (r=0.626, p<0.05; ICC=0.544,
95% CI 0.3, 0.7)
2. Absolute agreement between tool & FFQ for nearly
60% of elements ranged from very good to moderate
(N=0.41-1, p<0.0001)
3. Bland-$OWPDQ/2$UDQJHGIURPíWR
(mean=1.40)
Outcome associated with 
tool use
Validity in middle-aged Spanish adults (mean age 41.4 
years) from a cross-sectional study
Comments 1. Based on Mediterranean Food Guide Pyramid
developed by Mediterranean Diet Foundation
2. First tool to also assess Mediterranean lifestyle habits
3. Dietary reference method limited by similar recall
bias
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Life stage indexes
Author, year, country (Serra-Majem et al., 2004), Spain
Index tool name KIDMED (Mediterranean Diet Quality Index)
a priori or posteriori a priori
Score range 0-12
Adherence categorised as:
RSWLPDO
medium:4–7
YHU\ORZ
Elements assessed 16 elements:
• Positive:
1. Fruit or FJ daily
2. Second fruit daily
3. Fresh or ckd veg once/d
4. Fresh or ckd veg >1/d
5. Fish 2-3x/wk
6. Legumes >1x/wk
7. Pasta or rice t5x/wk
8. Cereals or bread for BF
9. Nuts t2-3x/wk
10. Olive oil used at home
11. Has a dairy product for BF
12. Has 2 yoghurts &/or cheese daily
• Negative:
13. Fast food >1x/wk
14. Skips BF
15. Has pastries for BF
16. Sweets or lollies several times daily
Cut-off points used & 
scoring
Absolute
1 point awarded for each positive element & 1 point 
deducted for each negative element, if met criteria
Score derivation source 
for index
KIDMED tool
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Diet quality in Spanish children & adolescents (2 to 24 
years of age) from the EnKid study
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Comments 1. First tool to assess Mediterranean diet adherence in
children & adolescents
Author, year, country (Mariscal-Arcas et al., 2009), Spain
Index tool name MDS-2 variant: MDS-P (Mediterranean Diet Score for 
Pregnancy)
a priori or posteriori a priori - elements only
Score range 0-11
Adherence categorised as:
SRRU
adequate:5–8
KLJK
Elements assessed 11 elements:
1. Vegetables
2. Fruit & nuts
3. Legumes
4. Cereals
5. Fish
6. MUFA:SFA
7. Meat
8. Dairy
9. Iron
10. Calcium
11. Folic acid
Cut-off points used & 
scoring
Median
1 point for each positive element above & each negative 
element below median for sex
3 points added if intake of 3 PLFURQXWULHQWV5',RU
if receiving medically prescribed nutrient supplement
Score derivation source 
for index
FFQ for pregnant women (validated)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Diet quality in pregnant Spanish women based on a
Mediterranean-type diet, with micronutrient 
consideration, from a prospective study
Comments 1. Alcohol group removed as avoided by pregnant
women
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Meal index
Author, year, country (Monteagudo et al., 2013), Spain
Index tool name BQI (Breakfast Quality Index)
a priori or posteriori a priori
Score range 1-10
Adherence categorised as:
SRRU
medium: 4-7
DGHTXDWH
Elements assessed 10 elements:
1. Cereals & derivatives (bread, biscuits, bakery
products)
2. Fruit & vegetables (includes FJ)
3. Dairy products (FC & semi-skim milk, shakes)
4. Foods rich in sugars (jam, honey) <5% E
5. MUFA rich fats (olive & vegetable oil)
6. MUFA:SFA > median
7. Compliance with E intake recommendations (20-25%
E)
8. Cereals + fruit + dairy in same meal
9. Calcium (200-300 mg)
10. Absence of SFA & trans rich fats (butter, margarine)
Cut-off points used & 
scoring
Absolute
1 point awarded for each element if met criteria
See Table 1 in paper for scoring
Score derivation source 
for index
FFQ (validated)
Validated against dietary 
reference method Y/N
N
Dietary reference 
method used
N/A
Statistics for dietary 
reference method
N/A
Validity results against 
dietary reference 
method*
N/A
Outcome associated with 
tool use
Breakfast quality in Spanish (from Granada & Balearic 
Islands) children & adolescents (aged 8-17 years) from 
a cross-sectional study
Comments 1. Novel tool to evaluate quality of breakfast within a
Mediterranean context
&, and; ANOVA, analysis of variance; BF, breakfast; BL, baseline; BRCA 1 & BRCA 2 
genetic mutations, mutations of two tumour suppressor genes; ckd, cooked; CV, 
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cardiovascular; d, day; DASH, Dietary Approaches to Stop Hypertension; E, energy; 
EPIC, European Prospective Investigation into Cancer and Nutrition; EPICOR, (long-
tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome 
patients) study; EVOO, extra virgin olive oil; FC, full cream; FFQ, food frequency 
questionnaire; FJ, fruit juice; FR, food record; HEI, Healthy Eating Index; hr, hour; 
hsCRP, high sensitivity C-reactive protein; ICC, intra-class correlation coefficient; K, 
potassium; LOA, limits of agreement; max., maximum; Mg, magnesium; min, minimum; 
MUFA, monounsaturated fatty acids; N, no; N/A, not available; NHS, Nurses’ Health 
Study; PA, physical activity; PAD, peripheral artery disease; proc, processed; 
PREDIMED, Prevencion con Dieta Mediterranea; PUFA, polyunsaturated fatty acids; Q,
question; RCT, randomised controlled trial; RDI, Recommended Dietary Intake; SCS,
Seven Countries Study; SFA, saturated fatty acids; std, standard; TBSP, tablespoon; vs.,
versus; wk, week; Y, yes.
* Reliability data is also stated where provided.
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Mediterranean Diet Adherence Screener (MEDAS)
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MEDAS question (Schroder et al., 2011) Criteria for 1 
point*
1. Do you use olive oil as the principal source of fat for
cooking?
Yes
2. How much olive oil do you consume per day (including
that used in frying, salads, meals eaten away from home,
etc.)?
7%63
3. How many servings of vegetables do you consume per
day? Count garnish and side servings as 1/2 point; a full
serving is 200 g.
 (at least 1 portion 
raw or as salad)
4. How many pieces of fruit (including fresh-squeezed juice)
do you consume per day?

5. How many servings of red meat, hamburger, or sausages
do you consume per day? A full serving is 100–150 g.
<1
6. How many servings (12 g) of butter, margarine, or cream
do you consume per day?
<1
7. How many carbonated and/or sugar-sweetened beverages
do you consume per day?
<1
8. Do you drink wine? How much do you consume per week? FXSV
9. How many servings (150 g) of pulses do you consume per
week?

10. How many servings of fish/seafood do you consume per
week? (100–150 g of fish, 4–5 pieces or 200 g of seafood)

11. How many times do you consume commercial (not
homemade) pastry such as cookies or cake per week?
<3 (Martínez-
González et al., 
2012)
12. How many times do you consume nuts per week? (1
serving = 30 g)

494
13. Do you prefer to eat chicken, turkey or rabbit instead of
beef, pork, hamburgers, or sausages?
Yes
14. How many times per week do you consume boiled
vegetables, pasta, rice, or other dishes with a sauce of
tomato, garlic, onion, or leeks sautéed in olive oil?

TBSP, tablespoon; g, grams.
* zero points are awarded if criteria is not met.
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Human Research Ethics Committee (HREC)
The University of New South Wales
UNSW Sydney, NSW, Australia, 2052
T: +612 9385 622 or +612 9385 7257
E: humanethics@unsw.edu.au
W:https://research.unsw.edu.au/human-research-ethics-home
21-Apr-2016
Dear Scientia Professor Henry Brodaty,
Project Title Maintain Your Brain (MYB)
HC No HC16252
Re Notification of Ethics Approval
Approval Period 21-Apr-2016 - 20-Apr-2021
Thank you for submitting the above research project to the HREC Committee A for ethical review. This
project was considered by the HREC Committee A at its meeting on 19-Apr-2016.
I am pleased to advise you that the HREC Committee A has granted ethical approval of this research
project, subject to the following conditions being met:
Evidence of the trial being registered on the Australian New Zealand Clinical Trials Registry.
The provision of a withdrawal of consent form following the participant information sheet.
'>Conditions of Approval Specific to Project:
Conditions of Approval - All Projects:
The Chief Investigator will immediately report anything that might warrant review of ethical approval of
the project.
The Chief Investigator will notify the HREC Committee A of any event that requires a modification to the
protocol or other project documents and submit any required amendments in accordance with the
inst ruct ions prov ided by the HREC Committee A.  These  i ns t ruc t i ons  can  be  f ound  a t
https://research.unsw.edu.au/research-ethics-and-compliance-support-recs.
The Chief Investigator will submit any necessary reports related to the safety of research participants
in accordance with HREC Committee A policy and procedures. These instructions can be found at
https://research.unsw.edu.au/research-ethics-and-compliance-support-recs.
The Chief Investigator will report to the HREC Committee A annually in the specified format and notify
the HREC Committee A when the project is completed at all sites.
The Chief Investigator will notify the HREC Committee A if the project is discontinued at a participating
site before the expected completion date, with reasons provided.
The Chief Investigator will notify the HREC Committee A of any plan to extend the duration of the project
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past the approval period listed above and will submit any associated required documentation.
Iinstructions for obtaining an extension of approval can be found at https://research.unsw.edu.au
/research-ethics-and-compliance-support-recs.
The Chief Investigator will notify the HREC Committee A of his or her inabil ity to continue as
Coordinating Chief Investigator including the name of and contact information for a replacement.
A copy of this ethical approval letter must be submitted to all Investigators and sites prior to commencing
the project.
The HREC Committee A Terms of Reference, Standard Operating Procedures, membership and standard
forms are available from https://research.unsw.edu.au/research-ethics-and-compliance-support-recs.
If you would like any assistance, or further information, please contact the ethics office on:
P: +61 2 9385 6222, + 61 2 9385 7257 or + 61 2 9385 7007
E: humanethics@unsw.edu.au
The HREC Committee A wishes you continued success in your research.
Kind Regards
HREC Presiding Chairperson
This HREC is constituted and operates in accordance with the National Health and Medical
Research Council’s (NHMRC) National Statement on Ethical Conduct in Human Research
(2007). The processes used by this HREC to review multi-centre research proposals have
been certified by the National Health and Medical Research Council.
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APPENDIX NINE
Research Food Diary app instructions
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1 
Instructions on How to Keep a 3 Day Food Diary 
Thank you for agreeing to keep a 3 day electronic food diary of your food intake.  The instructions 
below will give you all the information you need to do this easily.  They are organised in four key 
sections. 
Please carefully read through the instruction booklet, or refer to the individual sections below. If you 
are still unsure about any part of this study phase, please get in touch with us via 
maintainyourbrain@sydney.edu.au . 
Page 
x Checklist Before You Start……………………………………………………….………………………….2 
x How to Download ‘Research Food Diary’ and Set Up Your Diary Account …………3 
- Special instructions for iPad users …………………………………………………..……………..6 
x How to Use ‘Research Food Diary’ …………………………………………………..………………...9 
- Adding food to your diary……………………………………………………………………………….9 
- Scanning a product barcode to add a food to your diary……………………………….10 
- Creating a recipe to add home made foods into your diary…………………………..12 
- Editing a recipe……………………………………………………………………………………………..16 
- Deleting a recipe..………………………………………………………...………………………………17 
- Deleting a food item………………………………………………..……………………………………17 
- Substituting a food item if its not in the Research Food Diary database………..18 
x How to Submit Your 3 Day Food Diary…...…………………………………………………………19 
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2 
Checklist Before You Start & General Tips About Logging Food Intake 
1. Please record EVERYTHING you eat or drink – meals, snacks, hot drinks,
alcohol and water - over three days, including one weekend day (or
non-working day) and two week days.
The days do not need to be consecutive but must fall within a one week period.
2. Log foods and drinks straight away as you consume them.  You will need to carry
your device with you to do this using an app called ‘Research Food Diary’.
3. Don’t change your diet during this period – we are interested in your usual intake.
4. Select the options most relevant to you from within the app, including brands,
formulations (e.g. full cream vs. low fat, flavoured vs. plain, added sugar vs. ‘diet’,
light vs. full strength) and your serve sizes.
5. Log your serve sizes using ‘weight’ in grams if you know this.  Otherwise, estimate
your serve sizes using household measures such as teaspoons, tablespoons or
cups. It is important to measure your foods using a measure instead of guessing
portions for accuracy.
6. Ensure you record all the extras (e.g. dressing for salad; sugar in tea; milk in
coffee; margarine on bread; oil, salt or herbs used in cooking).
7. For meals made with a recipe (e.g. beef and vegetable casserole), see below for
how to record the recipe in the app first and then select the number of serves you
personally consumed.
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3 
How to Download ‘Research Food Diary’ and Set Up Your Diary Account 
Research Food Diary is a free iPhone app for tracking and recording your diet. This app is compatible 
with devices such as iPhone, iPad and iPod touch using iOS 8.0 or later.  
You will need to have an iTunes account and be connected to the internet (e.g. through a WiFi network 
or your mobile 3G/4G network) to download the app. If you do not have an iTunes account, you will 
need to set one up first.  
Information on how to set up an iTunes account can be found here: https://support.apple.com/en-
au/HT204034  
For iPhone 
1. To download this app onto your iPhone, select the App Store from your home screen.
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4 
2. Tap on the “Search” icon and type “Research Food Diary” into the search field.
3. Select Research Food Diary from the search results. Tap the  icon. An  icon will then 
appear, tap this to download the Research Food Diary app.
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5 
4. You may see a screen asking you to enter your iTunes password. Enter this to allow the
download to proceed. The download may take several minutes depending on the speed of your
internet connection.
5. Once the download is completed the  icon should appear on the main screen of your iOS
device(s). Note – if you have many apps on your device it may appear on another screen so you
will have to swipe between screens to find it. Tap on this icon to open and begin using the
Research Food Diary app.
6. Create an account using Sign Up with Email.
7. To start adding food to your diary within the app, please see instructions below on: How to use
Research Food Diary.
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For iPad and iPod Touch 
1. To download this app onto your iPad or iPod Touch, select the App Store on your device.
2. Tap on the “Search” box on the top right corner and type “Research Food Diary” into the
search field. Then tap on the  button.
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3. You will be directed to a page which says ’no results for “Research Food Diary”’.  Tap on ‘iPad
Only’ on the top left corner of your device. This will open up a dropdown menu. Tap on ‘iPhone
Only’ to display ”Research Food Diary” on the search results.
4. Select Research Food Diary from the search results. Tap the  icon. An  icon will then 
appear, tap this to download the Research Food Diary app.
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5. You may see a screen asking you to enter your iTunes password. Enter this to allow the
download to proceed. The download may take several minutes depending on the speed of your
internet connection.
6. Once download is completed the  icon should appear on the main screen of your iPad.
Note – if you have many apps on your device it may appear on another screen so you will have
to swipe between screens to find it. Tap on this icon to open and begin using the Research Food
Diary app.
8. Create an account using Sign Up with Email.
7. To start adding food to your diary within the app, please see instructions below on: How to use
‘Research Food Diary’.
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How to Use ‘Research Food Diary’
Adding food to your diary 
There are three ways you can add food to your diary.  First, by searching the foods database.  Second, 
by scanning the barcode of food packaging.  Third, by adding a recipe of a mixed dish to your diary and 
then selecting the number of serves you personally consumed from that recipe. Instructions for each 
method are detailed below. 
To log a food by searching from the foods database: 
1. On the “Diary” screen tap a meal, (e.g. “Breakfast”), to open the meal.
2. Tap  magnifying glass icon at the bottom left under the meal.
3. In the “Find a food…” search field, enter food name then tap on Search.
4. Select the most appropriate item from the list. If multiple options are provided to further
narrow down the type of food, please select the most relevant option for you.
5. Tap on the “Amount” box and enter the amount consumed.
6. Choose your serving size from the list (e.g. slice, cups, grams etc).
7. Tap “Add” at the top right of the screen.
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TIP: If the food has a barcode, instead of searching, try scanning it. 
To log a food by scanning its barcode: 
1. On the “Diary” screen tap a meal, (e.g. “Breakfast”), to open the meal.
2. Tap the  barcode icon below the meal.
*Note that you may need to authorize permission for Research Food Diary to access your
camera. Tap “Yes” when prompted.
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3. View the barcode of the food item through your device's camera.
4. Hold still while the barcode is scanned automatically.
5. Tap the “Amount” box and type the amount.
6. Choose your serving size from the list (e.g. slice, cups, grams etc.) then tap “Add” at the top of
the screen.
7. To return to the meal, tap the meal name at the top left of the screen.
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Creating a recipe 
Creating a recipe while logging your foods 
1. On the “Diary” screen tap a meal, (e.g. “Breakfast”), to open the meal to which you want to
add the recipe.
2. Tap the  magnifying glass icon at the bottom left under the meal.
3. Tap “Recipes” on the top right side of the tab.
4. Tap the (+) at the bottom of the recipe list.
5. Tap the “Recipe Name” field and enter the recipe name.
6. Tap “Add ingredients” field to add ingredients.
7. Tap the  magnifying glass icon to search for an ingredient, or the  barcode icon to scan
the barcode of an ingredient
8. Enter the ingredients in the same way that you enter foods into your diary.
9. Tap the “Serves” box below the Ingredients box and specify the number of serves produced by
that recipe, then tap on <Recipe in the top left to return to the recipe screen
10. Tap “Done” at the top of the screen once you've finished.
11. Tap “OK” when asked “Add <recipe> to diary now?”.
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12. To log in the food item into your diary, tap the “Amount” box and choose your serve size from
the list (e.g. slice, cups, grams etc.).
13. Tap “Add”
14. at the top of the screen.
15. Tap the meal name at the top left of the screen to return to your diary.
TIP: 
x The recipe is automatically added to your recipe list. 
x To use this recipe in your diary at another time: 
1. Open the meal to which you want to add it.
2. Tap the  magnifying glass icon and tap the “Recipes” tab on top of your screen.
3. Your recipe will be listed there in alphabetical order.
4. Tap the recipe to add it to your meal.
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Creating a recipe at any time to add to your recipe list 
1. Tap “Recipes” at the bottom of the screen.
2. Tap the (+) in the top right corner of the screen.
3. Type the recipe name in the “Recipe Name” box.
4. In the “Ingredients” box, tap the  magnifying glass icon to search for an ingredient, or the 
 barcode icon to scan the barcode of an ingredient. 
5. Enter the ingredients in the same way that you enter foods into your diary.
6. Tap the “Serves” box and type the number of serves.
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7. Tap “Add” on the top right corner.
8. Repeat for all the remaining ingredients for that recipe.
9. Tap “Done” at the top right of the screen.
Converting foods in my diary to a recipe
1. On the “Diary” screen tap a meal, (e.g. “Breakfast”) to open it.
2. Tap the  Tick icon on the bottom right corner. 
3. Select the foods that are the ingredients of the recipe.
4. Tap “Recipe” at the bottom of the screen.
5. Type a name for the recipe.
6. Edit the ingredients and serves, as required, by tapping on them individually.
7. Tap “Done” at the top of the screen.
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Editing a recipe 
1. Tap “Recipes” at the bottom of the screen.
2. Select the recipe that you would like to edit.
x To modify the recipe name tap on the name for the recipe and change it.
x To add an ingredient: 
1. Tap the  magnifying glass icon or the  barcode icon.
2. Add a food item, just as you would add it to a meal.
x To modify quantities in a recipe: 
1. Tap on the name of an ingredient in the recipe.
2. Modify the amount and measurements and tap on top left <Recipe to go back to the
main recipe screen.
x To modify serving yield:  
1. Tap the box under the ingredients “Makes … Serve”.
2. Modify the amount and measurements (e.g. grams instead of serves) and tap on top
left <Recipe to go back to the main screen.
x To delete an ingredient 
1. Tap the  Edit icon. 
2. Tap the red circle beside the ingredient, then tap . 
3. Tap “Done” at the top right of the screen.
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Deleting a recipe 
1. Tap “More” on the bottom right of your screen.
2. Tap the “Recipes” tab.
3. Swipe left on a recipe name and tap
– OR –
1. Tap the  Edit icon at the bottom of the recipe list. 
2. Tap the red circle beside the recipe, then tap
3. Tap the  Edit icon again to exit Edit mode.  
Deleting a food item 
1. Tap a meal, (e.g. “Breakfast”) on the Diary screen to open the meal.
2. Tap the   Tick icon in the bottom right corner.  
3. Select all the ingredients you want to delete.
4. Tap “Delete” at the bottom left of the screen.
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What to do if you can’t find your meal in Research Food Diary 
There may be times when you are unable to find your exact meal in Research Food Diary.   
For example, when you are eating at a friends place or having a takeaway meal.  
To record meals that are not in ‘Research Food Diary’ 
1. Add the meal as a new recipe.  (See instructions above for ‘Creating a recipe’).
2. In “Recipe Name” specify if your meal was homemade or a takeaway (e.g. “Homemade
Vegetarian Laksa” or “Takeaway Vegetarian Laksa”).
3. Looking at your meal, estimate the quantity of each ingredient and log this (e.g. noodles 1 cup,
bean sprouts ½ cup, vegetable broth 1 ½ cups).
4. Don’t forget to include all the extras such as sauces, herb garnishes, fried onion or whatever
you can see in the dish.
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How to Submit Your 3 Day Food Diary
1. Once you have completed your 3-day food diary, please review each day in your diary first,
to ensure you have not missed logging any meals, snacks or drinks.
2. To email your diary to the Dietitian tap on the “More” icon at the bottom right corner of the
screen. Then select “Settings” and tap on “Email Diary to Your Dietitian”.  Do not click on
‘Connect with Health’ as this won’t send your diary to us.
3. When prompted please select the “Last month”. Please address your diary to
maintainyourbrain@sydney.edu.au and type your full name on the subject line as below.
Once done, tap on “Send” on the top right corner.
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Dietitian assisted food record checklist
Purpose: to ask about forgotten foods/drinks in 3-day food record; what and how much 
consumed; brands (where relevant as FoodWorks maps to generic foods except for 
sodium which may be brand specific) and cooking methods; query and record 
serves/omissions by probing with open ended questions.
Prior to starting interview, for context, ask participants whether a) any measuring devices 
used e.g. kitchen scales, b) recorded throughout or end of day, c) typical or atypical days
reported, d) electronic or paper record used.
Occasion Context specific prompts
Breakfast x Water - lemon
x Cold drink – juice (100%/fruit juice drink), smoothie 
(dairy/alternative)
x Hot drink – sweetener, milk/type, coffee style, caffeinated, 
flavouring
x Cereal – RTE/cooked, sugar/honey, nut/seed sprinkles,
dairy/alternative, fruit (if canned syrup type/water)
x Bread/toast – yellow fat spread, other spreads
x Protein (eggs/meat/baked beans) – fat/oil, salt, spices/herbs
x Yoghurt – plain/flavoured/diet/fat content/non-dairy
x Weekend - bacon/sausages, vegetables, pastries
Lunch x Sandwich/wrap – spread, sauce/mayo, filling
x Soup – bread/roll, spread
x Salad – protein (drainage for canned fish), carbs, nuts/croutons, 
oil/acid/mayo, salt, herbs
x Leftovers – as for dinner
x Yoghurt (plain/flavoured/diet/fat content/non-dairy), fruit, cake
(icing/dried fruit), biscuits (savoury/sweet)
x Cold drink – canned/bottled
x Hot drink – sweetener, milk/type, coffee style, caffeinated, 
flavouring
Dinner x Soup – bread/roll, spread
x Protein – meat cut/fat trimming, oil/fat, 
crumbed/battered/cooking method, sauce, salt
x Carbs (rice/pasta/grains) – oil/fat, cooking method, sauce, salt
x Vegetables/salad – dressing/mayo, butter/oil, salt, acid,
nut/seed sprinkles
x Bread/rolls – spread
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RTE, ready to eat.
x Mixed dishes – check ingredients, cooking method, fats/oils, 
paste, salt, serves
x Dessert – ice cream/custard (flavour), fruit (if canned, syrup 
type/water)
x Cheese (cream/fat content) and biscuits/crackers
x Cold drink - soft drink/cordial/energy drinks/juice/milk
x Hot drink – sweetener, milk/type, coffee style, caffeinated, 
flavouring
x Alcohol - 150 ml wine, 375 ml beer stubbie/can, nip spirits
Snacks
(prompt 
after dinner 
e.g. TV
viewing)
x Crisps/hot chips
x Biscuits/muffins/pastries
x Cheese and biscuits/crackers
x Lollies/chocolates
x Nuts (salt)/dried fruits/fresh fruit/canned fruit (syrup 
type/water)
Throughout 
the day
x Water – tap/mineral/flavoured
x Soft drinks/cordials/energy drinks/juice/milk
x Hot drink – sweetener, milk/type, coffee style, caffeinated, 
flavouring
Other 
information
x Brands/names of takeaway outlets/restaurants
x Herbs/spices for breakfast/lunch/dinner
x Quantity if portions appear too small/large
x Check composite dishes for added fats/oils, sugar, salt, cream
etc.
x If composite dishes are vague and guessed, re-enter using 
representative recipes with total serves
526
APPENDIX ELEVEN
Front sheet for validation and reliability testing
of MediCul
527
Name:
Gender: M OR F
DOB:
Age:
Height: (Ax B)
Weight: (Ax B)
Actigraph: Y   OR   N
Address:
Phone (H):
Mobile:
Email:
Study ID:
Date:
FRONT SHEET: VALIDATION & RELIABILITY OF MEDICUL
1. Are you the person responsible for most of the food shopping in your household?
N OR Y OR shared
If no or shared, who else does the grocery shopping for you? ________________
2. Are you the person responsible for most of the cooking in your household?
N OR  Y OR shared
If no or shared, who else does the cooking for you? ________________________
3. Are you currently following any type of special diet? N  OR  Y
If yes, please tick.
Diabetes Cholesterol lowering Gluten free/Wheat free 
Allergy/Food Intolerance Weight loss             Vegetarian/Vegan         
Low salt   Other ___________________________
4. Do you have any specific nutritional concerns or goals? N OR   Y
If yes, what are they? ________________________________________________
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3-day paper food record template
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Name:_____________________
     Study ID:___________________
  Date:______________________
   Administrator:______________ 
3-day Food Record
Instructions
x Please fill in this food intake record on 3 days, including 2 weekdays and 1 
weekend day.
x The days in which food intake is recorded do not need to be consecutive, but need 
to be within the same 1 week period. 
x You should fill in the details immediately after you eat or drink, for each meal 
or snack.  Do not wait till the end of the day to remember everything.
x Detailed directions for how to fill in the food record are at the top of each day. An 
example of one day is on the following page. 
When you have completed the food record please return it to the research dietitian
Sue Radd.  Or call Michael Inskip on his office number 9351 9138 or mobile 0423 471 
510 for alternate instructions on how to return this form.
If you have any questions about how you should complete the food record, please 
contact one of the study dietitian’s: Prof Vicki Flood on 0412 118 977 or email Sue
Radd on srad3618@usyd.edu.au
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Instructions for completing the food record
x Write down everything that you eat and drink over one day from waking to 
going to sleep. It is important that you do this straight away after you eat or 
drink, rather than waiting till the end of the day. This also includes any
snacks, water and vitamin and mineral supplements you have.
x Use a new line for each food, drink or supplement.
x Record the type of eating occasion in the appropriate column. For example, 
breakfast, lunch, dinner, morning tea, afternoon tea or snack.
x Record each food individually.  For example, while you may state ‘tuna sandwich’
in the first row for lunch, you should then list each of the individual foods contained
in the sandwich in the rows below, together with their amounts.
x Include the amounts in household measures or natural portion sizes. For example,
2 slices of bread, ½ cup rice, ¼ cup peas. Please use the set of standard spoon,
cup and jug measures we have provided to assist in recording this information.
o If you wish to use abbreviations for spoon measures please use the following:
 1 teaspoon = 1 tsp
 1 tablespoon = 1 TBSP
x Record the cooking method used, where applicable. For example, grilled, 
BBQ, dry fried, deep fried, baked, boiled, steamed, stir fried etc. 
x Give a detailed description of the food or drink and include brand names where 
possible. For example, Arnott's Milk Arrowroot® biscuit, Yalla Humus or Cobram 
Estate Extra Virgin Olive Oil robust flavour.
x Don't forget to include any sauces, mayonnaise, dressings or gravies that are 
used. We are interested to find out about your usual eating patterns, so please 
keep your food intake as usual.
x If you record a day that is not typical, please indicate in the box at the end of each 
food record day and tell us how it differs from your usual intake.  For example, I 
attended a wedding.
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Example of one day
Was your intake unusual in any way? No  Yes ¥
If yes, in what way? __Had dinner at the Club, which I do once per month__
Date: 22/03/2015 Day: Friday              
Location Time Meal/Eating 
Occasion
Foods/Drinks/Water/Supplements Cooking 
Method (where
applicable)
Amount/Size
EATEN
Home 7am Breakfast Skim milk (Dairy Farmers) - 1 cup
Weet-bix - 2 Weet-bix
White sugar - 1 tsp
Toast – white bread (Tip Top) - 2 slices
Margarine (Gold’n Canola) - 2 tsp
Strawberry jam (Coles) - 2 tsp
Home 9am Supplement Berocca Performance - 1 tablet
Neighbours  
place 10am Morning tea Coffee, instant - 1 cup
HeartActive milk (Dairy Farmer’s) - 1 TBSP
Doughnut, home made Deep fried 1
Home
12md Lunch
Cheese and salad sandwich:
White bread (Tip Top)
Margarine (Meadow-lea)
Tasty cheese (Coon)
Lettuce, shredded
Tomato, sliced
Carrot, grated
Beetroot, sliced
-
2 slices
2 tsp
1 slice
1 leaf
2 slices
1 TBSP
1 large slice
Home 1pm Water 1 cup
Home 3pm Snack Tim Tams chocolate biscuits (Arnott’s) - 2
Orange cordial (Home Brand) - 1 cup
At the Club 6:30pm Dinner 2 thin beef sausages Grilled 2 thin, length 10 cm
Potato, peeled Steamed 1 medium
Carrots, peeled Steamed ¼ cup
Green peas, frozen Boiled ¼ cup   
Red wine, shiraz (Penfolds) - 300 ml
Vanilla ice cream (Dairy Farmer’s) - 2 small scoops
Chocolate sauce (Cottees) - 2 tablespoons
Home 8pm Snack Banana - 1 medium
Home 9pm Supper HeartActive milk (Dairy Farmer’s) - 1 cup
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DAY 1    FOOD INTAKE RECORD  (WEEKDAY)
9 Write down everything that you eat and drink over one day from waking to going to sleep. It is 
important that you do this straight away after you eat or drink, rather than waiting till the end of 
the day. This also includes any snacks, water and vitamin and mineral supplements you have.
9 Use a new line for each food, drink or supplement.
9 Record the type of eating occasion in the appropriate column. For example, breakfast, lunch, dinner, 
morning tea, afternoon tea or snack.
9 Record each food individually.  For example, while you may state ‘tuna sandwich’ in the first row for 
lunch, you should then list each of the individual foods contained in the sandwich in the rows below,
together with their amounts.
9 Include the amounts in household measures or natural portion sizes. For example: 2 slices of bread, ½ 
cup rice, ¼ cup peas. Please use the set of standard spoon, cup and jug measures we have provided.
9 Record the cooking method used, where applicable. For example, grilled, BBQ, dry fried, deep fried, 
baked, boiled, steamed, stir fried etc. 
9 Give a detailed description of the food or drink and include brand names where possible. For example,
Arnott's Milk Arrowroot® biscuit, biscuit, Yalla Humus or Cobram Estate Extra Virgin Olive Oil robust 
flavour. 
9 Don't forget to include any sauces, mayonnaise, dressings or gravies that are used. We are interested to 
find out about your usual eating patterns, so please keep your food intake as usual. 
9 If you record a day that is not typical, please indicate in the box at the end of each food record day and
tell us how it differs from your usual intake. For example, I attended a wedding.
Date: Day:   
Location Time Meal/Eating 
occasion
Foods/Drinks/Water/Supplements Cooking method 
(where 
applicable)
Amount/Size 
EATEN
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Was your intake unusual in any way? No  Yes 
If yes, in what way? ___________________________________________________
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DAY 2    FOOD INTAKE RECORD  (WEEKDAY)
9 Write down everything that you eat and drink over one day from waking to going to sleep. It is 
important that you do this straight away after you eat or drink, rather than waiting till the end of 
the day. This also includes any snacks, water and vitamin and mineral supplements you have.
9 Use a new line for each food, drink or supplement. 
9 Record the type of eating occasion in the appropriate column.  For example, breakfast, lunch, dinner, 
morning tea, afternoon tea or snack.
9 Record each food individually.  For example, while you may state ‘tuna sandwich’ in the first row for 
lunch, you should then list each of the individual foods contained in the sandwich in the rows below,
together with their amounts.
9 Include the amounts in household measures or natural portion sizes.  For example: 2 slices of bread, ½ 
cup rice, ¼ cup peas.  Please use the set of standard spoon, cup and jug measures we have provided.
9 Record the cooking method used, where applicable. For example, grilled, BBQ, dry fried, deep fried, 
baked, boiled, steamed, stir fried etc. 
9 Give a detailed description of the food or drink and include brand names where possible.  For example,
Arnott's Milk Arrowroot® biscuit, biscuit, Yalla Humus or Cobram Estate Extra Virgin Olive Oil robust 
flavour. 
9 Don't forget to include any sauces, mayonnaise, dressings or gravies that are used.  We are interested to 
find out about your usual eating patterns, so please keep your food intake as usual. 
9 If you record a day that is not typical, please indicate in the box at the end of each food record day and 
tell us how it differs from your usual intake.  For example, I attended a wedding.
Date: Day:    
Location Time Meal/Eating 
occasion
Foods/Drinks/Water/Supplements Cooking method 
(where 
applicable)
Amount/Size 
EATEN
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Was your intake unusual in any way? No  Yes 
If yes, in what way? ___________________________________________________
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DAY 3    FOOD INTAKE RECORD  (WEEKEND)
9 Write down everything that you eat and drink over one day from waking to going to sleep. It is 
important that you do this straight away after you eat or drink, rather than waiting till the end of 
the day. This also includes any snacks, water and vitamin and mineral supplements you have.
9 Use a new line for each food, drink or supplement. 
9 Record the type of eating occasion in the appropriate column.  For example, breakfast, lunch, dinner, 
morning tea, afternoon tea or snack.
9 Record each food individually.  For example, while you may state ‘tuna sandwich’ in the first row for 
lunch, you should then list each of the individual foods contained in the sandwich in the rows below,
together with their amounts.
9 Include the amounts in household measures or natural portion sizes.  For example: 2 slices of bread, ½ 
cup rice, ¼ cup peas. Please use the set of standard spoon, cup and jug measures we have provided.
9 Record the cooking method used, where applicable. For example, grilled, BBQ, dry fried, deep fried, 
baked, boiled, steamed, stir fried etc. 
9 Give a detailed description of the food or drink and include brand names where possible.  For example,
Arnott's Milk Arrowroot® biscuit, biscuit, Yalla Humus or Cobram Estate Extra Virgin Olive Oil robust 
flavour. 
9 Don't forget to include any sauces, mayonnaise, dressings or gravies that are used.  We are interested to 
find out about your usual eating patterns, so please keep your food intake as usual. 
9 If you record a day that is not typical, please indicate in the box at the end of each food record day and 
tell us how it differs from your usual intake.  For example, I attended a wedding.
Date: Day:    
Location Time Meal/Eating 
occasion
Foods/Drinks/Water/Supplements Cooking method 
(where 
applicable)
Amount/Size 
EATEN
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Was your intake unusual in any way? No  Yes 
If yes, in what way? ___________________________________________________
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FAQ on completing the 3-day food record
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Frequently Asked Questions on Completing the 3-day Food Record 
Do the days need to be consecutive? 
No, they can be any days of your choice, so long as they occur in the same 1 week period. 
Should I pick my ‘best’ days to record? 
No.  It’s important that you pick 3 typical days where you record your usual intake, not what you 
think might impress the researchers or is easiest to record.  Otherwise, your response will not reflect 
usual intake.   
Do I really need to measure everything I eat and drink?  
Yes.  It is important once you serve or pour out the food/drink you intend you eat, that you first 
measure the amounts before eating, using the equipment provided.  You should then record these 
measurements on your food record.  If you go for second helpings, don’t forget to also measure 
these.  
Measure everything by using the cups, spoons and jug provided.  If items are difficult to measure this 
way, you can use the kitchen scales provided to weigh foods.  These are optional. 
Record everything immediately after eating your meals/snacks to ensure it is accurate.  Don’t wait 
till the evening to try and remember all the foods and amounts you had during the day. 
What is the easiest way to measure various foods and drinks? 
We recommend that you first plate up what you are intending to eat (or pour out your drink), just 
like you would normally do.  You can then measure each item in turn and transfer to another 
plate/cup from which you will consume it.  Please note, it is important that you portion out foods 
and amounts as you would normally eat them.  You should not change these while keeping the 3-day 
food record. 
If you are using the scales, it is important to zero the reading once you place your plate on top and 
before you add any food for weighing. 
How do I measure dishes that contain a mixture of foods? 
This can be tricky.  Do your best to ‘pull apart’ the cooked ingredients, where possible, and measure 
each in turn.  For example, if you were going to eat a beef and vegetable curry, you would first 
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portion out your usual amount onto a plate.  You could then pick out the meat pieces and weigh 
these before transferring onto another plate.  This would be followed by measuring each vegetable 
contained in the curry, in turn, and also transferring this to the other plate ready for eating.  
Alternatively, you could provide the recipe for the dish to the dietitian and advise how much of the 
recipe e.g. serves, you personally consumed at a given meal. 
If it is too difficult to measure the individual ingredients within a mixed dish/recipe, don’t worry.  
Just measure/weigh the total mixed dish you intend to eat and provide a description of what it 
contained. 
 
What if I feel like I might be recording too much detail? 
We love details.  It’s best to record everything you know about the food, drink or supplement you 
may be taking at the time you consume it.  Otherwise, we might need to come back and ask you for 
the details later. 
 
What if I am out and about on one of the days? 
We suggest you take the cups and spoons with you and measure things as best you can.  You might 
need to ask for a separate plate to transfer foods once you measure them, before eating. 
 
How do I record my nutritional supplements? 
It’s important that you accurately record the type and dose of any supplements you are taking.  We 
suggest you bring the bottles with you when you hand in your food record so the dietitian can check.  
Alternatively, you can take a photo on your phone of the front and back of each supplement bottle, 
where the details of the formulation are printed. 
 
What if I run out of space to record my food items? 
Just attach an additional paper to the back and clearly mark which day it relates to. 
 
Do I need to return the measuring equipment to The University of Sydney? 
The measuring spoons, cups and jug are yours to keep after you have finished keeping the 3-day 
food record.  The kitchen scales, however, need to be returned for future use by other people. 
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Dear friends,
We’d like to welcome you most warmly to the 2018 Challis Bequest Society lunch, a 
wonderful opportunity to celebrate your generosity and thank you for making the 
University of Sydney a part of your lives. Bequests, both large and small, play a vital 
role in shaping the future careers of our academics and students.
Great things are achieved when passion is matched by opportunity. Take, for 
instance, the story of Dr Angela Crean. When she’d finished her PhD in animal 
reproduction, Angela struggled to find a long-term position as a scientist, and she 
was about to walk away from the career she loved. Opportunity came in the form of 
a scholarship for early-career researchers that came about from a bequest from the 
late Mabs Melville.
For Angela, winning that scholarship marked the beginning of a spectacular rise that 
has seen her work acclaimed internationally – in 2016, she won the $25,000 
L’Oreal-UNESCO for Women in Science Fellowship, and in 2017, she took out the 
Young Tall Poppy Science Award in NSW. Her research into reproduction, both 
animal and human, has the potential to change lives. Without Mabs Melville’s 
generous bequest, Angela’s passion for scientific research would have gone 
unfulfilled.
Like Dr Crean, everyone in this room shares a passion for changing lives. But you have 
all taken the next step by choosing to create opportunity for others. And in so doing, 
you are leaving a lasting legacy. We thank you most sincerely. 
Belinda Hutchinson AM Dr Michael Spence AC
Chancellor Vice-Chancellor and Principal
Welcome
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Order of proceedings
11.45am Carillon recital
Amy Johansen, University Organist and Carillonist
12pm Drinks and canapés
Heathcliffe Auchinachie, Sydney Conservatorium of Music 
12.35pm Welcome, Master of Ceremonies       
Alexandra Miller (BAS ’10, MPACS ’11)
Associate Director, Planned Giving, Division of Alumni and Development
Acknowledgement of Country 
Liam Coe, Bachelor of Architecture and Environments, third year
Entertainment Showcase
Kirralee Elliott, Sydney Conservatorium of Music
Jack Dawson, Sydney Conservatorium of Music
12.50pm Main course
1.30pm Keynote speaker
Dr Craig Barker (BA(Hons) ’96 PhD’ 05)
Manager, Education and Public Programs, Sydney University Museums 
1.45pm Vice-Chancellor and Principal’s address
Dr Michael Spence AC (BA ’85 LLB ’87)
2.15pm Dessert, tea and coffee
3pm Event concludes
A hearing loop is available for today’s event. Hearing aid users will 
need to use their T-switch (telecoil). 
Please let us know if you are experiencing difficulties.
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Today’s menu is inspired 
by the Mediterranean diet
Canapés 
Lamb dolmades, beetroot goats curd (gf)
Mushroom baklava, almond cream (vegan, df)
Olive crostini, heirloom tomatoes, Persian feta, oregano (v, gf)
Grilled haloumi, honey and mint (v, gf)
Pita bread, taramasalata, salmon roe 
Goat and oregano mini pies 
Main course (alternate serve)
Sous vide lamb rump, ancient grains, preserved lemon dressing, eggplant chutney, 
moussaka, cherry vine tomatoes (gf) 
or
Roast La Ionica chicken crown, beetroot leaf and fetta pie, green beans, walnuts 
Side dishes
Greek salad (v, gf)
Roast potatoes, olive and lemon (vegan, gf, df)
Sonoma sourdough breads, Cobram Estate Olive Oil
Dessert (two mini desserts per person)
Mini baklava, walnut crumb 
Rice pudding, rose water & lemon (gf)
Loukoumades, Greek doughnuts, honey syrup 
Coffee and tea
Crave coffee and variety of T2 teas
Chocolate truffles
Beverages
Marchand and Burch Cremant de Bourgogne, Burgundy, France
Teusner Woodside Adelaide Hills Sauvignon Blanc, Barossa Valley, SA
Teusner Joshua Grenache Mataro Shiraz, Barossa Valley, SA
v - vegetarian, gf - gluten-free, df - dairy free 
If you have notified us of dietary requirements, we will cater for these separately, please 
advise your wait staff.
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Research shows that a Mediterranean diet can protect against 
metabolic syndrome, helps prevent and control diabetes, may 
reverse fatty liver disease, and possibly slash the risk of 
Alzheimer's disease. The more closely you adhere to this diet, the 
stronger your protection from these health issues will be. 
So, what constitutes a Mediterranean diet? Health Sciences PhD researcher 
Sue Radd (AdvAPD AdvAN) lists 10 ways you can incorporate this 
prevention-style diet into your daily routine:
1. Olive oil daily
Ditch the margarine and vegetable oils. Enjoy extra virgin olive oil on your
salads and in cooking. It enhances the absorption of antioxidants into the
body and has anti-inflammatory effects to protect your health.
2. Legumes at least twice weekly
You should get a good serving of beans, such as chickpeas or lentils, to
reduce saturated fat and increase your fibre intake. Legumes protect
against multiple chronic diseases and are a great alternative to meat.
3. Meat in very small amounts
Research shows that people who eat red meat are at an increased risk of
early death from heart disease, stroke or diabetes. Limit your meat intake
to small amounts monthly, and where possible, replace meat with legumes.
4. Vegetables every day
Include a half cup of tomatoes and a half cup of leafy greens, plus at least
two cups of other coloured vegetables. Vegetables provide a myriad of
antioxidants and anti-inflammatory phytonutrients for good health.
5. Go wholegrain
Intact, cracked or coarsely milled flours and their products - think dark,
dense, grainy bread - were staple foods in Greece. Dietary fibre from
wholegrains and other plant foods, may help reduce blood cholesterol
levels and may lower risk of heart disease, obesity, and type 2 diabetes.
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6. Seasoning is key
Incorporate onion, garlic, herbs and spices - not only will they make your
food taste great, they amplify the antioxidants delivered to your plate.
7. No day without fresh fruit
Fruit is the perfect snack. Unlike cakes and biscuits, it’s a whole food packed
with fibre and phytonutrients, not just a source of sugar. Eaten at the end of
a meal, as was done traditionally, fruit may help dampen the inflammation
that can occur in the lining of your blood vessels following a meal.
8. Snack on nuts and seeds
Nuts and seeds contain healthful mono and polyunsaturated fats, as well as
minerals and multiple phytonutrients. They help lower high cholesterol levels
and a Mediterranean diet including daily nuts has been shown to protect
against having a first heart attack and stroke!
9. Dairy in moderation
Dairy was enjoyed in moderation in the traditional Mediterranean diet -
about two serves per day - and mainly eaten by adults as a fermented
food, such as yoghurt and soft white cheese, e.g. ricotta, fetta. Milk was
reserved for children and the elderly.
10. Drink water
Humans are made up of 70 percent water, and our blood is 90 percent
water. Water should be your main source of hydration. Aim for at least five
cups per day (1.25 litres) of pure water in addition to other drinks. To
function properly, all the cells and organs of the body need water. It is also
used to lubricate the joints, protect the spinal cord and other sensitive
tissues, regulate body temperature, and assist the passage of food through
the intestines.
You will find a Mediterranean recipe card within your program 
compliments of Sue Radd.
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